<SEC-DOCUMENT>0000355019-21-000044.txt : 20211115
<SEC-HEADER>0000355019-21-000044.hdr.sgml : 20211115
<ACCEPTANCE-DATETIME>20211115171410
ACCESSION NUMBER:		0000355019-21-000044
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		66
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211115
DATE AS OF CHANGE:		20211115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10248
		FILM NUMBER:		211412395

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>fonar_10-q.htm
<DESCRIPTION>FONAR REPORT 10-Q FOR QUARTER ENDED SEPTEMBER 30, 2021
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:FONR="http://fonar.com/20210930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_FONR_fonar.com_20210930 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20210701_20210930 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000355019 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DCurrentFiscalYearEndDate_06/30 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DDocumentFiscalYearFocus_2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DDocumentFiscalPeriodFocus_Q1 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 11pt Arial, Helvetica, Sans-Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityCentralIndexKey">0000355019</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate">06/30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:DocumentFiscalPeriodFocus">Q1</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl0027" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl0028" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric>
  <ix:nonFraction name="FONR:UnearnedRevenueOnServiceContractsRelatedParties" contextRef="AsOf2021-06-30" id="xdx2ixbrl0114" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-09-30_custom_ClassANonVotingPreferredStockMember" id="xdx2ixbrl0169" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember" id="xdx2ixbrl0171" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0181" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0183" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-09-30_us-gaap_CommonClassBMember" id="xdx2ixbrl0205" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember" id="xdx2ixbrl0207" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-09-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0217" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0219" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember15724062" id="xdx2ixbrl0366" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0367" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0369" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0370" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember15724062" id="xdx2ixbrl0373" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0374" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0375" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0376" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember15724062" id="xdx2ixbrl0380" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0381" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0382" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0383" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember15724078" id="xdx2ixbrl0401" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0402" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0404" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0405" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember15724078" id="xdx2ixbrl0408" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0409" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0410" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0411" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember15724078" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0416" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0417" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0418" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl0450" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:GainOnForgivenessOfPppLoan" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl0454" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxCreditsAndAdjustments" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl0468" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl0475" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl0519" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0625" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0629" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2021-09-30_us-gaap_DoubtfulMember" id="xdx2ixbrl0673" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2021-09-30_us-gaap_DoubtfulMember" id="xdx2ixbrl0679" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2021-06-30_us-gaap_DoubtfulMember" id="xdx2ixbrl0703" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2021-06-30_us-gaap_DoubtfulMember" id="xdx2ixbrl0709" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-09-30" id="xdx2ixbrl0931" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl0982" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2020-07-012020-09-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1012" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fonr-20210930.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-07-01to2021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-03_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-03_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-03_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-03_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember15724062">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CommonStockMember15724062">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_CommonStockMember15724078">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_CommonStockMember15724078">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_DoubtfulMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_DoubtfulMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-29_custom_RocklandManagementGroupMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012021-03-29_custom_RocklandManagementGroupMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 11pt; margin-bottom: 3pt"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt; width: 100%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 18pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">FORM
<span id="xdx_906_edei--DocumentType_c20210701__20210930_zOsrNRF7dCwd"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:DocumentType">10-Q</ix:nonNumeric></span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 14pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 12pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Washington,
D.C. 20549</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 12pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span id="xdx_905_edei--DocumentQuarterlyReport_c20210701__20210930_z1UyC74OuQD6" style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric></span><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;QUARTERLY
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT</span> <span style="font-size: 10pt; font-style: normal; font-weight: normal">OF
1934</span></p>

<p style="font: 12pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span id="xdx_90B_edei--DocumentTransitionReport_c20210701__20210930_zVII6Hkz3rH7" style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 31.5pt; text-align: center; text-indent: -0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;For
the quarterly period ended <span id="xdx_90A_edei--DocumentPeriodEndDate_c20210701__20210930_zcwksWS7cUv5"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">SEPTEMBER 30, 2021</ix:nonNumeric></span></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 31.5pt; text-align: center; text-indent: -0.5in"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Commission
file number <span id="xdx_90B_edei--EntityFileNumber_c20210701__20210930_z3K36O4sPWD6"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityFileNumber">0-10248</ix:nonNumeric></span></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><img src="fonar-logo.jpg" alt="" style="height: 30px; width: 200px" />&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 24pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span id="xdx_903_edei--EntityRegistrantName_c20210701__20210930_zu1FVZ9AI8A5" style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityRegistrantName">FONAR CORPORATION</ix:nonNumeric></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20210701__20210930_ztZ0LSrl8EHj" style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></td>
<td style="line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><span id="xdx_901_edei--EntityTaxIdentificationNumber_c20210701__20210930_zV6CQwuEEyQ4" style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityTaxIdentificationNumber">11-2464137</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(State
or other jurisdiction of <br /> incorporation or organization)</span></td>
<td style="line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(I.R.S.
Employer <br /> Identification No.)</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: black 1pt solid; width: 45%; padding-left: 5.4pt; text-align: center; line-height: 115%"><span id="xdx_90D_edei--EntityAddressAddressLine1_c20210701__20210930_zkWWn87Z4sQl" style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityAddressAddressLine1">110 Marcus Drive</ix:nonNumeric></span> <span id="xdx_902_edei--EntityAddressCityOrTown_c20210701__20210930" style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityAddressCityOrTown">Melville</ix:nonNumeric></span><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">,
<span id="xdx_90B_edei--EntityAddressStateOrProvince_c20210701__20210930"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></td>
<td style="width: 10%; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: black 1pt solid; width: 45%; padding-left: 5.4pt; text-align: center; line-height: 115%"><span id="xdx_900_edei--EntityAddressPostalZipCode_c20210701__20210930" style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityAddressPostalZipCode">11747</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Address
of principal executive offices)</span></td>
<td style="line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Zip
Code)</span></td></tr>
</table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Registrant&#8217;s
telephone number, including area code: <span id="xdx_905_edei--CityAreaCode_c20210701__20210930_zy4qQB2Gkp94"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:CityAreaCode">(631)</ix:nonNumeric></span></span> <span id="xdx_903_edei--LocalPhoneNumber_c20210701__20210930_zY3J442FFx4c" style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:LocalPhoneNumber">694-2929</ix:nonNumeric></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Indicate
by check mark whether the registrant (1) has f<span style="font-family: Arial, Helvetica, Sans-Serif">iled all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <span id="xdx_90C_edei--EntityCurrentReportingStatus_c20210701__20210930_zzlvBcX1cONa"><span style="-sec-ix-hidden: xdx2ixbrl0027">YES
</span></span></span></span><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#9746;&#160;NO
&#9744;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for shorter period that the registrant was required
to submit such files <span id="xdx_90F_edei--EntityInteractiveDataCurrent_c20210701__20210930_zubNV9lGfqY2"><span style="-sec-ix-hidden: xdx2ixbrl0028">YES</span></span></span><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#9746;
NO &#9744;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See definition of accelerated filer, large accelerated filer, smaller reporting company and emerging growth
company in Rule 12b-2 of the Exchange Act. (Check one):Large accelerated filer &#9744; Accelerated filer &#9744; <span id="xdx_906_edei--EntityFilerCategory_c20210701__20210930"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span></span> <span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#9746;
Smaller reporting company <span id="xdx_90E_edei--EntitySmallBusiness_c20210701__20210930"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span> <span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Emerging
growth company <span id="xdx_908_edei--EntityEmergingGrowthCompany_c20210701__20210930"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES &#9744;&#160;<span id="xdx_909_edei--EntityShellCompany_c20210701__20210930_zVRHoU9HyK3e"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt:booleanfalse" name="dei:EntityShellCompany">NO</ix:nonNumeric>
</span></span><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#9746;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the close of the latest practicable date.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Outstanding
    at November 3, 2021</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; width: 70%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Common
    Stock, par value $.0001</span></td><td style="width: 10%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 18%; text-align: right"><span id="xdx_904_edei--EntityCommonStockSharesOutstanding_iI_c20211103__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5aBHK7l8x37" style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-11-03_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,210</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class B
    Common Stock, par value $.0001</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span id="xdx_900_edei--EntityCommonStockSharesOutstanding_iI_pn3n3_c20211103__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zM7tVcJ36UUi" style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-11-03_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">146</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class C
    Common Stock, par value $.0001</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span id="xdx_90C_edei--EntityCommonStockSharesOutstanding_iI_pn3n3_c20211103__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zltcjf7fQYdc" style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-11-03_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class A
    Preferred Stock, par value $.0001</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span id="xdx_90F_edei--EntityCommonStockSharesOutstanding_iI_pn3n3_c20211103__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zS9CV70gckRa" style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-11-03_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">313,438</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">INDEX</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">PART
I - FINANCIAL INFORMATION</span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td colspan="2" style="border-bottom: black 1pt solid; padding: 0; text-align: center; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">PAGE</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; width: 91%; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; width: 2%; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; width: 6%; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Item
1. Financial Statements</span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><a href="#BalanceSheet"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Condensed Consolidated Balance Sheets - September 30, 2021 (Unaudited) and June 30, 2021</span></a></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><a href="#IncomeStatement"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Condensed Consolidated Statements of Income for the Three Months Ended September 30, 2021 and September 30, 2020 (Unaudited)</span></a></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><a href="#TheCompany"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Condensed Consolidated Statements of Changes in Equity for the Three Months Ended September 30, 2021 and September 30, 2020 (Unaudited)</span></a></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">7</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><a href="#CashFlow"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2021 and September 30, 2020 (Unaudited)</span></a></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">8</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><a href="#NotesToFinancialStatements"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></a></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">9</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#MDA">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">23</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#QualitativeDisclosures">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">33</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#ControlsAndProcedures">Item 4. Controls and Procedures</a></span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">34</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">PART
II - OTHER INFORMATION</span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">34</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#LegalProceedings">Item 1. Legal Proceedings</a></span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">34</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#RiskFactors">Item 1A. Risk Factors</a></span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">34</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#UseOfProceeds">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">37</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#DescriptionOfSecurities">Item 3. Defaults Upon Senior Securities</a></span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">37</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#CautionaryNote">Item 4. Mine Safety Disclosures</a></span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">37</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#MoreInformation">Item 5. Other Information</a></span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">37</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#Exhibits">Item 6. Exhibits</a></span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">37</span></td>
</tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#Signatures">Signatures</a></span></td>
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">37</span></td>
</tr>
</table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="BalanceSheet"></span>ASSETS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_111_pn3n3_zwLBqtdJMcT2" summary="xdx: Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_492_20210930" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_497_20210630" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, <br /> 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, <br /> 2021 *</span></td></tr>
<tr id="xdx_403_eus-gaap--AssetsCurrentAbstract_iB_z6ejErVG9ofj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Current Assets:</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_maCzDVT_zcNs4bT5LzNk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;Cash
    and cash equivalents</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,405</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,460</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--ShortTermInvestments_i01I_maCzDVT_zkzXUVTBk6hj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Short
    term investments</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--AccountsReceivableServiceAndRepairFees_i01I_maCzDVT_z4ifSEXM6WFj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Accounts
    receivable &#8211; net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,548</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,526</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--AccountReceivableRelatedParties_i01I_maCzDVT_zhh9DRWMkX6h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Accounts
    receivable - related party</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--MedicalReceivable_i01I_maCzDVT_z8owETlPijU6" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Medical
    receivable &#8211; net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,356</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,901</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--ManagementAndOtherFees_i01I_maCzDVT_z5imGuC8zh7j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Management
    and other fees receivable - net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,695</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,948</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_i01I_maCzDVT_zAwgtTY4CkY8" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management
    and other fees receivable &#8211; related medical practices &#8211; net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,998</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,814</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_i01I_maCzDVT_zkPUNuGR5JG3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Inventories</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,835</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,663</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_maCzDVT_z1e3kw85Stph" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Prepaid
    expenses and other current assets</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,416</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,227</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--AssetsCurrent_i01TI_mtCzDVT_maCzuiv_zddJb5X8CGgd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;Total
    Current Assets</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109,387</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">108,583</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40D_ecustom--AccountsReceivableNetLongTerm_i01I_maCzuiv_zB5MEqDbj13f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Accounts
    receivable &#8211; long term</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,609</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,880</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_maCzuiv_zZHqj9PmTcbh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Deferred
    income tax asset</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,764</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,959</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCzuiv_z44ctfUzoryd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Property
    and equipment &#8211; net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,971</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,850</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maCzuiv_z5dc0F9hZkZd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Right-of-use
    Asset &#8211; operating lease</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,535</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,133</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--FinanceLeaseRightOfUseAsset_i01I_maCzuiv_z5vFRT7v7r1h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Right-of-use
    Asset &#8211; financing lease</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,077</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,127</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--Goodwill_i01I_maCzuiv_zGo3bmt4LCa3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Goodwill</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,269</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,269</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maCzuiv_z8JnkMJGcYdl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Other
    intangible assets &#8211; net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,957</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,038</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--OtherAssets_i01I_maCzuiv_zKNhxTSpBTck" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Other
    assets</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">660</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">667</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--Assets_i01TI_mtCzuiv_zTpj6hGDcafh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;&#160;Total
    Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">188,229</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">189,506</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">*Condensed
from audited financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">See
accompanying notes to condensed consolidated financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">LIABILITIES
AND STOCKHOLDERS&#8217; EQUITY</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, <br /> 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30,&#160;<br /> 2021 *</span></td></tr>
<tr id="xdx_40A_eus-gaap--LiabilitiesCurrentAbstract_iB_zfsDHwy80dvd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Current Liabilities:</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_i01I_maCz5ge_zq4ROj2AZyc" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Current portion of
    long-term debt and capital leases</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">173</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_i01I_maCz5ge_zmiQgdDtW1Nj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts payable</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,133</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,866</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--OtherLiabilitiesCurrent_i01I_maCz5ge_zttkSW7v3SDd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other current liabilities</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,990</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,162</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--DeferredRevenueCurrent_i01I_maCz5ge_zJZqmrM3XECk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Unearned revenue on service contracts</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,328</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,366</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--UnearnedRevenueOnServiceContractsRelatedParties_i01I_maCz5ge_zCDPRqZDYv18" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Unearned revenue on service contracts
    &#8211; related party</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:UnearnedRevenueOnServiceContractsRelatedParties" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0114">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_maCz5ge_zUSNhwOjzSv9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Contract liabilities</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityCurrent_iI_maCz5ge_zkmwYWFgRxFe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Operating lease liability &#8211;
    current portion</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,669</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,533</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--FinanceLeaseLiabilityCurrent_iI_maCz5ge_zmnKk3Ptoyok" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Financing lease liability &#8211;
    current portion</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">205</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">203</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--CustomerDeposits_iI_maCz5ge_zn14Ft5pckM9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Customer deposits</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">789</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">731</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--LiabilitiesCurrent_iTI_mtCz5ge_maCzE8Z_zlNm21lNYgki" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total Current Liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,247</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,049</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--LiabilitiesNoncurrentAbstract_iB_zH6ViNLr6j2g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Long-Term Liabilities:</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--DeferredRevenueNoncurrent_i01I_maLNzUct_zO0GKQGc8iid" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Unearned revenue on service contracts</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,545</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,801</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_i01I_maLNzUct_zHAZMk1mw6Zc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Deferred income tax liability</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">238</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">238</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--AccountsPayableRelatedPartiesNoncurrent_i01I_maLNzUct_zZKijT6ESk8h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Due to related medical practices</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AccountsPayableRelatedPartiesNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AccountsPayableRelatedPartiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maLNzUct_zfUgx2BeEde3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Operating lease liability &#8211;
    net of current portion</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,292</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,975</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--FinanceLeaseLiabilityNoncurrent_i01I_maLNzUct_zNyr25X8zk2j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Financing lease liability &#8211;
    net of current portion</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">997</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,049</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--LongTermDebtAndCapitalLeaseObligations_i01I_maLNzUct_zDYzp4Kl0Sqe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Long-term debt and capital leases,
    less current portion</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">190</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">760</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--OtherLiabilities_i01I_maLNzUct_z4Iux7K5xUy6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">155</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">171</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesNoncurrent_i01TI_maCzE8Z_mtLNzUct_zxJPBBaxbSH9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total Long-Term Liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,510</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,087</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--Liabilities_i01TI_mtCzE8Z_maCzWxc_maLASEzpsr_zGzD8q8NSdQ" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total Liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48,757</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54,136</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">*Condensed
from audited financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">See
accompanying notes to condensed consolidated financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">LIABILITIES
AND STOCKHOLDERS&#8217; EQUITY (Continued)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021 *</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class A non-voting preferred
    stock $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zcRA4bUZHuQ5"><span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z0YRzbBZPC21"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30_custom_ClassANonVotingPreferredStockMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">par value; <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zMrTFpJSZEp8"><span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z4suJmawcwyb"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-09-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">453</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">shares authorized at September 30, 2021 and
    June 30, 2021, <span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zyOUdCeKM881"><span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zCGKB06tNQWj"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zm67lJ0Htj4"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zRHwTl1EBI29"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-09-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-09-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">313</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">issued and outstanding at September 30, 2021
    and June 30, 2021</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_eus-gaap--PreferredStockValue_iI_pp0p0_c20210930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zyEHV8r3e6o7" title="Preferred Stock Value" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0169">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_eus-gaap--PreferredStockValue_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zEZc0W3q8LNe" title="Preferred Stock Value" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0171">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Preferred stock $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z81u9JAxZnY8"><span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zlfUyA0Pe1Lc"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember" decimals="INF" unitRef="USDPShares">.001</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">par value; <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z0FHCQDlZlEe"><span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z2kVMYsV2HPa"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">567</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">shares authorized at September 30, 2021 and
    June 30, 2021, issued and outstanding &#8211; <span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_dn_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z5KqBsxLBvp3"><span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_dn_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zwWanyQX1QBg"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_dn_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zHYZC8LLuwbl"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_dn_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zARvTULtKzR5"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_986_eus-gaap--PreferredStockValue_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pp0p0" title="Preferred Stock Value" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0181">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--PreferredStockValue_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pp0p0" title="Preferred Stock Value" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0183">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Common Stock $<span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z9LPAYwkFpGk"><span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zeFP9WlaMpD8"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">par value; <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zURheXR0UYZd"><span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ztpFVFoIroHl"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">8,500</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">shares authorized at September 30, 2021 and
    June 30, 2021, <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ztUzdVLGauAa"><span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z0PhlCmK9kRi"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,566</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">issued at September 30, 2021 and June 30, 2021,
    <span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zPlFfSRGEZ85"><span id="xdx_907_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLoc2Nuzu9U1"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">outstanding at September 30, 2021 and June 30,
    2021</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_987_eus-gaap--CommonStockValue_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zoTUYDG15Pnd" title="Common Stock Value" style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_eus-gaap--CommonStockValue_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zmScIiBjNcij" title="Common Stock Value" style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class B Common Stock (10 votes per share) $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z7vEg5JZZ4f2"><span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z3lMCHw5GVi9"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30_us-gaap_CommonClassBMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">par value; <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z2kxawuvJzd8"><span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zqIqbePNOwck"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">227</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">shares authorized at September 30, 2021 and
    June 30, 2021; .<span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjN2NE58tiJj"><span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zqpCzLl9L5ch"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zkiTO61sS40e"><span id="xdx_907_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zR4MxMopK4Ha"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">146</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">issued and outstanding at September 30, 2021
    and June 30, 2021</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_eus-gaap--CommonStockValue_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pp0p0" title="Common Stock Value" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0205">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--CommonStockValue_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pp0p0" title="Common Stock Value" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0207">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class C Common Stock (25 votes per share) $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4vYv1xihEal"><span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zO5Q68JcsyXg"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30_us-gaap_CommonClassCMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">par value; <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxlWOm4hXwc7"><span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zmVCHSoPTU17"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">567</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">shares authorized at September 30, 2021 and
    June 30, 2021, <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0UyYJgeDGeh"><span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUhlB7esiXo1"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6LIkF7HvBmb"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrZMsqdb8ZE2"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span>
    </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">issued and outstanding at September 30, 2021
    and June 30, 2021</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_989_eus-gaap--CommonStockValue_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" title="Common Stock Value" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0217">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_986_eus-gaap--CommonStockValue_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" title="Common Stock Value" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0219">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--AdditionalPaidInCapital_iI_maSEz0Nk_zXpbTQM7Zoug" style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Paid-in capital in excess of par value</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">185,101</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">185,101</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_maSEz0Nk_zaqJStZxNljk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accumulated deficit</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">42,121</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">46,008</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_402_eus-gaap--TreasuryStockValue_iNI_di_msSEz0Nk_zoMJec0Xouda" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Treasury stock, at cost - <span id="xdx_90A_eus-gaap--TreasuryStockShares_iI_pn3n3_c20210930_zjhEGdLoqtR4"><span id="xdx_905_eus-gaap--TreasuryStockShares_iI_pn3n3_c20210630_zayU5E7ubby"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">12</ix:nonFraction></ix:nonFraction></span></span>
    shares of common stock at September 30, 2021 and June 30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">675</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">675</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_402_eus-gaap--StockholdersEquity_iTI_mtSEz0Nk_maSEIPAzEfH_z18N3o8GX285" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total Fonar Corporation&#8217;s
    Stockholders&#8217; Equity</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">142,306</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">138,419</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--MinorityInterest_iI_maCz7Kh_maSEIPAzEfH_zlKxYT7QPZN5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Noncontrolling interests</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,834</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,049</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_40E_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iI_mtSEIPAzEfH_maLASEzpsr_zhhwWvAAAvU9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total Stockholders&#8217; Equity</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">139,472</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">135,370</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtLASEzpsr_zWX1XtOj4e6f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total Liabilities and Stockholders&#8217;
    Equity</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">188,229</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">189,506</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">*Condensed
from audited financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">See
accompanying notes to condensed consolidated financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="IncomeStatement"></span>CONDENSED
CONSOLIDATED STATEMENTS OF INCOME</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_113_pn3n3_zWxpHVsiagS9" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20210701__20210930_zeeRTKtN4Sx8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20200701__20200930_zz2hKYFtOYDc" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">FOR
    THE THREE MONTHS &#160; ENDED SEPTEMBER 30,</span></td></tr>
<tr id="xdx_40C_eus-gaap--RevenuesAbstract_iB_zZw79TC4rrnd" style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">REVENUES</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2020</span></td></tr>
<tr id="xdx_402_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_i01_maRz9pC_zCCStBIwbil" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Patient
    fee revenue &#8211; net of contractual allowances and discounts</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,851</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,091</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--ProductSalesNet_i01_maRz9pC_zMgbieox9hal" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Product
    sales &#8211; net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--ServiceAndRepairFeesNet_i01_maRz9pC_z2XcBIxKYK02" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Service
    and repair fees &#8211; net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,936</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,925</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--ServiceAndRepairFeesRelatedPartiesNet_i01_maRz9pC_zFn6dkxCMfm5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Service
    and repair fees - related parties &#8211; net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_ecustom--ManagementAndOtherFeesNet_i01_maRz9pC_z2zCExOthzxk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management
    and other fees &#8211; net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,972</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,214</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--ManagementAndOtherFeesRelatedMedicalPracticesNet_i01_maRz9pC_z7BrFmCHsqt8" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management
    and other fees - related medical practices &#8211; net</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,795</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,693</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--Revenues_iT_mtRz9pC_maCzHim_zS1VbqbT2g9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 30pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total Revenues
    &#8211; Net</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,730</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,979</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--CostsAndExpensesAbstract_iB_zerlMQyfVcSd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">COSTS AND EXPENSES</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--OtherCostOfOperatingRevenue_i01_maCzCxI_znQCJ3L3dE8a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Costs related
    to patient fee revenue</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,156</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,521</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--CostsRelatedToProductSales_i01_maCzCxI_zvcNv8P17v7a" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Costs related
    to product sales</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">132</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40A_ecustom--CostsRelatedToServiceAndRepairFees_i01_maCzCxI_zejhzkgcBSg3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Costs related
    to service and repair fees</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">724</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">626</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--CostsRelatedToServiceAndRepairFeesRelatedParties_i01_maCzCxI_zRFRkOYrJEr7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Costs related
    to service and repair fees - related parties</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--CostsRelatedToManagementAndOtherFees_i01_maCzCxI_z9j3sx58kHqj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Costs related
    to management and other fees</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,877</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,550</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_403_ecustom--CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_i01_maCzCxI_zRCbpJcSJ7Aa" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Costs related
    to management and other fees &#8211; related medical practices</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,637</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,428</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maCzCxI_z94CvGkAoc7l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Research
    and development</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">386</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCzCxI_zGIA44q3y7ae" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Selling,
    general and administrative</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,090</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,163</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--CostsAndExpenses_i01T_mtCzCxI_msCzHim_zW95aLOxX2Eg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 30pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total Costs
    and Expenses</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,989</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,829</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iT_mtCzHim_maILFCOzkPe_zzK33fFQNyU1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Income From
    Operations</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,741</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,150</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--OtherNonoperatingIncomeExpense_maILFCOzkPe_zRzE01CAJut4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other Income
    (Expenses)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">811</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">140</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_402_eus-gaap--InterestExpense_iN_di_msILFCOzkPe_z7Sq2rCZVPFc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Interest
    Expense</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--InvestmentIncomeNet_maILFCOzkPe_zNcwDqlX7Msg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Investment
    Income</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">112</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_maCzKpD_mtILFCOzkPe_z93Eb2XjmqR5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Income Before
    Provision for Income Taxes and Noncontrolling Interests</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,598</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCzKpD_zpsH6nTJ4qS4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Provision
    for Income Taxes</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,416</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">849</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_40D_eus-gaap--ProfitLoss_iT_mtCzKpD_zRZmABqNOFV3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net Income</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,182</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,251</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_zJAoc2xoaBAl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net Income
    - Noncontrolling Interests</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,295</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">743</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_400_eus-gaap--NetIncomeLoss_z01s6TD5W5nh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net Income
    &#8211; Attributable to FONAR</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,887</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,508</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net Income
    Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsEWmB3bMTS9" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,652</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zNFF9LzQiVyl" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,355</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net Income
    Available to Class A Non-Voting Preferred Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zo87EjIZBLa5" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_PreferredClassAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">175</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zozoejyeaQi5" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_PreferredClassAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">114</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 30pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net Income
    Available to Class C Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zSAs5Hdx9Uk" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zql29p2fQMig" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basic Net
    Income Per Common Share Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_eus-gaap--EarningsPerShareBasic_pid_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zk2oxNwjOu1a" title="Basic Net Income Per Common Share Available to Common Stockholders" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.56</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasic_pid_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zpHb75EGmLMb" title="Basic Net Income Per Common Share Available to Common Stockholders" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.37</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareDiluted_pid_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znGBHZ8h9WRk" title="Diluted Net Income Per Common Share Available to Common Stockholders" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.55</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_pid_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zFZpsC9yvCWa" title="Diluted Net Income Per Common Share Available to Common Stockholders" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.36</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basic and
    Diluted Income Per Share &#8211; Class C Common</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_982_eus-gaap--EarningsPerShareBasicAndDiluted_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Basic and Diluted Income Per Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_eus-gaap--EarningsPerShareBasicAndDiluted_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Basic and Diluted Income Per Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Weighted Average Basic Shares
    Outstanding &#8211; Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zIkLvu7BU1L5" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8xxkpiNUSG7" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,447</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Weighted Average Diluted Shares Outstanding - Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8NRosBq11Pi" title="Weighted Average Diluted Shares Outstanding - Common Stockholders" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,682</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zexffKrjR594" title="Weighted Average Diluted Shares Outstanding - Common Stockholders" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,575</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Weighted
    Average Basic and Diluted Shares Outstanding &#8211; Class C Common</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zRT1i6fpUc87" title="Weighted Average Basic and Diluted Shares Outstanding  Class C Common" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpL0crPlfFj6" title="Weighted Average Basic and Diluted Shares Outstanding Class C Common" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">See
accompanying notes to condensed consolidated financial statements.&#160;&#160;</span></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="TheCompany"></span>CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">For
the Three Months Ending September 30, 2021</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_114_pn3n3_zswlIeW7qN2k" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_z0D0apXhAUd1" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zSEIajKk1rzl" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_ziOSDtTb4SLc" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockMember_zBPqMhNagklj" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zrrEpl38NDrg" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_4B8_zByXxFGYDLk2" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Paid
    in capital in excess of par value</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accumulated
    Deficit</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Treasury
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Non
    Controlling Interests</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total</span></td></tr>
<tr id="xdx_43E_c20210701__20210930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_ztqnLFvcxPWc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Balance - June 30, 2021</span></td><td style="width: 2%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember15724062" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">185,101</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">46,008</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="width: 2%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">675</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="width: 2%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,049</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="width: 2%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">135,370</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLoss_zzoYTAVc55Zf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net income</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0366">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0367">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,887</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0369">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0370">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,887</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_znXldnvEQtjd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Distributions - Non controlling</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0373">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0374">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0375">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0376">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,080</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,080</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_405_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_zxobl6f2ULT8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Income - Non controlling interests</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0380">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0381">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0382">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0383">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,295</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,295</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_43F_c20210701__20210930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zuZXk2AtbUS3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Balance - September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember15724078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">185,101</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">42,121</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">675</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,834</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">139,472</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">For
the Three Months Ending September 30, 2020</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Paid
    in capital in excess of par value</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accumulated
    Deficit</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Treasury
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Non
    Controlling Interests</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total</span></td></tr>
<tr id="xdx_43B_c20200701__20200930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zEgqeN0127ld" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Balance June 30, 2020</span></td><td style="width: 2%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">183,076</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">56,215</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="width: 2%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">675</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="width: 2%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126,242</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--NetIncomeLoss_zqR6lHu5fG64" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net income</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0401">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0402">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,508</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0404">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0405">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,508</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zjwTcLFJ3XFd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Distributions - Non controlling</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0408">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0409">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0410">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0411">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,440</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,440</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_405_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_zVfPs6wAxnli" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Income - Non controlling interests</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0415">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0416">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0417">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0418">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">743</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">743</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_437_c20200701__20200930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zTu1uhPmne73" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Balance September 30, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">183,076</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">53,707</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">675</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">642</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">128,053</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">See
accompanying notes to condensed consolidated financial statements.&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="CashFlow"></span>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_112_pn3n3_zpzApOzW1TTa" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20210701__20210930_z9HqIn6ti1J9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_494_20200701__20200930_z8W2AG9g6r1a" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">FOR
    THE THREE MONTHS ENDED SEPTEMBER 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2020</span></td></tr>
<tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zwUuxOqQtdv1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Cash Flows from Operating Activities:</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--ProfitLoss_maCzE9O_zBlksESaEYgi" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net income</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,182</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,251</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zY1M5ak4p0x6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Adjustments to reconcile net
    income to net cash provided by operating activities:</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--OtherDepreciationAndAmortization_i01_maCzE9O_zplNF6dKfLyd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Depreciation
    and amortization</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,169</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">968</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i01_maCzE9O_zB6PTSjagLgl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Amortization
    on right-of-use assets</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">648</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">953</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--ProvisionForBadDebts_i01_maCzE9O_zPMcV3u1D0Jj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Provision
    (Recovery) for bad debts</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">502</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,227</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01_maCzE9O_z6jvGQZUnjXf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Deferred
    income tax &#8211; net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,195</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">849</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--IncreaseDecreaseInIntangibleAssetsCurrent_i01N_di_msCzE9O_zpz7WeuAEfQl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Abandoned
    patents</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0450">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--GainOnForgivenessOfPppLoan_i01N_di_msCzE9O_zTi7ros22Xu3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Gain on
    forgiveness of PPP loan</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="FONR:GainOnForgivenessOfPppLoan" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">701</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0454">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_iB_z9wsz3U3lSMb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Increase) decrease in operating
    assets, net:</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msCzE9O_zGzCceyEuav3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts,
    medical and management fee receivable(s)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,730</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,109</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_406_eus-gaap--IncreaseDecreaseInReceivables_i01N_di_msCzE9O_zLdtqy4y5Z32" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Notes receivable</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--IncreaseDecreaseInInventories_i01N_di_msCzE9O_zCkyCJ0mWHEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Inventories</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">172</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_40E_eus-gaap--IncomeTaxCreditsAndAdjustments_i01_maCzE9O_zQ2oG12b1Fpi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Income tax
    receivable</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0468">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncomeTaxCreditsAndAdjustments" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">671</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--IncreaseDecreaseInPrepaidExpense_i01N_di_msCzE9O_zrZp0AISZNLh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Prepaid
    expenses and other current assets</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">188</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">125</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i01N_di_msCzE9O_zjkCdNCjP5U7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other assets</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0475">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--IncreaseDecreaseInOperatingLiabilitiesAbstract_iB_zsUBl0Tdwkec" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Increase (decrease) in operating
    liabilities, net:</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--IncreaseDecreaseInAccountsPayable_i01_maCzE9O_z9uNaR7onkQ8" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts
    payable</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">733</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">117</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_400_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i01_maCzE9O_z5T2X9jlVQNc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other current
    liabilities</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,383</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">36</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_406_eus-gaap--IncreaseDecreaseInOperatingLiabilities_i01_maCzE9O_zLT0OHVdXuWg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Operating
    lease liabilities</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLiabilities" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">547</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLiabilities" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">796</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_404_ecustom--IncreaseDecreaseInFinancingLiabilities_i01N_di_msCzE9O_zB5jD4U66txf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Financing
    lease liability</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_403_ecustom--IncreaseDecreaseInCustomerAdvance_i01_maCzE9O_zUO4kjmRVvT1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Customer
    advances</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i01_maCzE9O_zd1WINtMt4ce" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">16</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzE9O_maCze3g_zmScyP2dlHSg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net cash provided by operating
    activities</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,241</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,782</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zt3hSDofFgo4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Cash Flows from Investing Activities:</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCz066_zT9grxdEjBlg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Purchases
    of property and equipment</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,180</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">415</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_405_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di_msCz066_zb8IzjBNl3re" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Cost of patents</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCz066_maCze3g_zWqFniyo9qVg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net cash
    used in investing activities</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,209</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">435</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_z4I6zuW8A9ta" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Cash Flows from Financing Activities:</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--RepaymentsOfNotesPayable_i01N_di_msCz3iH_zLpxBqslapMi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Repayment
    of borrowings and capital lease obligations</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_408_eus-gaap--ProceedsFromIssuanceOfDebt_i01_maCz3iH_zUTmFmFxg5S2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Proceeds
    from debt</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0519">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--PaymentsOfDividendsMinorityInterest_i01N_di_msCz3iH_zBPWE9TmZ2Me" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Distributions
    to noncontrolling interests</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,080</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,440</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCz3iH_maCze3g_zMjme9Chduo6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net cash used in financing activities</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,087</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,386</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_i01T_mtCze3g_z5sYK6f8qvNj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;Net (Decrease) Increase
    in Cash and Cash Equivalents</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,055</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,961</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01S_zCWkZBOoGtj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Cash and Cash Equivalents - Beginning
    of Period</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,460</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,802</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01E_zKjGPpMVufZd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Cash and Cash Equivalents - End
    of Period</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,405</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,763</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">See
accompanying notes to condensed consolidated financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="NotesToFinancialStatements"></span>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_80E_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zOxOHE8xSzR2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_827_z6NfTa50rth8" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Description
of Business</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
<span id="xdx_90B_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_z7ZtizcLqXi7"><ix:nonFraction name="FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent" contextRef="AsOf2015-07-01_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24.2</ix:nonFraction></span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_903_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_zKX2HBiLI2Ak"><ix:nonFraction name="FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" contextRef="AsOf2015-07-01_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45.8</ix:nonFraction></span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
in HDM, and the original investors in HDM retained a <span id="xdx_904_ecustom--OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_z2EfZ877LPEa"><ix:nonFraction name="FONR:OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" contextRef="AsOf2015-07-01_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30.0</ix:nonFraction></span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted
by HDM, operating under the name &#8220;Health Management Company of America&#8221;.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basis
of Presentation and Liquidity</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they
do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America
for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2021, are not necessarily
indicative of the results that may be expected for the fiscal year ending June 30, 2022. For further information, refer to the consolidated
financial statements and footnotes thereto included in the Company&#8217;s Annual Report on Form 10-K filed on October 13, 2021 for the
fiscal year ended June 30, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">During
March 2020 the global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies
which has adversely effected our workforce, liquidity, financial conditions, revenues, profitability and business operations. Generally
COVID-19 had caused us to require that much of our workforce work from home and has restricted the ability of our personnel to travel
for marketing purposes or to service our customers. The Company experienced a sudden drop in scan volume for a short term period and
the Company has recovered to pre-COVID-19 levels. At the end of fiscal year ending June 30, 2020, the Company was able to enact certain
decisions to allow the Company to survive during the global pandemic and from further losses or additional decreases in scan volume.
The Company also received some government stimulus funds from the Paycheck Protection Program (&#8220;PPP&#8221;) and Medicare advances/stimulus
payments. During the three months ended September 30, 2021 the PPP loan was forgiven in its entirety. Although we are unable to predict
if there will be additional consequences on our operations from the continuing global pandemic of COVID-19 and the new variants, the
Company believes with positive cash flows, low debt and cash on hand, it will be able to continue operations going forward.&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 9 -->
    <div id="xdx_232_zehMDw5Yzgsg" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_237_zWsxzFYVWvkc" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_232_zj1onhoraPJ8" style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_236_z0V9c9ktOIYe" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" id="xdx_239_zX0R95SPzbph" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_230_zcQky2ToSzW2" style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zpLtS7H308Nh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zxWzGTiR9sZ6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zuKNxbJ6nbci" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_234_zj0cIYeNQUx3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zemBVekwNeD2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_237_zkk4SgCj0Cje" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zZEVmXTVIBli" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zuBX8dKgUndl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z1mkYEZJGCh8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zO9Yleq9oVMd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82E_z6zAJ0VrVMCj" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_844_eus-gaap--ConsolidationPolicyTextBlock_zRFp41aw2B73" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86A_zNckY6tiKf2f" style="font-size: 10pt; font-style: normal; font-weight: normal">Principles
of Consolidation</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zuSIzjJlOt2j" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_861_zY6G7Tgz45db" style="font-size: 10pt; font-style: normal; font-weight: normal">Revenues</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies and significant judgments employed in the
determination of revenue.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:BusinessCombinationsPolicy"><p id="xdx_84F_eus-gaap--BusinessCombinationsPolicy_z0WJvoRtU4Mk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;<span id="xdx_86E_zWPMiC0efh65">Business
Combination</span></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">When
the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets
acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition dated is measured as the excess
of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While
we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates
are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the
acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon
the conclusion of the measurement period of final determination of the values of assets acquired or liabilities assumed, whichever comes
first, any subsequent adjustments are recorded to our consolidated statements of operations.&#160;</span></p>

<ix:exclude><p id="xdx_237_zwcmjnIyXoP2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 10 -->
    <div id="xdx_239_zVz6bj1HM2Sd" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_234_zlPPJWoks8lg" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_23D_zpxuCZs2kuGk" style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_23F_zJrW4tgE1qJ4" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" id="xdx_23E_zss6uEE4PQQh" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_238_zLmfgzOj0Qlc" style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zJYswDHqDsGi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zeCUjX7cVy08" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zB3Q6FfWzv5e" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zv9zQHFux18k" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_ztyvjMKIzYdd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_230_zACVUcOUvcyj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_znwyPQ29iXgl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_237_z4rTf3KmdVW3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zgHIPzVOCO32" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zROMAClfqGP9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_znwt7BsAQiV7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_ziZjS8NbgFYl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_863_zr6gpZh2VdIc" style="font-size: 10pt; font-style: normal; font-weight: normal">Earnings
Per Share</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basic
earnings per share (&#8220;EPS&#8221;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2021 and 2020, diluted EPS for
common shareholders includes <span id="xdx_900_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930_zRGgjiWukwv4" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930_zsLpUrZaFvle" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></ix:nonFraction></span>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">shares upon conversion of Class C Common.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zBAIkv4wzRm" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0; padding-right: 0; text-align: left"><span id="xdx_8B6_zpgUjzLOxoVa" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Earnings
    Per Share</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Three
    months ended <br /> September 30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Three
    months ended <br /> September 30, 2020</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class
    C Common <br /> Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class
    C Common <br /> Stock</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basic</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Numerator: <br /> Net
    income available to common stockholders</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930_zapWaqXUg9Ba" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,887</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zt9qzMRXgra3" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,652</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPd7plTdMyYb" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930_zWaFONMC5WUc" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,508</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdb52kLqzIq1" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,355</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbHWtFHrqGX2" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Denominator:</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Weighted average shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zZGzybf8aWF3" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zrTTZGX63aM9" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6EPyJNKHyx3" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930_znioEuMtifx1" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,447</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zem4oWtHDibj" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,447</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXsWTKvqriN3" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basic income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930_zyba36IObr4l" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.59</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwNGz6iK5rMb" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.56</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z22A9sQVrbta" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930_zc33GDSt62of" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.39</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGWwIusDHrT7" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.37</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zlk4pcvuKUBk" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.10</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diluted</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Denominator: <br /> Weighted average shares outstanding</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zibF3BrrcCwc" title="Shares included upon conversion of Class C Common to calculate a diluted EPS" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo7vmVRTwnSj" title="Shares included upon conversion of Class C Common to calculate a diluted EPS" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zabzg3gXongi" title="Shares included upon conversion of Class C Common to calculate a diluted EPS" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,447</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4gp0r7FYfhk" title="Shares included upon conversion of Class C Common to calculate a diluted EPS" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Convertible Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zyeE9emioBkk" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_989_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJzOPcmKiUqb" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0625">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMUsLZ32MLU8" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zi5xdh23VMa1" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0629">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total Denominator for diluted
    earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zCY5SrFzpCYk" title="Total Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,682</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zG9jNDgEBGJl" title="Total Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfgqvcUq5Gek" title="Total Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,575</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpwXxoxGln9a" title="Total Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diluted income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z47tJrsSrexa" title="Diluted income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.55</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHdabjKGqTnb" title="Diluted income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ztZIHlcvNGdk" title="Diluted income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.36</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zW2QXtGoXyq7" title="Diluted income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.10</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:exclude><p id="xdx_23A_zzOVHIR6LPi6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 11 -->
    <div id="xdx_23C_zpRSfQgaBJG5" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_237_zXwNQf5wusJg" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_23F_zTVZLE8Lz6Ye" style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_237_zFLMTRluHDFj" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" id="xdx_236_zQ4gig0w7oyc" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zE88JJKkmIg7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_znQAYyo9oPh5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zbI3blqcZFDg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_230_zuqicleKurnf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zi1YuXTPq0Rj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zidV1lKS5Fod" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zYJdrWc69JL8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_234_zZQeLH4kBdnj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zoNdRmFDZGu2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zG1ANGtPhuel" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zfoALXKiLgjf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znt3dwjaq6wg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86F_z1mcmUne0oHh" style="font-size: 10pt; font-style: normal; font-weight: normal">Recent
Accounting Standards</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2021 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2021 or 2020, and it does not believe that any
of those standards will have a significant impact on our consolidated financial statements at the time they become effective.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p id="xdx_801_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zRzWFLudV2N1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_827_zyd1XH8tZC4a" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Receivables,
net is comprised of the following at September 30, 2021, and June 30, 2021:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zZwyXMrb0gJ5" summary="xdx: Disclosure - NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0; padding-right: 0"><span id="xdx_8BE_zKErKQJGpNOk" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Receivables
    - Non Current - net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2021-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,990</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_ecustom--AccountsReceivableServiceAndRepairFees_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2021-09-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">442</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_ecustom--AccountsReceivableServiceAndRepairFees_c20210930_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,548</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts receivable - related
    party</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--AccountsReceivableNetRelatedParty_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2021-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98D_ecustom--AccountsReceivableNetRelatedParty_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0673">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_ecustom--AccountsReceivableNetRelatedParty_c20210930_pn3n3" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medical receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_ecustom--MedicalReceivable_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2021-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,356</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0679">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_ecustom--MedicalReceivable_c20210930_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,356</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagementAndOtherFees_NonRelatedParties" contextRef="AsOf2021-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,975</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagementAndOtherFees_NonRelatedParties" contextRef="AsOf2021-09-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,280</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930_pn3n3" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagementAndOtherFees_NonRelatedParties" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,695</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management and other fees receivable
    from related medical practices (&#8220;PC&#8217;s&#8221;)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2021-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,191</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2021-09-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,193</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930_pn3n3" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,998</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,968</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_ecustom--AccountsReceivableServiceAndRepairFees_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2021-06-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">442</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_ecustom--AccountsReceivableServiceAndRepairFees_c20210630_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,526</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts receivable - related
    party</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_ecustom--AccountsReceivableNetRelatedParty_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_ecustom--AccountsReceivableNetRelatedParty_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0703">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98E_ecustom--AccountsReceivableNetRelatedParty_c20210630_pn3n3" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medical receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,901</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_ecustom--MedicalReceivable_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0709">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_ecustom--MedicalReceivable_c20210630_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,901</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagementAndOtherFees_NonRelatedParties" contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">46,735</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagementAndOtherFees_NonRelatedParties" contextRef="AsOf2021-06-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,787</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630_pn3n3" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagementAndOtherFees_NonRelatedParties" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,948</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management and other fees receivable
    from related medical practices (&#8220;PC&#8217;s&#8221;)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,998</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2021-06-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,184</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630_pn3n3" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,814</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AF_z7MZbY5xXYkg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;The
Company&#8217;s customers are concentrated in the healthcare industry.&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 12 -->
    <div id="xdx_23E_zv6tcQq7uB43" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_238_zoq3Ue2Jcgbg" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_236_zbkqwTaR78W2" style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_234_zaRwFuGZ2JYf" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" id="xdx_233_zFyNno4y7Bkg" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zDzWI0mIE5sg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zedFJgSTU236" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zu3OLdLWALq6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zkLNlubnxiM1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zbtVqKuaK8hj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z05U8wi0CsEi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zzJldnKxumD1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_235_z2SwGx6ZA4o1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zW7JaOE6xEK5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zCsP4vf7Tx6k" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts
Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Long
Term Accounts Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following four years at September 30, 2021 are as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="FONR:TotalFacilitiesOwnedOrManagedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_pn3n3_zIEgmEnxEeri" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_z5OOdbrLwPoe" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Total
    Facilities</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_49B_20210930_zALTXVd8Gbc1" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_maARBFLzybP_zeW2aaPFWfH1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2022</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 10%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 43%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ContractReceivableDueOneToTwoYears" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,020</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_maARBFLzybP_zG1vgNbMTITh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2023</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ContractReceivableDueTwoToThreeYears" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,020</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_maARBFLzybP_zQTQ3hTYzOAg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2024</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ContractReceivableDueThreeToFourYears" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">413</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pn3n3_maARBFLzybP_zWdZ4kiuZ35j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2025</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:ContractReceivableDueFourToFiveYears" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">92</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_iTI_pn3n3_mtARBFLzybP_z8APCFbsDaih" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,545</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AC_zis1att3I655" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medical
Receivables</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management
and Other Fees Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company&#8217;s receivables from the related and non-related professional corporations (PC&#8217;s) substantially consist of fees outstanding
under management agreements. Payment of the outstanding fees is dependent on collection by the PC&#8217;s of fees from third party medical
reimbursement organizations, principally insurance companies and health management organizations.&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 13 -->
    <div id="xdx_237_z4kkxNcd9364" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_236_z1VMMkSuwQD2" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_235_zeKcPh5Zbblk" style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_232_zYmgC8JEhUXl" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" id="xdx_23E_zcSqvxMEPNbk" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_238_zgvd9m5JKUWa" style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zc9924JHYufi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zOMCFSAhJxm9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zt4Qji6Ef8Uc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_230_z8JYmRQbNrp9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zQRTYaM0W59k" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_230_zqb6pSueXypf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zj14OjKYrg5k" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_231_zsQ9DI4Ivgd2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zTQ9tWdW0Hdf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zO2YDiILP08d" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zqcMMlhY0YI1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zZ6c6MeZPfF4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management
and Other Fees Receivable (Continued)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Payment
of the management fee receivables from the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner
their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_90B_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20210701__20210930_zrIXHpiBIUm7"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">66.7</ix:nonFraction></span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
and <span id="xdx_900_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20200701__20200930_zI8NOnkhZDd5"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">66</ix:nonFraction></span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
of the PCs&#8217; net revenues for the three months ended September 30, 2021 and 2020, respectively, were derived from no-fault and personal
injury protection claims. The Company considers the aging of its accounts receivable in determining the amount of allowance for doubtful
accounts. The Company generally takes all legally available steps to collect its receivables. Credit losses associated with the receivables
are provided for in the condensed consolidated financial statements and have historically been within management&#8217;s expectations.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net
revenues from management and other fees charged to the related PCs accounted for approximately <span id="xdx_90A_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20210701__20210930_zhxDlplxsCog"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.8</ix:nonFraction></span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
and <span id="xdx_900_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20200701__20200930_zRkd8qcGsF74"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.8</ix:nonFraction></span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
of the consolidated net revenues for the three months ended September 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. Additional Company managed entities also operate under a guaranty agreement,
pursuant to which management fees are payable to the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company&#8217;s patient fee revenue, net of contractual allowances and discounts for the three months ended September 30, 2021 and 2020
are summarized in the following table.</span>&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="FONR:ScheduleOfPatientFeeRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_pn3n3_zY6juRZ34H92" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B2_zV46w3Or2E5d" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Schedule of patient fee revenue</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">For
    the Three Months Ended September 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Commercial Insurance/
    Managed Care</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zVJYYLC7mYpf" title="Patient fee revenue, net of contractual allowances and discounts" style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012021-09-30_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,086</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zFwzeYHcw6Tc" title="Patient fee revenue, net of contractual allowances and discounts" style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2020-07-012020-09-30_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">946</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medicare/Medicaid</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zOYhwflRmHnk" title="Patient fee revenue, net of contractual allowances and discounts" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012021-09-30_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">249</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zaP399fNHk71" title="Patient fee revenue, net of contractual allowances and discounts" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2020-07-012020-09-30_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">197</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Workers&#8217; Compensation/Personal
    Injury</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zdkvFj3I9da1" title="Patient fee revenue, net of contractual allowances and discounts" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012021-09-30_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,124</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zvSqn46Bl4ak" title="Patient fee revenue, net of contractual allowances and discounts" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2020-07-012020-09-30_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,387</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVq1nxn1Wrha" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012021-09-30_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,392</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zS6U4PSS3cy2" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2020-07-012020-09-30_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">561</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Patient Fee Revenue, net of contractual
    allowances and discounts</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930_zfHI3kiWagFf" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,851</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930_zAVcKbmDl2sh" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,091</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>



<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 14 -->
    <div id="xdx_234_zr3bN8YKYy7i" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_238_z63FzRhny7p" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_236_z92EJ2e8NFFe" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" id="xdx_231_z6D3sg0zs979" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zIZRoKFrLjwg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zzfJTHgoKdqc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zNHaYfSwOsYi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_239_zexUmyq5IJCe" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zfELfojA5Kq6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_232_zDiOzUSe6vX1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zPWHLPPsRtPe" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zo5FrqWFUATf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zGpsp4ywJFp2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_806_eus-gaap--LesseeOperatingLeasesTextBlock_z4ctQmoJW6Th" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span id="xdx_82A_zeszTjwrrjai" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
4 &#8211; OPERATING &amp; FINANCING LEASES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">During
February 2016, FAS issued ASU 2016-02, Leases (Topic 842). The new standard requires lessees to apply a dual approach, classifying leases
as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase by the
lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line
basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with
a term of greater than 12 months regardless of their classification. Lease with a term of 12 months or less will be accounted for similar
to previous guidance for operating leases. The standard was effective for us beginning July 1, 2019. We have elected the optional transition
method to apply the standard as of the effective date and therefore, we will not apply the standard to the comparative periods presented
in the consolidated financial statements. We have also elected the transition package of the practical expedients permitted within the
standard which eliminates the requirements to reassess prior conclusions about lease identification, lease classification and indirect
costs. The adoption of this guidance had a material impact on the Company&#8217;s balance sheet by virtue of including the present value
of its future operating lease payments as a liability of $<span id="xdx_909_eus-gaap--OperatingLeasePayments_pn3n3_dm_c20210701__20210930_zeANIR5rp0G7" title="Operating lease payments"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">33.3</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">million and related right-to-use lease assets as
of July 1, 2019. At the time of adoption of this guidance we had no significant financing leases.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:exclude><p id="xdx_238_zN76I07pyHHb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 15 -->
    <div id="xdx_230_z3MO4dSNVgkh" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23A_zEfIpwM13Dck" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_23E_zh2WYihQbSi2" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" id="xdx_235_zdFlpt7d63t2" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_232_z1i5nsybUt9g" style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zzOTGU3WxOTi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zuqRzg4IpgC1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zv0wIbkwtYPh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zz6Wup8sgyP9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zQ0eqg5iJ0Qb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z10fqpXmWbp4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zFiNTR7NrQz3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zurT1i2n8pM4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zsqAo8PJj8S8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zlrXLfCG3iCa" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
4 &#8211; OPERATING &amp; FINANCING LEASES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_z4pYz0UkCTRg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of September 30,
2021 is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_pn3n3_z5Gnn7v1d3F5" summary="xdx: Disclosure - NOTE 4 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="xdx_8B9_z4rcWVDy9Gzj" style="display: none">Reconcilliation
of operating and financing lease payments&#160;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Operating Lease Payments 2023" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Financing Lease Payments 2023" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Year
    Ending &#160; September 30,</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Operating
    Lease &#160; Payments</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Financing
    Lease Payments</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2022</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20210930_pn3n3" title="Operating Lease Payments 2022" style="width: 26%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,166</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20210930_pn3n3" title="Financing Lease Payments 2022" style="width: 26%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2023</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20210930_pn3n3" title="Operating Lease Payments 2023" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,170</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20210930_pn3n3" title="Financing Lease Payments 2023" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2024</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20210930_pn3n3" title="Operating Lease Payments 2024" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,895</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20210930_pn3n3" title="Financing Lease Payments 2024" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2025</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20210930_pn3n3" title="Operating Lease Payments 2025" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,711</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20210930_pn3n3" title="Financing Lease Payments 2025" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2026</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20210930_pn3n3" title="Operating Lease Payments 2026" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,248</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20210930_pn3n3" title="Financing Lease Payments 2026" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20210930_pn3n3" title="Operating Lease Payments Thereafter" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,928</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20210930_pn3n3" title="Financing Lease Payments Thereafter" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">104</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Present
    value discount</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_ecustom--PresentValueDiscount_iNI_pn3n3_di_c20210930_zWg6udo3osk2" title="Operating Lease Payments Present Value discount" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="FONR:PresentValueDiscount" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,157</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_ecustom--PresentValueDiscountFinancingLease_iNI_pn3n3_di_c20210930_zlDf3ddYTkpi" title="Financing Lease Payments Present Value discount" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="FONR:PresentValueDiscountFinancingLease" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20210930_zgjxRLR7fhQa" title="Operating Lease Payments Total lease liability" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,961</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20210930_pn3n3" title="Financing Lease Payments Total lease liability" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,202</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_800_eus-gaap--InventoryDisclosureTextBlock_zSXcNYbbLjda" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span id="xdx_820_z1kiDZV7M9z7" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
5 - INVENTORIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_z9vgGW5nzzN6" summary="xdx: Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0; padding-right: 0"><span id="xdx_8B2_zOGco7sVgFNi" style="font: normal 10pt Arial, Helvetica, Sans-Serif; display: none">Inventories</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_49B_20210930_zFF5H0LucJ33" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_49E_20210630_zuiwsc7kWRA7" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr id="xdx_40B_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWz0B3_zQqgXrpUJL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Purchased parts,
    components and supplies</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,553</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,393</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWz0B3_z5RhkbH7ME6e" style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Work-in-process</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">282</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">270</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWz0B3_zlWwyX51cnQd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">TOTAL INVENTORIES</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,835</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,663</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock"><p id="xdx_801_eus-gaap--ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_z2vYf5hHWsek" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span id="xdx_829_zwKrBqDHTSdi" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
6 &#8211; CONTRACT ASSETS AND LIABILITIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Information
relating to uncompleted contracts about contract assets and (liabilities) is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_pn3n3_z4s8ciae4skj" summary="xdx: Disclosure - NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: rgb(204,238,255)"><span style="color: Black; font-size: 10pt; font-style: normal; font-weight: normal"><span id="xdx_8BF_zEHfpAuSKoac" style="display: none">Costs
and &#160;Estimated Earnings on Uncompleted Contracts</span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20210930_ztarKTYxLW34" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20210630_zsHMKgVWhkt5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr id="xdx_404_ecustom--CostsIncurredOnUncompletedContracts_iI_pn3n3_maCAEEOzAiq_maCAEEOzkha_zahTmLeTEWzd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Costs incurred on
    uncompleted contracts</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsIncurredOnUncompletedContracts" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">295</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsIncurredOnUncompletedContracts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">295</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--EstimatedEarnings_iI_pn3n3_maCAEEOzAiq_maCAEEOzkha_zFigRQYmhJF1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Estimated earnings</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:EstimatedEarnings" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">568</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:EstimatedEarnings" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">568</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pn3n3_mtCAEEOzAiq_maTCAEEzvJg_mtCAEEOzkha_z6mRDgb5NF41" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Costs and estimated earnings
    on uncompleted contracts</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsAndEstimatedEarningsOnUncompletedContracts" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">863</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CostsAndEstimatedEarningsOnUncompletedContracts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">863</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--BillingsToDate_iNI_pn3n3_di_maTCAEEzvJg_maTCAEEzMMZ_zgm7WCBXOyzi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Less: Billings to date</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:BillingsToDate" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">878</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:BillingsToDate" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">878</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet_iTI_pn3n3_mtTCAEEzvJg_mtTCAEEzMMZ_z4R13Bh9Eijl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total costs and estimated
    earnings in excess of billings on uncompleted contracts</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="FONR:TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="FONR:TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<ix:exclude><p id="xdx_234_zzBfsdghUcT1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 16 -->
    <div id="xdx_235_zs5qFT1zplw" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23A_zWS28e5bDtG9" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_231_zEzNye77i7P1" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" id="xdx_23B_zuFhQ0l6pPXa" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_23F_zYNd9oVsxfdd" style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_z7Ww6nqe6iWi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zmJJ3599kuMa" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zyJJvPBHUCr9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zneTGT1mLR03" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zzIGkSWfhLWg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_234_zQnpEGoHp7f3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zJhTIga1w4lf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zd2OiK0lk1X8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_z3MOpSkIJCUe" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_80A_eus-gaap--IntangibleAssetsDisclosureTextBlock_zXPM9xefXAu9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_826_zOt0ZfJoBKBa" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
7 &#8211; OTHER INTANGIBLE ASSETS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zkHS6AOIX49e" summary="xdx: Disclosure - NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BB_zdaoeOeNH7zc" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Other
    Intagible Assets - Net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Capitalized software
    development costs</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" title="Gross other intangible assets" style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-09-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,005</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" title="Gross other intangible assets" style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,005</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Patents and copyrights</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Gross other intangible assets" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-09-30_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,274</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Gross other intangible assets" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,245</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Non-compete</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Gross other intangible assets" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-09-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,150</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Gross other intangible assets" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,150</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Customer relationships</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Gross other intangible assets" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-09-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,900</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Gross other intangible assets" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,900</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Gross Other intangible assets</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930_pn3n3" title="Gross other intangible assets" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,329</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pn3n3" title="Gross other intangible assets" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,300</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Less: Accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210930_pn3n3" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,372</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210630_pn3n3" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,262</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other Intangible Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20210930_pn3n3" title="Other intangible assets-net" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,957</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20210630_pn3n3" title="Other intangible assets-net" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,038</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Amortization
of patents and copyrights for the three months ended September 30, 2021 and 2020 amounted to $<span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012021-09-30_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">and $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20200930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-07-012020-09-30_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45</ix:nonFraction></span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Amortization
of non-compete for the three months ended September 30, 2021 and 2020 amounted to $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012021-09-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">and $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20200930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-07-012020-09-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Amortization
of customer relationships for the three months ended September 30, 2021 and 2020 amounted to $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012021-09-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">and $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20200930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-07-012020-09-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p id="xdx_807_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zOcanxingsnj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_826_zIbqlD0UKeuj" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
8 &#8211; OTHER CURRENT LIABILITIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zOkpzMHiFCL6" summary="xdx: Disclosure - NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BB_znwJwVTjV5Qj" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Other
    Current Liabilities</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_49C_20210930_zsSWJvPMTq6e" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_490_20210630_zeLVmc4rE5Wf" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr id="xdx_403_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCz1Nt_zo97CUsrgcBd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accrued salaries,
    commissions and payroll taxes</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,595</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,407</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maOLCz1Nt_z5XeFMnKaHbj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Litigation accruals</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0931">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">900</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCz1Nt_zKYgcDago4ee" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Sales tax payable</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">674</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">645</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCz1Nt_zqK8PHIk9by1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">State income taxes payable</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:StateIncomeTaxesPayable" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">351</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:StateIncomeTaxesPayable" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">774</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCz1Nt_z6MnZgwWD0M5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Legal and other professional
    fees</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCz1Nt_zLH0hvTL9oXj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounting fees</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">131</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">127</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCz1Nt_zWMqDllrkryb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Self-funded health insurance
    reserve</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCz1Nt_zx7abxKtrKT3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accrued interest and penalty</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">279</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">493</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCz1Nt_zM5o7SYwXeXc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">907</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">716</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCz1Nt_ztzKyS5NLqEe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other Current Liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,990</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,162</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:exclude><p id="xdx_231_zABWr8l1KN15" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 17 -->
    <div id="xdx_239_znZWxKiWx70k" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_237_z1QmwqsVNwp3" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_230_zeT7HfYu9fqg" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" id="xdx_234_zblVjOkC4TH9" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_235_zewoO6Khnucc" style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zWnp3lHDrtZ7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_239_znIExQCvnkkf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zMfnOtCg3gK2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zqcPflRZG6Ta" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_234_z7tbG7NYFPjb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zAjD58MPlOCd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zFToMk6Uy8pi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zudwmtvVt20b" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_ztUyZeknuDbb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_z2sJg0UXjxbl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_802_eus-gaap--SegmentReportingDisclosureTextBlock_zGCKWVAcmhSb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_828_zEZDlZ8HNrD2" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
9 - SEGMENT AND RELATED INFORMATION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
accounting policies of the segments are the same as those described in the summary of significant accounting policies as disclosed in
the Company&#8217;s 10-K as of June 30, 2021. All inter-segment sales are market-based. The Company evaluates performance based on income
or loss from operations.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:exclude><p id="xdx_235_zhYLJpQQ4TL2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
9 - SEGMENT AND RELATED INFORMATION (Continued)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Summarized
financial information concerning the Company&#8217;s reportable segments is shown in the following table:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal"></span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zwDXIR6nqRbh" summary="xdx: Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="xdx_8B9_ze0wWT4lOdf8" style="display: none">Suuummarrized
Segment Financial Information</span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Net revenues from external customers" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Net revenues from external customers" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Net revenues from external customers" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medical
    <br /> Equipment</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management
    <br /> of Diagnostic <br /> Imaging <br />
    Centers</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Totals</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: none"><span style="font-size: 10pt; font-style: normal; font-weight: normal">For the three months ended
    Sept. 30, 2021</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net revenues from
    external customers</span></td><td style="width: 5%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,112</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,618</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930_pn3n3" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,730</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Inter-segment net revenues</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zr9Mmrr0ILlj" title="Inter-segment net revenues" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">236</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zv1DLoYg1Uh3" title="Inter-segment net revenues" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0982">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930_ze5QfQTgetc" title="Inter-segment net revenues" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">236</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Loss) Income from operations</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="(Loss) Income from operations" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">490</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="(Loss) Income from operations" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,231</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930_pn3n3" title="(Loss) Income from operations" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,741</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Depreciation and amortization</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Depreciation and amortization" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">67</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Depreciation and amortization" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,102</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930_pn3n3" title="Depreciation and amortization" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,169</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Capital expenditures</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Capital expenditures" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">121</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Capital expenditures" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,088</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98D_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930_pn3n3" title="Capital expenditures" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,209</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the three
    months ended Sept. 30, 2020</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net revenues from external customers</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Net revenues from external customers" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2020-07-012020-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,981</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Net revenues from external customers" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2020-07-012020-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,998</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930_pn3n3" title="Net revenues from external customers" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,979</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Inter-segment net revenues</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zdyNt3ETXxxj" title="Inter-segment net revenues" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2020-07-012020-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">219</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zPdz7yQlU8yg" title="Inter-segment net revenues" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl1012">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930_zdlOap0pubAc" title="Inter-segment net revenues" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">219</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Loss) Income from operations</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="(Loss) Income from operations" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2020-07-012020-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">561</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="(Loss) Income from operations" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2020-07-012020-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,711</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930_pn3n3" title="(Loss) Income from operations" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,150</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Depreciation and amortization</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Depreciation and amortization" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-07-012020-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">67</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Depreciation and amortization" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-07-012020-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">901</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930_pn3n3" title="Depreciation and amortization" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">968</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Capital expenditures</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Capital expenditures" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2020-07-012020-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Capital expenditures" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2020-07-012020-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">415</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930_pn3n3" title="Capital expenditures" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">435</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock"><p id="xdx_808_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zz0aqZyK2lU5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_82D_zIbm6yIwFyP" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">During
the three months ended September 30, 2021 and September 30, 2020, the Company paid $<span id="xdx_90F_eus-gaap--InterestPaid_pn3n3_c20210701__20210930_ziH6sas0tgV7" title="Interest paid"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">189</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">and $<span id="xdx_90A_eus-gaap--InterestPaid_pn3n3_c20200701__20200930_zBuqsQyqe9m7" title="Interest paid"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">for interest, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">During
the three months ended September 30, 2021 and September 30, 2020, the Company paid $<span id="xdx_90B_eus-gaap--IncomeTaxesPaid_pn3n3_c20210701__20210930_zp9U3ytXEMod" title="Income taxes paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">221</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">and $<span id="xdx_903_eus-gaap--IncomeTaxesPaid_pn3n3_c20200701__20200930_zh3zvjvRbxS7" title="Income taxes paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">145</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">for income taxes, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_232_zhZc03JDfkL7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 18 -->
    <div id="xdx_233_zsuXe8171YBk" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_236_zL1PhpIJUvEl" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_238_zUIwF5tKEcX3" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" id="xdx_230_zJsDf6yN4URh" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_z2ZjA1X7wd78" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z9bw6xQAPYV5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zH5m8bMMFiH" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_232_zL3ivNr2VQFh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zOJnzKHyBIS3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zHcQWQ0aqtlg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zIEjGZimBx9l" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zjvPneTrOand" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zIQrATYULSN4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zvm5FKJuav7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_824_zXutgyPSxHsd" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
11 &#8211; COMMITMENTS AND CONTINGENCIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Litigation</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other
Matters</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">In
September 2019, the Company was notified by one of its landlords that it was required to vacate the premises within 180 days under the
demolition clause in the lease. The Company believed the lease renewal which was not negotiated in good faith since the renewal was negotiated
in February 2018. The Company is in the process of relocating to a new location but the original lease provided for penalty payments
in the event that the Company had not vacated the lease space. The Company had been making normal rent payments throughout the course
of the arbitration proceedings. The case was settled for $900 of leasehold holdover charges which was paid in August 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90F_ecustom--LitigationSettelementDescription_c20210701__20210930_zlaQdZ9EBP8e" title="Litigation settelement description" style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="FONR:LitigationSettelementDescription">In
September 2020, the Company entered into a settlement agreement with an unrelated third party for a claim made during March 2018 which
was scheduled for arbitration. The settlement was for $1.2 million of which $900 was paid by the Company&#8217;s insurance in September
2020. The Company paid the remaining balance of $315 in September 2020.</ix:nonNumeric></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company has satisfied most of its delinquencies in filing sales tax returns for certain states, for which the Company has transacted
business. The Company has recorded tax obligations of approximately $<span id="xdx_900_eus-gaap--SalesAndExciseTaxPayableCurrentAndNoncurrent_iI_pn3n3_c20210930_zW8Yn9zuG9Pa" title="Recorded tax obligations"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">674</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">plus interest and penalties of approximately $<span id="xdx_905_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_pn3n3_c20210930_zIinc7R0jk31" title="Interest and penalties"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">232</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">until the remaining states have been resolved.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 20pt; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_904_ecustom--MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_c20210930_pn3n3"><ix:nonFraction name="FONR:MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">per person and for a maximum potential claim liability
based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when
estimating its health insurance program liability and related expense. As of September 30, 2021 and June 30, 2021, the Company had approximately
$<span id="xdx_909_eus-gaap--SelfInsuranceReserve_iI_pn3n3_c20210930_zRXROiB3d5l2" title="Self-funded health insurance reserve"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24</ix:nonFraction> </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">and
$<span id="xdx_907_eus-gaap--SelfInsuranceReserve_iI_pn3n3_c20210630_zyhgBkerVKyj" title="Self-funded health insurance reserve"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62</ix:nonFraction></span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">,
respectively, in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221;
in the condensed consolidated balance sheets.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_234_zk5YXRQnjUxl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 19 -->
    <div id="xdx_238_zuebfLxDp4X6" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23A_z6XestiAfxx1" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_232_zp688Zw6Osu8" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" id="xdx_235_znJ48kWb5ir5" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_23E_zGlfkVsUmwX1" style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zf7vIyttwwE2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zgRWr21ayKfj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_232_zOityyQsysQl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zQK9xiAXjuGf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_238_zDYABIuXzhc4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zZecWhFt5Pti" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zPOKCBXLCvA6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zUkXO2q7ytmd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zi9E873kEWIk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zvJVuQYHchXa" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zfg2RC08Q3Gc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
11 &#8211; COMMITMENTS AND CONTINGENCIES (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zxoKwMgR7ti1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_zww9G6UGPGUl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_821_zYuAQyVQ4xmd" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
12 - INCOME TAXES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">In
accordance with ASC 740-270, Income Taxes &#8211; Interim Reporting, the Company is required at the end of each interim period to determine
the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The resulting tax expense
(or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in the interim period as
they occur. For the three months ended September 30, 2021, the Company recorded income tax expense of $<span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20210701__20210930_zDXLmke81qH6" title="Income tax expense"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,416</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">in 2021 as compared to $<span id="xdx_904_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20200701__20200930_zhDgMoKiOnp9" title="Income tax expense"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">849</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">in 2020. The 2021 provision is comprised of a current
income tax component of $<span id="xdx_907_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_c20210701__20210930_zgmlvsmDh9ke" title="Income tax component - current"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">221</ix:nonFraction></span></span> <span style="font-size: 10pt; font-style: normal; font-weight: normal">and
a deferred income tax component of $<span id="xdx_908_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_c20210701__20210930_z8vzL2WsAKAa" title="Income tax component - deferred"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,195</ix:nonFraction></span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">.
Obligations for any liability associated with the current income tax provision, has been reduced, primarily resulting from the benefits
and utilization of net operating loss carryforwards.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#8220;Interest expense, net&#8221;. Penalties if incurred would be recognized as a component of &#8220;Selling,
general and administrative&#8221; expenses.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2017.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_23C_zZi1ow8PCNnh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 20 -->
    <div id="xdx_23F_zKkxusn5u1yl" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23F_zQJLzQ67oN8d" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_238_zfNxYlFTtqCe" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" id="xdx_236_zGhheteWHptd" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zGYLLUTCahl5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zu3qAKI6mWGj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zK3ojNjq8c8j" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zYLd20YOAjh2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zdLPX2n7msw" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zOwqFKXPMYZf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zKYij43hxRd8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zc0T6AzUcmVh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zVwooJQVs4sf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zWhSvfUoE3hf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_z83Pr5rbTRi4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zLHUcmaA82Ri" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
12 - INCOME TAXES (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zOIrKVO0kKB1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company recorded a deferred tax asset of $<span id="xdx_908_eus-gaap--DeferredTaxAssetsNet_iI_pn3n3_c20210930_zVgmyt9rZufk" title="Deferred tax asset"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,764</ix:nonFraction></span></span> <span style="font-size: 10pt; font-style: normal; font-weight: normal">and
a deferred tax liability of $<span id="xdx_904_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pn3n3_c20210930_zwJQafUV1Rh7" title="Deferred tax liability"><ix:nonFraction name="us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">238</ix:nonFraction>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">as of September 30, 2021, primarily relating to
net operating loss carryforwards of approximately $<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20210930_z3tnWJeO3QU5" title="Operating Loss Carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,224</ix:nonFraction></span></span>
<span style="font-size: 10pt; font-style: normal; font-weight: normal">available to offset future taxable income through 2032. The net
operating losses begin to expire in 2023 for federal tax and state income tax purposes.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">On
March 27, 2020 Congress enacted the CARES Act (Coronavirus Aid, Relief and Economic Security Act). The Act provides numerous tax provisions
and other stimulus measures, including temporary changes regarding prior and future operation losses, temporary changes to prior and
future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security
taxes, technical corrections to prior tax legislation for tax depreciation of certain qualified improvement property and enhanced recoverability
of AMT tax credits.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_909_ecustom--ReimbursementOfAlternativeMinimumTaxCreditsDescription_c20210701__20210930_zBOwhZLPngVi" title="Reimbursement of alternative minimum tax credits description" style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="FONR:ReimbursementOfAlternativeMinimumTaxCreditsDescription">At
the present time, the only impact of the CARES Act to the Company is allowing a full reimbursement of $1,342 of tax credits relating
to the alternative minimum tax credits. The Company received the first half payment in June 2020. The balance of alternative minimum
tax credits of $671 was received in July 2020. Previously, these credits were to be refunded over a 3 year period.</ix:nonNumeric></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">As
we continue to monitor tax implications of the CARES Act and other state and federal stimulus tax legislation, we may make adjustments
to our estimates and record additional amounts for tax assets and liabilities.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of September 30, 2021, no such changes in ownership have occurred.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry and tax planning strategies in making this assessment. At present, the Company believes
that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">A
valuation allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:exclude><p id="xdx_238_zG77UpuVvuTg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 21 -->
    <div id="xdx_238_zjiK6hDhVJe3" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23D_zlzMtaaPPZv5" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_236_zky1Zy4P4NLg" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" id="xdx_237_zFfcGKYAI1pl" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zJOzUt8oy5Cf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zi1GL4GVyU07" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_232_zHvTZ0uKByZ4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zDGnUalf8b3i" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_234_z77vBEiI3Kj4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zNdBei6ALgef" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zNdrJtPqjxii" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zjdql7dHeNOh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zA1c98vLHHSf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zkJ0sBg9f8X2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_80A_eus-gaap--BusinessCombinationDisclosureTextBlock_zHhTOKRL8Oq2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_82A_zdD7kiaZiIIa" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
13 &#8211; ACQUISITION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">On
March 29, 2021, the Company completed the acquisition of certain assets of Rockland Management Group, located in West Yonkers. The Company
used an incremental borrowing rate of 4% to value the right to use asset in connection with the assumed operating lease obligation. We
made a preliminary fair value determination of the acquired assets and assumed liabilities as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_pn3n3_zqPQ8UdLIkf9" summary="xdx: Disclosure - NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B5_zg6DZWhDoGf" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Fair
    value assets and assumed liabilities</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_495_20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_zsfvCAcNLncb" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Property and equipment</span></td><td style="width: 10%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 18%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Right to use assets</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">434</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Intangible assets</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--SecurityDeposit_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Security Deposit</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--RightToUseLiability_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Right to use liability</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(<ix:nonFraction name="FONR:RightToUseLiability" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">434</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_404_eus-gaap--Goodwill_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">284</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--TotalPurchaseConsideration_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total purchase consideration</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:TotalPurchaseConsideration" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,123</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A6_zxQMSHNvJXTf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">In
accordance with ASC 805-10-25-1, Business Combinations &#8211; Overall Recognition, the Company recorded the transaction as a business
combination. ASC 805-10-25-1 provides the requirements of recording the transaction by applying the acquisition method. The acquisition
method requires the Company to determine if the assets and liabilities acquired are a business or not. Under ASC 805-10-25-1, it must
be determined if there is a specific acquisition party, acquisition date, identifiable assets acquired and liabilities assumed and you
must be able to recognized and measure goodwill or a gain from the purchase. Based upon this guidance, the acquisition had been recorded
as a business combination.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
net assets acquired and consideration is as follow:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_pn3n3_zmjrW7Xyvmgk" summary="xdx: Disclosure - NOTE 13 - ACQUISITION - Net assets acquired (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B0_zPpkI8Mx7BT7" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Net
    assets acquired</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_498_20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_z4hX3ZMa57A9" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--LeaseholdImprovementsGross_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Leasehold Improvements</span></td><td style="width: 10%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 18%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">550</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_ecustom--DiagnosticEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diagnostic Equipment</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:DiagnosticEquipment" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--FiniteLivedCustomerListsGross_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Customer Lists</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:FiniteLivedCustomerListsGross" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--CovenantNotToCompete_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Covenant Not to Compete</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:CovenantNotToCompete" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--SecurityDeposit_iI_pn3n3_zjVLjuySKGfl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Security Deposit</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_ecustom--ClosingCostsExpensed_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Closing costs - expensed</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="FONR:ClosingCostsExpensed" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--Goodwill_iI_pn3n3_z45ctut2uIAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">284</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Cash Consideration Paid</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--BusinessCombinationConsiderationTransferredOther1_c20210301__20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_pn3n3" title="Cash Consideration Paid" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredOther1" contextRef="From2021-03-012021-03-29_custom_RocklandManagementGroupMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,126</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A7_z07JSnwLhmo7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
results of operations of Rockland Management Group were diminutive and did not affect the pro forma results of operations.<br /></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 22 -->
    <div id="xdx_231_zX9yFC1tBUv5" style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_239_zRUI9VopVabd" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_237_z2RIlv5B42Oa" style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div id="xdx_232_zo0FQHQKIJUh" style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td id="xdx_23C_zhVDEiv588zf" style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zpsAP1791W94" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_232_zfBLSjfZweG3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zQFYvrG36Dk8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_ztB1naR00LQ8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zZIJeA0MZ9Me" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">SEPTEMBER
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zpJ2MSk6CL45" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zJB5Z6kYd24" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zIU1bQsmSNub" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_znQ24BzorLq5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zxokCFuIQRyc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zH4TKZrlW2Bk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_829_zC7T5i4ipTdi" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
14 &#8211; SUBSEQUENT EVENTS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company has evaluated events that occurred subsequent to September 30, 2021 and through the date the condensed consolidated financial
statements were issued.</span></p>

</ix:nonNumeric><p id="xdx_81D_zsxBoq8IczY5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="MDA"></span>Item
2. &#8211; MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">For
the three month period ended September 30, 2021, we reported a net income of $5.2 million on revenues of $23.7 million as compared to
net income of $3.3 million on revenues of $21.0 million for the three month period ended September 30, 2020. Operating income increased
from $4.2 million for the three month period ended September 30, 2020 to $5.7 million for the three month period ended September 30,
2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
revenue increase, from $21.0 million for the first three months of fiscal 2021 to $23.7 million for the first three months of fiscal
2022, was primarily due to increases in patient fee revenue of $1.8 million, from $5.1 million for the first three months of fiscal 2021
to $6.9 million for the first three months of fiscal 2022. Revenues from product sales and service and repair fees increased by $100,000
from $2.0 million for the first three months of fiscal 2020 to $2.1 million for the first three months of fiscal 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">While
our revenues increased, our costs and expenses increased, by a lesser amount resulting in our operating income increasing to $5.7 million
for the three months ended September 30, 2021 as compared to $4.2 million for the three months ended September 30, 2020. In terms of
percentages, costs and expenses increased 6.9% from $16.8 million for the first three months of fiscal 2021 to $18.0 million for the
first three months of fiscal 2022, while revenues increased 13.1%, from $21.0 million for the first three months of fiscal 2021 to $23.7
million for the first three months of fiscal 2022.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Fonar&#8217;s
wholly owned subsidiary, Health Management Corporation of America (&#8220;HMCA&#8221;), has the controlling interest, in Health Diagnostics
Management, LLC (&#8220;HDM&#8221;). HMCA presently has a direct ownership interest of 70.0% in HDM, and the investors in HDM have a
30.0% ownership interest. The management of the diagnostic imaging centers business segment is being conducted by HDM, operating under
the name &#8220;Health Management Company of America&#8221;. For the sake of simplicity, HMCA, and HDM are referred to as &#8220;HMCA&#8221;,
unless otherwise indicated.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
most significant adverse impact on our Company in fiscal 2020 and the first quarter of fiscal 2021 has been the COVID-19 pandemic. Although
it had seemed the worst had passed, by August 2020, subsequent events have shown a spike in new cases and the emergence of new strains
of the virus. This is by no means a problem confined to our Company, but regardless of our best efforts and improved ability to cope
with the pandemic, the impact on our results of operation and financial condition is potentially volatile and severe.<br /></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Since
March 2020 the global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies
which have adversely affected our workforce, liquidity, financial conditions, revenues, profitability and business operations. Generally
COVID-19 has caused us to require that a portion of our workforce work from home and restricted the ability of our personnel to travel
for marketing purposes or to service our customers. During the fourth quarter of fiscal 2020, the Company was able to enact certain decisions
to allow the Company to survive during the global pandemic and prevent further losses or additional decreases in scan volume. Although
we are unable to predict if there will be additional consequences on our operations from the continuing global pandemic of COVID-19,
the Company believes with the positive cash flows, low debt and cash on hand, it will be able to continue operations going forward. One
of the concerns we have are the increased strictness in enforcement of COVID-19 mandates, such as the requirement that employees in healthcare
facilities be vaccinated or frequently tested. We are in fact facing some of these challenges now. So far we have been able to navigate
through these requirements and avoid any significant disruption to our business</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Forward
Looking Statements</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Certain
statements made in this Quarterly Report on Form 10-Q are &#8220;forward-looking statements&#8221; (within the meaning of the Private
Securities Litigation Reform Act of 1995) regarding the plans and objectives of Management for future operations. Such statements involve
known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially
different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking
statements included herein are based on current expectations that involve numerous risks and uncertainties. Our plans and objectives
are based, in part, on assumptions involving the expansion of business. Assumptions relating to the foregoing involve judgments with
respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult
or impossible to predict accurately and many of which are beyond our control. Although we believe that our assumptions underlying the
forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that
the forward-looking statements included in this Report will prove to be accurate. In light of the significant uncertainties inherent
in the forward-looking statement included herein, the inclusion of such information should not be regarded as a representation by us
or any other person that our objectives and plans will be achieved.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Results
of Operations</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">We
operate in two industry segments: the manufacture and servicing of medical (MRI) equipment, which is conducted by Fonar, and diagnostic
facilities management services, which is conducted through HMCA.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Manufacturing
and Service of MRI Equipment</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Revenues
from MRI product sales increased to $148,000 for the first three months of fiscal 2022 from $28,000 for the first three months of fiscal
2021. Costs related to product sales decreased from $132,000 for the three month period ended September 30, 2020 to $109,000 for the
three month period ended September 30, 2021. Economic uncertainty and lower reimbursement rates for MRI scans, have depressed the market
for our MRI scanner products, notwithstanding our scanners&#8217; unique technological capabilities (e.g. multi positional scanning).
Due to the low sales volumes of out MRI product, period to period comparisons are not necessarily indicative of any trends.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Service
revenues remained constant at $2.0 million for the three month period ended September 30, 2020 and $2.0 million for the three month period
ended September 30, 2021. Continuing lower sales volumes have been a factor ultimately contributing to the decrease in service revenues,
as the revenue from new scanners being placed under service agreements, following the expiration of their warranties, is insufficient
to replace the revenue lost as a result of older scanners being taken out of service.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Costs
relating to providing service were $635,000 in the first three months of fiscal 2021 and $734,000 in the first three months of fiscal
2022. Because of our ability to monitor the performance of customers&#8217; scanners from our facilities in Melville, New York on a daily
basis and to detect and repair any irregularities before more serious and costly problems develop, we have been able to control our costs
of providing service.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">There
were approximately $82,000 in foreign revenues for the first three months of fiscal 2022 as compared to approximately $121,000 in foreign
revenues for the first three months of fiscal 2021, representing a decrease in foreign revenues of 32.2%. We do not regard this as a
material trend, but as part of a normal although sometimes volatile variation resulting from low volumes of foreign sales.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">We
recognize MRI scanner sales revenues on the &#8220;percentage of completion&#8221; basis, which means the revenues are recognized as
the scanner is manufactured. Revenues recognized in a particular quarter do not necessarily reflect new orders or progress payments made
by customers in that quarter. We build the scanner as the customer meets certain benchmarks in site preparation and our installation
of the scanner, in order to minimize the time lag between incurring costs of manufacturing and our receipt of the cash progress payments
from the customer which are due upon delivery. Consequently, there can be a disparity between the revenues recognized in a fiscal period
and the number of product sales. Generally, the revenues from a scanner sale are recognized in a fiscal quarter or quarters following
the quarter in which the sale was made.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Revenues
for the medical equipment segment increased to $2.1 million for the first three months of fiscal 2022 from $2.0 million for the first
three months of fiscal 2021. Operating losses for our medical equipment segment decreased to an operating loss of $490,000, for the first
three months of fiscal 2022 as compared to an operating loss of $561,000 for the first three months of fiscal 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diagnostic
Facilities Management Services</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">HMCA
revenues increased in the first three months of fiscal 2022 by 13.8% to $21.6 million from $19.0 million for the first three months of
fiscal 2021. The percentage of our revenues derived from our diagnostic facilities management segment relative to the percentage of our
revenues derived from our medical equipment segment increased slightly to 91.1% for the first three months of fiscal 2022, from 90.6%
for the first three months of fiscal 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">HMCA&#8217;s
current strategy is to counter the effects of lower reimbursement rates by increasing the scan volume of the facilities it owns or
manages by adding additional scanners at current centers and increasing our marketing efforts. As a result of the COVID-19 virus,
however, the Company had seen its scan volume decrease. Nevertheless, the Company continued its program of adding additional
scanners. As a result of the scan volume recovered, even though the continuation of the COVID-19 virus may delay the completion of
the installation of some of the scanners. If scan volumes decrease however, or remain at lower volumes, the Company, notwithstanding
its ample cash reserves, may need to consider reducing the size of its operations temporarily as a last resort. New York State
mandated that as of October 7, 2021, all workers at hospitals, long-term care facilities and diagnostic centers be
COVID-19-vaccinated. Workers who refused to be vaccinated either resigned, were transferred to a non-diagnostic facility within the
company, or were dismissed. The resulting reduction in the number of workers at HMCA-managed sites has been challenging and has
significantly reduced the pool of qualified and vaccinated workers looking for jobs. HMCA-managed sites struggling with reduced
staff either cut their business hours and therefore scan fewer patients or, when possible, maintain regular business hours by paying
employees who are willing to work extra hours at overtime rates. While it is too early to quantify, New York&#8217;s vaccination
mandate is having a negative effect on our business in Fiscal 2022.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Although
the COVID-19 virus and government mandates have adversely affected our marketing efforts our scan volumes in fiscal 2020 and the beginning
of fiscal 2021, the number of scans performed at our centers and at our client&#8217;s centers has recovered to pre-COVID-19 levels and
has increased from approximately 42,000 in the first three months of fiscal 2021 to approximately 48,000 in the first three months of
fiscal 2022.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">We
now manage/own a total of 39 MRI scanners. Twenty-five (25) MRI scanners are located in New York and fourteen (14) are located in Florida.
HMCA experienced an operating income of $6.2 million for the first three months of fiscal 2022 compared to operating income of $4.7 million
for the first three months of fiscal 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
ability of HMCA to maintain its profitability is principally due to HMCA&#8217;s success in marketing the scanning services of the facilities
managed or owned by HMCA, notwithstanding the decrease in reimbursement rates paid for MRI scans by insurers, Medicare and other government
programs and the lockdowns imposed as a result of the COVID-19 virus. The reductions in reimbursement rates are not unique to HMCA or
HMCA&#8217;s clients but are being experienced by the industry in general.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">HMCA&#8217;s
cost of revenues for the first three months of fiscal 2022 as compared to the first three months of fiscal 2021 increased by 22.9% from
$9.5 million to $11.7 million primarily as a result of an increase in scan volume.<br /></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Consolidated</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">For
the first three months of fiscal 2022, our consolidated net revenues increased by 13.1% to $23.7 million from $21.0 million for the first
three months of fiscal 2021, and total costs and expenses increased by 6.9% to $18.0 million from $16.8 million for the first three months
of fiscal 2022 and for the first three months of fiscal 2021 respectively. As a result, our operating income increased to $5.7 million
in the first three months of fiscal 2022 as compared to $4.2 million in the first three months of fiscal 2021. A decrease in selling,
general and other administrative costs in particular resulted in the decrease of cost and expenses.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Selling,
general and administrative expenses decreased to $5.1 million in the first three months of fiscal 2022 from $6.2 million in the first
three months of fiscal 2021. This decrease in selling, general and administrative expenses was due mainly to less reserves taken on management
fees. Some of these reserves had been taken in the ordinary course of business and some in connection with the impact of the COVID-19
virus. The compensatory element of stock issuances, which is included in selling, general and administrative expenses, remained constant
at $0 for the first three months of fiscal 2022 and 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Research
and development expenses decreased by 3.5% to $386,000 for the first three months of fiscal 2022 from $400,000 for the first three months
of fiscal 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Interest
expense in the first three months of fiscal 2021 decreased by 22.7% to $17,000 from $22,000 in the first three months of fiscal 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Inventories
increased to $1.8 million at September 30, 2021 as compared to $1.7 million at June 30, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net
management fee and medical receivables increased by 2.4% to $58.0 million at September 30, 2021 from $56.7 million at June 30, 2021 as
a result of slower collections. The slower collections were primarily due to an increase in no-fault and workers&#8217; compensation
revenue, which typically takes longer to collect.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
results of operations for the first three months of fiscal 2022 reflect an increase in revenues from management, patient and other fees,
as compared to the first three months of fiscal 2021 ($21.6 million for the first three months of fiscal 2022 as compared to $19.0 million
for the first three months of fiscal 2021), and a increase in MRI equipment segment revenues ($2.1 million as compared to $2.0 million).
Revenues were 8.9% from the MRI equipment segment as compared to 91.1% from HMCA, for the first three months of fiscal 2022, as compared
to 9.4% from the MRI equipment segment and 90.6% from HMCA for the first three months of fiscal 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">On
March 27, 2020, the CARES Act was signed into law and is intended to provide over $2 trillion in stimulus benefits for the U.S. economy.
The CARES Act provides for certain federal income tax changes, including an increase in the interest expense tax deduction limitation,
the deferral of the employer portion of Social Security payroll taxes, refundable payroll tax credits, net operating loss carryback periods,
alternative minimum tax credit refunds and bonus depreciation of qualified improvement property. The federal income tax changes brought
about by the CARES Act are complex and further guidance is expected. We received a cash benefit from the ability to receive a full reimbursement
of $1.3 million of tax credits relating to the alternative minimum tax credits in the prior fiscal year plus additional cash benefits
from the deferral of the employer portion of Social Security payroll taxes.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">As
a result of the Patient Protection and Affordable Care Act (PPACA) we have experienced a reduction of reimbursement rates and less interest
in our MRI equipment. Any changes to the PPACA may result in further changes in the healthcare industry and our business.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">We
are committed to improving our operating results and dealing with the challenges posed by legislative and regulatory requirements. Nevertheless,
factors beyond our control, such as the COVID-19 virus, the timing and rate of market growth, economic conditions, the availability of
credit and payor reimbursement rates, or unexpected expenditures and the timing of such expenditures, make it difficult to forecast future
operating results.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">As
mentioned, one of the effects of the PPACA on our business has been the reduction in Medicare reimbursement rates for MRI scans. This
also has resulted in a reduction in the reimbursement rates by commercial insurers and government programs which tie their reimbursement
rates to the Medicare rates. Nevertheless, the patient volume of the scanning centers we manage or own has enabled us to maintain healthy
operating results in spite of these challenges. We believe we are pursuing the correct policies to cope with these problems and the problems
caused by the COVID-19 pandemic, and to improve the Company&#8217;s operating results.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Our
Upright&#174; MRI (also referred to as the Stand-Up&#174; MRI), together with our works-in-progress, are intended to significantly improve
our competitive position.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Upright&#174; MRI scanner, which operates at 6000 gauss (.6 Tesla) field strength, allows patients to be scanned while standing, sitting,
reclining and in multiple flexion and extension positions. It is common in visualizing the spine that abnormalities are visualized in
some positions and not others. This enables surgical corrections that heretofore would not have been addressable for lack of visualizing
the symptom causing the pathology and therefore, in general enables the treating physician to achieve a better treatment outcome for
his patient. A floor-recessed elevator brings the patient to the height appropriate for the targeted image region. A custom-built multi-position
adjustable bed will allow patients to sit or lie on their backs, sides or stomachs at any angle. This allows the MRI technologist to
ask the patient to position himself/herself in the exact position that generates his/her pain so that images of the patient in the position
that explicitly generates the patient&#8217;s pain can be nailed down. Full-range-of-motion studies of the joints in virtually any direction
are possible, a particularly promising feature for sports injuries.<br /></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">In
addition FONAR has announced the publication of a book &#8220;THE CRANIOCERVICAL SYNDROME and MRI&#8221; that highlights the unique attributes
of FONAR UPRIGHT&#174; MRI Imaging (S. Karger, A.G. based in Basel, Switzerland- www.karger.com/Book/Home/261956) which has been published
by S. Karger, an approximately 125 year old company and an academic publisher of scientific and medical journals and books. The seven
chapter monograph examines the rapid advances in MRI made possible by the FONAR UPRIGHT&#174; Multi-Position MRI that are transforming
the treatment of patients suffering from the craniocervical syndrome (CCS). It is written by leading international experts in the field
to practitioners with a better understanding of the subtle anatomy and MRI appearances at the craniocervical junction, along with insight
into the clinical significance of cerebrospinal fluid (CSF) flow measurements and its potential role in generating the devastating impairments
of the neurodegenerative diseases: Alzheimer&#8217;s (5.1 million patients in the United States), childhood and adult Autism (3.0 million),
Parkinson&#8217;s (1.0 million), Multiple Sclerosis (250,000-350,000) and Amyotrophic Lateral Sclerosis (ALS) (30,000). It calls attention
to the revolutionary importance of FONAR&#8217;s UPRIGHT&#174; MRI imaging technology and the prospect of significantly relieving the
suffering of the above totaled 9.38 million patients afflicted with these disorders.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Fonar
also announced a major diagnostic breakthrough in multiple sclerosis achieved with advanced Upright&#174; MRI. Medical researchers at
FONAR published a paper reporting a diagnostic breakthrough in multiple sclerosis (MS), based on observations made possible by the Company&#8217;s
unique Upright&#174; Multi-Position&#8482; MRI scanner. The findings reveal that the cause of multiple sclerosis may be biomechanical
and related to earlier trauma to the neck, which can result in obstruction of the flow of cerebrospinal fluid (CSF), which is produced
and stored in the central anatomic structures of the brain known as the ventricles. Since the ventricles produce a large net volume of
CSF each day (500 cc), the obstruction can result in a build up of pressure within the ventricles, resulting in leakage of the CSF and
the antigenic polypeptides it contains into the surrounding brain tissue. This leakage could be responsible for generating the brain
lesions of multiple sclerosis.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
paper, titled &#8220;The Possible Role of Cranio-Cervical Trauma and Abnormal CSF Hydrodynamics in the Genesis of Multiple Sclerosis,&#8221;
appears in the journal Physiological Chemistry and Physics and Medical NMR (Sept. 20, 2011).</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">This
capability of the Fonar Upright&#174; technology has demonstrated its key value on patients with the Arnold-Chiari syndrome [Cerebellar
Tonsil Extopia (CTE)], which is believed to affect 200,000 to 500,000 Americans. In this syndrome, brain stem compression and subsequent
severe neurological symptoms occur in these patients, because the brain stem descends and is compressed at the base of the skull in the
foramen magnum, which is the circular bony opening at the base of the skull where the spinal cord exits the skull. Conventional lie-down
MRI scanners cannot make an adequate evaluation of this pathology since the patient&#8217;s pathology is most visible and the symptoms
most acute when the patient is scanned in the upright fully weight-bearing position.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">A
combined study of 1,200 neck pain patients published in &#8220;Brain Injury&#8221; (July 2010) by eight university medical centers reported
that cerebellar tonsil ectopia (CTE) of 1mm or greater was found and visualized 2.5 times (250%) more frequently when patients who had
sustained automobile whiplash injuries were scanned upright rather than lying down.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Upright&#174; MRI has also demonstrated its value for patients suffering from scoliosis. Scoliosis patients have been typically subjected
to routine x-ray exams for years and must be imaged upright for an adequate evaluation of their scoliosis. Because the patient must be
standing for a complete evaluation of the extent of the patient&#8217;s scoliosis, an x-ray machine has been the only modality that could
provide that service. The Upright&#174; MRI is the only MRI scanner which allows the patient to stand during the MRI exam. Fonar has
developed an RF receiver and scanning protocol that for the first time allows scoliosis patients to obtain diagnostic pictures of their
spines without the risks of x-rays. A study by the National Cancer Institute (2000) of 5,466 women with scoliosis reported a 70% increase
in breast cancer resulting from 24.7 chest x-rays these patients received on the average in the course of their scoliosis treatment.
The Upright&#174; MRI examination of scoliosis enables the needed imaging evaluation of the degree of spine scoliosis without exposing
the patient to the risk of breast cancer from x-radiation. Currently scoliosis affects more than 3,000,000 American women.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">In
addition, the University of California, Los Angeles (UCLA) reported their results of their study of 1,302 patients utilizing the Fonar
Upright&#174; MRI at the 22nd Annual Meeting of the North American Spine Society on October 23, 2007. The UCLA study showed the superior
ability of the Fonar Upright&#174; MRI to detect spine pathology, including spondylolisthesis, disc herniations and disc degeneration,
as compared to visualizations of the spine produced by traditional single position static MRIs.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;The
UCLA study by MRI of 1,302 back pain patients when they were in the Fonar Upright&#174; MRI and examined in a full range of flexion and
extension positions made possible by Fonar&#8217;s new Upright&#174; technology established that significant &#8220;misses&#8221; of
pathology were occurring with static single position MRI imaging. At L4-5, the vertebral level responsible for 49.8% of lumbar disc herniations,
35.1% of the spondylolistheses (vertebral instabilities) visualized by the Upright&#174; MRI, were being missed by static single position
MRI (510 patients). Since this vertebral segment is responsible for the majority of all disc herniations, the finding may reveal a significant
cause of failed back surgeries. The UCLA study further showed the &#8220;miss-rate&#8221; of vertebral instabilities by static only MRI
was even higher, 38.7%, at the L3-4 vertebral segment. Additionally, the UCLA study showed that MRI examinations of the cervical spine
that did not perform extension images of the neck &#8220;missed&#8221; disc bulges 23.75% of the time (163 patients).</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
UCLA study further reported that they were able to quantitatively measure the dimensions of the central spinal canal with the &#8220;highest
accuracy&#8221; using the FONAR Upright&#174; MRI thereby enabling the extent of spinal canal stenosis that existed in patients to be
measured. Spinal canal stenosis gives rise to the symptom complex intermittent neurogenic claudication manifest as debilitating pain
in the back and lower extremities, weakness and difficulties in ambulation and leg paresthesias. Spinal canal stenosis is a spinal compression
syndrome separate and distinct from the more common nerve compression syndrome of the spinal nerves as they exit the vertebral column
through the bony neural foramen.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Fonar Upright&#174; MRI can also be useful for MRI directed emergency neuro-surgical procedures as the surgeon would have unhindered
access to the patient&#8217;s head when the patient is supine with no restrictions in the vertical direction. This easy-entry, mid-field-strength
scanner could prove ideal for trauma centers where a quick MRI-screening within the first critical hour of treatment will greatly improve
patients&#8217; chances for survival and optimize the extent of recovery.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;MRI
has brought a new dimension to MEDICAL TREATMENT, the power to VISUALIZE ANATOMIC DETAIL in the body&#8217;s VITAL SOFT TISSUES (brain,
heart, kidney, liver, spleen, lungs, pancreas, intestines) plus MRI&#8217;s new power to non-invasively QUANTIFY (e.g. measure T1, T2,
diffusion, chemical spectra) the response of these VITAL TISSUES to treatment.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Liquidity
and Capital Resources</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Cash
and cash equivalents, and short term investments decreased by 2.4% from $44.5 million at June 30, 2021 to $43.4 million at September
30, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Cash
provided by operating activities for the first three months of fiscal 2022 was $1.2 million. Cash provided by operating activities was
attributable principally to net income of $5.2 million, depreciation and amortization of $1.2 million, amortization on right-to-use assets
of $648,000, provision for bad debts of $502,000 and deferred income tax of $1.2 million, offset by an increase in accounts, management
fee receivables and medical receivables of $1.7 million and a decrease in other current liabilities of $3.4 million.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Cash
used in investing activities for the first three months of fiscal 2022 was $1.2 million. Cash used in investing activities during the
first three months of fiscal 2022 consisted of patent costs of $29,000 and the purchase of property and equipment of $1.2 million.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Cash
used in financing activities for the first three months of fiscal 2022 was $1.1 million. The principal uses of cash in financing activities
during the first three months of fiscal 2022 were the repayment of principal on long-term debt and capital lease obligations of $7,000
and distributions to non-controlling interests of $1.1 million.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total
liabilities decreased by 9.9% to $48.8 million at September 30, 2021 from $54.1 million at June 30, 2021. &#8220;Other&#8221; current
liabilities decreased by 34.6% to $6.0 million at September 30, 2021 from $9.2 million at June 30, 2021. The current portion of our service
contract liabilities remained constant at $4.4 million. Customer deposits increased from $731,000 at June 30, 2021 to $789,000 at September
30, 2021 as a result of an increase in services performed.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">As
of September 30, 2021, the total of $6.0 million in &#8220;other&#8221; current liabilities included accrued salaries and payroll taxes
of $3.6 million, and sales taxes of $674,000 plus accrued interest and penalties of $279,000.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Our
working capital increased to $93.1 million at September 30, 2021 from $88.5 million at June 30, 2021. This resulted from an increase
in current assets ($108.6 million at June 30, 2021 as compared to $109.4 million at September 30, 2021), and a decrease in current liabilities
from $20.0 million at June 30, 2021 to $16.2 million at September 30, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry, and tax planning strategies in making this assessment. At the present, the Company
believes that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized.
In recognition of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, (principally
related to research and development tax credits and allowance for doubtful accounts). A valuation allowance will be maintained until
sufficient positive evidence exists to support the reversal of any portion or all of the valuation allowance.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company&#8217;s effective income tax rate is based on expected income, statutory rates and tax planning opportunities available in the
various jurisdictions in which it operates. For interim financial reporting, the Company estimates the annual income tax rate based on
projected taxable income for the full year and records a quarterly income tax provision or benefit in accordance with the anticipated
annual rate. The Company refines the estimates of the year&#8217;s taxable income on a periodic basis as new information becomes available,
including actual year-to-date financial results. This continual estimation process often results in a change to the expected effective
income tax rate for the year. When this occurs, the Company adjusts the income tax provision during the quarter in which the change in
estimate occurs so that the year-to-date provision reflects the expected income tax rate. Significant judgment is required in determining
the effective tax rate and in evaluating tax positions.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">On
March 27, 2020 Congress enacted the CARES Act (Coronavirus Aid, Relief and Economic Security Act). The Act provides numerous tax provisions
and other stimulus measures, including temporary changes regarding prior and future operating losses, temporary changes to the prior
and future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social
Security taxes, technical corrections to prior tax legislation for tax depreciation of certain qualified improvement property and the
creation of refundable employee retention credits. At the present time, the only impact of the CARES Act to the Company is allowing a
full reimbursement of $1.3 million of tax credits relating to the alternative minimum tax credits in prior fiscal years. Before the CARES
Act, these credits were to be refunded over a period of 3 years. We will also realize a cash benefit from the deferral of Social Security
payroll taxes.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">On
June 30, 2020, we entered into a $701,000 loan agreement under the Paycheck Protection Program (PPP) under the CARES Act that provides
for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses. The Company applied for this
additional loan exclusively for the Florida locations during June 2020 due to the fact that the COIVD-19 virus was increasing in Florida.
The loans and accrued interest are forgivable after 24 weeks as long as the proceeds are used for eligible purposes, including payroll,
benefits, rent and utilities and maintains certain payroll levels. The amount of loan forgiveness will be reduced if the borrower terminates
employees or reduces salaries during the 24 week period. This loan was forgiven during August 2021 in its entirety.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Fonar
is committed to making capital expenditures for the remainder of the 2022 fiscal year, for placing three additional scanners at facilities
located in Florida and New York. One of the facilities in Florida will be a new stand-alone facility and another will be the addition
of an additional machine in a current Florida location. The location in New York will also be a new stand-alone facility. The current
estimated costs of these capital expenditures is approximately $3.0 million.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Critical
to our business plan are the improvement and expansion of the MRI facilities managed or owned by HMCA, and increasing the number of scans
performed at those facilities. In addition, our business plan calls for a continuing commitment to providing our customers with enhanced
equipment service and maintenance capabilities and delivering state-of-the-art, innovative and high quality equipment and upgrades at
competitive prices.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management
is seeking to promote wider market recognition of Fonar&#8217;s scanner products, and to increase demand for Upright&#174; scanning at
the facilities HMCA owns or manages. Given the liquidity and credit constraints in the markets, the uncertainty resulting from the Patient
Protection and Affordable Care Act or its repeal or modification, and the impact of the COVID-19 virus on the economy in general, the
sale of medical equipment has and may continue to suffer.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company believes that its business plan has been responsible for the past eight consecutive fiscal years and first fiscal quarter of
fiscal 2022 of profitability and that its capital resources will be adequate to support operations through at least September 30, 2022.
The future effects on our business of healthcare legislation, the impact of the COVID-19 virus, the Deficit Reduction Act, the 2.3% excise
tax on sales of medical equipment, reimbursement rates, public health conditions and the general economic and business climate are not
known at the present time. Nevertheless, there is a possibility of adverse consequences to our business operations from these causes.
Although the Company can not predict the full effect of COVID-19 for the first fiscal quarter or any later period, the Company believes
that it has adequate revenues, cash reserves and other assets that will enable it to continue to operate until at least September 30,
2022.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="QualitativeDisclosures"></span>Item
3. Quantitative and Qualitative Disclosures About Market Risk</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company maintains its funds in liquid accounts. None of our investments are in fixed rate instruments.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">All
of our revenue, expense and capital purchasing activities are transacted in United States dollars.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="ControlsAndProcedures"></span>Item
4. Controls and Procedures.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Disclosure
Controls and Procedures</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">We
carried out an evaluation as of the end of the period covered by this Quarterly Report on Form 10-Q, under the supervision and with the
participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design
and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act
of 1934, as amended (the &#8216;&#8216;Exchange Act&#8217;&#8217;). Disclosure controls and procedures include, without limitation, controls
and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under
the Exchange Act is accumulated and communicated to the issuer&#8217;s management, including its principal executive and principal financial
officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based upon
our evaluation, our chief executive officer and chief financial officer have concluded that the Company&#8217;s internal control over
financial reporting was effective as of the September 30, 2021, in ensuring that material information that we are required to disclose
in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the same time periods
specified in the Securities and Exchange Commission rules and forms.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Changes
in Internal Control over Financial Reporting</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">There
were no changes in our system of internal control over financial reporting during our most recently completed fiscal quarter that have
materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">PART
II &#8211; OTHER INFORMATION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="LegalProceedings"></span>Item
1 &#8211; Legal Proceedings:&#9;There were no material changes in litigation from that reported in our Form 10-K for the fiscal year
ended June 30, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="RiskFactors"></span>Item
1A &#8211; Risk Factors: An investment in the securities of the Company is subject to various risks, the most significant of which are
summarized below.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1.
Reduced Reimbursement Rates. Most of our revenues are derived from our scanning center business conducted by HMCA. Our scanning center
clients and the Florida facilities owned by HMCA are experiencing lower reimbursement rates from Medicare, other government programs
and private insurance companies. To date, the impact of these reductions has been countered by increasing scanning volume notwithstanding
the COVID-19 pandemic, and reducing our operating expenses, thereby maintaining profitability in this business segment. There is, however,
no assurance that we will be able to continue to do so.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2.
Demand for MRI Scanners. The reduced reimbursement rates also affects our sales of MRI scanners negatively. With lower revenue projections,
prospective customers would demand lower prices for scanners. Although the reduced reimbursements may not affect foreign demand, a lower
number of sales in the aggregate could reduce economies of scale and consequently, profit margins.&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3.
Manufacturing Competition. Many if not most of our competing scanner manufacturers have significantly greater financial resources, production
capacity, and other resources than we do. Such competitors would include General Electric, Siemens, Hitachi and Phillips. Although Fonar
is the only company which can manufacture and sell the unique Stand-Up&#174; (Upright&#174;) MRI scanner, potential customers must be
convinced that the purchase of a Fonar scanner is their best choice. We believe that with time, that objective will be reached, particularly
with customers scanning patients having neck, back, knee and various orthopedic issues who would benefit from being scanned in weight-bearing
positions.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4.
Dependence on Referrals. HMCA derives substantially all of its revenue, directly or indirectly, from fees charged for the diagnostic
imaging services performed at the facilities. We depend on referrals of patients from unaffiliated physicians and other third parties
to the facilities we manage or own for the services we perform. If these physicians and other third parties were to reduce the number
of patients they refer or discontinue referring patients, scan volumes could decrease, which would reduce our net revenue and operating
margins.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5.
Pressure to Control Healthcare Costs. One of the principal objectives of health maintenance organizations and preferred provider organizations
is to control the cost of healthcare services. Healthcare providers participating in managed care plans may be required to refer diagnostic
imaging tests to certain providers depending on the plan in which a covered patient is enrolled. In addition, managed care contracting
has become very competitive. The expansion of health maintenance organizations, preferred provider organizations and other managed care
organizations in New York or Florida could have a negative impact on the utilization and pricing of services performed at the facilities
HMCA manages or owns to the extent these organizations exert control over patients&#8217; access to diagnostic imaging services, selections
of the provider of such services and reimbursement rates for those services.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6.
Scanning Facility Competition. The market for diagnostic imaging services is highly competitive. The facilities we manage or own compete
for patients on the basis of reputation, location and the quality of diagnostic imaging services. Groups of radiologists, established
hospitals, clinics and other independent organizations that own and operate imaging equipment are the principal competitors.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">7.
Eligibility Changes to Insurance Programs. Due to potential decreased availability of healthcare through private employers, the number
of patients who are uninsured or participate in governmental programs may increase. Healthcare reform legislation will continue to increase
the participation of individuals in the Medicaid program in states that elect to participate in the expanded Medicaid coverage. A shift
in payor mix from managed care and other private payors to government payors or an increase in the number of uninsured patients may result
in a reduction in the rates of reimbursement or an increase in uncollectible receivables or uncompensated care, with a corresponding
decrease in net revenue. Policies now being offered under various insurance plans are expected to reduce demand for MRI scans as they
become less affordable. Changes in the eligibility requirements for governmental programs such as the Medicaid program and state decisions
on whether to participate in the expansion of such programs also could increase the number of patients who participate in such programs
and the number of uninsured patients. Even for those patients who remain in private insurance plans, changes to those plans could increase
patient financial responsibility, resulting in a greater risk of uncollectible receivables. These factors and events could have a material
adverse effect on our business, financial condition, and results of operations.&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">8.
Possible changes in Florida Insurance Law. In early 2019, two senate bills and one house bill in Florida were introduced, all of them
calling for the repeal of PIP and replacing PI with $25,000 Bodily Injury Coverage and Property Damage Liability Coverage. Another Florida
senate bill was introduced that would preserve PIP but dramatically cut reimbursement rates. None of the proposed bills ever made it
onto the 2019 legislative agenda. During Fonar&#8217;s fiscal 2021, the Florida house and senate reached an agreement and passed similar
legislation. It was, however, vetoed by the Governor. We cannot predict whether such efforts by the Florida legislature will continue
or be successful. Currently, drivers and passengers get car damages and PIP, paid for up to $10,000, no matter who is at fault in an
accident. Drivers have to pay an additional cost to insurance companies to pay for bodily injuries which covers them if they are at fault.
While PIP is required, coverage for bodily injury is not.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Over
the past several years there have been various bills introduced by a number of Florida legislators to eliminate PIP and instead mandate
coverage including some combination of a minimum of bodily injury and a reduced or no amount of medical payments (Medpay coverage). Eliminating
PIP would mean that the $10,000 drivers now get paid toward medical costs through their insurers might not be there for them to pay for
injured drivers. Importantly, payments would be reduced by approximately 60% due to claims being paid at commercial rates or through
legal settlements instead of at the presently prevailing PIP fee schedule. This would negatively impact our Florida diagnostic imaging
facilities (both those we own and those we manage) with more unpaid bills, lower reimbursement rates and elongated waiting times. To
date proponents of these changes have been unsuccessful.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">9.
Federal and state privacy and information security laws. We must comply with numerous federal and state laws and regulations governing
the collection, dissemination, access, use, security and privacy of Protected Health Information (&#8216;PHI&#8217;), including Health
Insurance Portability and Accountability Act (&#8216;HIPAA&#8217;) and its implementing privacy and security regulations, as amended
by the federal Health Information Technology for Economic and Clinical Health (&#8216;HITECH&#8217;) Act and collectively referred to
as HIPAA. If we fail to comply with applicable privacy and security laws, regulations and standards, properly maintain the integrity
of our data, protect our proprietary rights to our systems, or defend against cybersecurity attacks, our business, reputation, results
of operations, financial position and cash flows could be materially and adversely affected.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Information
security risks have significantly increased in recent years because of the proliferation of new technologies, the use of the internet
and telecommunications technologies to conduct our operations, and the increased sophistication and activities of organized crime, hackers,
terrorists and other external parties, including foreign state agents. Our operations rely on the secure processing, transmission and
storage of confidential, proprietary and other information in our computer systems and networks.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">10.
COVID-19. Although we believe we have taken the proper steps and are making a good recovery from the impact of the first wave of the
COVID-19 virus, new strains of the disease have developed and future variants may continue to develop. The course and severity of the
virus in the following months, and the ultimate and economic and medical impact it will have worldwide and at home, have so far eluded
more than minimal predictability.&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">11.
Other changes in Domestic and Worldwide Economic Conditions. We are subject to risk arising from adverse changes in general domestic
and global economic and other conditions, including recessions or economic slowdowns and disruptions of credit markets. Turbulence and
uncertainty in the United States and international markets and economies may adversely affect our workforce, liquidity, financial condition,
revenues, profitability and business operations generally.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="UseOfProceeds"></span>Item
2 &#8211; Unregistered Sales of Equity Securities and Use of Proceeds: None</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="DescriptionOfSecurities"></span>Item
3 - Defaults Upon Senior Securities: None</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="CautionaryNote"></span>Item
4 - Mine Safety Disclosure: Not Applicable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="MoreInformation"></span>Item
5 - Other Information: None</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="Exhibits"></span>Item
6 - Exhibits and Reports on Form 8-K:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0; width: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0; line-height: 115%; width: 5%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">a)</span></td>
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0; width: 90%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-31.htm">Exhibit 31.1 Certification</a>. See Exhibits</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">b)</span></td>
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-32.htm">Exhibit 32.1 Certification</a>. See Exhibits</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0; text-indent: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-indent: 0; line-height: 115%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">c)</span></td>
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501921000032/fonar_8k.htm" style="-sec-extract: exhibit">Report on Form 8-K filed on October 12, 2021, Item 2.02: Results of Operations and Financial Condition for the fiscal year ended June 30, 2021</a>.</span></td></tr>
</table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="Signatures"></span>SIGNATURES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 55%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; width: 45%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Registrant)</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 11pt/115% Calibri, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">By:
/s/ Timothy Damadian</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Timothy
Damadian</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">President
and</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Principal
Executive Officer</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 11pt/115% Calibri, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">/s/
Raymond V. Damadian</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Raymond
V. Damadian</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Chairman
of the Board,</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Treasurer
and</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Acting
Principal Financial Officer</span></td></tr>
</table>



<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Dated:
November 15, 2021</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Page
37</span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 2pt solid; font-size: 1pt; width: 100%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>



<p style="margin: 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>fonar_exhibit-31.htm
<DESCRIPTION>SECTION 302 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Exhibit
31.1</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">CERTIFICATION</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Timothy
Damadian and Raymond V. Damadian each certify that:</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">I
                                            have reviewed this report on Form 10-Q of Fonar Corporation;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Based
                                            on my knowledge, this report does not contain any untrue statement of a material fact or
                                            omit to state a material fact necessary to make the statements made, in light of the circumstances
                                            under which such statements were made, not misleading with respect to the period covered
                                            by this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Based
                                            on my knowledge, the financial statements, and other financial information included in this
                                            report, fairly present in all material respects the financial condition, results of operations
                                            and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">I
                                            am responsible for establishing and maintaining disclosure controls and procedures (as defined
                                            in Exchange Act Rules 13a-15(e) and 15(e)) and internal control over financial reporting
                                            (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f) for the registrant and have:</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">designed
                                            such disclosure controls and procedures or caused such disclosure controls over procedures
                                            to be designed under my supervision to ensure that material information relating to the registrant,
                                            including its consolidated subsidiaries, is made known to us by others within those entities,
                                            particularly during the period in which this report is being prepared;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">designed
                                            such internal control over financial reporting, or caused such internal control over financial
                                            reporting to be designed under my supervision, to provide reasonable assurance regarding
                                            the reliability of financial reporting and the preparation of financial statements for external
                                            purposes in accordance with generally accepted accounting principles;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">evaluated
                                            the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented
                                            in this report my conclusions about the effectiveness of the disclosure controls and procedures
                                            as of the end of the period covered by this report; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">disclosed
                                            in this report any change in the registrant&rsquo;s internal control over financial reporting
                                            that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
                                            fourth fiscal quarter in the case of an annual report) that has materially affected, or is
                                            reasonably likely to materially affect, the registrant&rsquo;s internal control over financial
                                            reporting; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">I
                                            have disclosed, based on my most recent evaluation of internal control over financial reporting,
                                            to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board
                                            of directors (or persons performing the equivalent functions):</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">all
                                            significant deficiencies and material weaknesses in the design or operation of internal control
                                            over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
                                            ability to record, process, summarize and report financial information; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Any
                                            fraud, whether or not material, that involves management or other employees who have a significant
                                            role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Date:
November 15, 2021</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">____________________________</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">/s/
Timothy Damadian</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Timothy
Damadian</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">President
and</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Principal
Executive Officer</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">____________________________</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">/s/
Raymond V. Damadian</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Raymond
V. Damadian</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Chairman
of the Board, Treasurer and</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Acting
Principal Financial Officer</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>3
<FILENAME>fonar_exhibit-32.htm
<DESCRIPTION>SECTION 906 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Exhibit
32.1</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">CERTIFICATION
PURSUANT TO</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">18
U.S.C. SECTION 1350,</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">AS
ADOPTED PURSUANT TO</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">In
connection with the Quarterly Report of FONAR Corporation and Subsidiaries (the &ldquo;Company&rdquo;) on Form 10Q for the fiscal
quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;),
I, Timothy Damadian, President and Chief Executive Officer, and I, Raymond V. Damadian, Chairman of the Board, Treasurer and Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley
Act of 2002, that:</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/Timothy
Damadian</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">____________________________</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Timothy
Damadian</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">President
and Chief Executive Officer</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
Raymond V. Damadian</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">____________________________</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Raymond
V. Damadian</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Chairman
of the Board, Treasurer and</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Chief
Financial Officer</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 4in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">November 15, 2021</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">A
signed original of this written statement required by Section 906 has been provided to Fonar Corporation and will be retained
by Fonar Corporation and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>fonar-logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar-logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "8 ^<# 2(  A$! Q$!_\0
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M$:C^%I9B?S ']:SF^+7B GY;730/0Q2'_P!G%<)16+Q-5]3T8Y/@E_R[_/\
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M;$VMOF.(=C@\G\:Y>O.JXN2DU'8^LP>0TIT8RK7YF>V_\+5\.?\ 3Y_WX_\
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MFR[_ ,+5\.?]/G_?G_Z]'_"U?#OI>?\ ?G_Z]>*45YWURH?6?ZO83N_O_P"
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M)\[6HU*,^2HK,6BBBJ,CP7XB_P#(]7_TC_\ 05KE>WX?TKJ?B+_R/5_](_\
MT%:Y7M^%>)6_B2/TC+_]UI^B_(7O1V_S[4=Z!T'^?2LSK#_"BD[4M !1110
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M #[P?]_EH_X5AXF_Y]X/^_RUVG_"VM$_Y]KW_OA?\:/^%M:)_P ^U[_WPO\
MC1[+#?S?B'U[-_\ GW^'_!.+_P"%8>)O^?>#_O\ +1_PK#Q-_P ^\'_?Y:[3
M_A;6A_\ /M>_]\+_ (T?\+:T/_GVO?\ OA?\:/98;^;\0^O9O_S[_#_@G%_\
M*P\3?\^\'_?Y:/\ A6/B;_GW@_[_ "UVG_"VM$_Y]KW_ +X7_&C_ (6UH?\
MS[7O_?"_XT>RPW\WXA]>S?\ Y]_A_P $XO\ X5CXF_Y]X/\ O\M'_"L?$W_/
MO!_W^6NT_P"%M:'_ ,^U[_WPO^-'_"VM#_Y]KW_OVO\ C1[+#?S?B'U[-_\
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ML&[X>#\E^04445!TA1110!Z]\(?^0)J'_7P/_017HPKSKX0_\@2__P"O@?\
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M/^?C^X^D_P"WM)_Z"-M_W\%']O:3_P!!&V_[^"OFS ]!1@>@H^O/L'^K4/\
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MAK K?\$_\CEI?_77^AJZ?QHYL9_N\_1_D?0M%%%>X?FH4444 %%%% !1110
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M3NKH_.9PE"3A+="T444R0KSKXN_\@2P_Z^#_ .@UZ+7G/Q=_Y EA_P!?!_\
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MY3PN'<$^1;+HC<_X3+Q%_P!!:X_[ZH_X3+Q%_P!!:X_[ZK#HI>TGW+^J8?\
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M"O.OB[_R!+#_ *^#_P"@UZ(:\[^+O_($L?\ KX/_ *#6.(_A,]#*O]\I^O\
MF>04445XQ^AB4M%% !1110 =**** "BBB@ HHHH **** "BBB@ HHH- !10,
M Y(S6UHU]H=K,C:II<MR >JRX'Y=Z<5=[V,JM1PBY*+?H5]&T#4=>NU@L8&;
MGYI",(GU->Z>%O"]IX8T_P B ^9,YW2S,.6./T''2JWAKQ)X;O8%M=*>&V('
M$! 0_P#UZZ:O4P]&$%S)W9\5FN8XBO+V<X\L5T_S%HHHKJ/&/!/B+_R/5_\
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M_06_\A?_ %Z/JM7L']MX+^;\&>845ZA_PI]O^@M_Y"_^O1_PI]O^@M_Y"_\
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M']^W'H/N445H\/"45%[(XZ>9UZ=:5:-N:6^A4_X53XD_OZ?_ -_V_P#B:/\
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E')M2;4HXT$ZQA-D@;.TOG^8HHHKIIP4(\J/(Q5>>(JNK/=G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>fonr-20210930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 8KlZs7xRiXgen8uCandcSaCFScPtxJFzmZkhv2p/fRlqny8k9SnMcyKeCYHmsV8F -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:FONR="http://fonar.com/20210930" elementFormDefault="qualified" targetNamespace="http://fonar.com/20210930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://fonar.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" id="CondensedConsolidatedStatementsOfIncome">
	  <link:definition>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" id="CondensedConsolidatedStatementsOfChangesInEquity">
	  <link:definition>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" id="CondensedConsolidatedStatementsOfCashFlows">
	  <link:definition>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentation" id="Note1DescriptionOfBusinessAndBasisOfPresentation">
	  <link:definition>00000007 - Disclosure - NOTE 1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" id="Note2-SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" id="Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable">
	  <link:definition>00000009 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note4OperatingFinancingLeases" id="Note4OperatingFinancingLeases">
	  <link:definition>00000010 - Disclosure - NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5-Inventories" id="Note5-Inventories">
	  <link:definition>00000011 - Disclosure - NOTE 5 - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6ContractAssetsAndLiabilities" id="Note6ContractAssetsAndLiabilities">
	  <link:definition>00000012 - Disclosure - NOTE 6 &#8211; CONTRACT ASSETS AND LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7OtherIntangibleAssets" id="Note7OtherIntangibleAssets">
	  <link:definition>00000013 - Disclosure - NOTE 7 &#8211; OTHER INTANGIBLE ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8OtherCurrentLiabilities" id="Note8OtherCurrentLiabilities">
	  <link:definition>00000014 - Disclosure - NOTE 8 &#8211; OTHER CURRENT LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note9-SegmentAndRelatedInformation" id="Note9-SegmentAndRelatedInformation">
	  <link:definition>00000015 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note10SupplementalCashFlowInformation" id="Note10SupplementalCashFlowInformation">
	  <link:definition>00000016 - Disclosure - NOTE 10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note11CommitmentsAndContingencies" id="Note11CommitmentsAndContingencies">
	  <link:definition>00000017 - Disclosure - NOTE 11 &#8211; COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note12-IncomeTaxes" id="Note12-IncomeTaxes">
	  <link:definition>00000018 - Disclosure - NOTE 12 - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note13Acquisition" id="Note13Acquisition">
	  <link:definition>00000019 - Disclosure - NOTE 13 &#8211; ACQUISITION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note14SubsequentEvents" id="Note14SubsequentEvents">
	  <link:definition>00000020 - Disclosure - NOTE 14 &#8211; SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" id="Note2-SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000021 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" id="Note2-SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000022 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" id="Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables">
	  <link:definition>00000023 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note4OperatingFinancingLeasesTables" id="Note4OperatingFinancingLeasesTables">
	  <link:definition>00000024 - Disclosure - NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5-InventoriesTables" id="Note5-InventoriesTables">
	  <link:definition>00000025 - Disclosure - NOTE 5 - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6ContractAssetsAndLiabilitiesTables" id="Note6ContractAssetsAndLiabilitiesTables">
	  <link:definition>00000026 - Disclosure - NOTE 6 &#8211; CONTRACT ASSETS AND LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7OtherIntangibleAssetsTables" id="Note7OtherIntangibleAssetsTables">
	  <link:definition>00000027 - Disclosure - NOTE 7 &#8211; OTHER INTANGIBLE ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8OtherCurrentLiabilitiesTables" id="Note8OtherCurrentLiabilitiesTables">
	  <link:definition>00000028 - Disclosure - NOTE 8 &#8211; OTHER CURRENT LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note9-SegmentAndRelatedInformationTables" id="Note9-SegmentAndRelatedInformationTables">
	  <link:definition>00000029 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note13AcquisitionTables" id="Note13AcquisitionTables">
	  <link:definition>00000030 - Disclosure - NOTE 13 &#8211; ACQUISITION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" id="Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative">
	  <link:definition>00000031 - Disclosure - NOTE 1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" id="Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details">
	  <link:definition>00000032 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000033 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails">
	  <link:definition>00000034 - Disclosure - NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails">
	  <link:definition>00000035 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails">
	  <link:definition>00000036 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" id="Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative">
	  <link:definition>00000037 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails" id="Note4-OperatingFinancingLeases-LeasePaymentsDetails">
	  <link:definition>00000038 - Disclosure - NOTE 4 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note4OperatingFinancingLeasesDetailsNarrative" id="Note4OperatingFinancingLeasesDetailsNarrative">
	  <link:definition>00000039 - Disclosure - NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5-Inventories-InventoriesDetails" id="Note5-Inventories-InventoriesDetails">
	  <link:definition>00000040 - Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" id="Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details">
	  <link:definition>00000041 - Disclosure - NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" id="Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails">
	  <link:definition>00000042 - Disclosure - NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative" id="Note7OtherIntangibleAssetsDetailsNarrative">
	  <link:definition>00000043 - Disclosure - NOTE 7 &#8211; OTHER INTANGIBLE ASSETS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" id="Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details">
	  <link:definition>00000044 - Disclosure - NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details" id="Note9-SegmentAndRelatedInformation-SumarizedSegments-Details">
	  <link:definition>00000045 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note10SupplementalCashFlowInformationDetailsNarrative" id="Note10SupplementalCashFlowInformationDetailsNarrative">
	  <link:definition>00000046 - Disclosure - NOTE 10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative" id="Note11CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000047 - Disclosure - NOTE 11 &#8211; COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" id="Note12-IncomeTaxesDetailsNarrative">
	  <link:definition>00000048 - Disclosure - NOTE 12 - INCOME TAXES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails" id="Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails">
	  <link:definition>00000049 - Disclosure - NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails" id="Note13-Acquisition-NetAssetsAcquiredDetails">
	  <link:definition>00000050 - Disclosure - NOTE 13 - ACQUISITION - Net assets acquired (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="FONR_ClassANonVotingPreferredStockMember" name="ClassANonVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HDMMember" name="HDMMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommercialInsuranceManagedCareMember" name="CommercialInsuranceManagedCareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicareMedicaidMember" name="MedicareMedicaidMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WorkersCompensationPersonalInjuryMember" name="WorkersCompensationPersonalInjuryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherRevenueSourceMember" name="OtherRevenueSourceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatentsAndCopyrightsMember" name="PatentsAndCopyrightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalEquipmentMember" name="MedicalEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementOfDiagnosticImagingCentersMember" name="ManagementOfDiagnosticImagingCentersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RocklandManagementGroupMember" name="RocklandManagementGroupMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableServiceAndRepairFees" name="AccountsReceivableServiceAndRepairFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountReceivableRelatedParties" name="AccountReceivableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivable" name="MedicalReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFees" name="ManagementAndOtherFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" name="ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetLongTerm" name="AccountsReceivableNetLongTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_UnearnedRevenueOnServiceContractsRelatedParties" name="UnearnedRevenueOnServiceContractsRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerDeposits" name="CustomerDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProductSalesNet" name="ProductSalesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesNet" name="ServiceAndRepairFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesRelatedPartiesNet" name="ServiceAndRepairFeesRelatedPartiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesNet" name="ManagementAndOtherFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" name="ManagementAndOtherFeesRelatedMedicalPracticesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToProductSales" name="CostsRelatedToProductSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFees" name="CostsRelatedToServiceAndRepairFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" name="CostsRelatedToServiceAndRepairFeesRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFees" name="CostsRelatedToManagementAndOtherFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" name="CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProvisionForBadDebts" name="ProvisionForBadDebts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_GainOnForgivenessOfPppLoan" name="GainOnForgivenessOfPppLoan" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInFinancingLiabilities" name="IncreaseDecreaseInFinancingLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInCustomerAdvance" name="IncreaseDecreaseInCustomerAdvance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureNote4OperatingFinancingLeasesAbstract" name="DisclosureNote4OperatingFinancingLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" name="TotalFacilitiesOwnedOrManagedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfPatientFeeRevenueTableTextBlock" name="ScheduleOfPatientFeeRevenueTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" name="LesseeOperatingLeasesLiabilityMaturityTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" name="HmcaOwnershipSizeOfImperialManagementServicesPercent" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" name="OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" name="OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConvertibleClassCStock" name="ConvertibleClassCStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetRelatedParty" name="AccountsReceivableNetRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFees_NonRelatedParties" name="ManagementAndOtherFees_NonRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" name="PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" name="PercentageOfConsolidatedNetRevenueFromManagementFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscount" name="PresentValueDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscountFinancingLease" name="PresentValueDiscountFinancingLease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsIncurredOnUncompletedContracts" name="CostsIncurredOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EstimatedEarnings" name="EstimatedEarnings" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" name="CostsAndEstimatedEarningsOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BillingsToDate" name="BillingsToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" name="TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StateIncomeTaxesPayable" name="StateIncomeTaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetRevenuesFromExternalCustomers" name="NetRevenuesFromExternalCustomers" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IntersegmentNetRevenues" name="IntersegmentNetRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LitigationSettelementDescription" name="LitigationSettelementDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" name="MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription" name="ReimbursementOfAlternativeMinimumTaxCreditsDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightToUseLiability" name="RightToUseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalPurchaseConsideration" name="TotalPurchaseConsideration" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DiagnosticEquipment" name="DiagnosticEquipment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CovenantNotToCompete" name="CovenantNotToCompete" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClosingCostsExpensed" name="ClosingCostsExpensed" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>fonr-20210930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20210930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20210930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:href="fonr-20210930.xsd#CondensedConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:href="fonr-20210930.xsd#CondensedConsolidatedStatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20210930.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20210930.xsd#Note1DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20210930.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4OperatingFinancingLeases" xlink:href="fonr-20210930.xsd#Note4OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-Inventories" xlink:href="fonr-20210930.xsd#Note5-Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6ContractAssetsAndLiabilities" xlink:href="fonr-20210930.xsd#Note6ContractAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OtherIntangibleAssets" xlink:href="fonr-20210930.xsd#Note7OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8OtherCurrentLiabilities" xlink:href="fonr-20210930.xsd#Note8OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SegmentAndRelatedInformation" xlink:href="fonr-20210930.xsd#Note9-SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10SupplementalCashFlowInformation" xlink:href="fonr-20210930.xsd#Note10SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11CommitmentsAndContingencies" xlink:href="fonr-20210930.xsd#Note11CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes" xlink:href="fonr-20210930.xsd#Note12-IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13Acquisition" xlink:href="fonr-20210930.xsd#Note13Acquisition" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note14SubsequentEvents" xlink:href="fonr-20210930.xsd#Note14SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20210930.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4OperatingFinancingLeasesTables" xlink:href="fonr-20210930.xsd#Note4OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-InventoriesTables" xlink:href="fonr-20210930.xsd#Note5-InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6ContractAssetsAndLiabilitiesTables" xlink:href="fonr-20210930.xsd#Note6ContractAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OtherIntangibleAssetsTables" xlink:href="fonr-20210930.xsd#Note7OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8OtherCurrentLiabilitiesTables" xlink:href="fonr-20210930.xsd#Note8OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SegmentAndRelatedInformationTables" xlink:href="fonr-20210930.xsd#Note9-SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13AcquisitionTables" xlink:href="fonr-20210930.xsd#Note13AcquisitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20210930.xsd#Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20210930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20210930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20210930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20210930.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20210930.xsd#Note4-OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4OperatingFinancingLeasesDetailsNarrative" xlink:href="fonr-20210930.xsd#Note4OperatingFinancingLeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-Inventories-InventoriesDetails" xlink:href="fonr-20210930.xsd#Note5-Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:href="fonr-20210930.xsd#Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20210930.xsd#Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20210930.xsd#Note7OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20210930.xsd#Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20210930.xsd#Note9-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20210930.xsd#Note10SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20210930.xsd#Note11CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" xlink:href="fonr-20210930.xsd#Note12-IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:href="fonr-20210930.xsd#Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails" xlink:href="fonr-20210930.xsd#Note13-Acquisition-NetAssetsAcquiredDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParties" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParties" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInIntangibleAssetsCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInIntangibleAssetsCurrent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="loc_FONRGainOnForgivenessOfPppLoan" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRGainOnForgivenessOfPppLoan" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxCreditsAndAdjustments" xlink:label="loc_us-gaapIncomeTaxCreditsAndAdjustments" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeTaxCreditsAndAdjustments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000007 - Disclosure - NOTE 1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000009 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4OperatingFinancingLeases" xlink:title="00000010 - Disclosure - NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-Inventories" xlink:title="00000011 - Disclosure - NOTE 5 - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6ContractAssetsAndLiabilities" xlink:title="00000012 - Disclosure - NOTE 6 &#8211; CONTRACT ASSETS AND LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OtherIntangibleAssets" xlink:title="00000013 - Disclosure - NOTE 7 &#8211; OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8OtherCurrentLiabilities" xlink:title="00000014 - Disclosure - NOTE 8 &#8211; OTHER CURRENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SegmentAndRelatedInformation" xlink:title="00000015 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10SupplementalCashFlowInformation" xlink:title="00000016 - Disclosure - NOTE 10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - NOTE 11 &#8211; COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes" xlink:title="00000018 - Disclosure - NOTE 12 - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13Acquisition" xlink:title="00000019 - Disclosure - NOTE 13 &#8211; ACQUISITION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note14SubsequentEvents" xlink:title="00000020 - Disclosure - NOTE 14 &#8211; SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000021 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000022 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000023 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4OperatingFinancingLeasesTables" xlink:title="00000024 - Disclosure - NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-InventoriesTables" xlink:title="00000025 - Disclosure - NOTE 5 - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6ContractAssetsAndLiabilitiesTables" xlink:title="00000026 - Disclosure - NOTE 6 &#8211; CONTRACT ASSETS AND LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OtherIntangibleAssetsTables" xlink:title="00000027 - Disclosure - NOTE 7 &#8211; OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8OtherCurrentLiabilitiesTables" xlink:title="00000028 - Disclosure - NOTE 8 &#8211; OTHER CURRENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SegmentAndRelatedInformationTables" xlink:title="00000029 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13AcquisitionTables" xlink:title="00000030 - Disclosure - NOTE 13 &#8211; ACQUISITION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000031 - Disclosure - NOTE 1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000032 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000033 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000034 - Disclosure - NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="00000035 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="loc_us-gaapContractReceivableDueOneToTwoYears" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="loc_us-gaapContractReceivableDueOneToTwoYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="loc_us-gaapContractReceivableDueTwoToThreeYears" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="loc_us-gaapContractReceivableDueTwoToThreeYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="loc_us-gaapContractReceivableDueThreeToFourYears" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="loc_us-gaapContractReceivableDueThreeToFourYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="loc_us-gaapContractReceivableDueFourToFiveYears" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="loc_us-gaapContractReceivableDueFourToFiveYears" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000036 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000037 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000038 - Disclosure - NOTE 4 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4OperatingFinancingLeasesDetailsNarrative" xlink:title="00000039 - Disclosure - NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-Inventories-InventoriesDetails" xlink:title="00000040 - Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:title="00000041 - Disclosure - NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:label="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="loc_FONRCostsIncurredOnUncompletedContracts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="loc_FONRCostsIncurredOnUncompletedContracts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_EstimatedEarnings" xlink:label="loc_FONREstimatedEarnings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="loc_FONREstimatedEarnings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" xlink:label="loc_FONRTotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRTotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" xlink:to="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_BillingsToDate" xlink:label="loc_FONRBillingsToDate" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRTotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" xlink:to="loc_FONRBillingsToDate" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000042 - Disclosure - NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative" xlink:title="00000043 - Disclosure - NOTE 7 &#8211; OTHER INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000044 - Disclosure - NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_StateIncomeTaxesPayable" xlink:label="loc_FONRStateIncomeTaxesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_FONRStateIncomeTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000045 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000046 - Disclosure - NOTE 10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000047 - Disclosure - NOTE 11 &#8211; COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" xlink:title="00000048 - Disclosure - NOTE 12 - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:title="00000049 - Disclosure - NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails" xlink:title="00000050 - Disclosure - NOTE 13 - ACQUISITION - Net assets acquired (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>fonr-20210930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20210930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20210930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:href="fonr-20210930.xsd#CondensedConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:href="fonr-20210930.xsd#CondensedConsolidatedStatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20210930.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20210930.xsd#Note1DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20210930.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4OperatingFinancingLeases" xlink:href="fonr-20210930.xsd#Note4OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-Inventories" xlink:href="fonr-20210930.xsd#Note5-Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6ContractAssetsAndLiabilities" xlink:href="fonr-20210930.xsd#Note6ContractAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OtherIntangibleAssets" xlink:href="fonr-20210930.xsd#Note7OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8OtherCurrentLiabilities" xlink:href="fonr-20210930.xsd#Note8OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SegmentAndRelatedInformation" xlink:href="fonr-20210930.xsd#Note9-SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10SupplementalCashFlowInformation" xlink:href="fonr-20210930.xsd#Note10SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11CommitmentsAndContingencies" xlink:href="fonr-20210930.xsd#Note11CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes" xlink:href="fonr-20210930.xsd#Note12-IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13Acquisition" xlink:href="fonr-20210930.xsd#Note13Acquisition" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note14SubsequentEvents" xlink:href="fonr-20210930.xsd#Note14SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20210930.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4OperatingFinancingLeasesTables" xlink:href="fonr-20210930.xsd#Note4OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-InventoriesTables" xlink:href="fonr-20210930.xsd#Note5-InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6ContractAssetsAndLiabilitiesTables" xlink:href="fonr-20210930.xsd#Note6ContractAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OtherIntangibleAssetsTables" xlink:href="fonr-20210930.xsd#Note7OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8OtherCurrentLiabilitiesTables" xlink:href="fonr-20210930.xsd#Note8OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SegmentAndRelatedInformationTables" xlink:href="fonr-20210930.xsd#Note9-SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13AcquisitionTables" xlink:href="fonr-20210930.xsd#Note13AcquisitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20210930.xsd#Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20210930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20210930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20210930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20210930.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20210930.xsd#Note4-OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4OperatingFinancingLeasesDetailsNarrative" xlink:href="fonr-20210930.xsd#Note4OperatingFinancingLeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-Inventories-InventoriesDetails" xlink:href="fonr-20210930.xsd#Note5-Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:href="fonr-20210930.xsd#Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20210930.xsd#Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20210930.xsd#Note7OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20210930.xsd#Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20210930.xsd#Note9-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20210930.xsd#Note10SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20210930.xsd#Note11CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" xlink:href="fonr-20210930.xsd#Note12-IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:href="fonr-20210930.xsd#Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails" xlink:href="fonr-20210930.xsd#Note13-Acquisition-NetAssetsAcquiredDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_60" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_60" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_60" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_60" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_60" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_60" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_60" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_60" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_60" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_60" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_60" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_60" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_60" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_60" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_60" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_60" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_60" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_60" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_60" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_60" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_60" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_60" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_60" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_60" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_60" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_60" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" xlink:type="arc" order="57" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapShortTermInvestments_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountReceivableRelatedParties_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRMedicalReceivable_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagementAndOtherFees_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssetsCurrent_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableNetLongTerm_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapGoodwill_130" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOtherAssets_130" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssets_130" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_130" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableCurrent_130" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_130" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueCurrent_130" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParties" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParties_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParties_130" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent_130" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_130" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent_130" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCustomerDeposits_130" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent_130" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueNoncurrent_130" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent_130" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_130" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilities_130" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesNoncurrent_130" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilities_130" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue_130" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue_130" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_130" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockValue_130" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_130" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterest_130" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_130" xlink:type="arc" order="49" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockShares_130" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRProductSalesNet_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRServiceAndRepairFeesNet_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRManagementAndOtherFeesNet_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToProductSales_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapCostsAndExpenses_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_90" xlink:type="arc" order="32" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000007 - Disclosure - NOTE 1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000009 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4OperatingFinancingLeases" xlink:title="00000010 - Disclosure - NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-Inventories" xlink:title="00000011 - Disclosure - NOTE 5 - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6ContractAssetsAndLiabilities" xlink:title="00000012 - Disclosure - NOTE 6 &#8211; CONTRACT ASSETS AND LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OtherIntangibleAssets" xlink:title="00000013 - Disclosure - NOTE 7 &#8211; OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8OtherCurrentLiabilities" xlink:title="00000014 - Disclosure - NOTE 8 &#8211; OTHER CURRENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SegmentAndRelatedInformation" xlink:title="00000015 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10SupplementalCashFlowInformation" xlink:title="00000016 - Disclosure - NOTE 10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - NOTE 11 &#8211; COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes" xlink:title="00000018 - Disclosure - NOTE 12 - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13Acquisition" xlink:title="00000019 - Disclosure - NOTE 13 &#8211; ACQUISITION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note14SubsequentEvents" xlink:title="00000020 - Disclosure - NOTE 14 &#8211; SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000021 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000022 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000023 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4OperatingFinancingLeasesTables" xlink:title="00000024 - Disclosure - NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-InventoriesTables" xlink:title="00000025 - Disclosure - NOTE 5 - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6ContractAssetsAndLiabilitiesTables" xlink:title="00000026 - Disclosure - NOTE 6 &#8211; CONTRACT ASSETS AND LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OtherIntangibleAssetsTables" xlink:title="00000027 - Disclosure - NOTE 7 &#8211; OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8OtherCurrentLiabilitiesTables" xlink:title="00000028 - Disclosure - NOTE 8 &#8211; OTHER CURRENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SegmentAndRelatedInformationTables" xlink:title="00000029 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13AcquisitionTables" xlink:title="00000030 - Disclosure - NOTE 13 &#8211; ACQUISITION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000031 - Disclosure - NOTE 1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRHDMMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_20" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000032 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ConvertibleClassCStock" xlink:label="loc_FONRConvertibleClassCStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConvertibleClassCStock_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_70" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000033 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000034 - Disclosure - NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DoubtfulMember" xlink:label="loc_us-gaapDoubtfulMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapDoubtfulMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRMedicalReceivable_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="loc_FONRManagementAndOtherFees_NonRelatedParties_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagementAndOtherFees_NonRelatedParties_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="00000035 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000036 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000037 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000038 - Disclosure - NOTE 4 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4OperatingFinancingLeasesDetailsNarrative" xlink:title="00000039 - Disclosure - NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-Inventories-InventoriesDetails" xlink:title="00000040 - Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:title="00000041 - Disclosure - NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000042 - Disclosure - NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative" xlink:title="00000043 - Disclosure - NOTE 7 &#8211; OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000044 - Disclosure - NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000045 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MedicalEquipmentMember" xlink:label="loc_FONRMedicalEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRMedicalEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_NetRevenuesFromExternalCustomers" xlink:label="loc_FONRNetRevenuesFromExternalCustomers_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetRevenuesFromExternalCustomers_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000046 - Disclosure - NOTE 10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000047 - Disclosure - NOTE 11 &#8211; COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" xlink:title="00000048 - Disclosure - NOTE 12 - INCOME TAXES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:title="00000049 - Disclosure - NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_RocklandManagementGroupMember" xlink:label="loc_FONRRocklandManagementGroupMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRRocklandManagementGroupMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets" xlink:label="loc_FONRBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSecurityDeposit_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_RightToUseLiability" xlink:label="loc_FONRRightToUseLiability_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRRightToUseLiability_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill_20" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_TotalPurchaseConsideration" xlink:label="loc_FONRTotalPurchaseConsideration_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRTotalPurchaseConsideration_20" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails" xlink:title="00000050 - Disclosure - NOTE 13 - ACQUISITION - Net assets acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_RocklandManagementGroupMember" xlink:label="loc_FONRRocklandManagementGroupMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRRocklandManagementGroupMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="loc_us-gaapLeaseholdImprovementsGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapLeaseholdImprovementsGross_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_DiagnosticEquipment" xlink:label="loc_FONRDiagnosticEquipment_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRDiagnosticEquipment_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedCustomerListsGross" xlink:label="loc_us-gaapFiniteLivedCustomerListsGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapFiniteLivedCustomerListsGross_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CovenantNotToCompete" xlink:label="loc_FONRCovenantNotToCompete_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRCovenantNotToCompete_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSecurityDeposit_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ClosingCostsExpensed" xlink:label="loc_FONRClosingCostsExpensed_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRClosingCostsExpensed_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredOther1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredOther1_30" xlink:type="arc" order="7" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>fonr-20210930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="us-gaap_CommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassCMember_lbl" xml:lang="en-US">Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="FONR_ClassANonVotingPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassAMember" xlink:label="us-gaap_PreferredClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredClassAMember" xlink:to="us-gaap_PreferredClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredClassAMember_lbl" xml:lang="en-US">Preferred Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_HDMMember" xlink:label="FONR_HDMMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMMember" xlink:to="FONR_HDMMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HDMMember_lbl" xml:lang="en-US">H D M [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xml:lang="en-US">Receivable Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DoubtfulMember" xlink:label="us-gaap_DoubtfulMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DoubtfulMember" xlink:to="us-gaap_DoubtfulMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DoubtfulMember_lbl" xml:lang="en-US">Doubtful [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="FONR_CommercialInsuranceManagedCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommercialInsuranceManagedCareMember_lbl" xml:lang="en-US">Commercial Insurance / Managed Care</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MedicareMedicaidMember" xlink:label="FONR_MedicareMedicaidMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicareMedicaidMember_lbl" xml:lang="en-US">Medicare/Medicaid</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="FONR_WorkersCompensationPersonalInjuryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_lbl" xml:lang="en-US">Workers Compensation/Personal Injury</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_OtherRevenueSourceMember" xlink:label="FONR_OtherRevenueSourceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherRevenueSourceMember_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="FONR_PatentsAndCopyrightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatentsAndCopyrightsMember_lbl" xml:lang="en-US">Patents and copyrights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xml:lang="en-US">Operating Activities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MedicalEquipmentMember" xlink:label="FONR_MedicalEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalEquipmentMember" xlink:to="FONR_MedicalEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalEquipmentMember_lbl" xml:lang="en-US">Medical Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xml:lang="en-US">Management Of Diagnostic Imaging Centers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_RocklandManagementGroupMember" xlink:label="FONR_RocklandManagementGroupMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RocklandManagementGroupMember" xlink:to="FONR_RocklandManagementGroupMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RocklandManagementGroupMember_lbl" xml:lang="en-US">Rockland Management Group [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">&#160;&#160;Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">&#160;Short term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="FONR_AccountsReceivableServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_lbl" xml:lang="en-US">&#160;Accounts receivable &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountReceivableRelatedParties" xlink:label="FONR_AccountReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountReceivableRelatedParties" xlink:to="FONR_AccountReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountReceivableRelatedParties_lbl" xml:lang="en-US">&#160;Accounts receivable - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MedicalReceivable" xlink:label="FONR_MedicalReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivable_lbl" xml:lang="en-US">&#160;Medical receivable &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFees" xlink:label="FONR_ManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees" xlink:to="FONR_ManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFees_lbl" xml:lang="en-US">&#160;Management and other fees receivable - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xml:lang="en-US">Management and other fees receivable &#8211; related medical practices &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xml:lang="en-US">&#160;Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">&#160;Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">&#160;&#160;Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="FONR_AccountsReceivableNetLongTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetLongTerm_lbl" xml:lang="en-US">&#160;Accounts receivable &#8211; long term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">&#160;Deferred income tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">&#160;Property and equipment &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">&#160;Right-of-use Asset &#8211; operating lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">&#160;Right-of-use Asset &#8211; financing lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">&#160;Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">&#160;Other intangible assets &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">&#160;Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">&#160;&#160;&#160;Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xml:lang="en-US">Current portion of long-term debt and capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParties" xlink:label="FONR_UnearnedRevenueOnServiceContractsRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_UnearnedRevenueOnServiceContractsRelatedParties" xlink:to="FONR_UnearnedRevenueOnServiceContractsRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_UnearnedRevenueOnServiceContractsRelatedParties_lbl" xml:lang="en-US">Unearned revenue on service contracts &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liability &#8211; current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xml:lang="en-US">Financing lease liability &#8211; current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CustomerDeposits" xlink:label="FONR_CustomerDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerDeposits" xlink:to="FONR_CustomerDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerDeposits_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred income tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableRelatedPartiesNoncurrent_lbl" xml:lang="en-US">Due to related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Financing lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xml:lang="en-US">Long-term debt and capital leases, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred Stock Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Paid-in capital in excess of par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost - 12 shares of common stock at September 30, 2021 and June 30, 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US">Treasury Stock, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">REVENUES</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xml:lang="en-US">Patient fee revenue &#8211; net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ProductSalesNet" xlink:label="FONR_ProductSalesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProductSalesNet" xlink:to="FONR_ProductSalesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProductSalesNet_lbl" xml:lang="en-US">Product sales &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="FONR_ServiceAndRepairFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesNet" xlink:to="FONR_ServiceAndRepairFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesNet_lbl" xml:lang="en-US">Service and repair fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xml:lang="en-US">Service and repair fees - related parties &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="FONR_ManagementAndOtherFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNet" xlink:to="FONR_ManagementAndOtherFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesNet_lbl" xml:lang="en-US">Management and other fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xml:lang="en-US">Management and other fees - related medical practices &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Total Revenues &#8211; Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US">COSTS AND EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="us-gaap_OtherCostOfOperatingRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostOfOperatingRevenue" xlink:to="us-gaap_OtherCostOfOperatingRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostOfOperatingRevenue_lbl" xml:lang="en-US">Costs related to patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToProductSales" xlink:label="FONR_CostsRelatedToProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToProductSales" xlink:to="FONR_CostsRelatedToProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToProductSales_lbl" xml:lang="en-US">Costs related to product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="FONR_CostsRelatedToServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFees" xlink:to="FONR_CostsRelatedToServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFees_lbl" xml:lang="en-US">Costs related to service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xml:lang="en-US">Costs related to service and repair fees - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="FONR_CostsRelatedToManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFees" xlink:to="FONR_CostsRelatedToManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFees_lbl" xml:lang="en-US">Costs related to management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xml:lang="en-US">Costs related to management and other fees &#8211; related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xml:lang="en-US">Income From Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other Income (Expenses)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income Before Provision for Income Taxes and Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net Income - Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income - Attributable to FONAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and Diluted Income Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Diluted Shares Outstanding - Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted Average Basic and Diluted Shares Outstanding Class C Common</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US">Distributions - Non controlling</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Income - Non controlling interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="us-gaap_OtherDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization on right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ProvisionForBadDebts" xlink:label="FONR_ProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProvisionForBadDebts_lbl" xml:lang="en-US">Provision (Recovery) for bad debts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income tax &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:label="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:to="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent_lbl" xml:lang="en-US">Abandoned patents</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="FONR_GainOnForgivenessOfPppLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnForgivenessOfPppLoan" xlink:to="FONR_GainOnForgivenessOfPppLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_GainOnForgivenessOfPppLoan_lbl" xml:lang="en-US">Gain on forgiveness of PPP loan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">(Increase) decrease in operating assets, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts, medical and management fee receivable(s)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="us-gaap_IncreaseDecreaseInReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxCreditsAndAdjustments" xlink:label="us-gaap_IncomeTaxCreditsAndAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxCreditsAndAdjustments" xlink:to="us-gaap_IncomeTaxCreditsAndAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxCreditsAndAdjustments_lbl" xml:lang="en-US">Income tax receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xml:lang="en-US">Increase (decrease) in operating liabilities, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilities_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xml:lang="en-US">Financing lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xml:lang="en-US">Customer advances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Cost of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of borrowings and capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Proceeds from debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">&#160;Distributions to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used in financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">&#160;Net (Decrease) Increase in Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and Cash Equivalents - Beginning of Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and Cash Equivalents - End of Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">NOTE 1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_DisclosureNote4OperatingFinancingLeasesAbstract" xlink:label="FONR_DisclosureNote4OperatingFinancingLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureNote4OperatingFinancingLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureNote4OperatingFinancingLeasesAbstract_lbl" xml:lang="en-US">Note 4 Operating Financing Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 5 - INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RegulatedOperationsAbstract" xlink:label="us-gaap_RegulatedOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RegulatedOperationsAbstract" xlink:to="us-gaap_RegulatedOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RegulatedOperationsAbstract_lbl" xml:lang="en-US">Regulated Operations [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" xlink:label="us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" xlink:to="us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_lbl" xml:lang="en-US">NOTE 6 &#8211; CONTRACT ASSETS AND LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 7 &#8211; OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">NOTE 8 &#8211; OTHER CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 9 - SEGMENT AND RELATED INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xml:lang="en-US">NOTE 10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 11 &#8211; COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 12 - INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 13 &#8211; ACQUISITION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">NOTE 14 &#8211; SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="us-gaap_BusinessCombinationsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xml:lang="en-US">Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xml:lang="en-US">Receivables - Non Current - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:to="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xml:lang="en-US">Total Facilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ScheduleOfPatientFeeRevenueTableTextBlock" xlink:label="FONR_ScheduleOfPatientFeeRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfPatientFeeRevenueTableTextBlock" xlink:to="FONR_ScheduleOfPatientFeeRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfPatientFeeRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" xlink:label="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" xlink:to="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Reconcilliation of operating and financing lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:label="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:to="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_lbl" xml:lang="en-US">Costs and Estimated Earnings on Uncompleted Contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Other Intagible Assets - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Other Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Suuummarrized Segment Financial Information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_lbl" xml:lang="en-US">Fair value assets and assumed liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherAssetsTableTextBlock_lbl" xml:lang="en-US">Net assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xml:lang="en-US">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xml:lang="en-US">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:label="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_lbl" xml:lang="en-US">The ownership interest of the original investors of HDM after reorganization of newly expanded HDM</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Basic Numerator: Net income available to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Basic Denominator: Weighted average shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Basic income per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Shares included upon conversion of Class C Common to calculate a diluted EPS</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ConvertibleClassCStock" xlink:label="FONR_ConvertibleClassCStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConvertibleClassCStock" xlink:to="FONR_ConvertibleClassCStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConvertibleClassCStock_lbl" xml:lang="en-US">Convertible Class C Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Total Denominator for diluted earnings per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted income per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_2_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="FONR_AccountsReceivableNetRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetRelatedParty" xlink:to="FONR_AccountsReceivableNetRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetRelatedParty_lbl" xml:lang="en-US">Accounts receivable - Related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_MedicalReceivable_2_lbl" xml:lang="en-US">Medical Receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees_NonRelatedParties" xlink:to="FONR_ManagementAndOtherFees_NonRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties_lbl" xml:lang="en-US">Management and other fees receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xml:lang="en-US">Management and other fees receivable from related medical practices ("PC's")</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="us-gaap_ContractReceivableDueOneToTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueOneToTwoYears" xlink:to="us-gaap_ContractReceivableDueOneToTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueOneToTwoYears_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueTwoToThreeYears" xlink:to="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueThreeToFourYears" xlink:to="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="us-gaap_ContractReceivableDueFourToFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueFourToFiveYears" xlink:to="us-gaap_ContractReceivableDueFourToFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueFourToFiveYears_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_lbl" xml:lang="en-US">Patient fee revenue, net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xml:lang="en-US">Percentage of PC's net revenue derived from no-fault and personal injury protection claim</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xml:lang="en-US">Percentage of consolidated net revenue from management fees charged to related party medical practices</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureNote4OperatingFinancingLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_DisclosureNote4OperatingFinancingLeasesAbstract_2_lbl" xml:lang="en-US">Note 4 - Operating Financing Leases - Lease Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">Operating Lease Payments 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">Financing Lease Payments 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">Operating Lease Payments 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">Financing Lease Payments 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">Operating Lease Payments 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">Financing Lease Payments 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">Operating Lease Payments 2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">Financing Lease Payments 2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">Operating Lease Payments 2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">Financing Lease Payments 2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Operating Lease Payments Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Financing Lease Payments Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PresentValueDiscount" xlink:label="FONR_PresentValueDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_PresentValueDiscount_lbl" xml:lang="en-US">Operating Lease Payments Present Value discount</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="FONR_PresentValueDiscountFinancingLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_PresentValueDiscountFinancingLease_lbl" xml:lang="en-US">Financing Lease Payments Present Value discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Operating Lease Payments Total lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Financing Lease Payments Total lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventorySupplies" xlink:label="us-gaap_OtherInventorySupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventorySupplies" xlink:to="us-gaap_OtherInventorySupplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventorySupplies_lbl" xml:lang="en-US">Purchased parts, components and supplies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xml:lang="en-US">TOTAL INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="FONR_CostsIncurredOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsIncurredOnUncompletedContracts" xlink:to="FONR_CostsIncurredOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsIncurredOnUncompletedContracts_lbl" xml:lang="en-US">Costs incurred on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_EstimatedEarnings" xlink:label="FONR_EstimatedEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedEarnings" xlink:to="FONR_EstimatedEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EstimatedEarnings_lbl" xml:lang="en-US">Estimated earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_lbl" xml:lang="en-US">Costs and estimated earnings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_BillingsToDate" xlink:label="FONR_BillingsToDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BillingsToDate" xlink:to="FONR_BillingsToDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_BillingsToDate_lbl" xml:lang="en-US">Less: Billings to date</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" xlink:label="FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" xlink:to="FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet_lbl" xml:lang="en-US">Total costs and estimated earnings in excess of billings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less: Accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Other intangible assets-net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Accrued salaries, commissions and payroll taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Litigation accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Sales tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_StateIncomeTaxesPayable" xlink:label="FONR_StateIncomeTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StateIncomeTaxesPayable" xlink:to="FONR_StateIncomeTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StateIncomeTaxesPayable_lbl" xml:lang="en-US">State income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Legal and other professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SelfInsuranceReserve" xlink:to="us-gaap_SelfInsuranceReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xml:lang="en-US">Self-funded health insurance reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xml:lang="en-US">Accrued interest and penalty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_NetRevenuesFromExternalCustomers" xlink:label="FONR_NetRevenuesFromExternalCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesFromExternalCustomers" xlink:to="FONR_NetRevenuesFromExternalCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetRevenuesFromExternalCustomers_lbl" xml:lang="en-US">Net revenues from external customers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_IntersegmentNetRevenues" xlink:label="FONR_IntersegmentNetRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IntersegmentNetRevenues_lbl" xml:lang="en-US">Inter-segment net revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">(Loss) Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_LitigationSettelementDescription" xlink:label="FONR_LitigationSettelementDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LitigationSettelementDescription" xlink:to="FONR_LitigationSettelementDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LitigationSettelementDescription_lbl" xml:lang="en-US">Litigation settelement description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Recorded tax obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Interest and penalties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:to="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_lbl" xml:lang="en-US">Maximum limit for individual claims under stop-loss umbrella policy for health insurances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax component - current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax component - deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:to="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xml:lang="en-US">Deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating Loss Carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription" xlink:label="FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription" xlink:to="FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription_lbl" xml:lang="en-US">Reimbursement of alternative minimum tax credits description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets" xlink:label="FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets" xlink:to="FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets_lbl" xml:lang="en-US">Right to use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security Deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_RightToUseLiability" xlink:label="FONR_RightToUseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightToUseLiability" xlink:to="FONR_RightToUseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightToUseLiability_lbl" xml:lang="en-US">Right to use liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Goodwill_2_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_TotalPurchaseConsideration" xlink:label="FONR_TotalPurchaseConsideration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalPurchaseConsideration" xlink:to="FONR_TotalPurchaseConsideration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalPurchaseConsideration_lbl" xml:lang="en-US">Total purchase consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="us-gaap_LeaseholdImprovementsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xml:lang="en-US">Leasehold Improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_DiagnosticEquipment" xlink:label="FONR_DiagnosticEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticEquipment" xlink:to="FONR_DiagnosticEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DiagnosticEquipment_lbl" xml:lang="en-US">Diagnostic Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedCustomerListsGross" xlink:label="us-gaap_FiniteLivedCustomerListsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedCustomerListsGross" xlink:to="us-gaap_FiniteLivedCustomerListsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedCustomerListsGross_lbl" xml:lang="en-US">Customer Lists</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CovenantNotToCompete" xlink:label="FONR_CovenantNotToCompete" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CovenantNotToCompete" xlink:to="FONR_CovenantNotToCompete_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CovenantNotToCompete_lbl" xml:lang="en-US">Covenant Not to Compete</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ClosingCostsExpensed" xlink:label="FONR_ClosingCostsExpensed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClosingCostsExpensed" xlink:to="FONR_ClosingCostsExpensed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClosingCostsExpensed_lbl" xml:lang="en-US">Closing costs - expensed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredOther1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredOther1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredOther1_lbl" xml:lang="en-US">Cash Consideration Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassANonVotingPreferredStockMember_doc" xml:lang="en-US">Class A Non Voting Preferred Stock Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_doc" xml:lang="en-US">Accounts receivable - net - Current from service and repair fees of Non Related MRI scanner customers; net of allowances for doubtful accounts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountReceivableRelatedParties" xlink:to="FONR_AccountReceivableRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountReceivableRelatedParties_doc" xml:lang="en-US">Accounts receivable from service and repair fees of Related MRI scanner customers; net of allowances for doubtful accounts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_doc" xml:lang="en-US">Management of, and other fees receivable from MRI Centers owned by related parties - net of allowances for doubtful accounts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_doc" xml:lang="en-US">Costs related To Management and other fees - Related medical practices</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xml:lang="en-US">Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name Health Management Company of America.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMMember" xlink:to="FONR_HDMMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_HDMMember_doc" xml:lang="en-US">HDM Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xml:lang="en-US">Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name Health Management Company of America.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_doc" xml:lang="en-US">Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name Health Management Company of America.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetRelatedParty" xlink:to="FONR_AccountsReceivableNetRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableNetRelatedParty_doc" xml:lang="en-US">Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees_NonRelatedParties" xlink:to="FONR_ManagementAndOtherFees_NonRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties_doc" xml:lang="en-US">Management and other fees receivable from MRI Centers owned by non-related parties - net of allowances for doubtful accounts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CommercialInsuranceManagedCareMember_doc" xml:lang="en-US">Commercial Insurance Managed Care Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicareMedicaidMember_doc" xml:lang="en-US">Medicare Medicaid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_doc" xml:lang="en-US">Workers Compensation Personal Injury</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OtherRevenueSourceMember_doc" xml:lang="en-US">Other Revenue Source</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xml:lang="en-US">Percentage of PCs net revenue derived from nofault and personal injury protection claims.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xml:lang="en-US">Percentage of consolidated net revenue from management fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PresentValueDiscount_doc" xml:lang="en-US">Present value discount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PresentValueDiscountFinancingLease_doc" xml:lang="en-US">Present value discount financing lease.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedEarnings" xlink:to="FONR_EstimatedEarnings_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_EstimatedEarnings_doc" xml:lang="en-US">Estimated Earnings on uncompleted contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_doc" xml:lang="en-US">Costs and estimated earnings on uncompleted contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BillingsToDate" xlink:to="FONR_BillingsToDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_BillingsToDate_doc" xml:lang="en-US">Amount within current period that has been billed to customer.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" xlink:to="FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet_doc" xml:lang="en-US">Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings, net of current billings in excess of costs and estimated earnings on uncompleted contracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PatentsAndCopyrightsMember_doc" xml:lang="en-US">Patents and copyrights - Member - Custom elements</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesFromExternalCustomers" xlink:to="FONR_NetRevenuesFromExternalCustomers_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NetRevenuesFromExternalCustomers_doc" xml:lang="en-US">Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalEquipmentMember" xlink:to="FONR_MedicalEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicalEquipmentMember_doc" xml:lang="en-US">Medical equipment - Member - Custom element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xml:lang="en-US">Management of Diagnostic Imaging Centers - Member - Custom element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LitigationSettelementDescription" xlink:to="FONR_LitigationSettelementDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_LitigationSettelementDescription_doc" xml:lang="en-US">Description related to litigation settelement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:to="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_doc" xml:lang="en-US">The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription" xlink:to="FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription_doc" xml:lang="en-US">Description of reimbursement of alternative minimum tax credits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets" xlink:to="FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets_doc" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right to use assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightToUseLiability" xlink:to="FONR_RightToUseLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_RightToUseLiability_doc" xml:lang="en-US">Right to use liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticEquipment" xlink:to="FONR_DiagnosticEquipment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DiagnosticEquipment_doc" xml:lang="en-US">Diagnostic Equipment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CovenantNotToCompete" xlink:to="FONR_CovenantNotToCompete_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CovenantNotToCompete_doc" xml:lang="en-US">Covenant not to compete.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClosingCostsExpensed" xlink:to="FONR_ClosingCostsExpensed_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClosingCostsExpensed_doc" xml:lang="en-US">Closing Costs Expensed.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_2_lbl" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Revenues [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:to="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent_2_lbl" xml:lang="en-US">Increase (Decrease) in Intangible Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnForgivenessOfPppLoan" xlink:to="FONR_GainOnForgivenessOfPppLoan_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_GainOnForgivenessOfPppLoan_2_lbl" xml:lang="en-US">GainOnForgivenessOfPppLoan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_2_lbl" xml:lang="en-US">IncreaseDecreaseInFinancingLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_2_lbl" xml:lang="en-US">Construction Contractor, Receivable, Excluding Contract Retainage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscount_3_lbl" xml:lang="en-US">PresentValueDiscount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscountFinancingLease_3_lbl" xml:lang="en-US">PresentValueDiscountFinancingLease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_3_lbl" xml:lang="en-US">Management and other fees - related medical practices - net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BillingsToDate" xlink:to="FONR_BillingsToDate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BillingsToDate_3_lbl" xml:lang="en-US">Less: Billings to date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" xlink:to="FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet_3_lbl" xml:lang="en-US">TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>fonr-20210930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20210930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20210930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:href="fonr-20210930.xsd#CondensedConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:href="fonr-20210930.xsd#CondensedConsolidatedStatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20210930.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20210930.xsd#Note1DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20210930.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4OperatingFinancingLeases" xlink:href="fonr-20210930.xsd#Note4OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-Inventories" xlink:href="fonr-20210930.xsd#Note5-Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6ContractAssetsAndLiabilities" xlink:href="fonr-20210930.xsd#Note6ContractAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OtherIntangibleAssets" xlink:href="fonr-20210930.xsd#Note7OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8OtherCurrentLiabilities" xlink:href="fonr-20210930.xsd#Note8OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SegmentAndRelatedInformation" xlink:href="fonr-20210930.xsd#Note9-SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10SupplementalCashFlowInformation" xlink:href="fonr-20210930.xsd#Note10SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11CommitmentsAndContingencies" xlink:href="fonr-20210930.xsd#Note11CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes" xlink:href="fonr-20210930.xsd#Note12-IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13Acquisition" xlink:href="fonr-20210930.xsd#Note13Acquisition" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note14SubsequentEvents" xlink:href="fonr-20210930.xsd#Note14SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20210930.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4OperatingFinancingLeasesTables" xlink:href="fonr-20210930.xsd#Note4OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-InventoriesTables" xlink:href="fonr-20210930.xsd#Note5-InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6ContractAssetsAndLiabilitiesTables" xlink:href="fonr-20210930.xsd#Note6ContractAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OtherIntangibleAssetsTables" xlink:href="fonr-20210930.xsd#Note7OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8OtherCurrentLiabilitiesTables" xlink:href="fonr-20210930.xsd#Note8OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SegmentAndRelatedInformationTables" xlink:href="fonr-20210930.xsd#Note9-SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13AcquisitionTables" xlink:href="fonr-20210930.xsd#Note13AcquisitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20210930.xsd#Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20210930.xsd#Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20210930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20210930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20210930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20210930.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20210930.xsd#Note4-OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4OperatingFinancingLeasesDetailsNarrative" xlink:href="fonr-20210930.xsd#Note4OperatingFinancingLeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-Inventories-InventoriesDetails" xlink:href="fonr-20210930.xsd#Note5-Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:href="fonr-20210930.xsd#Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20210930.xsd#Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20210930.xsd#Note7OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20210930.xsd#Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20210930.xsd#Note9-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20210930.xsd#Note10SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20210930.xsd#Note11CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" xlink:href="fonr-20210930.xsd#Note12-IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:href="fonr-20210930.xsd#Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails" xlink:href="fonr-20210930.xsd#Note13-Acquisition-NetAssetsAcquiredDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParties" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParties" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInIntangibleAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInIntangibleAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="loc_FONRGainOnForgivenessOfPppLoan" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRGainOnForgivenessOfPppLoan" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxCreditsAndAdjustments" xlink:label="loc_us-gaapIncomeTaxCreditsAndAdjustments" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncomeTaxCreditsAndAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000007 - Disclosure - NOTE 1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000009 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4OperatingFinancingLeases" xlink:title="00000010 - Disclosure - NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES">
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_DisclosureNote4OperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-Inventories" xlink:title="00000011 - Disclosure - NOTE 5 - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6ContractAssetsAndLiabilities" xlink:title="00000012 - Disclosure - NOTE 6 &#8211; CONTRACT ASSETS AND LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RegulatedOperationsAbstract" xlink:label="loc_us-gaapRegulatedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" xlink:label="loc_us-gaapScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_us-gaapScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OtherIntangibleAssets" xlink:title="00000013 - Disclosure - NOTE 7 &#8211; OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8OtherCurrentLiabilities" xlink:title="00000014 - Disclosure - NOTE 8 &#8211; OTHER CURRENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SegmentAndRelatedInformation" xlink:title="00000015 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10SupplementalCashFlowInformation" xlink:title="00000016 - Disclosure - NOTE 10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - NOTE 11 &#8211; COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes" xlink:title="00000018 - Disclosure - NOTE 12 - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13Acquisition" xlink:title="00000019 - Disclosure - NOTE 13 &#8211; ACQUISITION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note14SubsequentEvents" xlink:title="00000020 - Disclosure - NOTE 14 &#8211; SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000021 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaapBusinessCombinationsPolicy" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessCombinationsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000022 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000023 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ScheduleOfPatientFeeRevenueTableTextBlock" xlink:label="loc_FONRScheduleOfPatientFeeRevenueTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRScheduleOfPatientFeeRevenueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4OperatingFinancingLeasesTables" xlink:title="00000024 - Disclosure - NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_DisclosureNote4OperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" xlink:label="loc_FONRLesseeOperatingLeasesLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_FONRLesseeOperatingLeasesLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-InventoriesTables" xlink:title="00000025 - Disclosure - NOTE 5 - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6ContractAssetsAndLiabilitiesTables" xlink:title="00000026 - Disclosure - NOTE 6 &#8211; CONTRACT ASSETS AND LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RegulatedOperationsAbstract" xlink:label="loc_us-gaapRegulatedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:label="loc_us-gaapCostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OtherIntangibleAssetsTables" xlink:title="00000027 - Disclosure - NOTE 7 &#8211; OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8OtherCurrentLiabilitiesTables" xlink:title="00000028 - Disclosure - NOTE 8 &#8211; OTHER CURRENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SegmentAndRelatedInformationTables" xlink:title="00000029 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13AcquisitionTables" xlink:title="00000030 - Disclosure - NOTE 13 &#8211; ACQUISITION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativeAssetsAtFairValueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherAssetsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000031 - Disclosure - NOTE 1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtOwnershipAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRHDMMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000032 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ConvertibleClassCStock" xlink:label="loc_FONRConvertibleClassCStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConvertibleClassCStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000033 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000034 - Disclosure - NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DoubtfulMember" xlink:label="loc_us-gaapDoubtfulMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapDoubtfulMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="loc_FONRManagementAndOtherFees_NonRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagementAndOtherFees_NonRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="00000035 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="loc_us-gaapContractReceivableDueOneToTwoYears" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueOneToTwoYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="loc_us-gaapContractReceivableDueTwoToThreeYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueTwoToThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="loc_us-gaapContractReceivableDueThreeToFourYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueThreeToFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="loc_us-gaapContractReceivableDueFourToFiveYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueFourToFiveYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000036 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000037 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000038 - Disclosure - NOTE 4 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_DisclosureNote4OperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_FONRPresentValueDiscount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_FONRPresentValueDiscountFinancingLease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4OperatingFinancingLeasesDetailsNarrative" xlink:title="00000039 - Disclosure - NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_DisclosureNote4OperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote4OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-Inventories-InventoriesDetails" xlink:title="00000040 - Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:title="00000041 - Disclosure - NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RegulatedOperationsAbstract" xlink:label="loc_us-gaapRegulatedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="loc_FONRCostsIncurredOnUncompletedContracts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONRCostsIncurredOnUncompletedContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_EstimatedEarnings" xlink:label="loc_FONREstimatedEarnings" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONREstimatedEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:label="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_BillingsToDate" xlink:label="loc_FONRBillingsToDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONRBillingsToDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" xlink:label="loc_FONRTotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONRTotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000042 - Disclosure - NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative" xlink:title="00000043 - Disclosure - NOTE 7 &#8211; OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000044 - Disclosure - NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_StateIncomeTaxesPayable" xlink:label="loc_FONRStateIncomeTaxesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_FONRStateIncomeTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000045 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MedicalEquipmentMember" xlink:label="loc_FONRMedicalEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRMedicalEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_NetRevenuesFromExternalCustomers" xlink:label="loc_FONRNetRevenuesFromExternalCustomers" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetRevenuesFromExternalCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000046 - Disclosure - NOTE 10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000047 - Disclosure - NOTE 11 &#8211; COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_LitigationSettelementDescription" xlink:label="loc_FONRLitigationSettelementDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRLitigationSettelementDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrentAndNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:label="loc_FONRMaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRMaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" xlink:title="00000048 - Disclosure - NOTE 12 - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="loc_us-gaapIncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription" xlink:label="loc_FONRReimbursementOfAlternativeMinimumTaxCreditsDescription" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRReimbursementOfAlternativeMinimumTaxCreditsDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:title="00000049 - Disclosure - NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_RocklandManagementGroupMember" xlink:label="loc_FONRRocklandManagementGroupMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRRocklandManagementGroupMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets" xlink:label="loc_FONRBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_RightToUseLiability" xlink:label="loc_FONRRightToUseLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRRightToUseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_TotalPurchaseConsideration" xlink:label="loc_FONRTotalPurchaseConsideration" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRTotalPurchaseConsideration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails" xlink:title="00000050 - Disclosure - NOTE 13 - ACQUISITION - Net assets acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_RocklandManagementGroupMember" xlink:label="loc_FONRRocklandManagementGroupMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRRocklandManagementGroupMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="loc_us-gaapLeaseholdImprovementsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapLeaseholdImprovementsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_DiagnosticEquipment" xlink:label="loc_FONRDiagnosticEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRDiagnosticEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedCustomerListsGross" xlink:label="loc_us-gaapFiniteLivedCustomerListsGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapFiniteLivedCustomerListsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_CovenantNotToCompete" xlink:label="loc_FONRCovenantNotToCompete" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRCovenantNotToCompete" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210930.xsd#FONR_ClosingCostsExpensed" xlink:label="loc_FONRClosingCostsExpensed" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRClosingCostsExpensed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredOther1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredOther1" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>fonar_10-q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FONR="http://fonar.com/20210930"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fonr-20210930.xsd" xlink:type="simple"/>
    <context id="From2021-07-01to2021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-11-03_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-03</instant>
        </period>
    </context>
    <context id="AsOf2021-11-03_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-03</instant>
        </period>
    </context>
    <context id="AsOf2021-11-03_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-03</instant>
        </period>
    </context>
    <context id="AsOf2021-11-03_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-03</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2020-07-012020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember15724062">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CommonStockMember15724062">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_CommonStockMember15724078">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_CommonStockMember15724078">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_DoubtfulMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_DoubtfulMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_MedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_MedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-29_custom_RocklandManagementGroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="From2021-03-012021-03-29_custom_RocklandManagementGroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-29</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-07-01to2021-09-30">0000355019</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-07-01to2021-09-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2021-07-01to2021-09-30">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2021-07-01to2021-09-30">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2021-07-01to2021-09-30">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCurrentReportingStatus contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl0027">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl0028">Yes</dei:EntityInteractiveDataCurrent>
    <FONR:UnearnedRevenueOnServiceContractsRelatedParties
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl0114"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-09-30_custom_ClassANonVotingPreferredStockMember"
      id="xdx2ixbrl0169"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember"
      id="xdx2ixbrl0171"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0181"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0183"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-09-30_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0205"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0207"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-09-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0217"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0219"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember15724062"
      id="xdx2ixbrl0366"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0367"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0370"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember15724062"
      id="xdx2ixbrl0373"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0374"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0375"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0376"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember15724062"
      id="xdx2ixbrl0380"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0381"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0382"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0383"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember15724078"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0402"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0404"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0405"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember15724078"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0409"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0410"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0411"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember15724078"
      id="xdx2ixbrl0415"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0416"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0417"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0418"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl0450"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:GainOnForgivenessOfPppLoan
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl0454"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxCreditsAndAdjustments
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl0468"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl0475"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:ConvertibleClassCStock
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0625"
      unitRef="Shares"
      xsi:nil="true"/>
    <FONR:ConvertibleClassCStock
      contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0629"
      unitRef="Shares"
      xsi:nil="true"/>
    <FONR:AccountsReceivableNetRelatedParty
      contextRef="AsOf2021-09-30_us-gaap_DoubtfulMember"
      id="xdx2ixbrl0673"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:MedicalReceivable
      contextRef="AsOf2021-09-30_us-gaap_DoubtfulMember"
      id="xdx2ixbrl0679"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AccountsReceivableNetRelatedParty
      contextRef="AsOf2021-06-30_us-gaap_DoubtfulMember"
      id="xdx2ixbrl0703"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:MedicalReceivable
      contextRef="AsOf2021-06-30_us-gaap_DoubtfulMember"
      id="xdx2ixbrl0709"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2021-09-30"
      id="xdx2ixbrl0931"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl0982"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2020-07-012020-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1012"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2021-07-01to2021-09-30">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2021-07-01to2021-09-30">true</dei:DocumentQuarterlyReport>
    <dei:DocumentTransitionReport contextRef="From2021-07-01to2021-09-30">false</dei:DocumentTransitionReport>
    <dei:DocumentPeriodEndDate contextRef="From2021-07-01to2021-09-30">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber contextRef="From2021-07-01to2021-09-30">0-10248</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2021-07-01to2021-09-30">FONAR CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-07-01to2021-09-30">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-07-01to2021-09-30">11-2464137</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-07-01to2021-09-30">110 Marcus Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-07-01to2021-09-30">Melville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-07-01to2021-09-30">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-07-01to2021-09-30">11747</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-07-01to2021-09-30">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-07-01to2021-09-30">694-2929</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2021-07-01to2021-09-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2021-07-01to2021-09-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-07-01to2021-09-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2021-07-01to2021-09-30">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2021-11-03_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6554210</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2021-11-03_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2021-11-03_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">382513000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2021-11-03_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313438000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">43405000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">44460000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ShortTermInvestments contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">32000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">32000</us-gaap:ShortTermInvestments>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">4548000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">4526000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountReceivableRelatedParties contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">102000</FONR:AccountReceivableRelatedParties>
    <FONR:AccountReceivableRelatedParties contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">12000</FONR:AccountReceivableRelatedParties>
    <FONR:MedicalReceivable contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">18356000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">17901000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFees contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">31695000</FONR:ManagementAndOtherFees>
    <FONR:ManagementAndOtherFees contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">30948000</FONR:ManagementAndOtherFees>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">7998000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">7814000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">1835000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">1663000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">1416000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">1227000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">109387000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">108583000</us-gaap:AssetsCurrent>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">2609000</FONR:AccountsReceivableNetLongTerm>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">2880000</FONR:AccountsReceivableNetLongTerm>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">14764000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">15959000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">21971000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">21850000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">29535000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">30133000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">1077000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">1127000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">4269000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">4269000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">3957000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">4038000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssets contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">660000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">667000</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">188229000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">189506000</us-gaap:Assets>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">35000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">173000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">1133000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">1866000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">5990000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">9162000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">4328000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">4366000</us-gaap:DeferredRevenueCurrent>
    <FONR:UnearnedRevenueOnServiceContractsRelatedParties contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">83000</FONR:UnearnedRevenueOnServiceContractsRelatedParties>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">15000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">15000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">3669000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">3533000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">205000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">203000</us-gaap:FinanceLeaseLiabilityCurrent>
    <FONR:CustomerDeposits contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">789000</FONR:CustomerDeposits>
    <FONR:CustomerDeposits contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">731000</FONR:CustomerDeposits>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">16247000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">20049000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">2545000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">2801000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">238000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">238000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">93000</us-gaap:AccountsPayableRelatedPartiesNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesNoncurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">93000</us-gaap:AccountsPayableRelatedPartiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">28292000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">28975000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">997000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">1049000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">190000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">760000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OtherLiabilities contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">155000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">171000</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">32510000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">34087000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">48757000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">54136000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-09-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-09-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-09-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6566000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6566000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-09-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-09-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">185101000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">185101000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">-42121000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">-46008000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares contextRef="AsOf2021-09-30" decimals="-3" unitRef="Shares">12000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares contextRef="AsOf2021-06-30" decimals="-3" unitRef="Shares">12000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">675000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">675000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">142306000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">138419000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">-2834000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">-3049000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">139472000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">135370000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">188229000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">189506000</us-gaap:LiabilitiesAndStockholdersEquity>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">6851000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">5091000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:ProductSalesNet
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">148000</FONR:ProductSalesNet>
    <FONR:ProductSalesNet
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">28000</FONR:ProductSalesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1936000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">1925000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">28000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">28000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">11972000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">11214000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">2795000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">2693000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:Revenues
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">23730000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">20979000</us-gaap:Revenues>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">3156000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">2521000</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:CostsRelatedToProductSales
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">109000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToProductSales
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">132000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">724000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">626000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">10000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">9000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">6877000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">5550000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1637000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">1428000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">386000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">5090000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">6163000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">17989000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">16829000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">5741000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">4150000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">811000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-140000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">17000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">22000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">63000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">112000</us-gaap:InvestmentIncomeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">6598000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">4100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1416000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">849000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">5182000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">3251000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1295000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">743000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">3887000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">2508000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3652000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">2355000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_PreferredClassAMember"
      decimals="-3"
      unitRef="USD">175000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_PreferredClassAMember"
      decimals="-3"
      unitRef="USD">114000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">60000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">39000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6447000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6682000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6575000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember15724062"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">185101000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-46008000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-675000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-3049000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">135370000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">3887000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">3887000</us-gaap:NetIncomeLoss>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1080000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1080000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1295000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1295000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember15724078"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">185101000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-42121000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-675000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-2834000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">139472000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">183076000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-56215000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-675000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">55000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-06-30" decimals="-3" unitRef="USD">126242000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">2508000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">2508000</us-gaap:NetIncomeLoss>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1440000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">1440000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">743000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">743000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">183076000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-53707000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-675000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-642000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">128053000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">5182000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">3251000</us-gaap:ProfitLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1169000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">968000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">648000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">953000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <FONR:ProvisionForBadDebts
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">502000</FONR:ProvisionForBadDebts>
    <FONR:ProvisionForBadDebts
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">2227000</FONR:ProvisionForBadDebts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1195000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">849000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-1000</us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent>
    <FONR:GainOnForgivenessOfPppLoan
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">701000</FONR:GainOnForgivenessOfPppLoan>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1730000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">4109000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-11000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-14000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">172000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">49000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncomeTaxCreditsAndAdjustments
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">671000</us-gaap:IncomeTaxCreditsAndAdjustments>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">188000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">125000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">4000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-733000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-117000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-3383000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-36000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLiabilities
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-547000</us-gaap:IncreaseDecreaseInOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLiabilities
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-796000</us-gaap:IncreaseDecreaseInOperatingLiabilities>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">50000</FONR:IncreaseDecreaseInFinancingLiabilities>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-12000</FONR:IncreaseDecreaseInFinancingLiabilities>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">58000</FONR:IncreaseDecreaseInCustomerAdvance>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">58000</FONR:IncreaseDecreaseInCustomerAdvance>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-16000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">10000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1241000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">3782000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1180000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">415000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">29000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">20000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-1209000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-435000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">7000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">9000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">63000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1080000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">1440000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-1087000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-1386000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-1055000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">1961000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">44460000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-06-30" decimals="-3" unitRef="USD">36802000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">43405000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">38763000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_80E_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zOxOHE8xSzR2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_827_z6NfTa50rth8" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
1 &#x2013; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Description
of Business&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
&lt;span id="xdx_90B_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_z7ZtizcLqXi7"&gt;24.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;%
interest in HDM. Health Management Corporation of America retained a direct ownership interest of &lt;span id="xdx_903_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_zKX2HBiLI2Ak"&gt;45.8&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;%
in HDM, and the original investors in HDM retained a &lt;span id="xdx_904_ecustom--OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_z2EfZ877LPEa"&gt;30.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;%
ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted
by HDM, operating under the name &#x201c;Health Management Company of America&#x201d;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Basis
of Presentation and Liquidity&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they
do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America
for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2021, are not necessarily
indicative of the results that may be expected for the fiscal year ending June 30, 2022. For further information, refer to the consolidated
financial statements and footnotes thereto included in the Company&#x2019;s Annual Report on Form 10-K filed on October 13, 2021 for the
fiscal year ended June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;During
March 2020 the global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies
which has adversely effected our workforce, liquidity, financial conditions, revenues, profitability and business operations. Generally
COVID-19 had caused us to require that much of our workforce work from home and has restricted the ability of our personnel to travel
for marketing purposes or to service our customers. The Company experienced a sudden drop in scan volume for a short term period and
the Company has recovered to pre-COVID-19 levels. At the end of fiscal year ending June 30, 2020, the Company was able to enact certain
decisions to allow the Company to survive during the global pandemic and from further losses or additional decreases in scan volume.
The Company also received some government stimulus funds from the Paycheck Protection Program (&#x201c;PPP&#x201d;) and Medicare advances/stimulus
payments. During the three months ended September 30, 2021 the PPP loan was forgiven in its entirety. Although we are unable to predict
if there will be additional consequences on our operations from the continuing global pandemic of COVID-19 and the new variants, the
Company believes with positive cash flows, low debt and cash on hand, it will be able to continue operations going forward.&#160;&lt;/span&gt;&lt;/p&gt;





















</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent
      contextRef="AsOf2015-07-01_custom_HDMMember"
      decimals="INF"
      unitRef="Pure">0.242</FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent>
    <FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent
      contextRef="AsOf2015-07-01_custom_HDMMember"
      decimals="INF"
      unitRef="Pure">0.458</FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent>
    <FONR:OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent
      contextRef="AsOf2015-07-01_custom_HDMMember"
      decimals="INF"
      unitRef="Pure">0.300</FONR:OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zO9Yleq9oVMd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_82E_z6zAJ0VrVMCj" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--ConsolidationPolicyTextBlock_zRFp41aw2B73" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_86A_zNckY6tiKf2f" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#x201c;Company&#x201d;). All significant intercompany accounts and transactions have been eliminated
in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zuSIzjJlOt2j" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_861_zY6G7Tgz45db" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Revenues&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#x2019;s revenue recognition policies and significant judgments employed in the
determination of revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--BusinessCombinationsPolicy_z0WJvoRtU4Mk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;span id="xdx_86E_zWPMiC0efh65"&gt;Business
Combination&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;When
the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets
acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition dated is measured as the excess
of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While
we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates
are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the
acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon
the conclusion of the measurement period of final determination of the values of assets acquired or liabilities assumed, whichever comes
first, any subsequent adjustments are recorded to our consolidated statements of operations.&#160;&lt;/span&gt;&lt;/p&gt;



























&lt;p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_ziZjS8NbgFYl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_863_zr6gpZh2VdIc" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the Two-Class method&#x201d;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2021 and 2020, diluted EPS for
common shareholders includes &lt;span id="xdx_900_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930_zRGgjiWukwv4" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930_zsLpUrZaFvle" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;128&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;shares upon conversion of Class C Common.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zBAIkv4wzRm" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0; padding-right: 0; text-align: left"&gt;&lt;span id="xdx_8B6_zpgUjzLOxoVa" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Earnings
    Per Share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Three
    months ended &lt;br/&gt; September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Three
    months ended &lt;br/&gt; September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Numerator: &lt;br/&gt; Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930_zapWaqXUg9Ba" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,887&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zt9qzMRXgra3" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,652&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPd7plTdMyYb" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930_zWaFONMC5WUc" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2,508&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdb52kLqzIq1" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2,355&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbHWtFHrqGX2" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zZGzybf8aWF3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zrTTZGX63aM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6EPyJNKHyx3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930_znioEuMtifx1" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,447&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zem4oWtHDibj" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,447&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXsWTKvqriN3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Basic income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930_zyba36IObr4l" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.59&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwNGz6iK5rMb" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.56&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z22A9sQVrbta" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930_zc33GDSt62of" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.39&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGWwIusDHrT7" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.37&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zlk4pcvuKUBk" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Denominator: &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zibF3BrrcCwc" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo7vmVRTwnSj" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zabzg3gXongi" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,447&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4gp0r7FYfhk" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Convertible Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zyeE9emioBkk" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJzOPcmKiUqb" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0625"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMUsLZ32MLU8" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zi5xdh23VMa1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0629"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total Denominator for diluted
    earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zCY5SrFzpCYk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,682&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zG9jNDgEBGJl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfgqvcUq5Gek" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,575&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpwXxoxGln9a" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Diluted income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z47tJrsSrexa" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHdabjKGqTnb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ztZIHlcvNGdk" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.36&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zW2QXtGoXyq7" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



























&lt;p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znt3dwjaq6wg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_86F_z1mcmUne0oHh" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2021 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2021 or 2020, and it does not believe that any
of those standards will have a significant impact on our consolidated financial statements at the time they become effective.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_844_eus-gaap--ConsolidationPolicyTextBlock_zRFp41aw2B73" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_86A_zNckY6tiKf2f" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#x201c;Company&#x201d;). All significant intercompany accounts and transactions have been eliminated
in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zuSIzjJlOt2j" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_861_zY6G7Tgz45db" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Revenues&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#x2019;s revenue recognition policies and significant judgments employed in the
determination of revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_84F_eus-gaap--BusinessCombinationsPolicy_z0WJvoRtU4Mk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;span id="xdx_86E_zWPMiC0efh65"&gt;Business
Combination&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;When
the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets
acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition dated is measured as the excess
of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While
we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates
are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the
acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon
the conclusion of the measurement period of final determination of the values of assets acquired or liabilities assumed, whichever comes
first, any subsequent adjustments are recorded to our consolidated statements of operations.&#160;&lt;/span&gt;&lt;/p&gt;



























</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_ziZjS8NbgFYl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_863_zr6gpZh2VdIc" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the Two-Class method&#x201d;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2021 and 2020, diluted EPS for
common shareholders includes &lt;span id="xdx_900_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930_zRGgjiWukwv4" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930_zsLpUrZaFvle" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;128&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;shares upon conversion of Class C Common.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zBAIkv4wzRm" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0; padding-right: 0; text-align: left"&gt;&lt;span id="xdx_8B6_zpgUjzLOxoVa" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Earnings
    Per Share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Three
    months ended &lt;br/&gt; September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Three
    months ended &lt;br/&gt; September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Numerator: &lt;br/&gt; Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930_zapWaqXUg9Ba" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,887&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zt9qzMRXgra3" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,652&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPd7plTdMyYb" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930_zWaFONMC5WUc" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2,508&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdb52kLqzIq1" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2,355&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbHWtFHrqGX2" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zZGzybf8aWF3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zrTTZGX63aM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6EPyJNKHyx3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930_znioEuMtifx1" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,447&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zem4oWtHDibj" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,447&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXsWTKvqriN3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Basic income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930_zyba36IObr4l" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.59&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwNGz6iK5rMb" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.56&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z22A9sQVrbta" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930_zc33GDSt62of" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.39&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGWwIusDHrT7" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.37&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zlk4pcvuKUBk" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Denominator: &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zibF3BrrcCwc" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo7vmVRTwnSj" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zabzg3gXongi" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,447&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4gp0r7FYfhk" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Convertible Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zyeE9emioBkk" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJzOPcmKiUqb" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0625"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMUsLZ32MLU8" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zi5xdh23VMa1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0629"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total Denominator for diluted
    earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zCY5SrFzpCYk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,682&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zG9jNDgEBGJl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfgqvcUq5Gek" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,575&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpwXxoxGln9a" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Diluted income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z47tJrsSrexa" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHdabjKGqTnb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ztZIHlcvNGdk" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.36&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zW2QXtGoXyq7" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



























</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="Shares">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="Shares">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zBAIkv4wzRm" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0; padding-right: 0; text-align: left"&gt;&lt;span id="xdx_8B6_zpgUjzLOxoVa" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Earnings
    Per Share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Three
    months ended &lt;br/&gt; September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Three
    months ended &lt;br/&gt; September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Numerator: &lt;br/&gt; Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930_zapWaqXUg9Ba" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,887&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zt9qzMRXgra3" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,652&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPd7plTdMyYb" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930_zWaFONMC5WUc" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2,508&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdb52kLqzIq1" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2,355&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbHWtFHrqGX2" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zZGzybf8aWF3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zrTTZGX63aM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6EPyJNKHyx3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930_znioEuMtifx1" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,447&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zem4oWtHDibj" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,447&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXsWTKvqriN3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Basic income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930_zyba36IObr4l" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.59&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwNGz6iK5rMb" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.56&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z22A9sQVrbta" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930_zc33GDSt62of" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.39&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGWwIusDHrT7" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.37&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zlk4pcvuKUBk" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Denominator: &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zibF3BrrcCwc" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo7vmVRTwnSj" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zabzg3gXongi" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,447&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4gp0r7FYfhk" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Convertible Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zyeE9emioBkk" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJzOPcmKiUqb" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0625"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMUsLZ32MLU8" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zi5xdh23VMa1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0629"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total Denominator for diluted
    earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zCY5SrFzpCYk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,682&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zG9jNDgEBGJl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfgqvcUq5Gek" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,575&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpwXxoxGln9a" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Diluted income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z47tJrsSrexa" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHdabjKGqTnb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ztZIHlcvNGdk" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.36&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zW2QXtGoXyq7" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;0.10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">3887000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3652000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">60000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">2508000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">2355000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">39000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="Shares">6447000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6447000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-07-01to2021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6447000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <FONR:ConvertibleClassCStock
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <FONR:ConvertibleClassCStock
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6682000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6575000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012020-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znt3dwjaq6wg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_86F_z1mcmUne0oHh" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2021 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2021 or 2020, and it does not believe that any
of those standards will have a significant impact on our consolidated financial statements at the time they become effective.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_801_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zRzWFLudV2N1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_827_zyd1XH8tZC4a" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
3 &#x2013; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Receivables,
net is comprised of the following at September 30, 2021, and June 30, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zZwyXMrb0gJ5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-top: 0; padding-right: 0"&gt;&lt;span id="xdx_8BE_zKErKQJGpNOk" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Receivables
    - Non Current - net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,990&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AccountsReceivableServiceAndRepairFees_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;442&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AccountsReceivableServiceAndRepairFees_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,548&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accounts receivable - related
    party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AccountsReceivableNetRelatedParty_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AccountsReceivableNetRelatedParty_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0673"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AccountsReceivableNetRelatedParty_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Medical receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--MedicalReceivable_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;18,356&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MedicalReceivable_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0679"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--MedicalReceivable_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;18,356&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Management and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;47,975&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;16,280&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;31,695&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Management and other fees receivable
    from related medical practices (&#x201c;PC&#x2019;s&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;12,191&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,193&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;7,998&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,968&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccountsReceivableServiceAndRepairFees_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;442&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AccountsReceivableServiceAndRepairFees_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,526&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accounts receivable - related
    party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AccountsReceivableNetRelatedParty_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AccountsReceivableNetRelatedParty_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0703"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AccountsReceivableNetRelatedParty_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Medical receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MedicalReceivable_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;17,901&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--MedicalReceivable_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0709"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--MedicalReceivable_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;17,901&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Management and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;46,735&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;15,787&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;30,948&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Management and other fees receivable
    from related medical practices (&#x201c;PC&#x2019;s&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;11,998&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,184&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;7,814&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AF_z7MZbY5xXYkg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;The
Company&#x2019;s customers are concentrated in the healthcare industry.&#160;&lt;/span&gt;&lt;/p&gt;























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accounts
Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Credit
risk with respect to the Company&#x2019;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Long
Term Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following four years at September 30, 2021 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_pn3n3_zIEgmEnxEeri" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_z5OOdbrLwPoe" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total
    Facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49B_20210930_zALTXVd8Gbc1" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_maARBFLzybP_zeW2aaPFWfH1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 43%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_maARBFLzybP_zG1vgNbMTITh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,020&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_maARBFLzybP_zQTQ3hTYzOAg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;413&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pn3n3_maARBFLzybP_zWdZ4kiuZ35j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;92&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_iTI_pn3n3_mtARBFLzybP_z8APCFbsDaih" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2,545&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AC_zis1att3I655" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Medical
Receivables&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#x2019;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#x2019;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Management
and Other Fees Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
Company&#x2019;s receivables from the related and non-related professional corporations (PC&#x2019;s) substantially consist of fees outstanding
under management agreements. Payment of the outstanding fees is dependent on collection by the PC&#x2019;s of fees from third party medical
reimbursement organizations, principally insurance companies and health management organizations.&#160;&lt;/span&gt;&lt;/p&gt;



























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Payment
of the management fee receivables from the PC&#x2019;s may be impaired by the inability of the PC&#x2019;s to collect in a timely manner
their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately &lt;span id="xdx_90B_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20210701__20210930_zrIXHpiBIUm7"&gt;66.7&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;%
and &lt;span id="xdx_900_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20200701__20200930_zI8NOnkhZDd5"&gt;66&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;%
of the PCs&#x2019; net revenues for the three months ended September 30, 2021 and 2020, respectively, were derived from no-fault and personal
injury protection claims. The Company considers the aging of its accounts receivable in determining the amount of allowance for doubtful
accounts. The Company generally takes all legally available steps to collect its receivables. Credit losses associated with the receivables
are provided for in the condensed consolidated financial statements and have historically been within management&#x2019;s expectations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Net
revenues from management and other fees charged to the related PCs accounted for approximately &lt;span id="xdx_90A_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20210701__20210930_zhxDlplxsCog"&gt;11.8&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;%
and &lt;span id="xdx_900_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20200701__20200930_zRkd8qcGsF74"&gt;12.8&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;%
of the consolidated net revenues for the three months ended September 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp;amp; Diagnostic Center, PA (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. Additional Company managed entities also operate under a guaranty agreement,
pursuant to which management fees are payable to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
Company&#x2019;s patient fee revenue, net of contractual allowances and discounts for the three months ended September 30, 2021 and 2020
are summarized in the following table.&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_pn3n3_zY6juRZ34H92" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B2_zV46w3Or2E5d" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Schedule of patient fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;For
    the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Commercial Insurance/
    Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zVJYYLC7mYpf" style="width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,086&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zFwzeYHcw6Tc" style="width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;946&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zOYhwflRmHnk" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;249&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zaP399fNHk71" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;197&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Workers&#x2019; Compensation/Personal
    Injury&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zdkvFj3I9da1" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,124&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zvSqn46Bl4ak" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,387&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVq1nxn1Wrha" style="border-bottom: Black 1pt solid; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,392&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zS6U4PSS3cy2" style="border-bottom: Black 1pt solid; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;561&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Patient Fee Revenue, net of contractual
    allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930_zfHI3kiWagFf" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,851&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930_zAVcKbmDl2sh" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,091&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;





















</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zZwyXMrb0gJ5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-top: 0; padding-right: 0"&gt;&lt;span id="xdx_8BE_zKErKQJGpNOk" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Receivables
    - Non Current - net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,990&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AccountsReceivableServiceAndRepairFees_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;442&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AccountsReceivableServiceAndRepairFees_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,548&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accounts receivable - related
    party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AccountsReceivableNetRelatedParty_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AccountsReceivableNetRelatedParty_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0673"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AccountsReceivableNetRelatedParty_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Medical receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--MedicalReceivable_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;18,356&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MedicalReceivable_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0679"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--MedicalReceivable_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;18,356&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Management and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;47,975&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;16,280&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;31,695&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Management and other fees receivable
    from related medical practices (&#x201c;PC&#x2019;s&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;12,191&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,193&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;7,998&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,968&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccountsReceivableServiceAndRepairFees_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;442&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AccountsReceivableServiceAndRepairFees_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,526&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accounts receivable - related
    party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AccountsReceivableNetRelatedParty_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AccountsReceivableNetRelatedParty_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0703"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AccountsReceivableNetRelatedParty_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Medical receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MedicalReceivable_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;17,901&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--MedicalReceivable_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0709"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--MedicalReceivable_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;17,901&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Management and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;46,735&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;15,787&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;30,948&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Management and other fees receivable
    from related medical practices (&#x201c;PC&#x2019;s&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;11,998&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,184&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;7,814&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2021-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">4990000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2021-09-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">442000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">4548000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableNetRelatedParty
      contextRef="AsOf2021-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">102000</FONR:AccountsReceivableNetRelatedParty>
    <FONR:AccountsReceivableNetRelatedParty contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">102000</FONR:AccountsReceivableNetRelatedParty>
    <FONR:MedicalReceivable
      contextRef="AsOf2021-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">18356000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">18356000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFees_NonRelatedParties
      contextRef="AsOf2021-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">47975000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties
      contextRef="AsOf2021-09-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">16280000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">31695000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2021-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">12191000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2021-09-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">4193000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">7998000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">4968000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2021-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">442000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">4526000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableNetRelatedParty
      contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">12000</FONR:AccountsReceivableNetRelatedParty>
    <FONR:AccountsReceivableNetRelatedParty contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">12000</FONR:AccountsReceivableNetRelatedParty>
    <FONR:MedicalReceivable
      contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">17901000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">17901000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFees_NonRelatedParties
      contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">46735000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties
      contextRef="AsOf2021-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">15787000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">30948000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">11998000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2021-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">4184000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">7814000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:TotalFacilitiesOwnedOrManagedTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_pn3n3_zIEgmEnxEeri" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_z5OOdbrLwPoe" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total
    Facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49B_20210930_zALTXVd8Gbc1" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_maARBFLzybP_zeW2aaPFWfH1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 43%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_maARBFLzybP_zG1vgNbMTITh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,020&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_maARBFLzybP_zQTQ3hTYzOAg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;413&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pn3n3_maARBFLzybP_zWdZ4kiuZ35j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;92&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_iTI_pn3n3_mtARBFLzybP_z8APCFbsDaih" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2,545&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</FONR:TotalFacilitiesOwnedOrManagedTableTextBlock>
    <us-gaap:ContractReceivableDueOneToTwoYears contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">1020000</us-gaap:ContractReceivableDueOneToTwoYears>
    <us-gaap:ContractReceivableDueTwoToThreeYears contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">1020000</us-gaap:ContractReceivableDueTwoToThreeYears>
    <us-gaap:ContractReceivableDueThreeToFourYears contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">413000</us-gaap:ContractReceivableDueThreeToFourYears>
    <us-gaap:ContractReceivableDueFourToFiveYears contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">92000</us-gaap:ContractReceivableDueFourToFiveYears>
    <us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">2545000</us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2021-07-01to2021-09-30"
      decimals="INF"
      unitRef="Pure">0.667</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Pure">0.66</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2021-07-01to2021-09-30"
      decimals="INF"
      unitRef="Pure">0.118</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Pure">0.128</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:ScheduleOfPatientFeeRevenueTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_pn3n3_zY6juRZ34H92" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B2_zV46w3Or2E5d" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Schedule of patient fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;For
    the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Commercial Insurance/
    Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zVJYYLC7mYpf" style="width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,086&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zFwzeYHcw6Tc" style="width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;946&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zOYhwflRmHnk" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;249&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zaP399fNHk71" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;197&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Workers&#x2019; Compensation/Personal
    Injury&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zdkvFj3I9da1" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,124&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zvSqn46Bl4ak" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,387&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVq1nxn1Wrha" style="border-bottom: Black 1pt solid; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,392&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zS6U4PSS3cy2" style="border-bottom: Black 1pt solid; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;561&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Patient Fee Revenue, net of contractual
    allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930_zfHI3kiWagFf" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,851&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930_zAVcKbmDl2sh" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,091&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;





















</FONR:ScheduleOfPatientFeeRevenueTableTextBlock>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012021-09-30_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      unitRef="USD">1086000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2020-07-012020-09-30_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      unitRef="USD">946000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012021-09-30_custom_MedicareMedicaidMember"
      decimals="-3"
      unitRef="USD">249000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2020-07-012020-09-30_custom_MedicareMedicaidMember"
      decimals="-3"
      unitRef="USD">197000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012021-09-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      unitRef="USD">4124000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2020-07-012020-09-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      unitRef="USD">3387000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012021-09-30_custom_OtherRevenueSourceMember"
      decimals="-3"
      unitRef="USD">1392000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2020-07-012020-09-30_custom_OtherRevenueSourceMember"
      decimals="-3"
      unitRef="USD">561000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">6851000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">5091000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_806_eus-gaap--LesseeOperatingLeasesTextBlock_z4ctQmoJW6Th" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"&gt;&lt;span id="xdx_82A_zeszTjwrrjai" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
4 &#x2013; OPERATING &amp;amp; FINANCING LEASES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;During
February 2016, FAS issued ASU 2016-02, Leases (Topic 842). The new standard requires lessees to apply a dual approach, classifying leases
as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase by the
lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line
basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with
a term of greater than 12 months regardless of their classification. Lease with a term of 12 months or less will be accounted for similar
to previous guidance for operating leases. The standard was effective for us beginning July 1, 2019. We have elected the optional transition
method to apply the standard as of the effective date and therefore, we will not apply the standard to the comparative periods presented
in the consolidated financial statements. We have also elected the transition package of the practical expedients permitted within the
standard which eliminates the requirements to reassess prior conclusions about lease identification, lease classification and indirect
costs. The adoption of this guidance had a material impact on the Company&#x2019;s balance sheet by virtue of including the present value
of its future operating lease payments as a liability of $&lt;span id="xdx_909_eus-gaap--OperatingLeasePayments_pn3n3_dm_c20210701__20210930_zeANIR5rp0G7" title="Operating lease payments"&gt;33.3
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;million and related right-to-use lease assets as
of July 1, 2019. At the time of adoption of this guidance we had no significant financing leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#x2018;ASC&#x2019;) 842 &#x2013;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#x201c;IBR&#x201d;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of September 30,
2021 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_pn3n3_z5Gnn7v1d3F5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 4 - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span id="xdx_8B9_z4rcWVDy9Gzj" style="display: none"&gt;Reconcilliation
of operating and financing lease payments&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Operating Lease Payments 2023"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Financing Lease Payments 2023"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Year
    Ending &#160; September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Operating
    Lease &#160; Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Financing
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 26%; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20210930_pn3n3" style="width: 26%; text-align: right" title="Operating Lease Payments 2022"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,166&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20210930_pn3n3" style="width: 26%; text-align: right" title="Financing Lease Payments 2022"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2023"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,170&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2023"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2024"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,895&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2024"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2025"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,711&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2025"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2026"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,248&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2026"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments Thereafter"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;15,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments Thereafter"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;104&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Present
    value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PresentValueDiscount_iNI_pn3n3_di_c20210930_zWg6udo3osk2" style="border-bottom: Black 1pt solid; text-align: right" title="Operating Lease Payments Present Value discount"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(8,157&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PresentValueDiscountFinancingLease_iNI_pn3n3_di_c20210930_zlDf3ddYTkpi" style="border-bottom: Black 1pt solid; text-align: right" title="Financing Lease Payments Present Value discount"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(122&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20210930_zgjxRLR7fhQa" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease Payments Total lease liability"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;31,961&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Financing Lease Payments Total lease liability"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,202&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">33300000</us-gaap:OperatingLeasePayments>
    <FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_pn3n3_z5Gnn7v1d3F5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 4 - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span id="xdx_8B9_z4rcWVDy9Gzj" style="display: none"&gt;Reconcilliation
of operating and financing lease payments&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Operating Lease Payments 2023"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Financing Lease Payments 2023"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Year
    Ending &#160; September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Operating
    Lease &#160; Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Financing
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 26%; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20210930_pn3n3" style="width: 26%; text-align: right" title="Operating Lease Payments 2022"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,166&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20210930_pn3n3" style="width: 26%; text-align: right" title="Financing Lease Payments 2022"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2023"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,170&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2023"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2024"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,895&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2024"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2025"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,711&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2025"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2026"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,248&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2026"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments Thereafter"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;15,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments Thereafter"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;104&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Present
    value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PresentValueDiscount_iNI_pn3n3_di_c20210930_zWg6udo3osk2" style="border-bottom: Black 1pt solid; text-align: right" title="Operating Lease Payments Present Value discount"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(8,157&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PresentValueDiscountFinancingLease_iNI_pn3n3_di_c20210930_zlDf3ddYTkpi" style="border-bottom: Black 1pt solid; text-align: right" title="Financing Lease Payments Present Value discount"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(122&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20210930_zgjxRLR7fhQa" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease Payments Total lease liability"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;31,961&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Financing Lease Payments Total lease liability"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,202&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">5166000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">5170000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">4895000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">4711000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">4248000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">15928000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">104000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <FONR:PresentValueDiscount contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">8157000</FONR:PresentValueDiscount>
    <FONR:PresentValueDiscountFinancingLease contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">122000</FONR:PresentValueDiscountFinancingLease>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">31961000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">1202000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_800_eus-gaap--InventoryDisclosureTextBlock_zSXcNYbbLjda" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"&gt;&lt;span id="xdx_820_z1kiDZV7M9z7" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
5 - INVENTORIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_z9vgGW5nzzN6" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0; padding-right: 0"&gt;&lt;span id="xdx_8B2_zOGco7sVgFNi" style="font: normal 10pt Arial, Helvetica, Sans-Serif; display: none"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49B_20210930_zFF5H0LucJ33" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49E_20210630_zuiwsc7kWRA7" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWz0B3_zQqgXrpUJL2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Purchased parts,
    components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,553&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,393&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWz0B3_z5RhkbH7ME6e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;282&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;270&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWz0B3_zlWwyX51cnQd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;TOTAL INVENTORIES&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,835&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,663&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_z9vgGW5nzzN6" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0; padding-right: 0"&gt;&lt;span id="xdx_8B2_zOGco7sVgFNi" style="font: normal 10pt Arial, Helvetica, Sans-Serif; display: none"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49B_20210930_zFF5H0LucJ33" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49E_20210630_zuiwsc7kWRA7" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWz0B3_zQqgXrpUJL2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Purchased parts,
    components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,553&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,393&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWz0B3_z5RhkbH7ME6e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;282&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;270&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWz0B3_zlWwyX51cnQd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;TOTAL INVENTORIES&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,835&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,663&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">1553000</us-gaap:OtherInventorySupplies>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">1393000</us-gaap:OtherInventorySupplies>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">282000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">270000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">1835000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">1663000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_801_eus-gaap--ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_z2vYf5hHWsek" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"&gt;&lt;span id="xdx_829_zwKrBqDHTSdi" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
6 &#x2013; CONTRACT ASSETS AND LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Information
relating to uncompleted contracts about contract assets and (liabilities) is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_pn3n3_z4s8ciae4skj" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&lt;span style="color: Black; font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span id="xdx_8BF_zEHfpAuSKoac" style="display: none"&gt;Costs
and &#160;Estimated Earnings on Uncompleted Contracts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20210930_ztarKTYxLW34" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20210630_zsHMKgVWhkt5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--CostsIncurredOnUncompletedContracts_iI_pn3n3_maCAEEOzAiq_maCAEEOzkha_zahTmLeTEWzd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Costs incurred on
    uncompleted contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;295&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;295&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--EstimatedEarnings_iI_pn3n3_maCAEEOzAiq_maCAEEOzkha_zFigRQYmhJF1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Estimated earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;568&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;568&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pn3n3_mtCAEEOzAiq_maTCAEEzvJg_mtCAEEOzkha_z6mRDgb5NF41" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Costs and estimated earnings
    on uncompleted contracts&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;863&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;863&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--BillingsToDate_iNI_pn3n3_di_maTCAEEzvJg_maTCAEEzMMZ_zgm7WCBXOyzi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Less: Billings to date&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;878&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;878&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet_iTI_pn3n3_mtTCAEEzvJg_mtTCAEEzMMZ_z4R13Bh9Eijl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total costs and estimated
    earnings in excess of billings on uncompleted contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(15&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(15&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"/&gt;























</us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock>
    <us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_pn3n3_z4s8ciae4skj" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&lt;span style="color: Black; font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span id="xdx_8BF_zEHfpAuSKoac" style="display: none"&gt;Costs
and &#160;Estimated Earnings on Uncompleted Contracts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20210930_ztarKTYxLW34" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20210630_zsHMKgVWhkt5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--CostsIncurredOnUncompletedContracts_iI_pn3n3_maCAEEOzAiq_maCAEEOzkha_zahTmLeTEWzd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Costs incurred on
    uncompleted contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;295&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;295&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--EstimatedEarnings_iI_pn3n3_maCAEEOzAiq_maCAEEOzkha_zFigRQYmhJF1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Estimated earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;568&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;568&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pn3n3_mtCAEEOzAiq_maTCAEEzvJg_mtCAEEOzkha_z6mRDgb5NF41" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Costs and estimated earnings
    on uncompleted contracts&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;863&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;863&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--BillingsToDate_iNI_pn3n3_di_maTCAEEzvJg_maTCAEEzMMZ_zgm7WCBXOyzi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Less: Billings to date&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;878&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;878&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet_iTI_pn3n3_mtTCAEEzvJg_mtTCAEEzMMZ_z4R13Bh9Eijl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total costs and estimated
    earnings in excess of billings on uncompleted contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(15&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(15&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock>
    <FONR:CostsIncurredOnUncompletedContracts contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">295000</FONR:CostsIncurredOnUncompletedContracts>
    <FONR:CostsIncurredOnUncompletedContracts contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">295000</FONR:CostsIncurredOnUncompletedContracts>
    <FONR:EstimatedEarnings contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">568000</FONR:EstimatedEarnings>
    <FONR:EstimatedEarnings contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">568000</FONR:EstimatedEarnings>
    <FONR:CostsAndEstimatedEarningsOnUncompletedContracts contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">863000</FONR:CostsAndEstimatedEarningsOnUncompletedContracts>
    <FONR:CostsAndEstimatedEarningsOnUncompletedContracts contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">863000</FONR:CostsAndEstimatedEarningsOnUncompletedContracts>
    <FONR:BillingsToDate contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">-878000</FONR:BillingsToDate>
    <FONR:BillingsToDate contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">-878000</FONR:BillingsToDate>
    <FONR:TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">-15000</FONR:TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet>
    <FONR:TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">-15000</FONR:TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_80A_eus-gaap--IntangibleAssetsDisclosureTextBlock_zXPM9xefXAu9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_826_zOt0ZfJoBKBa" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
7 &#x2013; OTHER INTANGIBLE ASSETS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zkHS6AOIX49e" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BB_zdaoeOeNH7zc" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other
    Intagible Assets - Net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Capitalized software
    development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Patents and copyrights&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,274&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,245&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Gross Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;20,329&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;20,300&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Less: Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210930_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;16,372&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210630_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;16,262&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,957&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,038&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Amortization
of patents and copyrights for the three months ended September 30, 2021 and 2020 amounted to $&lt;span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3"&gt;47
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;and $&lt;span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20200930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3"&gt;45&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Amortization
of non-compete for the three months ended September 30, 2021 and 2020 amounted to $&lt;span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3"&gt;13
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;and $&lt;span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20200930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Amortization
of customer relationships for the three months ended September 30, 2021 and 2020 amounted to $&lt;span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3"&gt;50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;and $&lt;span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20200930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3"&gt;48&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zkHS6AOIX49e" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BB_zdaoeOeNH7zc" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other
    Intagible Assets - Net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Capitalized software
    development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Patents and copyrights&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,274&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,245&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Gross Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;20,329&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;20,300&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Less: Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210930_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;16,372&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210630_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;16,262&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,957&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,038&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-09-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="-3"
      unitRef="USD">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="-3"
      unitRef="USD">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-09-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">5274000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-06-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">5245000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-09-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-09-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">20329000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">20300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">16372000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">16262000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">3957000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">4038000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012021-09-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">47000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-07-012020-09-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">45000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012021-09-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">13000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-07-012020-09-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012021-09-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-07-012020-09-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">48000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_807_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zOcanxingsnj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_826_zIbqlD0UKeuj" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
8 &#x2013; OTHER CURRENT LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zOkpzMHiFCL6" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BB_znwJwVTjV5Qj" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other
    Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20210930_zsSWJvPMTq6e" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_490_20210630_zeLVmc4rE5Wf" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCz1Nt_zo97CUsrgcBd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accrued salaries,
    commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,595&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,407&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maOLCz1Nt_z5XeFMnKaHbj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Litigation accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0931"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCz1Nt_zKYgcDago4ee" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Sales tax payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;674&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;645&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCz1Nt_zqK8PHIk9by1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;State income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;351&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;774&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCz1Nt_z6MnZgwWD0M5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Legal and other professional
    fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCz1Nt_zLH0hvTL9oXj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accounting fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;131&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;127&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCz1Nt_zWMqDllrkryb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Self-funded health insurance
    reserve&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;62&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCz1Nt_zx7abxKtrKT3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accrued interest and penalty&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;279&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;493&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCz1Nt_zM5o7SYwXeXc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;907&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;716&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCz1Nt_ztzKyS5NLqEe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,990&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;9,162&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

























</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zOkpzMHiFCL6" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BB_znwJwVTjV5Qj" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other
    Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20210930_zsSWJvPMTq6e" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_490_20210630_zeLVmc4rE5Wf" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCz1Nt_zo97CUsrgcBd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accrued salaries,
    commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3,595&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,407&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maOLCz1Nt_z5XeFMnKaHbj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Litigation accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0931"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCz1Nt_zKYgcDago4ee" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Sales tax payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;674&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;645&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCz1Nt_zqK8PHIk9by1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;State income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;351&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;774&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCz1Nt_z6MnZgwWD0M5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Legal and other professional
    fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCz1Nt_zLH0hvTL9oXj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accounting fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;131&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;127&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCz1Nt_zWMqDllrkryb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Self-funded health insurance
    reserve&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;62&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCz1Nt_zx7abxKtrKT3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Accrued interest and penalty&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;279&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;493&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCz1Nt_zM5o7SYwXeXc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;907&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;716&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCz1Nt_ztzKyS5NLqEe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,990&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;9,162&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">3595000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">5407000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">900000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">674000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">645000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <FONR:StateIncomeTaxesPayable contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">351000</FONR:StateIncomeTaxesPayable>
    <FONR:StateIncomeTaxesPayable contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">774000</FONR:StateIncomeTaxesPayable>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">29000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">38000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">131000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">127000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">24000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">62000</us-gaap:SelfInsuranceReserve>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">279000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">493000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">907000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">716000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">5990000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">9162000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_802_eus-gaap--SegmentReportingDisclosureTextBlock_zGCKWVAcmhSb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_828_zEZDlZ8HNrD2" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
9 - SEGMENT AND RELATED INFORMATION&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
accounting policies of the segments are the same as those described in the summary of significant accounting policies as disclosed in
the Company&#x2019;s 10-K as of June 30, 2021. All inter-segment sales are market-based. The Company evaluates performance based on income
or loss from operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Summarized
financial information concerning the Company&#x2019;s reportable segments is shown in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zwDXIR6nqRbh" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span id="xdx_8B9_ze0wWT4lOdf8" style="display: none"&gt;Suuummarrized
Segment Financial Information&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Net revenues from external customers"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Net revenues from external customers"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Net revenues from external customers"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Medical
    &lt;br/&gt; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Management
    &lt;br/&gt; of Diagnostic &lt;br/&gt; Imaging &lt;br/&gt;
    Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: none"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;For the three months ended
    Sept. 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Net revenues from
    external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2,112&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;21,618&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;23,730&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Inter-segment net revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zr9Mmrr0ILlj" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;236&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zv1DLoYg1Uh3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0982"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930_ze5QfQTgetc" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;236&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(Loss) Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(490&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,231&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,741&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;67&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,102&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,169&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;121&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,088&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For the three
    months ended Sept. 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Net revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,981&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;18,998&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930_pn3n3" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;20,979&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Inter-segment net revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zdyNt3ETXxxj" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;219&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zPdz7yQlU8yg" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1012"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930_zdlOap0pubAc" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;219&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(Loss) Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(561&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,711&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;67&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;901&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;968&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;415&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;435&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2021-07-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zwDXIR6nqRbh" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span id="xdx_8B9_ze0wWT4lOdf8" style="display: none"&gt;Suuummarrized
Segment Financial Information&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Net revenues from external customers"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Net revenues from external customers"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Net revenues from external customers"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Medical
    &lt;br/&gt; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Management
    &lt;br/&gt; of Diagnostic &lt;br/&gt; Imaging &lt;br/&gt;
    Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: none"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;For the three months ended
    Sept. 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Net revenues from
    external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;2,112&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;21,618&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;23,730&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Inter-segment net revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zr9Mmrr0ILlj" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;236&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zv1DLoYg1Uh3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0982"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930_ze5QfQTgetc" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;236&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(Loss) Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(490&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;6,231&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;5,741&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;67&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,102&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,169&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;121&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,088&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For the three
    months ended Sept. 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Net revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,981&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;18,998&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930_pn3n3" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;20,979&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Inter-segment net revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zdyNt3ETXxxj" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;219&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zPdz7yQlU8yg" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1012"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930_zdlOap0pubAc" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;219&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(Loss) Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(561&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,711&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;67&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;901&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;968&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;415&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;435&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">2112000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">21618000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">23730000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">236000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">236000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">-490000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">6231000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">5741000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">67000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">1102000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1169000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">121000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">1088000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1209000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2020-07-012020-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">1981000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2020-07-012020-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">18998000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">20979000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:IntersegmentNetRevenues
      contextRef="From2020-07-012020-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">219000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">219000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2020-07-012020-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">-561000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2020-07-012020-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">4711000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">4150000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-07-012020-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">67000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-07-012020-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">901000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">968000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2020-07-012020-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">20000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2020-07-012020-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">415000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">435000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_808_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zz0aqZyK2lU5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_82D_zIbm6yIwFyP" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
10 &#x2013; SUPPLEMENTAL CASH FLOW INFORMATION&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;During
the three months ended September 30, 2021 and September 30, 2020, the Company paid $&lt;span id="xdx_90F_eus-gaap--InterestPaid_pn3n3_c20210701__20210930_ziH6sas0tgV7" title="Interest paid"&gt;189
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;and $&lt;span id="xdx_90A_eus-gaap--InterestPaid_pn3n3_c20200701__20200930_zBuqsQyqe9m7" title="Interest paid"&gt;19
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;for interest, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;During
the three months ended September 30, 2021 and September 30, 2020, the Company paid $&lt;span id="xdx_90B_eus-gaap--IncomeTaxesPaid_pn3n3_c20210701__20210930_zp9U3ytXEMod" title="Income taxes paid"&gt;221
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;and $&lt;span id="xdx_903_eus-gaap--IncomeTaxesPaid_pn3n3_c20200701__20200930_zh3zvjvRbxS7" title="Income taxes paid"&gt;145
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;for income taxes, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;























</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:InterestPaid
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">189000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">19000</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">221000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">145000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zvm5FKJuav7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_824_zXutgyPSxHsd" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
11 &#x2013; COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Litigation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Other
Matters&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;In
September 2019, the Company was notified by one of its landlords that it was required to vacate the premises within 180 days under the
demolition clause in the lease. The Company believed the lease renewal which was not negotiated in good faith since the renewal was negotiated
in February 2018. The Company is in the process of relocating to a new location but the original lease provided for penalty payments
in the event that the Company had not vacated the lease space. The Company had been making normal rent payments throughout the course
of the arbitration proceedings. The case was settled for $900 of leasehold holdover charges which was paid in August 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_90F_ecustom--LitigationSettelementDescription_c20210701__20210930_zlaQdZ9EBP8e" style="font-size: 10pt; font-style: normal; font-weight: normal" title="Litigation settelement description"&gt;In
September 2020, the Company entered into a settlement agreement with an unrelated third party for a claim made during March 2018 which
was scheduled for arbitration. The settlement was for $1.2 million of which $900 was paid by the Company&#x2019;s insurance in September
2020. The Company paid the remaining balance of $315 in September 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
Company has satisfied most of its delinquencies in filing sales tax returns for certain states, for which the Company has transacted
business. The Company has recorded tax obligations of approximately $&lt;span id="xdx_900_eus-gaap--SalesAndExciseTaxPayableCurrentAndNoncurrent_iI_pn3n3_c20210930_zW8Yn9zuG9Pa" title="Recorded tax obligations"&gt;674
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;plus interest and penalties of approximately $&lt;span id="xdx_905_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_pn3n3_c20210930_zIinc7R0jk31" title="Interest and penalties"&gt;232
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;until the remaining states have been resolved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 20pt; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum
potential liability for individual claims to $&lt;span id="xdx_904_ecustom--MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_c20210930_pn3n3"&gt;150
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;per person and for a maximum potential claim liability
based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when
estimating its health insurance program liability and related expense. As of September 30, 2021 and June 30, 2021, the Company had approximately
$&lt;span id="xdx_909_eus-gaap--SelfInsuranceReserve_iI_pn3n3_c20210930_zRXROiB3d5l2" title="Self-funded health insurance reserve"&gt;24 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;and
$&lt;span id="xdx_907_eus-gaap--SelfInsuranceReserve_iI_pn3n3_c20210630_zyhgBkerVKyj" title="Self-funded health insurance reserve"&gt;62&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;,
respectively, in reserve for its self-funded health insurance programs. The reserves are included in &#x201c;Other current liabilities&#x201d;
in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;





























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#x2019; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <FONR:LitigationSettelementDescription contextRef="From2021-07-01to2021-09-30">In
September 2020, the Company entered into a settlement agreement with an unrelated third party for a claim made during March 2018 which
was scheduled for arbitration. The settlement was for $1.2 million of which $900 was paid by the Company&#x2019;s insurance in September
2020. The Company paid the remaining balance of $315 in September 2020.</FONR:LitigationSettelementDescription>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">674000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">232000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <FONR:MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">150000</FONR:MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">24000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">62000</us-gaap:SelfInsuranceReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_zww9G6UGPGUl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_821_zYuAQyVQ4xmd" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
12 - INCOME TAXES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;In
accordance with ASC 740-270, Income Taxes &#x2013; Interim Reporting, the Company is required at the end of each interim period to determine
the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The resulting tax expense
(or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in the interim period as
they occur. For the three months ended September 30, 2021, the Company recorded income tax expense of $&lt;span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20210701__20210930_zDXLmke81qH6" title="Income tax expense"&gt;1,416
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;in 2021 as compared to $&lt;span id="xdx_904_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20200701__20200930_zhDgMoKiOnp9" title="Income tax expense"&gt;849
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;in 2020. The 2021 provision is comprised of a current
income tax component of $&lt;span id="xdx_907_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_c20210701__20210930_zgmlvsmDh9ke" title="Income tax component - current"&gt;221&lt;/span&gt;&lt;/span&gt; &lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;and
a deferred income tax component of $&lt;span id="xdx_908_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_c20210701__20210930_z8vzL2WsAKAa" title="Income tax component - deferred"&gt;1,195&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;.
Obligations for any liability associated with the current income tax provision, has been reduced, primarily resulting from the benefits
and utilization of net operating loss carryforwards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#x2019;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#x201c;Interest expense, net&#x201d;. Penalties if incurred would be recognized as a component of &#x201c;Selling,
general and administrative&#x201d; expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2017.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;































&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
Company recorded a deferred tax asset of $&lt;span id="xdx_908_eus-gaap--DeferredTaxAssetsNet_iI_pn3n3_c20210930_zVgmyt9rZufk" title="Deferred tax asset"&gt;14,764&lt;/span&gt;&lt;/span&gt; &lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;and
a deferred tax liability of $&lt;span id="xdx_904_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pn3n3_c20210930_zwJQafUV1Rh7" title="Deferred tax liability"&gt;238
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;as of September 30, 2021, primarily relating to
net operating loss carryforwards of approximately $&lt;span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20210930_z3tnWJeO3QU5" title="Operating Loss Carryforwards"&gt;49,224&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;available to offset future taxable income through 2032. The net
operating losses begin to expire in 2023 for federal tax and state income tax purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;On
March 27, 2020 Congress enacted the CARES Act (Coronavirus Aid, Relief and Economic Security Act). The Act provides numerous tax provisions
and other stimulus measures, including temporary changes regarding prior and future operation losses, temporary changes to prior and
future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security
taxes, technical corrections to prior tax legislation for tax depreciation of certain qualified improvement property and enhanced recoverability
of AMT tax credits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_909_ecustom--ReimbursementOfAlternativeMinimumTaxCreditsDescription_c20210701__20210930_zBOwhZLPngVi" style="font-size: 10pt; font-style: normal; font-weight: normal" title="Reimbursement of alternative minimum tax credits description"&gt;At
the present time, the only impact of the CARES Act to the Company is allowing a full reimbursement of $1,342 of tax credits relating
to the alternative minimum tax credits. The Company received the first half payment in June 2020. The balance of alternative minimum
tax credits of $671 was received in July 2020. Previously, these credits were to be refunded over a 3 year period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;As
we continue to monitor tax implications of the CARES Act and other state and federal stimulus tax legislation, we may make adjustments
to our estimates and record additional amounts for tax assets and liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of September 30, 2021, no such changes in ownership have occurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry and tax planning strategies in making this assessment. At present, the Company believes
that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;A
valuation allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

























</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1416000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">849000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">221000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2021-07-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1195000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">14764000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">238000</us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">49224000</us-gaap:OperatingLossCarryforwards>
    <FONR:ReimbursementOfAlternativeMinimumTaxCreditsDescription contextRef="From2021-07-01to2021-09-30">At
the present time, the only impact of the CARES Act to the Company is allowing a full reimbursement of $1,342 of tax credits relating
to the alternative minimum tax credits. The Company received the first half payment in June 2020. The balance of alternative minimum
tax credits of $671 was received in July 2020. Previously, these credits were to be refunded over a 3 year period.</FONR:ReimbursementOfAlternativeMinimumTaxCreditsDescription>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_80A_eus-gaap--BusinessCombinationDisclosureTextBlock_zHhTOKRL8Oq2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_82A_zdD7kiaZiIIa" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
13 &#x2013; ACQUISITION&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;On
March 29, 2021, the Company completed the acquisition of certain assets of Rockland Management Group, located in West Yonkers. The Company
used an incremental borrowing rate of 4% to value the right to use asset in connection with the assumed operating lease obligation. We
made a preliminary fair value determination of the acquired assets and assumed liabilities as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_pn3n3_zqPQ8UdLIkf9" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B5_zg6DZWhDoGf" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Fair
    value assets and assumed liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_495_20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_zsfvCAcNLncb" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;650&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Right to use assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;434&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--SecurityDeposit_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Security Deposit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--RightToUseLiability_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Right to use liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(434&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--Goodwill_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;284&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--TotalPurchaseConsideration_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,123&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A6_zxQMSHNvJXTf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;In
accordance with ASC 805-10-25-1, Business Combinations &#x2013; Overall Recognition, the Company recorded the transaction as a business
combination. ASC 805-10-25-1 provides the requirements of recording the transaction by applying the acquisition method. The acquisition
method requires the Company to determine if the assets and liabilities acquired are a business or not. Under ASC 805-10-25-1, it must
be determined if there is a specific acquisition party, acquisition date, identifiable assets acquired and liabilities assumed and you
must be able to recognized and measure goodwill or a gain from the purchase. Based upon this guidance, the acquisition had been recorded
as a business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
net assets acquired and consideration is as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_pn3n3_zmjrW7Xyvmgk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - NOTE 13 - ACQUISITION - Net assets acquired (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B0_zPpkI8Mx7BT7" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Net
    assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_z4hX3ZMa57A9" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--LeaseholdImprovementsGross_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Leasehold Improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;550&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--DiagnosticEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Diagnostic Equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--FiniteLivedCustomerListsGross_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Customer Lists&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--CovenantNotToCompete_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Covenant Not to Compete&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--SecurityDeposit_iI_pn3n3_zjVLjuySKGfl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Security Deposit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--ClosingCostsExpensed_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Closing costs - expensed&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--Goodwill_iI_pn3n3_z45ctut2uIAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;284&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Cash Consideration Paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--BusinessCombinationConsiderationTransferredOther1_c20210301__20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Cash Consideration Paid"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,126&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A7_z07JSnwLhmo7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
results of operations of Rockland Management Group were diminutive and did not affect the pro forma results of operations.&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;























</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_pn3n3_zqPQ8UdLIkf9" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B5_zg6DZWhDoGf" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Fair
    value assets and assumed liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_495_20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_zsfvCAcNLncb" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;650&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Right to use assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;434&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--SecurityDeposit_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Security Deposit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--RightToUseLiability_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Right to use liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;(434&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--Goodwill_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;284&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--TotalPurchaseConsideration_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,123&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">650000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <FONR:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">434000</FONR:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">150000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">39000</us-gaap:SecurityDeposit>
    <FONR:RightToUseLiability
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">-434000</FONR:RightToUseLiability>
    <us-gaap:Goodwill
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">284000</us-gaap:Goodwill>
    <FONR:TotalPurchaseConsideration
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">1123000</FONR:TotalPurchaseConsideration>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_pn3n3_zmjrW7Xyvmgk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - NOTE 13 - ACQUISITION - Net assets acquired (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B0_zPpkI8Mx7BT7" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal"&gt;Net
    assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_z4hX3ZMa57A9" style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--LeaseholdImprovementsGross_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Leasehold Improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;550&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--DiagnosticEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Diagnostic Equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--FiniteLivedCustomerListsGross_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Customer Lists&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--CovenantNotToCompete_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Covenant Not to Compete&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--SecurityDeposit_iI_pn3n3_zjVLjuySKGfl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Security Deposit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--ClosingCostsExpensed_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Closing costs - expensed&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--Goodwill_iI_pn3n3_z45ctut2uIAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;284&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;Cash Consideration Paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--BusinessCombinationConsiderationTransferredOther1_c20210301__20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Cash Consideration Paid"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;1,126&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">550000</us-gaap:LeaseholdImprovementsGross>
    <FONR:DiagnosticEquipment
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">100000</FONR:DiagnosticEquipment>
    <us-gaap:FiniteLivedCustomerListsGross
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">100000</us-gaap:FiniteLivedCustomerListsGross>
    <FONR:CovenantNotToCompete
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">50000</FONR:CovenantNotToCompete>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">39000</us-gaap:SecurityDeposit>
    <FONR:ClosingCostsExpensed
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">3000</FONR:ClosingCostsExpensed>
    <us-gaap:Goodwill
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">284000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="From2021-03-012021-03-29_custom_RocklandManagementGroupMember"
      decimals="-3"
      unitRef="USD">1126000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zH4TKZrlW2Bk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_829_zC7T5i4ipTdi" style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;NOTE
14 &#x2013; SUBSEQUENT EVENTS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; font-style: normal; font-weight: normal"&gt;The
Company has evaluated events that occurred subsequent to September 30, 2021 and through the date the condensed consolidated financial
statements were issued.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623766396296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Nov. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-10248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FONAR CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000355019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-2464137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">110 Marcus Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Melville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">694-2929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,554,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623762572792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">&#160;&#160;Cash and cash equivalents</a></td>
<td class="nump">$ 43,405<span></span>
</td>
<td class="nump">$ 44,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">&#160;Short term investments</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">&#160;Accounts receivable &#8211; net</a></td>
<td class="nump">4,548<span></span>
</td>
<td class="nump">4,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountReceivableRelatedParties', window );">&#160;Accounts receivable - related party</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">&#160;Medical receivable &#8211; net</a></td>
<td class="nump">18,356<span></span>
</td>
<td class="nump">17,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFees', window );">&#160;Management and other fees receivable - net</a></td>
<td class="nump">31,695<span></span>
</td>
<td class="nump">30,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable &#8211; related medical practices &#8211; net</a></td>
<td class="nump">7,998<span></span>
</td>
<td class="nump">7,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">&#160;Inventories</a></td>
<td class="nump">1,835<span></span>
</td>
<td class="nump">1,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">&#160;Prepaid expenses and other current assets</a></td>
<td class="nump">1,416<span></span>
</td>
<td class="nump">1,227<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">&#160;&#160;Total Current Assets</a></td>
<td class="nump">109,387<span></span>
</td>
<td class="nump">108,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableNetLongTerm', window );">&#160;Accounts receivable &#8211; long term</a></td>
<td class="nump">2,609<span></span>
</td>
<td class="nump">2,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">&#160;Deferred income tax asset</a></td>
<td class="nump">14,764<span></span>
</td>
<td class="nump">15,959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">&#160;Property and equipment &#8211; net</a></td>
<td class="nump">21,971<span></span>
</td>
<td class="nump">21,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">&#160;Right-of-use Asset &#8211; operating lease</a></td>
<td class="nump">29,535<span></span>
</td>
<td class="nump">30,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">&#160;Right-of-use Asset &#8211; financing lease</a></td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">1,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">&#160;Goodwill</a></td>
<td class="nump">4,269<span></span>
</td>
<td class="nump">4,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">&#160;Other intangible assets &#8211; net</a></td>
<td class="nump">3,957<span></span>
</td>
<td class="nump">4,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">&#160;Other assets</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">667<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">&#160;&#160;&#160;Total Assets</a></td>
<td class="nump">188,229<span></span>
</td>
<td class="nump">189,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt and capital leases</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,133<span></span>
</td>
<td class="nump">1,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">5,990<span></span>
</td>
<td class="nump">9,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">4,328<span></span>
</td>
<td class="nump">4,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_UnearnedRevenueOnServiceContractsRelatedParties', window );">Unearned revenue on service contracts &#8211; related party</a></td>
<td class="nump">83<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability &#8211; current portion</a></td>
<td class="nump">3,669<span></span>
</td>
<td class="nump">3,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Financing lease liability &#8211; current portion</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CustomerDeposits', window );">Customer deposits</a></td>
<td class="nump">789<span></span>
</td>
<td class="nump">731<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">16,247<span></span>
</td>
<td class="nump">20,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">2,545<span></span>
</td>
<td class="nump">2,801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent', window );">Deferred income tax liability</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesNoncurrent', window );">Due to related medical practices</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability &#8211; net of current portion</a></td>
<td class="nump">28,292<span></span>
</td>
<td class="nump">28,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing lease liability &#8211; net of current portion</a></td>
<td class="nump">997<span></span>
</td>
<td class="nump">1,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt and capital leases, less current portion</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liabilities</a></td>
<td class="nump">32,510<span></span>
</td>
<td class="nump">34,087<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">48,757<span></span>
</td>
<td class="nump">54,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital in excess of par value</a></td>
<td class="nump">185,101<span></span>
</td>
<td class="nump">185,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(42,121)<span></span>
</td>
<td class="num">(46,008)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost - 12 shares of common stock at September 30, 2021 and June 30, 2021</a></td>
<td class="num">(675)<span></span>
</td>
<td class="num">(675)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</a></td>
<td class="nump">142,306<span></span>
</td>
<td class="nump">138,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="num">(2,834)<span></span>
</td>
<td class="num">(3,049)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Stockholders&#8217; Equity</a></td>
<td class="nump">139,472<span></span>
</td>
<td class="nump">135,370<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity</a></td>
<td class="nump">188,229<span></span>
</td>
<td class="nump">189,506<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Related MRI scanner customers; net of allowances for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable - net - Current from service and repair fees of Non Related MRI scanner customers; net of allowances for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management of, and other fees receivable from MRI Centers owned by related parties - net of allowances for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_UnearnedRevenueOnServiceContractsRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_UnearnedRevenueOnServiceContractsRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accounts payable to related parties, due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1),(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623768529416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">453<span></span>
</td>
<td class="nump">453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">8,500<span></span>
</td>
<td class="nump">8,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">6,566<span></span>
</td>
<td class="nump">6,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">6,554<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623768465560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts', window );">Patient fee revenue &#8211; net of contractual allowances and discounts</a></td>
<td class="nump">$ 6,851<span></span>
</td>
<td class="nump">$ 5,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ProductSalesNet', window );">Product sales &#8211; net</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesNet', window );">Service and repair fees &#8211; net</a></td>
<td class="nump">1,936<span></span>
</td>
<td class="nump">1,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesRelatedPartiesNet', window );">Service and repair fees - related parties &#8211; net</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNet', window );">Management and other fees &#8211; net</a></td>
<td class="nump">11,972<span></span>
</td>
<td class="nump">11,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet', window );">Management and other fees - related medical practices &#8211; net</a></td>
<td class="nump">2,795<span></span>
</td>
<td class="nump">2,693<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="nump">23,730<span></span>
</td>
<td class="nump">20,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Costs related to patient fee revenue</a></td>
<td class="nump">3,156<span></span>
</td>
<td class="nump">2,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToProductSales', window );">Costs related to product sales</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFees', window );">Costs related to service and repair fees</a></td>
<td class="nump">724<span></span>
</td>
<td class="nump">626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties', window );">Costs related to service and repair fees - related parties</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFees', window );">Costs related to management and other fees</a></td>
<td class="nump">6,877<span></span>
</td>
<td class="nump">5,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices', window );">Costs related to management and other fees &#8211; related medical practices</a></td>
<td class="nump">1,637<span></span>
</td>
<td class="nump">1,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">386<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">5,090<span></span>
</td>
<td class="nump">6,163<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">17,989<span></span>
</td>
<td class="nump">16,829<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet', window );">Income From Operations</a></td>
<td class="nump">5,741<span></span>
</td>
<td class="nump">4,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other Income (Expenses)</a></td>
<td class="nump">811<span></span>
</td>
<td class="num">(140)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment Income</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income Before Provision for Income Taxes and Noncontrolling Interests</a></td>
<td class="nump">6,598<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="num">(1,416)<span></span>
</td>
<td class="num">(849)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">5,182<span></span>
</td>
<td class="nump">3,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income - Noncontrolling Interests</a></td>
<td class="num">(1,295)<span></span>
</td>
<td class="num">(743)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Attributable to FONAR</a></td>
<td class="nump">$ 3,887<span></span>
</td>
<td class="nump">$ 2,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.59<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">6,554<span></span>
</td>
<td class="nump">6,447<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Attributable to FONAR</a></td>
<td class="nump">$ 3,652<span></span>
</td>
<td class="nump">$ 2,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">6,554<span></span>
</td>
<td class="nump">6,447<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding - Common Stockholders</a></td>
<td class="nump">6,682<span></span>
</td>
<td class="nump">6,575<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember', window );">Preferred Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Attributable to FONAR</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Attributable to FONAR</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">0.16<span></span>
</td>
<td class="nump">0.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and Diluted Income Per Share</a></td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding - Common Stockholders</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted Average Basic and Diluted Shares Outstanding Class C Common</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs related To Management and other fees - Related medical practices</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFeesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProductSalesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProductSalesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesRelatedPartiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesRelatedPartiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623766332008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2020</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 183,076<span></span>
</td>
<td class="num">$ (56,215)<span></span>
</td>
<td class="num">$ (675)<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 126,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,508<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions - Non controlling</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,440)<span></span>
</td>
<td class="num">(1,440)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Income - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">743<span></span>
</td>
<td class="nump">743<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2020</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">183,076<span></span>
</td>
<td class="num">(53,707)<span></span>
</td>
<td class="num">(675)<span></span>
</td>
<td class="num">(642)<span></span>
</td>
<td class="nump">128,053<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2021</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">185,101<span></span>
</td>
<td class="num">(46,008)<span></span>
</td>
<td class="num">(675)<span></span>
</td>
<td class="num">(3,049)<span></span>
</td>
<td class="nump">135,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,887<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions - Non controlling</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,080)<span></span>
</td>
<td class="num">(1,080)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Income - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,295<span></span>
</td>
<td class="nump">1,295<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2021</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 185,101<span></span>
</td>
<td class="num">$ (42,121)<span></span>
</td>
<td class="num">$ (675)<span></span>
</td>
<td class="num">$ (2,834)<span></span>
</td>
<td class="nump">$ 139,472<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623768417368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 5,182<span></span>
</td>
<td class="nump">$ 3,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,169<span></span>
</td>
<td class="nump">968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization on right-of-use assets</a></td>
<td class="nump">648<span></span>
</td>
<td class="nump">953<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ProvisionForBadDebts', window );">Provision (Recovery) for bad debts</a></td>
<td class="nump">502<span></span>
</td>
<td class="nump">2,227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax &#8211; net</a></td>
<td class="nump">1,195<span></span>
</td>
<td class="nump">849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent', window );">Abandoned patents</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_GainOnForgivenessOfPppLoan', window );">Gain on forgiveness of PPP loan</a></td>
<td class="num">(701)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>(Increase) decrease in operating assets, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts, medical and management fee receivable(s)</a></td>
<td class="num">(1,730)<span></span>
</td>
<td class="num">(4,109)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Notes receivable</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(172)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxCreditsAndAdjustments', window );">Income tax receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(188)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>Increase (decrease) in operating liabilities, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(733)<span></span>
</td>
<td class="num">(117)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="num">(3,383)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(547)<span></span>
</td>
<td class="num">(796)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_IncreaseDecreaseInFinancingLiabilities', window );">Financing lease liability</a></td>
<td class="num">(50)<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_IncreaseDecreaseInCustomerAdvance', window );">Customer advances</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Other liabilities</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,241<span></span>
</td>
<td class="nump">3,782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(1,180)<span></span>
</td>
<td class="num">(415)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cost of patents</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,209)<span></span>
</td>
<td class="num">(435)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of borrowings and capital lease obligations</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">&#160;Distributions to noncontrolling interests</a></td>
<td class="num">(1,080)<span></span>
</td>
<td class="num">(1,440)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,087)<span></span>
</td>
<td class="num">(1,386)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">&#160;Net (Decrease) Increase in Cash and Cash Equivalents</a></td>
<td class="num">(1,055)<span></span>
</td>
<td class="nump">1,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents - Beginning of Period</a></td>
<td class="nump">44,460<span></span>
</td>
<td class="nump">36,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents - End of Period</a></td>
<td class="nump">$ 43,405<span></span>
</td>
<td class="nump">$ 38,763<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_GainOnForgivenessOfPppLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_GainOnForgivenessOfPppLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInCustomerAdvance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInCustomerAdvance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInFinancingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInFinancingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxCreditsAndAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A credit or adjustment for government or taxing authority authorized decrease in taxes owed as a result of meeting certain tax policy conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxCreditsAndAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in intangible assets (for example patents and licenses).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623764801688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">NOTE 1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zOxOHE8xSzR2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_827_z6NfTa50rth8" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Description
of Business</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
<span id="xdx_90B_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_z7ZtizcLqXi7">24.2</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_903_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_zKX2HBiLI2Ak">45.8</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
in HDM, and the original investors in HDM retained a <span id="xdx_904_ecustom--OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_z2EfZ877LPEa">30.0</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted
by HDM, operating under the name &#8220;Health Management Company of America&#8221;.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basis
of Presentation and Liquidity</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they
do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America
for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2021, are not necessarily
indicative of the results that may be expected for the fiscal year ending June 30, 2022. For further information, refer to the consolidated
financial statements and footnotes thereto included in the Company&#8217;s Annual Report on Form 10-K filed on October 13, 2021 for the
fiscal year ended June 30, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">During
March 2020 the global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies
which has adversely effected our workforce, liquidity, financial conditions, revenues, profitability and business operations. Generally
COVID-19 had caused us to require that much of our workforce work from home and has restricted the ability of our personnel to travel
for marketing purposes or to service our customers. The Company experienced a sudden drop in scan volume for a short term period and
the Company has recovered to pre-COVID-19 levels. At the end of fiscal year ending June 30, 2020, the Company was able to enact certain
decisions to allow the Company to survive during the global pandemic and from further losses or additional decreases in scan volume.
The Company also received some government stimulus funds from the Paycheck Protection Program (&#8220;PPP&#8221;) and Medicare advances/stimulus
payments. During the three months ended September 30, 2021 the PPP loan was forgiven in its entirety. Although we are unable to predict
if there will be additional consequences on our operations from the continuing global pandemic of COVID-19 and the new variants, the
Company believes with positive cash flows, low debt and cash on hand, it will be able to continue operations going forward.&#160;</span></p>





















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623764832888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zO9Yleq9oVMd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82E_z6zAJ0VrVMCj" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p id="xdx_844_eus-gaap--ConsolidationPolicyTextBlock_zRFp41aw2B73" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86A_zNckY6tiKf2f" style="font-size: 10pt; font-style: normal; font-weight: normal">Principles
of Consolidation</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zuSIzjJlOt2j" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_861_zY6G7Tgz45db" style="font-size: 10pt; font-style: normal; font-weight: normal">Revenues</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies and significant judgments employed in the
determination of revenue.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p id="xdx_84F_eus-gaap--BusinessCombinationsPolicy_z0WJvoRtU4Mk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;<span id="xdx_86E_zWPMiC0efh65">Business
Combination</span></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">When
the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets
acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition dated is measured as the excess
of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While
we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates
are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the
acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon
the conclusion of the measurement period of final determination of the values of assets acquired or liabilities assumed, whichever comes
first, any subsequent adjustments are recorded to our consolidated statements of operations.&#160;</span></p>



























<p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_ziZjS8NbgFYl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_863_zr6gpZh2VdIc" style="font-size: 10pt; font-style: normal; font-weight: normal">Earnings
Per Share</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basic
earnings per share (&#8220;EPS&#8221;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2021 and 2020, diluted EPS for
common shareholders includes <span id="xdx_900_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930_zRGgjiWukwv4" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930_zsLpUrZaFvle" title="Shares included upon conversion of Class C Common to calculate a diluted EPS">128</span>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">shares upon conversion of Class C Common.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zBAIkv4wzRm" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0; padding-right: 0; text-align: left"><span id="xdx_8B6_zpgUjzLOxoVa" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Earnings
    Per Share</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Three
    months ended <br/> September 30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Three
    months ended <br/> September 30, 2020</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class
    C Common <br/> Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class
    C Common <br/> Stock</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basic</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Numerator: <br/> Net
    income available to common stockholders</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930_zapWaqXUg9Ba" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,887</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zt9qzMRXgra3" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,652</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPd7plTdMyYb" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">60</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930_zWaFONMC5WUc" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2,508</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdb52kLqzIq1" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2,355</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbHWtFHrqGX2" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">39</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Denominator:</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Weighted average shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zZGzybf8aWF3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,554</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zrTTZGX63aM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,554</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6EPyJNKHyx3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930_znioEuMtifx1" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,447</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zem4oWtHDibj" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,447</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXsWTKvqriN3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basic income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930_zyba36IObr4l" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.59</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwNGz6iK5rMb" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.56</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z22A9sQVrbta" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.16</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930_zc33GDSt62of" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.39</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGWwIusDHrT7" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.37</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zlk4pcvuKUBk" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.10</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diluted</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Denominator: <br/> Weighted average shares outstanding</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zibF3BrrcCwc" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,554</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo7vmVRTwnSj" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zabzg3gXongi" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,447</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4gp0r7FYfhk" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Convertible Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zyeE9emioBkk" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"><span style="font-size: 10pt; font-style: normal; font-weight: normal">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_989_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJzOPcmKiUqb" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0625">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMUsLZ32MLU8" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"><span style="font-size: 10pt; font-style: normal; font-weight: normal">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zi5xdh23VMa1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0629">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total Denominator for diluted
    earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zCY5SrFzpCYk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,682</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zG9jNDgEBGJl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfgqvcUq5Gek" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,575</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpwXxoxGln9a" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diluted income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z47tJrsSrexa" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.55</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHdabjKGqTnb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.16</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ztZIHlcvNGdk" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.36</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zW2QXtGoXyq7" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.10</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>



























<p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znt3dwjaq6wg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86F_z1mcmUne0oHh" style="font-size: 10pt; font-style: normal; font-weight: normal">Recent
Accounting Standards</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2021 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2021 or 2020, and it does not believe that any
of those standards will have a significant impact on our consolidated financial statements at the time they become effective.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623764777320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</a></td>
<td class="text"><p id="xdx_801_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zRzWFLudV2N1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_827_zyd1XH8tZC4a" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Receivables,
net is comprised of the following at September 30, 2021, and June 30, 2021:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zZwyXMrb0gJ5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0; padding-right: 0"><span id="xdx_8BE_zKErKQJGpNOk" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Receivables
    - Non Current - net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,990</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_ecustom--AccountsReceivableServiceAndRepairFees_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">442</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_ecustom--AccountsReceivableServiceAndRepairFees_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,548</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts receivable - related
    party</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--AccountsReceivableNetRelatedParty_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font-size: 10pt; font-style: normal; font-weight: normal">102</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98D_ecustom--AccountsReceivableNetRelatedParty_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0673">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_ecustom--AccountsReceivableNetRelatedParty_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font-size: 10pt; font-style: normal; font-weight: normal">102</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medical receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_ecustom--MedicalReceivable_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font-size: 10pt; font-style: normal; font-weight: normal">18,356</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0679">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_ecustom--MedicalReceivable_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font-size: 10pt; font-style: normal; font-weight: normal">18,356</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">47,975</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">16,280</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">31,695</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management and other fees receivable
    from related medical practices (&#8220;PC&#8217;s&#8221;)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">12,191</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,193</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">7,998</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,968</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_ecustom--AccountsReceivableServiceAndRepairFees_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">442</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_ecustom--AccountsReceivableServiceAndRepairFees_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,526</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts receivable - related
    party</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_ecustom--AccountsReceivableNetRelatedParty_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font-size: 10pt; font-style: normal; font-weight: normal">12</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_ecustom--AccountsReceivableNetRelatedParty_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0703">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98E_ecustom--AccountsReceivableNetRelatedParty_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font-size: 10pt; font-style: normal; font-weight: normal">12</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medical receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font-size: 10pt; font-style: normal; font-weight: normal">17,901</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_ecustom--MedicalReceivable_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0709">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_ecustom--MedicalReceivable_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font-size: 10pt; font-style: normal; font-weight: normal">17,901</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">46,735</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">15,787</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">30,948</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management and other fees receivable
    from related medical practices (&#8220;PC&#8217;s&#8221;)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">11,998</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,184</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">7,814</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p id="xdx_8AF_z7MZbY5xXYkg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;The
Company&#8217;s customers are concentrated in the healthcare industry.&#160;</span></p>























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts
Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Long
Term Accounts Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following four years at September 30, 2021 are as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_pn3n3_zIEgmEnxEeri" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_z5OOdbrLwPoe" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Total
    Facilities</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_49B_20210930_zALTXVd8Gbc1" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_maARBFLzybP_zeW2aaPFWfH1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2022</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 10%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 43%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,020</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_maARBFLzybP_zG1vgNbMTITh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2023</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,020</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_maARBFLzybP_zQTQ3hTYzOAg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2024</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">413</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pn3n3_maARBFLzybP_zWdZ4kiuZ35j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2025</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">92</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_iTI_pn3n3_mtARBFLzybP_z8APCFbsDaih" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2,545</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p id="xdx_8AC_zis1att3I655" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medical
Receivables</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management
and Other Fees Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company&#8217;s receivables from the related and non-related professional corporations (PC&#8217;s) substantially consist of fees outstanding
under management agreements. Payment of the outstanding fees is dependent on collection by the PC&#8217;s of fees from third party medical
reimbursement organizations, principally insurance companies and health management organizations.&#160;</span></p>



























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Payment
of the management fee receivables from the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner
their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_90B_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20210701__20210930_zrIXHpiBIUm7">66.7</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
and <span id="xdx_900_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20200701__20200930_zI8NOnkhZDd5">66</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
of the PCs&#8217; net revenues for the three months ended September 30, 2021 and 2020, respectively, were derived from no-fault and personal
injury protection claims. The Company considers the aging of its accounts receivable in determining the amount of allowance for doubtful
accounts. The Company generally takes all legally available steps to collect its receivables. Credit losses associated with the receivables
are provided for in the condensed consolidated financial statements and have historically been within management&#8217;s expectations.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net
revenues from management and other fees charged to the related PCs accounted for approximately <span id="xdx_90A_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20210701__20210930_zhxDlplxsCog">11.8</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
and <span id="xdx_900_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20200701__20200930_zRkd8qcGsF74">12.8</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">%
of the consolidated net revenues for the three months ended September 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. Additional Company managed entities also operate under a guaranty agreement,
pursuant to which management fees are payable to the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company&#8217;s patient fee revenue, net of contractual allowances and discounts for the three months ended September 30, 2021 and 2020
are summarized in the following table.</span>&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_pn3n3_zY6juRZ34H92" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B2_zV46w3Or2E5d" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Schedule of patient fee revenue</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">For
    the Three Months Ended September 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Commercial Insurance/
    Managed Care</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zVJYYLC7mYpf" style="width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,086</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zFwzeYHcw6Tc" style="width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">946</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medicare/Medicaid</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zOYhwflRmHnk" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">249</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zaP399fNHk71" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">197</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Workers&#8217; Compensation/Personal
    Injury</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zdkvFj3I9da1" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,124</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zvSqn46Bl4ak" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,387</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVq1nxn1Wrha" style="border-bottom: Black 1pt solid; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,392</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zS6U4PSS3cy2" style="border-bottom: Black 1pt solid; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">561</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Patient Fee Revenue, net of contractual
    allowances and discounts</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930_zfHI3kiWagFf" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,851</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930_zAVcKbmDl2sh" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,091</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>



<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;</span></p>





















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623764883832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DisclosureNote4OperatingFinancingLeasesAbstract', window );"><strong>Note 4 Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--LesseeOperatingLeasesTextBlock_z4ctQmoJW6Th" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span id="xdx_82A_zeszTjwrrjai" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
4 &#8211; OPERATING &amp; FINANCING LEASES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">During
February 2016, FAS issued ASU 2016-02, Leases (Topic 842). The new standard requires lessees to apply a dual approach, classifying leases
as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase by the
lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line
basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with
a term of greater than 12 months regardless of their classification. Lease with a term of 12 months or less will be accounted for similar
to previous guidance for operating leases. The standard was effective for us beginning July 1, 2019. We have elected the optional transition
method to apply the standard as of the effective date and therefore, we will not apply the standard to the comparative periods presented
in the consolidated financial statements. We have also elected the transition package of the practical expedients permitted within the
standard which eliminates the requirements to reassess prior conclusions about lease identification, lease classification and indirect
costs. The adoption of this guidance had a material impact on the Company&#8217;s balance sheet by virtue of including the present value
of its future operating lease payments as a liability of $<span id="xdx_909_eus-gaap--OperatingLeasePayments_pn3n3_dm_c20210701__20210930_zeANIR5rp0G7" title="Operating lease payments">33.3
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">million and related right-to-use lease assets as
of July 1, 2019. At the time of adoption of this guidance we had no significant financing leases.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>



























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of September 30,
2021 is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_pn3n3_z5Gnn7v1d3F5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 4 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="xdx_8B9_z4rcWVDy9Gzj" style="display: none">Reconcilliation
of operating and financing lease payments&#160;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Operating Lease Payments 2023">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Financing Lease Payments 2023">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Year
    Ending &#160; September 30,</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Operating
    Lease &#160; Payments</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Financing
    Lease Payments</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2022</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20210930_pn3n3" style="width: 26%; text-align: right" title="Operating Lease Payments 2022"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,166</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20210930_pn3n3" style="width: 26%; text-align: right" title="Financing Lease Payments 2022"><span style="font-size: 10pt; font-style: normal; font-weight: normal">244</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2023</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2023"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,170</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2023"><span style="font-size: 10pt; font-style: normal; font-weight: normal">244</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2024</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2024"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,895</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2024"><span style="font-size: 10pt; font-style: normal; font-weight: normal">244</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2025</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2025"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,711</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2025"><span style="font-size: 10pt; font-style: normal; font-weight: normal">244</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2026</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2026"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,248</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2026"><span style="font-size: 10pt; font-style: normal; font-weight: normal">244</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments Thereafter"><span style="font-size: 10pt; font-style: normal; font-weight: normal">15,928</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments Thereafter"><span style="font-size: 10pt; font-style: normal; font-weight: normal">104</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Present
    value discount</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_ecustom--PresentValueDiscount_iNI_pn3n3_di_c20210930_zWg6udo3osk2" style="border-bottom: Black 1pt solid; text-align: right" title="Operating Lease Payments Present Value discount"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(8,157</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_ecustom--PresentValueDiscountFinancingLease_iNI_pn3n3_di_c20210930_zlDf3ddYTkpi" style="border-bottom: Black 1pt solid; text-align: right" title="Financing Lease Payments Present Value discount"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(122</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20210930_zgjxRLR7fhQa" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease Payments Total lease liability"><span style="font-size: 10pt; font-style: normal; font-weight: normal">31,961</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Financing Lease Payments Total lease liability"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,202</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureNote4OperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureNote4OperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623764806696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 5 - INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">NOTE 5 - INVENTORIES</a></td>
<td class="text"><p id="xdx_800_eus-gaap--InventoryDisclosureTextBlock_zSXcNYbbLjda" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span id="xdx_820_z1kiDZV7M9z7" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
5 - INVENTORIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_z9vgGW5nzzN6" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0; padding-right: 0"><span id="xdx_8B2_zOGco7sVgFNi" style="font: normal 10pt Arial, Helvetica, Sans-Serif; display: none">Inventories</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_49B_20210930_zFF5H0LucJ33" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_49E_20210630_zuiwsc7kWRA7" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr id="xdx_40B_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWz0B3_zQqgXrpUJL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Purchased parts,
    components and supplies</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,553</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,393</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWz0B3_z5RhkbH7ME6e" style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Work-in-process</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">282</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">270</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWz0B3_zlWwyX51cnQd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">TOTAL INVENTORIES</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,835</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,663</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623764613160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 &#8211; CONTRACT ASSETS AND LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegulatedOperationsAbstract', window );"><strong>Regulated Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock', window );">NOTE 6 &#8211; CONTRACT ASSETS AND LIABILITIES</a></td>
<td class="text"><p id="xdx_801_eus-gaap--ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_z2vYf5hHWsek" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span id="xdx_829_zwKrBqDHTSdi" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
6 &#8211; CONTRACT ASSETS AND LIABILITIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Information
relating to uncompleted contracts about contract assets and (liabilities) is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_pn3n3_z4s8ciae4skj" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: rgb(204,238,255)"><span style="color: Black; font-size: 10pt; font-style: normal; font-weight: normal"><span id="xdx_8BF_zEHfpAuSKoac" style="display: none">Costs
and &#160;Estimated Earnings on Uncompleted Contracts</span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20210930_ztarKTYxLW34" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20210630_zsHMKgVWhkt5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr id="xdx_404_ecustom--CostsIncurredOnUncompletedContracts_iI_pn3n3_maCAEEOzAiq_maCAEEOzkha_zahTmLeTEWzd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Costs incurred on
    uncompleted contracts</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">295</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">295</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--EstimatedEarnings_iI_pn3n3_maCAEEOzAiq_maCAEEOzkha_zFigRQYmhJF1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Estimated earnings</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">568</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">568</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pn3n3_mtCAEEOzAiq_maTCAEEzvJg_mtCAEEOzkha_z6mRDgb5NF41" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Costs and estimated earnings
    on uncompleted contracts</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">863</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">863</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--BillingsToDate_iNI_pn3n3_di_maTCAEEzvJg_maTCAEEzMMZ_zgm7WCBXOyzi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Less: Billings to date</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">878</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">878</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet_iTI_pn3n3_mtTCAEEzvJg_mtTCAEEzMMZ_z4R13Bh9Eijl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total costs and estimated
    earnings in excess of billings on uncompleted contracts</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(15</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(15</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"/>























<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegulatedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegulatedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for detailed information about regulatory assets and liabilities, including current and noncurrent assets created when regulatory agencies permit the deferral of costs to the balance sheet that would otherwise be required to appear on the company's income statement and would be charged against current expenses or revenues, as well as current and noncurrent liabilities created when regulatory agencies permit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623769374056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 &#8211; OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">NOTE 7 &#8211; OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--IntangibleAssetsDisclosureTextBlock_zXPM9xefXAu9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_826_zOt0ZfJoBKBa" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
7 &#8211; OTHER INTANGIBLE ASSETS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zkHS6AOIX49e" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BB_zdaoeOeNH7zc" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Other
    Intagible Assets - Net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Capitalized software
    development costs</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">7,005</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">7,005</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Patents and copyrights</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,274</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,245</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Non-compete</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,150</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,150</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Customer relationships</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,900</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,900</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Gross Other intangible assets</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">20,329</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">20,300</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Less: Accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210930_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">16,372</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210630_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">16,262</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other Intangible Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,957</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,038</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Amortization
of patents and copyrights for the three months ended September 30, 2021 and 2020 amounted to $<span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3">47
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">and $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20200930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3">45</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Amortization
of non-compete for the three months ended September 30, 2021 and 2020 amounted to $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3">13
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">and $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20200930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3">0</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Amortization
of customer relationships for the three months ended September 30, 2021 and 2020 amounted to $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3">50
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">and $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20200930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3">48</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623769374056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 8 &#8211; OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">NOTE 8 &#8211; OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p id="xdx_807_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zOcanxingsnj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_826_zIbqlD0UKeuj" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
8 &#8211; OTHER CURRENT LIABILITIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zOkpzMHiFCL6" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BB_znwJwVTjV5Qj" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Other
    Current Liabilities</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_49C_20210930_zsSWJvPMTq6e" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_490_20210630_zeLVmc4rE5Wf" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr id="xdx_403_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCz1Nt_zo97CUsrgcBd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accrued salaries,
    commissions and payroll taxes</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,595</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,407</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maOLCz1Nt_z5XeFMnKaHbj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Litigation accruals</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0931">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">900</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCz1Nt_zKYgcDago4ee" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Sales tax payable</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">674</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">645</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCz1Nt_zqK8PHIk9by1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">State income taxes payable</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">351</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">774</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCz1Nt_z6MnZgwWD0M5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Legal and other professional
    fees</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">29</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">38</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCz1Nt_zLH0hvTL9oXj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounting fees</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">131</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">127</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCz1Nt_zWMqDllrkryb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Self-funded health insurance
    reserve</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">24</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">62</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCz1Nt_zx7abxKtrKT3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accrued interest and penalty</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">279</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">493</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCz1Nt_zM5o7SYwXeXc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">907</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">716</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCz1Nt_ztzKyS5NLqEe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other Current Liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,990</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">9,162</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

























<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623766203704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 9 - SEGMENT AND RELATED INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">NOTE 9 - SEGMENT AND RELATED INFORMATION</a></td>
<td class="text"><p id="xdx_802_eus-gaap--SegmentReportingDisclosureTextBlock_zGCKWVAcmhSb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_828_zEZDlZ8HNrD2" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
9 - SEGMENT AND RELATED INFORMATION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
accounting policies of the segments are the same as those described in the summary of significant accounting policies as disclosed in
the Company&#8217;s 10-K as of June 30, 2021. All inter-segment sales are market-based. The Company evaluates performance based on income
or loss from operations.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>



<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Summarized
financial information concerning the Company&#8217;s reportable segments is shown in the following table:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal"/></p>

<table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zwDXIR6nqRbh" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="xdx_8B9_ze0wWT4lOdf8" style="display: none">Suuummarrized
Segment Financial Information</span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Net revenues from external customers">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Net revenues from external customers">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Net revenues from external customers">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medical
    <br/> Equipment</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management
    <br/> of Diagnostic <br/> Imaging <br/>
    Centers</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Totals</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: none"><span style="font-size: 10pt; font-style: normal; font-weight: normal">For the three months ended
    Sept. 30, 2021</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net revenues from
    external customers</span></td><td style="width: 5%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2,112</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font-size: 10pt; font-style: normal; font-weight: normal">21,618</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font-size: 10pt; font-style: normal; font-weight: normal">23,730</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Inter-segment net revenues</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zr9Mmrr0ILlj" style="text-align: right" title="Inter-segment net revenues"><span style="font-size: 10pt; font-style: normal; font-weight: normal">236</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zv1DLoYg1Uh3" style="text-align: right" title="Inter-segment net revenues"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0982">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930_ze5QfQTgetc" style="text-align: right" title="Inter-segment net revenues"><span style="font-size: 10pt; font-style: normal; font-weight: normal">236</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Loss) Income from operations</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(490</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,231</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,741</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Depreciation and amortization</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">67</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,102</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,169</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Capital expenditures</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font-size: 10pt; font-style: normal; font-weight: normal">121</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,088</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98D_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,209</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the three
    months ended Sept. 30, 2020</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net revenues from external customers</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Net revenues from external customers"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,981</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Net revenues from external customers"><span style="font-size: 10pt; font-style: normal; font-weight: normal">18,998</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930_pn3n3" style="text-align: right" title="Net revenues from external customers"><span style="font-size: 10pt; font-style: normal; font-weight: normal">20,979</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Inter-segment net revenues</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zdyNt3ETXxxj" style="text-align: right" title="Inter-segment net revenues"><span style="font-size: 10pt; font-style: normal; font-weight: normal">219</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zPdz7yQlU8yg" style="text-align: right" title="Inter-segment net revenues"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl1012">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930_zdlOap0pubAc" style="text-align: right" title="Inter-segment net revenues"><span style="font-size: 10pt; font-style: normal; font-weight: normal">219</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Loss) Income from operations</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(561</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,711</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,150</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Depreciation and amortization</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">67</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">901</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">968</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Capital expenditures</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font-size: 10pt; font-style: normal; font-weight: normal">20</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font-size: 10pt; font-style: normal; font-weight: normal">415</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font-size: 10pt; font-style: normal; font-weight: normal">435</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623764868552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">NOTE 10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION</a></td>
<td class="text"><p id="xdx_808_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zz0aqZyK2lU5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_82D_zIbm6yIwFyP" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">During
the three months ended September 30, 2021 and September 30, 2020, the Company paid $<span id="xdx_90F_eus-gaap--InterestPaid_pn3n3_c20210701__20210930_ziH6sas0tgV7" title="Interest paid">189
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">and $<span id="xdx_90A_eus-gaap--InterestPaid_pn3n3_c20200701__20200930_zBuqsQyqe9m7" title="Interest paid">19
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">for interest, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">During
the three months ended September 30, 2021 and September 30, 2020, the Company paid $<span id="xdx_90B_eus-gaap--IncomeTaxesPaid_pn3n3_c20210701__20210930_zp9U3ytXEMod" title="Income taxes paid">221
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">and $<span id="xdx_903_eus-gaap--IncomeTaxesPaid_pn3n3_c20200701__20200930_zh3zvjvRbxS7" title="Income taxes paid">145
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">for income taxes, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>























<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623766142296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 11 &#8211; COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">NOTE 11 &#8211; COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zvm5FKJuav7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_824_zXutgyPSxHsd" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
11 &#8211; COMMITMENTS AND CONTINGENCIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Litigation</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other
Matters</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">In
September 2019, the Company was notified by one of its landlords that it was required to vacate the premises within 180 days under the
demolition clause in the lease. The Company believed the lease renewal which was not negotiated in good faith since the renewal was negotiated
in February 2018. The Company is in the process of relocating to a new location but the original lease provided for penalty payments
in the event that the Company had not vacated the lease space. The Company had been making normal rent payments throughout the course
of the arbitration proceedings. The case was settled for $900 of leasehold holdover charges which was paid in August 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90F_ecustom--LitigationSettelementDescription_c20210701__20210930_zlaQdZ9EBP8e" style="font-size: 10pt; font-style: normal; font-weight: normal" title="Litigation settelement description">In
September 2020, the Company entered into a settlement agreement with an unrelated third party for a claim made during March 2018 which
was scheduled for arbitration. The settlement was for $1.2 million of which $900 was paid by the Company&#8217;s insurance in September
2020. The Company paid the remaining balance of $315 in September 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company has satisfied most of its delinquencies in filing sales tax returns for certain states, for which the Company has transacted
business. The Company has recorded tax obligations of approximately $<span id="xdx_900_eus-gaap--SalesAndExciseTaxPayableCurrentAndNoncurrent_iI_pn3n3_c20210930_zW8Yn9zuG9Pa" title="Recorded tax obligations">674
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">plus interest and penalties of approximately $<span id="xdx_905_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_pn3n3_c20210930_zIinc7R0jk31" title="Interest and penalties">232
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">until the remaining states have been resolved.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 20pt; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_904_ecustom--MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_c20210930_pn3n3">150
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">per person and for a maximum potential claim liability
based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when
estimating its health insurance program liability and related expense. As of September 30, 2021 and June 30, 2021, the Company had approximately
$<span id="xdx_909_eus-gaap--SelfInsuranceReserve_iI_pn3n3_c20210930_zRXROiB3d5l2" title="Self-funded health insurance reserve">24 </span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">and
$<span id="xdx_907_eus-gaap--SelfInsuranceReserve_iI_pn3n3_c20210630_zyhgBkerVKyj" title="Self-funded health insurance reserve">62</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">,
respectively, in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221;
in the condensed consolidated balance sheets.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>





























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623765910312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 12 - INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">NOTE 12 - INCOME TAXES</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_zww9G6UGPGUl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_821_zYuAQyVQ4xmd" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
12 - INCOME TAXES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">In
accordance with ASC 740-270, Income Taxes &#8211; Interim Reporting, the Company is required at the end of each interim period to determine
the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The resulting tax expense
(or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in the interim period as
they occur. For the three months ended September 30, 2021, the Company recorded income tax expense of $<span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20210701__20210930_zDXLmke81qH6" title="Income tax expense">1,416
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">in 2021 as compared to $<span id="xdx_904_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20200701__20200930_zhDgMoKiOnp9" title="Income tax expense">849
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">in 2020. The 2021 provision is comprised of a current
income tax component of $<span id="xdx_907_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_c20210701__20210930_zgmlvsmDh9ke" title="Income tax component - current">221</span></span> <span style="font-size: 10pt; font-style: normal; font-weight: normal">and
a deferred income tax component of $<span id="xdx_908_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_c20210701__20210930_z8vzL2WsAKAa" title="Income tax component - deferred">1,195</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">.
Obligations for any liability associated with the current income tax provision, has been reduced, primarily resulting from the benefits
and utilization of net operating loss carryforwards.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#8220;Interest expense, net&#8221;. Penalties if incurred would be recognized as a component of &#8220;Selling,
general and administrative&#8221; expenses.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2017.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>































<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company recorded a deferred tax asset of $<span id="xdx_908_eus-gaap--DeferredTaxAssetsNet_iI_pn3n3_c20210930_zVgmyt9rZufk" title="Deferred tax asset">14,764</span></span> <span style="font-size: 10pt; font-style: normal; font-weight: normal">and
a deferred tax liability of $<span id="xdx_904_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pn3n3_c20210930_zwJQafUV1Rh7" title="Deferred tax liability">238
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">as of September 30, 2021, primarily relating to
net operating loss carryforwards of approximately $<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20210930_z3tnWJeO3QU5" title="Operating Loss Carryforwards">49,224</span></span>
<span style="font-size: 10pt; font-style: normal; font-weight: normal">available to offset future taxable income through 2032. The net
operating losses begin to expire in 2023 for federal tax and state income tax purposes.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">On
March 27, 2020 Congress enacted the CARES Act (Coronavirus Aid, Relief and Economic Security Act). The Act provides numerous tax provisions
and other stimulus measures, including temporary changes regarding prior and future operation losses, temporary changes to prior and
future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security
taxes, technical corrections to prior tax legislation for tax depreciation of certain qualified improvement property and enhanced recoverability
of AMT tax credits.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_909_ecustom--ReimbursementOfAlternativeMinimumTaxCreditsDescription_c20210701__20210930_zBOwhZLPngVi" style="font-size: 10pt; font-style: normal; font-weight: normal" title="Reimbursement of alternative minimum tax credits description">At
the present time, the only impact of the CARES Act to the Company is allowing a full reimbursement of $1,342 of tax credits relating
to the alternative minimum tax credits. The Company received the first half payment in June 2020. The balance of alternative minimum
tax credits of $671 was received in July 2020. Previously, these credits were to be refunded over a 3 year period.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">As
we continue to monitor tax implications of the CARES Act and other state and federal stimulus tax legislation, we may make adjustments
to our estimates and record additional amounts for tax assets and liabilities.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of September 30, 2021, no such changes in ownership have occurred.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry and tax planning strategies in making this assessment. At present, the Company believes
that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">A
valuation allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

























<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623766185784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 13 &#8211; ACQUISITION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">NOTE 13 &#8211; ACQUISITION</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--BusinessCombinationDisclosureTextBlock_zHhTOKRL8Oq2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_82A_zdD7kiaZiIIa" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
13 &#8211; ACQUISITION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">On
March 29, 2021, the Company completed the acquisition of certain assets of Rockland Management Group, located in West Yonkers. The Company
used an incremental borrowing rate of 4% to value the right to use asset in connection with the assumed operating lease obligation. We
made a preliminary fair value determination of the acquired assets and assumed liabilities as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_pn3n3_zqPQ8UdLIkf9" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B5_zg6DZWhDoGf" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Fair
    value assets and assumed liabilities</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_495_20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_zsfvCAcNLncb" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Property and equipment</span></td><td style="width: 10%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 18%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">650</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Right to use assets</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">434</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Intangible assets</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">150</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--SecurityDeposit_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Security Deposit</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">39</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--RightToUseLiability_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Right to use liability</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(434</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_404_eus-gaap--Goodwill_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">284</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--TotalPurchaseConsideration_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total purchase consideration</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,123</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p id="xdx_8A6_zxQMSHNvJXTf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">In
accordance with ASC 805-10-25-1, Business Combinations &#8211; Overall Recognition, the Company recorded the transaction as a business
combination. ASC 805-10-25-1 provides the requirements of recording the transaction by applying the acquisition method. The acquisition
method requires the Company to determine if the assets and liabilities acquired are a business or not. Under ASC 805-10-25-1, it must
be determined if there is a specific acquisition party, acquisition date, identifiable assets acquired and liabilities assumed and you
must be able to recognized and measure goodwill or a gain from the purchase. Based upon this guidance, the acquisition had been recorded
as a business combination.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
net assets acquired and consideration is as follow:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_pn3n3_zmjrW7Xyvmgk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - NOTE 13 - ACQUISITION - Net assets acquired (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B0_zPpkI8Mx7BT7" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Net
    assets acquired</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_498_20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_z4hX3ZMa57A9" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--LeaseholdImprovementsGross_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Leasehold Improvements</span></td><td style="width: 10%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 18%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">550</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_ecustom--DiagnosticEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diagnostic Equipment</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">100</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--FiniteLivedCustomerListsGross_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Customer Lists</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">100</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--CovenantNotToCompete_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Covenant Not to Compete</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">50</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--SecurityDeposit_iI_pn3n3_zjVLjuySKGfl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Security Deposit</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">39</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_ecustom--ClosingCostsExpensed_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Closing costs - expensed</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--Goodwill_iI_pn3n3_z45ctut2uIAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">284</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Cash Consideration Paid</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--BusinessCombinationConsiderationTransferredOther1_c20210301__20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Cash Consideration Paid"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,126</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p id="xdx_8A7_z07JSnwLhmo7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
results of operations of Rockland Management Group were diminutive and did not affect the pro forma results of operations.<br/></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>























<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623765924184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 14 &#8211; SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">NOTE 14 &#8211; SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zH4TKZrlW2Bk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_829_zC7T5i4ipTdi" style="font-size: 10pt; font-style: normal; font-weight: normal">NOTE
14 &#8211; SUBSEQUENT EVENTS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
Company has evaluated events that occurred subsequent to September 30, 2021 and through the date the condensed consolidated financial
statements were issued.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623768377624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_844_eus-gaap--ConsolidationPolicyTextBlock_zRFp41aw2B73" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86A_zNckY6tiKf2f" style="font-size: 10pt; font-style: normal; font-weight: normal">Principles
of Consolidation</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenues</a></td>
<td class="text"><p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zuSIzjJlOt2j" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_861_zY6G7Tgz45db" style="font-size: 10pt; font-style: normal; font-weight: normal">Revenues</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies and significant judgments employed in the
determination of revenue.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combination</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--BusinessCombinationsPolicy_z0WJvoRtU4Mk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;<span id="xdx_86E_zWPMiC0efh65">Business
Combination</span></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">When
the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets
acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition dated is measured as the excess
of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While
we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates
are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the
acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon
the conclusion of the measurement period of final determination of the values of assets acquired or liabilities assumed, whichever comes
first, any subsequent adjustments are recorded to our consolidated statements of operations.&#160;</span></p>



























<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_ziZjS8NbgFYl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_863_zr6gpZh2VdIc" style="font-size: 10pt; font-style: normal; font-weight: normal">Earnings
Per Share</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basic
earnings per share (&#8220;EPS&#8221;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2021 and 2020, diluted EPS for
common shareholders includes <span id="xdx_900_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930_zRGgjiWukwv4" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930_zsLpUrZaFvle" title="Shares included upon conversion of Class C Common to calculate a diluted EPS">128</span>
</span></span><span style="font-size: 10pt; font-style: normal; font-weight: normal">shares upon conversion of Class C Common.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zBAIkv4wzRm" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0; padding-right: 0; text-align: left"><span id="xdx_8B6_zpgUjzLOxoVa" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Earnings
    Per Share</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Three
    months ended <br/> September 30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Three
    months ended <br/> September 30, 2020</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class
    C Common <br/> Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class
    C Common <br/> Stock</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basic</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Numerator: <br/> Net
    income available to common stockholders</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930_zapWaqXUg9Ba" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,887</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zt9qzMRXgra3" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,652</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPd7plTdMyYb" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">60</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930_zWaFONMC5WUc" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2,508</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdb52kLqzIq1" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2,355</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbHWtFHrqGX2" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">39</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Denominator:</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Weighted average shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zZGzybf8aWF3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,554</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zrTTZGX63aM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,554</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6EPyJNKHyx3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930_znioEuMtifx1" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,447</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zem4oWtHDibj" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,447</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXsWTKvqriN3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basic income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930_zyba36IObr4l" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.59</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwNGz6iK5rMb" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.56</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z22A9sQVrbta" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.16</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930_zc33GDSt62of" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.39</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGWwIusDHrT7" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.37</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zlk4pcvuKUBk" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.10</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diluted</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Denominator: <br/> Weighted average shares outstanding</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zibF3BrrcCwc" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,554</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo7vmVRTwnSj" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zabzg3gXongi" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,447</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4gp0r7FYfhk" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Convertible Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zyeE9emioBkk" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"><span style="font-size: 10pt; font-style: normal; font-weight: normal">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_989_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJzOPcmKiUqb" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0625">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMUsLZ32MLU8" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"><span style="font-size: 10pt; font-style: normal; font-weight: normal">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zi5xdh23VMa1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0629">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total Denominator for diluted
    earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zCY5SrFzpCYk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,682</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zG9jNDgEBGJl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfgqvcUq5Gek" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,575</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpwXxoxGln9a" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diluted income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z47tJrsSrexa" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.55</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHdabjKGqTnb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.16</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ztZIHlcvNGdk" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.36</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zW2QXtGoXyq7" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.10</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>



























<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znt3dwjaq6wg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86F_z1mcmUne0oHh" style="font-size: 10pt; font-style: normal; font-weight: normal">Recent
Accounting Standards</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2021 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2021 or 2020, and it does not believe that any
of those standards will have a significant impact on our consolidated financial statements at the time they become effective.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623929965832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zBAIkv4wzRm" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0; padding-right: 0; text-align: left"><span id="xdx_8B6_zpgUjzLOxoVa" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Earnings
    Per Share</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Three
    months ended <br/> September 30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Three
    months ended <br/> September 30, 2020</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class
    C Common <br/> Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Class
    C Common <br/> Stock</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basic</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Numerator: <br/> Net
    income available to common stockholders</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930_zapWaqXUg9Ba" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,887</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zt9qzMRXgra3" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,652</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPd7plTdMyYb" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">60</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930_zWaFONMC5WUc" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2,508</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdb52kLqzIq1" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2,355</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbHWtFHrqGX2" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font-size: 10pt; font-style: normal; font-weight: normal">39</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Denominator:</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Weighted average shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zZGzybf8aWF3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,554</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zrTTZGX63aM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,554</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6EPyJNKHyx3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930_znioEuMtifx1" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,447</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zem4oWtHDibj" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,447</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXsWTKvqriN3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Basic income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930_zyba36IObr4l" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.59</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwNGz6iK5rMb" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.56</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z22A9sQVrbta" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.16</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930_zc33GDSt62of" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.39</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGWwIusDHrT7" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.37</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareBasic_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zlk4pcvuKUBk" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.10</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diluted</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Denominator: <br/> Weighted average shares outstanding</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zibF3BrrcCwc" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,554</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo7vmVRTwnSj" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zabzg3gXongi" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,447</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4gp0r7FYfhk" style="text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Convertible Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zyeE9emioBkk" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"><span style="font-size: 10pt; font-style: normal; font-weight: normal">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_989_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJzOPcmKiUqb" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0625">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMUsLZ32MLU8" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"><span style="font-size: 10pt; font-style: normal; font-weight: normal">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zi5xdh23VMa1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Class C Stock"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0629">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total Denominator for diluted
    earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zCY5SrFzpCYk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,682</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zG9jNDgEBGJl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfgqvcUq5Gek" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,575</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpwXxoxGln9a" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diluted income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z47tJrsSrexa" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.55</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHdabjKGqTnb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.16</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ztZIHlcvNGdk" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.36</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zW2QXtGoXyq7" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"><span style="font-size: 10pt; font-style: normal; font-weight: normal">0.10</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623856845944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock', window );">Receivables - Non Current - net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zZwyXMrb0gJ5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0; padding-right: 0"><span id="xdx_8BE_zKErKQJGpNOk" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Receivables
    - Non Current - net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,990</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_ecustom--AccountsReceivableServiceAndRepairFees_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">442</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_ecustom--AccountsReceivableServiceAndRepairFees_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,548</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts receivable - related
    party</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--AccountsReceivableNetRelatedParty_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font-size: 10pt; font-style: normal; font-weight: normal">102</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98D_ecustom--AccountsReceivableNetRelatedParty_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0673">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_ecustom--AccountsReceivableNetRelatedParty_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font-size: 10pt; font-style: normal; font-weight: normal">102</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medical receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_ecustom--MedicalReceivable_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font-size: 10pt; font-style: normal; font-weight: normal">18,356</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0679">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_ecustom--MedicalReceivable_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font-size: 10pt; font-style: normal; font-weight: normal">18,356</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">47,975</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">16,280</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">31,695</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management and other fees receivable
    from related medical practices (&#8220;PC&#8217;s&#8221;)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">12,191</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,193</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">7,998</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,968</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_ecustom--AccountsReceivableServiceAndRepairFees_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">442</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_ecustom--AccountsReceivableServiceAndRepairFees_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,526</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounts receivable - related
    party</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_987_ecustom--AccountsReceivableNetRelatedParty_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font-size: 10pt; font-style: normal; font-weight: normal">12</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_ecustom--AccountsReceivableNetRelatedParty_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0703">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98E_ecustom--AccountsReceivableNetRelatedParty_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font-size: 10pt; font-style: normal; font-weight: normal">12</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medical receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font-size: 10pt; font-style: normal; font-weight: normal">17,901</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_ecustom--MedicalReceivable_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0709">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_ecustom--MedicalReceivable_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font-size: 10pt; font-style: normal; font-weight: normal">17,901</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">46,735</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">15,787</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_ecustom--ManagementAndOtherFees__NonRelatedParties_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font-size: 10pt; font-style: normal; font-weight: normal">30,948</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management and other fees receivable
    from related medical practices (&#8220;PC&#8217;s&#8221;)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">11,998</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,184</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">7,814</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock', window );">Total Facilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_pn3n3_zIEgmEnxEeri" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_z5OOdbrLwPoe" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Total
    Facilities</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_49B_20210930_zALTXVd8Gbc1" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_maARBFLzybP_zeW2aaPFWfH1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2022</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 10%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 43%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,020</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_maARBFLzybP_zG1vgNbMTITh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2023</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,020</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_maARBFLzybP_zQTQ3hTYzOAg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2024</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">413</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pn3n3_maARBFLzybP_zWdZ4kiuZ35j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2025</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">92</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_iTI_pn3n3_mtARBFLzybP_z8APCFbsDaih" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2,545</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ScheduleOfPatientFeeRevenueTableTextBlock', window );">Schedule of patient fee revenue</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_pn3n3_zY6juRZ34H92" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B2_zV46w3Or2E5d" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Schedule of patient fee revenue</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">For
    the Three Months Ended September 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Commercial Insurance/
    Managed Care</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zVJYYLC7mYpf" style="width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,086</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zFwzeYHcw6Tc" style="width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">946</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medicare/Medicaid</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zOYhwflRmHnk" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">249</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zaP399fNHk71" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">197</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Workers&#8217; Compensation/Personal
    Injury</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zdkvFj3I9da1" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,124</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zvSqn46Bl4ak" style="text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,387</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVq1nxn1Wrha" style="border-bottom: Black 1pt solid; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,392</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zS6U4PSS3cy2" style="border-bottom: Black 1pt solid; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">561</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Patient Fee Revenue, net of contractual
    allowances and discounts</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20210701__20210930_zfHI3kiWagFf" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,851</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20200701__20200930_zAVcKbmDl2sh" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,091</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>



<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;</span></p>





















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfPatientFeeRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfPatientFeeRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623764806696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DisclosureNote4OperatingFinancingLeasesAbstract', window );"><strong>Note 4 Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock', window );">Reconcilliation of operating and financing lease payments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_pn3n3_z5Gnn7v1d3F5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 4 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="xdx_8B9_z4rcWVDy9Gzj" style="display: none">Reconcilliation
of operating and financing lease payments&#160;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Operating Lease Payments 2023">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Financing Lease Payments 2023">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Year
    Ending &#160; September 30,</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Operating
    Lease &#160; Payments</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Financing
    Lease Payments</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2022</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20210930_pn3n3" style="width: 26%; text-align: right" title="Operating Lease Payments 2022"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,166</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20210930_pn3n3" style="width: 26%; text-align: right" title="Financing Lease Payments 2022"><span style="font-size: 10pt; font-style: normal; font-weight: normal">244</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2023</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2023"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,170</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2023"><span style="font-size: 10pt; font-style: normal; font-weight: normal">244</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2024</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2024"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,895</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2024"><span style="font-size: 10pt; font-style: normal; font-weight: normal">244</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2025</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2025"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,711</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2025"><span style="font-size: 10pt; font-style: normal; font-weight: normal">244</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2026</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments 2026"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,248</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments 2026"><span style="font-size: 10pt; font-style: normal; font-weight: normal">244</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20210930_pn3n3" style="text-align: right" title="Operating Lease Payments Thereafter"><span style="font-size: 10pt; font-style: normal; font-weight: normal">15,928</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20210930_pn3n3" style="text-align: right" title="Financing Lease Payments Thereafter"><span style="font-size: 10pt; font-style: normal; font-weight: normal">104</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Present
    value discount</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_980_ecustom--PresentValueDiscount_iNI_pn3n3_di_c20210930_zWg6udo3osk2" style="border-bottom: Black 1pt solid; text-align: right" title="Operating Lease Payments Present Value discount"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(8,157</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_ecustom--PresentValueDiscountFinancingLease_iNI_pn3n3_di_c20210930_zlDf3ddYTkpi" style="border-bottom: Black 1pt solid; text-align: right" title="Financing Lease Payments Present Value discount"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(122</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20210930_zgjxRLR7fhQa" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease Payments Total lease liability"><span style="font-size: 10pt; font-style: normal; font-weight: normal">31,961</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Financing Lease Payments Total lease liability"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,202</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureNote4OperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureNote4OperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623768697768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 5 - INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_z9vgGW5nzzN6" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0; padding-right: 0"><span id="xdx_8B2_zOGco7sVgFNi" style="font: normal 10pt Arial, Helvetica, Sans-Serif; display: none">Inventories</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_49B_20210930_zFF5H0LucJ33" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_49E_20210630_zuiwsc7kWRA7" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr id="xdx_40B_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWz0B3_zQqgXrpUJL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Purchased parts,
    components and supplies</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,553</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,393</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWz0B3_z5RhkbH7ME6e" style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Work-in-process</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">282</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">270</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWz0B3_zlWwyX51cnQd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">TOTAL INVENTORIES</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,835</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,663</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623859420216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 &#8211; CONTRACT ASSETS AND LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegulatedOperationsAbstract', window );"><strong>Regulated Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock', window );">Costs and Estimated Earnings on Uncompleted Contracts</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_pn3n3_z4s8ciae4skj" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="color: rgb(204,238,255)"><span style="color: Black; font-size: 10pt; font-style: normal; font-weight: normal"><span id="xdx_8BF_zEHfpAuSKoac" style="display: none">Costs
and &#160;Estimated Earnings on Uncompleted Contracts</span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20210930_ztarKTYxLW34" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20210630_zsHMKgVWhkt5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr id="xdx_404_ecustom--CostsIncurredOnUncompletedContracts_iI_pn3n3_maCAEEOzAiq_maCAEEOzkha_zahTmLeTEWzd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Costs incurred on
    uncompleted contracts</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">295</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">295</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--EstimatedEarnings_iI_pn3n3_maCAEEOzAiq_maCAEEOzkha_zFigRQYmhJF1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Estimated earnings</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">568</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">568</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pn3n3_mtCAEEOzAiq_maTCAEEzvJg_mtCAEEOzkha_z6mRDgb5NF41" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Costs and estimated earnings
    on uncompleted contracts</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">863</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">863</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--BillingsToDate_iNI_pn3n3_di_maTCAEEzvJg_maTCAEEzMMZ_zgm7WCBXOyzi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Less: Billings to date</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">878</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">878</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet_iTI_pn3n3_mtTCAEEzvJg_mtTCAEEzMMZ_z4R13Bh9Eijl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total costs and estimated
    earnings in excess of billings on uncompleted contracts</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(15</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(15</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-term contract or program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegulatedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegulatedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623764557624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 &#8211; OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Other Intagible Assets - Net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zkHS6AOIX49e" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BB_zdaoeOeNH7zc" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Other
    Intagible Assets - Net</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Capitalized software
    development costs</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">7,005</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">7,005</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Patents and copyrights</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,274</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,245</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Non-compete</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,150</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,150</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Customer relationships</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,900</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,900</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Gross Other intangible assets</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210930_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">20,329</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font-size: 10pt; font-style: normal; font-weight: normal">20,300</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Less: Accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210930_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">16,372</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210630_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">16,262</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other Intangible Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,957</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20210630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,038</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623764865992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 8 &#8211; OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Other Current Liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zOkpzMHiFCL6" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BB_znwJwVTjV5Qj" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Other
    Current Liabilities</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_49C_20210930_zsSWJvPMTq6e" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_490_20210630_zeLVmc4rE5Wf" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">September
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">June
    30, 2021</span></td></tr>
<tr id="xdx_403_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCz1Nt_zo97CUsrgcBd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accrued salaries,
    commissions and payroll taxes</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3,595</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 8%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,407</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maOLCz1Nt_z5XeFMnKaHbj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Litigation accruals</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0931">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">900</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCz1Nt_zKYgcDago4ee" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Sales tax payable</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">674</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">645</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCz1Nt_zqK8PHIk9by1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">State income taxes payable</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">351</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">774</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCz1Nt_z6MnZgwWD0M5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Legal and other professional
    fees</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">29</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">38</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCz1Nt_zLH0hvTL9oXj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accounting fees</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">131</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">127</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCz1Nt_zWMqDllrkryb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Self-funded health insurance
    reserve</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">24</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">62</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCz1Nt_zx7abxKtrKT3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Accrued interest and penalty</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">279</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">493</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCz1Nt_zM5o7SYwXeXc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">907</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">716</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCz1Nt_ztzKyS5NLqEe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Other Current Liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,990</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">9,162</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623766264152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 9 - SEGMENT AND RELATED INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Suuummarrized Segment Financial Information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zwDXIR6nqRbh" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span id="xdx_8B9_ze0wWT4lOdf8" style="display: none">Suuummarrized
Segment Financial Information</span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Net revenues from external customers">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Net revenues from external customers">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Net revenues from external customers">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Medical
    <br/> Equipment</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Management
    <br/> of Diagnostic <br/> Imaging <br/>
    Centers</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Totals</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: none"><span style="font-size: 10pt; font-style: normal; font-weight: normal">For the three months ended
    Sept. 30, 2021</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net revenues from
    external customers</span></td><td style="width: 5%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font-size: 10pt; font-style: normal; font-weight: normal">2,112</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font-size: 10pt; font-style: normal; font-weight: normal">21,618</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="width: 5%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font-size: 10pt; font-style: normal; font-weight: normal">23,730</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Inter-segment net revenues</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zr9Mmrr0ILlj" style="text-align: right" title="Inter-segment net revenues"><span style="font-size: 10pt; font-style: normal; font-weight: normal">236</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zv1DLoYg1Uh3" style="text-align: right" title="Inter-segment net revenues"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl0982">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20210930_ze5QfQTgetc" style="text-align: right" title="Inter-segment net revenues"><span style="font-size: 10pt; font-style: normal; font-weight: normal">236</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Loss) Income from operations</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(490</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font-size: 10pt; font-style: normal; font-weight: normal">6,231</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font-size: 10pt; font-style: normal; font-weight: normal">5,741</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Depreciation and amortization</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">67</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,102</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,169</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Capital expenditures</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font-size: 10pt; font-style: normal; font-weight: normal">121</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,088</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98D_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,209</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the three
    months ended Sept. 30, 2020</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Net revenues from external customers</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Net revenues from external customers"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,981</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Net revenues from external customers"><span style="font-size: 10pt; font-style: normal; font-weight: normal">18,998</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20200701__20200930_pn3n3" style="text-align: right" title="Net revenues from external customers"><span style="font-size: 10pt; font-style: normal; font-weight: normal">20,979</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Inter-segment net revenues</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zdyNt3ETXxxj" style="text-align: right" title="Inter-segment net revenues"><span style="font-size: 10pt; font-style: normal; font-weight: normal">219</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_986_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zPdz7yQlU8yg" style="text-align: right" title="Inter-segment net revenues"><span style="font-size: 10pt; font-style: normal; font-weight: normal"><span style="-sec-ix-hidden: xdx2ixbrl1012">&#8212;</span></span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_ecustom--IntersegmentNetRevenues_pn3n3_c20200701__20200930_zdlOap0pubAc" style="text-align: right" title="Inter-segment net revenues"><span style="font-size: 10pt; font-style: normal; font-weight: normal">219</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Loss) Income from operations</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(561</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,711</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20200930_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font-size: 10pt; font-style: normal; font-weight: normal">4,150</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Depreciation and amortization</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">67</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">901</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20200930_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font-size: 10pt; font-style: normal; font-weight: normal">968</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Capital expenditures</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font-size: 10pt; font-style: normal; font-weight: normal">20</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_984_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font-size: 10pt; font-style: normal; font-weight: normal">415</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20200701__20200930_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font-size: 10pt; font-style: normal; font-weight: normal">435</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623764648328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 13 &#8211; ACQUISITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock', window );">Fair value assets and assumed liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_pn3n3_zqPQ8UdLIkf9" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B5_zg6DZWhDoGf" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Fair
    value assets and assumed liabilities</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_495_20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_zsfvCAcNLncb" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Property and equipment</span></td><td style="width: 10%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 18%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">650</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Right to use assets</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">434</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Intangible assets</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">150</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--SecurityDeposit_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Security Deposit</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">39</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--RightToUseLiability_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Right to use liability</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(434</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">)</span></td></tr>
<tr id="xdx_404_eus-gaap--Goodwill_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">284</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--TotalPurchaseConsideration_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Total purchase consideration</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,123</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Net assets acquired</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_pn3n3_zmjrW7Xyvmgk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - NOTE 13 - ACQUISITION - Net assets acquired (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B0_zPpkI8Mx7BT7" style="display: none; font-size: 10pt; font-style: normal; font-weight: normal">Net
    assets acquired</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td id="xdx_498_20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_z4hX3ZMa57A9" style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--LeaseholdImprovementsGross_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Leasehold Improvements</span></td><td style="width: 10%"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td style="width: 18%; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">550</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_ecustom--DiagnosticEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Diagnostic Equipment</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">100</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--FiniteLivedCustomerListsGross_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Customer Lists</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">100</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--CovenantNotToCompete_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Covenant Not to Compete</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">50</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--SecurityDeposit_iI_pn3n3_zjVLjuySKGfl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Security Deposit</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">39</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40F_ecustom--ClosingCostsExpensed_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Closing costs - expensed</span></td><td><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">3</span></td><td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--Goodwill_iI_pn3n3_z45ctut2uIAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt; font-style: normal; font-weight: normal">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; font-style: normal; font-weight: normal">284</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Cash Consideration Paid</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">$</span></td><td id="xdx_989_eus-gaap--BusinessCombinationConsiderationTransferredOther1_c20210301__20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Cash Consideration Paid"><span style="font-size: 10pt; font-style: normal; font-weight: normal">1,126</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; font-style: normal; font-weight: normal">&#160;</span></td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative assets at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623769513960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 1 &#8211; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) - H D M [Member]<br></strong></div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent', window );">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM</a></td>
<td class="nump">24.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent', window );">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM</a></td>
<td class="nump">45.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent', window );">The ownership interest of the original investors of HDM after reorganization of newly expanded HDM</a></td>
<td class="nump">30.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name Health Management Company of America.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name Health Management Company of America.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name Health Management Company of America.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=FONR_HDMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=FONR_HDMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623766414856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 3,887<span></span>
</td>
<td class="nump">$ 2,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,554<span></span>
</td>
<td class="nump">6,447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic income per common share</a></td>
<td class="nump">$ 0.59<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Shares included upon conversion of Class C Common to calculate a diluted EPS</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 3,652<span></span>
</td>
<td class="nump">$ 2,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,554<span></span>
</td>
<td class="nump">6,447<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic income per common share</a></td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Shares included upon conversion of Class C Common to calculate a diluted EPS</a></td>
<td class="nump">6,554<span></span>
</td>
<td class="nump">6,447<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ConvertibleClassCStock', window );">Convertible Class C Stock</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total Denominator for diluted earnings per share</a></td>
<td class="nump">6,682<span></span>
</td>
<td class="nump">6,575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted income per common share</a></td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic income per common share</a></td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Shares included upon conversion of Class C Common to calculate a diluted EPS</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ConvertibleClassCStock', window );">Convertible Class C Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total Denominator for diluted earnings per share</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted income per common share</a></td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConvertibleClassCStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConvertibleClassCStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623764737480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Shares included upon conversion of Class C Common to calculate a diluted EPS</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623763441080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">$ 4,548<span></span>
</td>
<td class="nump">$ 4,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">18,356<span></span>
</td>
<td class="nump">17,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">31,695<span></span>
</td>
<td class="nump">30,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">7,998<span></span>
</td>
<td class="nump">7,814<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">4,990<span></span>
</td>
<td class="nump">4,968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">18,356<span></span>
</td>
<td class="nump">17,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">47,975<span></span>
</td>
<td class="nump">46,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">12,191<span></span>
</td>
<td class="nump">11,998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember', window );">Doubtful [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">442<span></span>
</td>
<td class="nump">442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">16,280<span></span>
</td>
<td class="nump">15,787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">$ 4,193<span></span>
</td>
<td class="nump">$ 4,184<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable - net - Current from service and repair fees of Non Related MRI scanner customers; net of allowances for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFees_NonRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management and other fees receivable from MRI Centers owned by non-related parties - net of allowances for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFees_NonRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management of, and other fees receivable from MRI Centers owned by related parties - net of allowances for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623769089112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractReceivableDueOneToTwoYears', window );">2022</a></td>
<td class="nump">$ 1,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractReceivableDueTwoToThreeYears', window );">2023</a></td>
<td class="nump">1,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractReceivableDueThreeToFourYears', window );">2024</a></td>
<td class="nump">413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractReceivableDueFourToFiveYears', window );">2025</a></td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms', window );">Total</a></td>
<td class="nump">$ 2,545<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123353855&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueFourToFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353855&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueFourToFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueOneToTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353855&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueOneToTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueThreeToFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353855&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueThreeToFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueTwoToThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353855&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueTwoToThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623858011080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 6,851<span></span>
</td>
<td class="nump">$ 5,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember', window );">Commercial Insurance / Managed Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">1,086<span></span>
</td>
<td class="nump">946<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember', window );">Medicare/Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember', window );">Workers Compensation/Personal Injury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">4,124<span></span>
</td>
<td class="nump">3,387<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 1,392<span></span>
</td>
<td class="nump">$ 561<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623766207928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims', window );">Percentage of PC's net revenue derived from no-fault and personal injury protection claim</a></td>
<td class="nump">66.70%<span></span>
</td>
<td class="nump">66.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees', window );">Percentage of consolidated net revenue from management fees charged to related party medical practices</a></td>
<td class="nump">11.80%<span></span>
</td>
<td class="nump">12.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of consolidated net revenue from management fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfConsolidatedNetRevenueFromManagementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of PCs net revenue derived from nofault and personal injury protection claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623857730200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 4 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DisclosureNote4OperatingFinancingLeasesAbstract', window );"><strong>Note 4 Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Operating Lease Payments 2022</a></td>
<td class="nump">$ 5,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Financing Lease Payments 2022</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Operating Lease Payments 2023</a></td>
<td class="nump">5,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">Financing Lease Payments 2023</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Operating Lease Payments 2024</a></td>
<td class="nump">4,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">Financing Lease Payments 2024</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Operating Lease Payments 2025</a></td>
<td class="nump">4,711<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">Financing Lease Payments 2025</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Operating Lease Payments 2026</a></td>
<td class="nump">4,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">Financing Lease Payments 2026</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Operating Lease Payments Thereafter</a></td>
<td class="nump">15,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Financing Lease Payments Thereafter</a></td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PresentValueDiscount', window );">Operating Lease Payments Present Value discount</a></td>
<td class="num">(8,157)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PresentValueDiscountFinancingLease', window );">Financing Lease Payments Present Value discount</a></td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease Payments Total lease liability</a></td>
<td class="nump">31,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Financing Lease Payments Total lease liability</a></td>
<td class="nump">$ 1,202<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureNote4OperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureNote4OperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscountFinancingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value discount financing lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscountFinancingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623768633640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 4 &#8211; OPERATING &amp; FINANCING LEASES (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DisclosureNote4OperatingFinancingLeasesAbstract', window );"><strong>Note 4 Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="nump">$ 33,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureNote4OperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureNote4OperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623858031528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 5 - INVENTORIES - Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInventorySupplies', window );">Purchased parts, components and supplies</a></td>
<td class="nump">$ 1,553<span></span>
</td>
<td class="nump">$ 1,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">282<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">TOTAL INVENTORIES</a></td>
<td class="nump">$ 1,835<span></span>
</td>
<td class="nump">$ 1,663<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1),(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventorySupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventorySupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623857665832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegulatedOperationsAbstract', window );"><strong>Regulated Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsIncurredOnUncompletedContracts', window );">Costs incurred on uncompleted contracts</a></td>
<td class="nump">$ 295<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_EstimatedEarnings', window );">Estimated earnings</a></td>
<td class="nump">568<span></span>
</td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsAndEstimatedEarningsOnUncompletedContracts', window );">Costs and estimated earnings on uncompleted contracts</a></td>
<td class="nump">863<span></span>
</td>
<td class="nump">863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_BillingsToDate', window );">Less: Billings to date</a></td>
<td class="nump">878<span></span>
</td>
<td class="nump">878<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet', window );">Total costs and estimated earnings in excess of billings on uncompleted contracts</a></td>
<td class="num">$ (15)<span></span>
</td>
<td class="num">$ (15)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BillingsToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount within current period that has been billed to customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BillingsToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsAndEstimatedEarningsOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs and estimated earnings on uncompleted contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsAndEstimatedEarningsOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsIncurredOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsIncurredOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EstimatedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated Earnings on uncompleted contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EstimatedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings, net of current billings in excess of costs and estimated earnings on uncompleted contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegulatedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegulatedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623769635560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">$ 20,329<span></span>
</td>
<td class="nump">$ 20,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="nump">16,372<span></span>
</td>
<td class="nump">16,262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets-net</a></td>
<td class="nump">3,957<span></span>
</td>
<td class="nump">4,038<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">7,005<span></span>
</td>
<td class="nump">7,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">5,274<span></span>
</td>
<td class="nump">5,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">4,150<span></span>
</td>
<td class="nump">4,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623857872328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 &#8211; OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623857901192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries, commissions and payroll taxes</a></td>
<td class="nump">$ 3,595<span></span>
</td>
<td class="nump">$ 5,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Litigation accruals</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales tax payable</a></td>
<td class="nump">674<span></span>
</td>
<td class="nump">645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_StateIncomeTaxesPayable', window );">State income taxes payable</a></td>
<td class="nump">351<span></span>
</td>
<td class="nump">774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal and other professional fees</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accounting fees</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Accrued interest and penalty</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">907<span></span>
</td>
<td class="nump">716<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Current Liabilities</a></td>
<td class="nump">$ 5,990<span></span>
</td>
<td class="nump">$ 9,162<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StateIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StateIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623766440072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetRevenuesFromExternalCustomers', window );">Net revenues from external customers</a></td>
<td class="nump">$ 23,730<span></span>
</td>
<td class="nump">$ 20,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="nump">5,741<span></span>
</td>
<td class="nump">4,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,169<span></span>
</td>
<td class="nump">968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">1,209<span></span>
</td>
<td class="nump">435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember', window );">Medical Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetRevenuesFromExternalCustomers', window );">Net revenues from external customers</a></td>
<td class="nump">2,112<span></span>
</td>
<td class="nump">1,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="num">(490)<span></span>
</td>
<td class="num">(561)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember', window );">Management Of Diagnostic Imaging Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetRevenuesFromExternalCustomers', window );">Net revenues from external customers</a></td>
<td class="nump">21,618<span></span>
</td>
<td class="nump">18,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="nump">6,231<span></span>
</td>
<td class="nump">4,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,102<span></span>
</td>
<td class="nump">901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">$ 1,088<span></span>
</td>
<td class="nump">$ 415<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IntersegmentNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IntersegmentNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetRevenuesFromExternalCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetRevenuesFromExternalCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623764562568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 10 &#8211; SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="nump">$ 189<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">$ 221<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623857997384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 11 &#8211; COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_LitigationSettelementDescription', window );">Litigation settelement description</a></td>
<td class="text">In
September 2020, the Company entered into a settlement agreement with an unrelated third party for a claim made during March 2018 which
was scheduled for arbitration. The settlement was for $1.2 million of which $900 was paid by the Company&#8217;s insurance in September
2020. The Company paid the remaining balance of $315 in September 2020.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent', window );">Recorded tax obligations</a></td>
<td class="nump">$ 674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Interest and penalties</a></td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance', window );">Maximum limit for individual claims under stop-loss umbrella policy for health insurances</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LitigationSettelementDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description related to litigation settelement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LitigationSettelementDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623769114824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 12 - INCOME TAXES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability', window );">Income tax expense</a></td>
<td class="nump">$ 1,416<span></span>
</td>
<td class="nump">$ 849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Income tax component - current</a></td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Income tax component - deferred</a></td>
<td class="nump">1,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax asset</a></td>
<td class="nump">14,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus', window );">Deferred tax liability</a></td>
<td class="nump">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 49,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription', window );">Reimbursement of alternative minimum tax credits description</a></td>
<td class="text">At
the present time, the only impact of the CARES Act to the Company is allowing a full reimbursement of $1,342 of tax credits relating
to the alternative minimum tax credits. The Company received the first half payment in June 2020. The balance of alternative minimum
tax credits of $671 was received in July 2020. Previously, these credits were to be refunded over a 3 year period.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of reimbursement of alternative minimum tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623857835640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 4,269<span></span>
</td>
<td class="nump">$ 4,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember', window );">Rockland Management Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets', window );">Right to use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_RightToUseLiability', window );">Right to use liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(434)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_TotalPurchaseConsideration', window );">Total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,123<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right to use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightToUseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right to use liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightToUseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalPurchaseConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalPurchaseConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140623857434488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 13 - ACQUISITION - Net assets acquired (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 29, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,269<span></span>
</td>
<td class="nump">$ 4,269<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember', window );">Rockland Management Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold Improvements</a></td>
<td class="nump">$ 550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DiagnosticEquipment', window );">Diagnostic Equipment</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedCustomerListsGross', window );">Customer Lists</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CovenantNotToCompete', window );">Covenant Not to Compete</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security Deposit</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ClosingCostsExpensed', window );">Closing costs - expensed</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredOther1', window );">Cash Consideration Paid</a></td>
<td class="nump">$ 1,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ClosingCostsExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Closing Costs Expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ClosingCostsExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CovenantNotToCompete">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Covenant not to compete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CovenantNotToCompete</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DiagnosticEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Diagnostic Equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DiagnosticEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredOther1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredOther1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedCustomerListsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date of an asset comprised of customer information, acquired in a business combination or other transaction, having a finite beneficial life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedCustomerListsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>61
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,*);U,'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #"B6]3@-<.2^T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)OITE9#Z&;B^))07!!\1:2V=U@DX9DI-VW-ZV[740?0,@E,W^^
M^0;2F2C-D/ Y#1$3.<PWD^]#EB9NV9$H2H!LCNAUKDLBE.9^2%Y3N:8#1&T^
M] %!-,TM>"1M-6F8@55<B4QUUDB34-.0SGAK5GS\3/T"LP:P1X^!,O": U/S
MQ'B:^@ZN@!E&F'S^+J!=B4OU3^S2 79.3MFMJ7$<Z[%=<F4'#F]/CR_+NI4+
MF70P6%YE)^D4<<LNDU_;N_O= U.B$;SBY6QV0DC>RHUXGUU_^%V%_6#=WOUC
MXXN@ZN#7OU!?4$L#!!0    ( ,*);U.97)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M4H12YP_ _:E29GN2_T"YQ=S]#U!+ P04    " #"B6]3?E6[FN$(   A+@
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MUSF5<7UWQMTZU^2LLT/F-%"),/#>=DX#E?."/>=4!\VI>Y ?6/%O,%!7J,K
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M#,-(S',8@U<8A1U>U CN(\;'#:)^L^@;8GQAHQ $D*11NJ5-6D&SUH)O&O1
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M0G00K&/G_D.5C9]N:KPER26Z,I23P0HL6F9E!>7*=YT<2<*T[!_DB#2("'I
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MO :DC^;]T_U/#K/TI7T03[]7H$UC@?2HL16.CH<_X'O2I=\ TDVP=?SN7MJ
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M!MPY@7Q_ZH>VG<L-?$4!D2AJ4QLEK4\:HJGG1JZ;;BQD\AV3E:>.0%V_%X+
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MB 917FJ2X&H_ZHS85+(OK_9#OLQB[@/0,"<TN7'DJH,E%W=99CK(T4Q' (H
M"Z+HS-21E.BL]D>I)[*:J08#DJ(C$']*4'Q8F*D2@2?4FZ\!K!D7PX'X% 0B
MGE31="CT%%F:"LC38,(Z*9N;Z@1]TLQ"C&6#Q4UYH+F&]2OJ!BVP.#::W3C[
M1 EI$K(#0Z/]0<<%FM2Z(0ZILDV"YP/Y0%S_(0CZ#::"( ",45<ICM0)C4_A
M7.[$P>BD,8>3?-=]GP532A&(&$3/*RMZ).NB'>N>/XH>307DO9AHQH"Q[*B1
M+?[KBLC7\!T(!95N[ ?Q9S'NGYP<\^_19(3?HR'^C/J3X0G_CB<3>OE;]$D5
MADD,VZ)O3VOXA7 <]2>3P_!W?#+&U>'A<?B+>V]+MP*Z($/G<##YS?\<\<^!
M_QG[A^-C_W 8->G:-?"96E(X]86DYYEJH^)1H@CR\7CTL7L=(.\(#@<QK_ %
M*CSJ'YV,@MK)\835!OO>]G2RXV)P>(B39XR*BSK?V69AF';B^F)VZ=GG"N%<
MTLL;] KZ<B+=#TK]6+7L-;N:^@\PFI9@P@P-W."E[4YWS;". U>89/O/1UBF
MZ)T"BKB ,/+3MQ$4_%RQLPIG-/ZD1*35Z5*^/MU'D9HUM;1^&'VY?R8&/A2F
M@A#PX$IYL42OW#N-VP[9:U-GB7>L\]$BVT22%2M_)M]^5NLX&CIV>V9HOIVD
MDA';^$]5])V&137LPGYBB^<)'O[?L#AJ+6YQ]?BPR7+W,QI:"/28XGF??O&[
M8)C=,*.IQN!=S ?BI2^P^YV/WI0W_&F?NC5P\=^_VZ?M?P\N_$?S[7+_KX=;
M26E'Q[T%M@X'QY.>L/YSOK]!I^5/Z'-352;G2QQWP9ZT .\7!ATEW)""]G\J
MY_\!4$L#!!0    ( ,*);U,!<YXL5 H  'T:   8    >&PO=V]R:W-H965T
M<R]S:&5E=#DN>&ULS5G;;MM($GWG5S2TLX,$H"U1-TNQ$\!1[!D/8L>PG9F'
MQ3ZTR);4$Y+-=#?M:+Y^3Q4OHA(Y"!8[P#XD)JGNNIXZ54V>/1G[R6V4\N)+
MEN;N=6_C??&JWW?Q1F72'9M"Y?AE96PF/6[MNN\*JV3"F[*T/QP,IOU,ZKSW
MYHR?W=HW9Z;TJ<[5K16NS#)IMV]5:IY>]Z)>\^!.KS>>'O3?G!5RK>Z5_UC<
M6MSU6RF)SE3NM,F%5:O7O?/HU=LQK><%OVOUY#K7@CQ9&O.);JZ2U[T!&:12
M%7N2(/'G42U4FI(@F/&YEMEK5=+&[G4C_9)]AR]+Z=3"I'_HQ&]>]V8]D:B5
M+%-_9YY^5;4_$Y(7F]3Q_^*I7COHB;ATWF3U9EB0Z;SZ*[_4<?B1#<-ZPY#M
MKA2QE>^DEV_.K'D2EE9#&EVPJ[P;QNF<DG+O+7[5V.??W'QXN! C\?,_9L,H
M.A7GB\6'CS</]^+N8G%Q]?OYV_<7H;B^>'>U.'_?>2;.;]Z)Z_.;\U\NKB]N
M'OCVP\.O%W?B\N*BN_FL[V$DJ>K'M4%O*X.&SQ@T$M<F]QLG+O)$)?O[^W"N
M]7#8>/AV^%V!]ZHX%J-!*(:#8?0=>:,V8B.6-WE&WIV*E7Z4RU0Y\:_SI?,6
MR/KW=P2/6\%C%CSZ_TG%=PTB/GCE"AFKUST4O%/V4?78RN#OLU)TPAL&.5A)
M.Q&;K+#:J428E? ;)58F!9OH?"VD%TBP5]E2V3;+H9!Y(GXK<]4^>A5T! ='
MX@:,L"BM5;D71P)Z@E9,T.P)?K'&N<Y&<4YJ91ZK '0H$E,N_:I,02VQ*7/O
MQ WDG#<W=K?O)S$.Y_,!_1T/^6XRGAU<>82;5'J5!(6T?HNUT6!817MX6MT%
MURK1L4SW%42S<#29XJ*SEA\%US('O6;D*87%((!6K)3ZVL*3<'XRH6W3<#@C
M6T=1.)U/?FA_L+(F:TP766U@0:6A8ZQ\058-!Z>W"S;OY-3Q@^CT)2D<AM$\
MXK!$\Q'^PI+Y+*#\_5VYF,ZZN1A.?S07>ZEX+A,P?Q#M9X(?_7 FIN')B#,Q
M"4]F)Y2)03@'8/[^3$04^2H3LS%G8A:-Q<-&!0O4H,RWS::Z-RGKA+0*%8I$
MY*!"4JIS+M*-DJG?Q/2SSA,LM]MCT<2YF\F%A94^0(5_0O?S&UCO"G1MX0T+
M^EJU/)"KQF%L*:Q)2NQVDBB: D74!>?YVJI"ZCIJH)949YKV):6JU06-9T(F
MCX2O1@]6@86 M=HLL!)2$5?Y #'1^"$*96E2PEI21LN6.DV)J;!"9I7=$- )
MG\-$M#R2SH%]4JTXH %17JI@V3'X[;#U%%@23K2(\49DU#?3K8"%GTL 5EG<
M8&+1KK6ECB2J!?MSXREO7N?P'4%[U G9B75.-2%S@5X=C/=2P4)LD\Y3[(X)
M(ZUXDFHQF(B8,RL.9O:05,;NM]D*V%^_L:9<;X3VK6#U*--2\G@'!V"N"YN?
M.+&X152T-Y8\XR5):6M48(9U)H?>K7 ;8RD8:3,L(GB9VW>JSJP+3+XV)*Y6
M)$N/W?HO-L,A,%@%X[^"(8<$-4B8 UZ4Y3I!&)"MY^!)":[R0C!X#[W! ^QJ
M:ZC3*[LEBDBGJ5BK7%$Y0N*CH@QS;%,(.2+G0J0_/XH)WVG*$AH+75U#I/:0
M:0TRCL5EZ1',5@&V+56 ;)IUKO\B5#ZBB/;;]<J45FR5)-P?ZMSL,RJBVN%>
M!0_&RS2XE+%.M4=Q!%A%K!V%@^& ;D:[R[$81R.ZF(CYL-J)E4/TVHFHF;H[
M!;3/;.<9Z2<N*#%]<AJ.D,ZC)@R[&'$T_49;D (WAT)NC07>7!EOR(.-<86&
M!7BTID#D3!.N $8,);_#C@CVVLH,\TX!$&%9RW2I6L,'RC;.,9R$1,-:#\BR
M ?5ZY.*^Q"0J4<PRQ8_XCP/?I*9BQRJS]18JQ:K@0=>7*1"<2 9\ )OLEF<K
MIJMFYLJ^[76:I #D<&<)I3GIK7HR=B"_.&!103D<6)K&U;JV5& ._-,9@;36
MT1(D=@<,8R*II6I*D^J@6Y.)(BQC;'4[U00>VV:JA,4R^1-LF['7%,,R;RJ=
MG&AYB YW3*5$47JE8R'7" /2TC[@)'=Y0CM7JLI>L9&/Q(L*3Q/HPH:Z"[2"
MZ^TIN)[$U8Q!2S;:$4E1?-47,(VFQD(EHB3@Y-"BCL6N^P>TY0-W_TLBBL,\
MT(:ZB^\:M[N&2:*("II[@'$%'H5EC#Q;&%O;^6(W,KRDEM7!&Z*--L-08>;"
MZ9]^)7@%525EG=%E;15? ;:W<MNT3S*JLZ_MT(DJ5)[PHKP;>B".MNR,:K5_
M4YM96^@Z6Y;6U2W;KF7>\'9(O3V/=<'^Z-R5EG$<<RQUW3*JHNTZLR>D]2=H
M:F:W$)8=3D3'@4QN">PZ(Z*MBHI6:#0IHK]M$Z;.%AHEJIA0'4N!>E)P (I!
M_P$6@[&;RNT&1QTD+[K3<9E*NQ\$,(*F624F)F-J*#&]&%BE )XC?@?" :(9
MJ%J8(6N.PQ( \#ISS8A%+0B *.K,Q]NX&=.L7ANT>&0]K]XV52"TZG.)<.SJ
M-U;62WA;S;^)=ES[B%>E"$-F 11_86:!']/I\8GX)]?,=(J+-HBNCB(=_QJJ
MK-BCB@]@6@U5U++1@P_V*TC%!6[KT09S8KH-Q9.B1H)@T=C(,=^+$TJ<9H\T
MT/F?I=U2U?D:UXT37PU4(&L*++/DNIXG:1(Z-$8A-@TSUA-=A\MW'-T]-P6-
MG'W%U11!)>'EIXIEJZ9$3>91ZFIT<%X5^U#<LP<R%_50AC,<27'.Q)KIAJ?"
MBH]VQ_/NX,-6UB<*A %$0&1* 3$I6A;)6*% 4+J "LC#=X#"C+RC5AJ'B9Y)
M)R0>:$K$O;%OBIE.D#M84 ZS9P]@\4;:=77^Z+(K0-9DJ'9%[F$SBHYG-3:C
M(5_6Z-QS\'^.3R09X9 ;.G0H'"O7T(#V=J<(E 2-JXQ!%HK;\U#<$R6+CX6X
MOKLB!+TUL11WTIN<?F<5>TM^EEEQ*MYIB#6.Y"YXXN7%+PA!SYY.7P9[L[$4
M:QQDT&6VNZ8!D@*#EWA(L7[:Z)CQ@QJA%P3-!D6=#9KV"=C5ZQE?<LO8W3]C
MAM6*@)$CZ9U37H^"W(AQCM5 )0T5AQH:F"<!S"O::DJH6IC0U,\3+.QR&/N+
M:CJOA!]T-/C6T:_=>=Z1XX.30#W\U<V( 14RNI#5O8EI-TQ50Z>K2>:_ Q\7
M=/7:GP\&=3GOC@6>/#@.[N,-QLF4Q\$#I@:7AEL:7"/MW??$^]H#ULZ:%W1(
MMTP.5TT_Z]<O4A*Q(,/X,#&C5V?S\;1^I6-5O[K0\& \%]'\)/BCZFU-TUAT
M6ES_MN'SJXK/QV&$X\@H',U.@FI0B\+1?"@FTRBXK3W#Z(:*>S8)P;-)^$E,
MP]F$WC!-PL$\$H?>/?<[GP00@#5_^'!\E/#5UX'V:?MMY;SZI+!;7GV8N0:S
M818 [Z^P=7!\,NE1J]ZT-]X4_(%A:3RF K[$H 1<TP+\OC)H;O4-*6B_.+WY
M#U!+ P04    " #"B6]3T+)$)E0'   L$0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970Q,"YX;6RU6-MNXS@2?==7$)[%H!MPQY;L7+IS 9Q,LIO!3'<09W:P
MC[1$V413I(:D[,Y^_9XB)5E.)XUYV9=8E%BW4U6GR%SLC/WJ-D)X]JU2VEV.
M-M[7GR83EV]$Q=V1J87&E]+8BGLL[7KB:BMX$80J-<FFTY-)Q:4>75V$=P_V
MZL(T7DDM'BQS355Q^WPME-E=CM)1]^)1KC>>7DRN+FJ^%DOA_Z@?+%:37DLA
M*Z&=-)I945Z.%NFGZSGM#QO^+<7.#9X91;(RYBLM[HO+T90<$DKDGC1P_&S%
MC5"*%,&-OUJ=H]XD"0Z?.^UW(7;$LN).W!CUIRS\YG)T-F*%*'FC_*/9_4NT
M\1R3OMPH%_ZR7=P[P^:\<=Y4K3 \J*2.O_Q;B\- X&SZAD#6"F3![V@H>/D+
M]_SJPIH=L[0;VN@AA!JDX9S4E)2EM_@J(>>O/G]YNF5S]O-/9UF:GK,O#[>/
MBZ?[S_]D/_.J/F=W]Y\7GV]H_=OM8GF[O)AX&"712=X:N(X&LC<,S-CO1ON-
M8[>Z$,6A_ 3.]AYGG<?7V0\5+D5]Q&;3,<NF6?H#?;,>@5G0=_P6 L8+(/"E
M%I9[J=?L3FJN<WKZ32#?[@<VYKV->; Q^_^A_$,#U+J?7,US<3E";SIAMV(4
MK"9_WRK[I;&(.KD3*]N@00%P>C)F=XLED\XUHF"+Y1_AY8=I-F[!8>^>3"US
M=C;/WA^QIXU@&IWH/-<%MP7:]J]&PB&FA',"O]XP7M?JF7%6-%S1PAJ>;\8L
M5]PY63X3\"KH3KAC0OJ-L*P,.1',6&;Z1,5=H2D+UM3H<>QE-8+(9:VPN62[
MC0CRD-/&A^]!"A$Q498B<$+PIK50L+JQ^8:VK)YI?Q(]I]@@TSHI<QXX92>5
M @=X8=&:HK<638AO8,YHRHK<K+7\+]1';XF/]-X#)C5T".=9!0VF"'%B"X"T
MG'CE R4\@2R4F2U,4"1DEH+LHSIBBQ9H,LJ5,UT""@*>O$!..+-!I2D_-' /
M 8'[D2]\B(XKR5=22?_,0/I0HSJD=TA&PGN[:TP!'WQ!+&G&JMCH5JR1>O*C
M=4[:%[@=Q>()^MA>WUZ%L2&.B.\*/N:Y:0!1$3QRLI**VP0AH=BWTC2.K1M9
MA HI7RF16)A]4>[X(/E!  I68BVU)IE?&Q1$2OR2?CQB?PJVX=@6Y@CA"$VF
MIBA0O<@.QA,MDC9Q?7W[H47>03&P6P"[ #N5C( 78LQV(H9,M?J*&BBG=6ZJ
MFE. T()(I2D<"UU/""52MYNT,TJ2E:(M;@F/H<L+#%5,\CZT4"C#^/9A,7#*
M5PSGSOW:TAC-H8BJNY"DB'RHI"=A2FBTG^S1WLA\ _5(FH9M%_2T91D<B:5)
M9>@H#HE\P/E<-33X4<8KG"6ZKBT@T)?1N'W[HBD)4ZD+J,]]DAOGV_SS(N8M
MQB('-;/A5/P5%3-A) %O[EG+)S>$MGX.+'IZ3G2C@E \,X$DMM+Z)B DR>N"
M:BAB%5+"MEPU(J'/B+5L?&/%RPH%S,\1"U0*'S0@I/[!9K.C68*25UUT5JB0
MUMC'WH0^CHI"-Y,:,GA8R8O(?QYG*M+[-AR[B(@VZ#2P%@&+,,I^+ Z:*FG1
MZ3K4A7:B0+?<AL;\CJZE#IMM:XLH8!&%:=.R+1L'W(M]3M\%^$_.%\N;-A'O
M:>1TLRT)?#(F])HZECP2,QA7??1(D>C#;@EO/,SSGJO=(4\>XCO(PB%I2LRM
M"F\:(EWN#ZN C+85\"+O<(A0.RBNCB9?'R3?SP=V.!^25^;#E\:"8S%GP"$5
MV=3PF(B,ME+*8H*4T&ODI;2F8AGU9SIESX);)/V^KW$K,.HA&\O(8?"O#91U
M/!#- BB%7(^374<V4.>)B  V.1?5GT3U!!B)E3QOL:1B;'U_.DC2%N=S6"+0
MP!:>>"D.*+85NC VYBB>H(5UXWY,TQ$'$\L'T;<[B/A3.@H&3AJMJ!=1CH*%
M8]8K(^9>#TU$EGN[/W61#"KFL (+6>P3W1\F?'L3ZN".O#J4*X50>&\:5=#0
M)$[%E%K!=?%-V%SBX!$K $T0N9>K9&4L#K,AGS200J-ET_/[Z\?PE*+1&A?/
M#X5TH4_;H03]H;S>Y+)P7C*.SE==K[03K#_NV# 1^)9CH*^42-KO;43HVH2
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MFJ#QV25=,=U(O7&LJKR\5LJ26+U9T.N(VB50?*V4W3NN0/O>CGX#4$L#!!0
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MEN21RY?)>]V6N[PK-*8/$RY$04I+F! #]"YZ[O)6RC)!L&<27NV#2\#'F&A
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MFIP-J 'J]FEJ%U8U_CE8*TO^^VE%KSEJ)T#G&Z7L<>$,=/\'T_\!4$L#!!0
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MV&,>(F)B.Z*7T+81Z0EB*KN82T:O--5!<AO''S5EB?*'L2Q-W(I6<@6$(MM
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MVLB!@IY_6[E-<POS%OWLAP$'LK7=PE?>-:+@E>6)IX]?%F@]H7ORRFBJ*52
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M4\ TEUGSX'05KJ&U=NA'^%G@F.7&*^!]IK7K'KR#_CP^^1=02P,$%     @
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MD)-.V97JM#1$SS6(IU1%52ZK1)<J$;&!%W+GK\(HW,QU+B%!9L*5>( <+)V
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MZE^-Z+D)VQ[M0O'&M*0M5]3@S#2G/PH*?8#V=YRKTT(3=/^HZ7=02P,$%
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MY1/JNH[7E*MWV4C&#-(LH?G+"]S(\H,0-P>Z^LB8T1*?FT)Y2LN4,+D%3C8
M_V78M^)^H,Q"RXL45]^UPCAXD[VQX:S84R=%2[!2%9(EJ/E>L?*<R\5$T^M?
M"GW@7GY0%WJ6&[LZ+&[LXXI,XLCXLR[A=^4BC YSX85OS<6+5+R6":3ON"\S
MH8_>G(G0ZOLZ$X'5C_HJ$XX58\'\_DRX*O)-)J*>SD3D]LB)'@^Z'@].]OB*
M2:1Q0Y,LSV0&XEA3GT0XWM0:UGB&-;!65%)=R_$<)?C/VQ[IN;[:!"3VC(;0
M&?&P%8-3'H:=A^%)#^]Q?DAK3"#;D(HB&<P2Y@93\0AE#<<</@EXW.'_N<7
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M-+KI8<VKIC$W"R,KUPR7TB#1;KK!MPR45<#_*RG-?F$='%['X;]02P,$%
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MRLL?QO5L?45S65Q,=.:OS NOO&AIPI3W/G>(;J*4@1BO14CC?"P$@Y97*>6
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M@IJX(2^LF1?6/&]IEW?W$,(9L+J=[>3PSI\0%JP5MJ&]A[1D*.6Q;3B.5ID
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M+W=O<FMS:&5E=',O<VAE970S-2YX;6R-5%]OVC 0_RI6U(=6ZIK@$-BJ$"E
MNB(56@'M'J8]F' 0JTZ<V0;:;S_;22.VAG8OB<^^WY^[Y!P>N'B6&8!"+SDK
MY,#)E"JO75>F&>1$7O$2"GVRX2(G2H=BZ\I2 %E;4,Y<['D]-R>T<*+0[CV(
M*.0[Q6@!#P+)79X3\3H$Q@\#I^.\;<SI-E-FPXW"DFQA >JQ?! Z<AN6-<VA
MD)072,!FX,2=ZV'?Y-N$)PH'>;1&II(5Y\\FF*P'CF<, 8-4&0:B7WL8 6.&
M2-OX77,ZC:0!'J_?V&]L[;J6%9$PXNP'7:MLX'QUT!HV9,?4G!]NH:XG,'PI
M9](^T:'.]1R4[J3B>0W6#G):5&_R4O?A"( [)P"X!F#KNQ*R+L=$D2@4_("$
MR=9L9F%+M6AMCA;FHRR4T*=4XU0TNU\FR$=?4#P:W3_.E@LT3T;)Y"D>WB67
M:)J,)Z/X[F@/Q;,QFL:S^'LR369+&]XO;Y,YNDF28["F7')%&+HA*65449#H
M? R*4"8OT!FB!5IF?"=)L9:AJW0IQI";UK:'E6U\PO8"RBOD>Y<(>[CSN!BC
M\[.+OUE<W8BF&[CI!K:TP0G:.:1 ]V3%M-F?\4HJH?^:7Q\0^PVQ;XG]$\3:
M)FZKLD+U+,K,SS[J>-@+W7V+5K?1ZGZFY;=I5:CN?VD%C5;PF5:W32MXI]7M
M^.U2O4:J]YE4T";5>R?U#;<K]1NE_H=*]K]MD^J_^UHXZ ;_B+E'PVCNM2D1
M6UI(Q&"C8=Y57_=&5'=%%2A>VOE<<:6GW2XS?;V", GZ?,.Y>@O,R#<7=O0'
M4$L#!!0    ( ,*);U-RE1@R)P,  +H)   9    >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;+U6VV[;.!#]E8'0AQ;(1C=?"]N +:O; +5CQ$[[S$BTQ:U$
M>DDJ;O]^AY2BJ+8C[%->+)*:<V;.L<CAY"3D3Y51JN%7D7,U=3*MCY]=5R49
M+8BZ%4?*\<U>R()HG,J#JXZ2DM2"BMP-/&_@%H1Q9S:Q:QLYFXA2YXS3C015
M%@61OQ<T%Z>IXSLO"P_LD&FSX,XF1W*@6ZH?CQN),[=A25E!N6*"@Z3[J3/W
M/T>^!=B([XR>5&L,1LJ3$#_-Y"Z=.IZIB.8TT8:"X..91C3/#1/6\6]-ZC0Y
M#; ]?F'_8L6CF">B:"3R'RS5V=09.9#2/2ES_2!.7VDMJ&_X$I$K^PNG.M9S
M("F5%D4-Q@H*QJLG^54;T0(@SW5 4 ."<T#O#4!8 T(KM*K,REH23683*4X@
M332RF8'UQJ)1#>/F;]QJB6\9XO1L?;^+(82_8!Y%]X_KW18>XBB^^SY??(MO
M8!4O[Z+YM]8:S-=+6,W7\[_C5;S>V>G][FO\ %_BN V&CTNJ"<O5)R1_W"[A
MXX=/\ $8AUTF2D5XJB:N1@6F#C>IJUU4U09O5!O"2G"=*8AY2M,_\2XJ;^0'
M+_(702?AEAYO(?1N(/ "_TH]T?^'>QWEA,V_$5J^\ V^#=&,<@U[2G&//%->
MTAO@N)G%'A)4+O&K+TD.),?M1WA"%:"1D#*5B)+KJXY6&0<VH]G4S[/!J(]:
MG]LR+X/ZWO@UZ \QO49,KU-,)(J"RH1AO7=<E=+4"RZL",?S(86(2-IA6;_)
MTG]WRZJ,O98;OC<:G%EV&33N#:X[-FBT##JUK&C*$K3%K0:LZPL?-IS#=_=G
M>"$]Z(W/[+F,\<?#Z_:,&BFC3BD_L"%0J0 _+.QBBI@^X&YP17#[C?U3RM\=
MCHV;-.-W=VQ\X4;/#WIGEET&A>'H#<]\[_6 ]SKEW.N,R@Y;_%:K\-_=F#IE
M^^3QPW%PYLR5J/[@_'AR6UT0#YZ#O1PHL+FKCM"L-A>0N6V[9^L+<S&QW?65
MIKK5K(@\,*X@IWND]&Z'> C(ZJ)03;0XVE[[)#1V;CO,\')%I0G ]WLA],O$
M)&BN:[/_ %!+ P04    " #"B6]3\&4 9L\"  #"!@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970S-RYX;6R55>]/VS 0_5=.F?9+8DV: D.LK92&,)!HJ0IL
M'Z9]<),K]>;8F>U2^.]W=D+6L=)M7Q+;N??\[IU]Z:^5_FZ6B!;N2R'-(%A:
M6QV'H<F76#+3415*^K)0NF26IOHV-)5&5GA0*<(XB@[#DG$9#/M^;:J'?;6R
M@DN<:C"KLF3Z881"K0=!-WA<F/';I74+X;!?L5N\0GM3337-PI:EX"5*PY4$
MC8M!D'2/TP,7[P,^<5R;C3&X3.9*?7>3\V(01$X0"LRM8V#TNL,4A7!$).-'
MPQFT6SK@YOB1_=3G3KG,F<%4B<^\L,M!<!1 @0NV$G:FUF?8Y.,%YDH8_X1U
M$QL%D*^,564#)@4EE_6;W3<^; "(9SL@;@#Q4\#^,X!> ^CY1&ME/JT39MFP
MK]4:M(LF-C?PWG@T9<.EJ^*5U?25$\X.)Y?7&?3@U8NCN-O] $F:7MY,KJ]@
MEJ79^:=D=)'MP3@[.4^3BXTU2"8G,$XFR<=LG$VN_?3R^BR;P6F6;8+AS0E:
MQH6!"=.:N9*][8>6A+OMP[P1.:I%QL^([,%82;LTD,D"B]_Q(27<9AT_9CV*
M=Q)>8=6!7K0'<11WM^A)_QT>[9#3:XO0\WP'S_#-,$=^Q^8"#7Q)YL9J.MU?
M=Q#OM\3[GKCW#/$4=8[2TG4$M8!I^MJ I,Z@\0[E"NFX:RI( 0NM2I#JG3_\
MP&0!%6JC)!/ Y;>5?H!**]M<O%PP7FZKX6XIAX>=]]'+;5[_%1<]Q?WFQ4'K
MQ<%_>)$K:93@!;.4_Z8GWHN228JC9F5A@524?,GT+05:17'"8RJF[0.46/"<
M;*I<Q7B.9ILQNW5UNYVC[<;\!1?_B:N-"3?:08DDW'5)2D*MI*WO2+O:-N+$
M]Y\GZR-JT'4__453=_<Q^<&E 8$+HHPZ[TFKKCMF/;&J\DUGKBRU,#]<TD\&
MM0N@[PM%!ZJ9N W:W];P)U!+ P04    " #"B6]3RWKP32$#   V#   &0
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MA?IGRDI6NBYL:+M3)A$%U"Q2@F:$$OEJ!:L:<0MVHCH#*JT8-O3BP\GB2M,
MU>OZ#LS=ZP)U1_T;\15)A3I@J<*\L[;Z3O!=D[J;2):9QG#&I&HSS7"M&GO,
M]09U?\E4 Y5/=*]9_%7H_P-02P,$%     @ PHEO4Z[2&3@V @  AP0  !D
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M"VF?<*AC'T('DIU4O&S 6D%)6?TF'TT?3@"!?P80-(# ZJX3694CHD@<"7X
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MVF3"+5,SM8.T!N9\*81^W-BYL/H?,/@/4$L#!!0    ( ,*);U-7U] MXP(
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M; -I)N#X6@C]U# $]4-P^AM02P,$%     @ PHEO4U2[/-8A P  -!(   T
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M\9?ESTE\7]07G /\_5U\ U!+ P04    " #"B6]3@(3XG< !    '@  $P
M %M#;VYT96YT7U1Y<&5S72YX;6S-V<ENPC 4!=!?0=E6Q'B #@(V;;<MB_Z
MFSP@(HDMVU#X^SIAD%K1J(A*O9M$B>UW7VSI;#)^VUGRO6U5UGZ2+$.P#XSY
M;$F5]JFQ5,>1N7&5#O'1+9C5V4HOB(G!8,0R4P>J0S\T-9+I^(GF>EV&WO,V
MOO:%J2>)H](GO<?]Q"9KDFAKRR+3(8ZS39U_2^D?$M*XLIWCEX7U-W%"PLXF
M-",_!QS6O6[(N2*GWDR[\**K.(MM2^;#KB2?=I<XTZ.9SXN,<I.MJ[@D]=:1
MSOV2*%1ENB]ZTYT<X@[3_LJOSF_+= 7&F3-GK(\GYNCRN..1-*O[-A8B%XKN
M3SPEQM)7?Q\UIYU3_LOLN+T?QJW:\_"LO5V_QU_/^%3_PCX$2!\2I \%TL<0
MI(\12!^W('W<@?1Q#](''Z T@B(J1R&5HYC*45#E**IR%%8YBJL<!5:.(JM
MD56@R"I09!4HL@H4606*K )%5H$BJT"15:#(*E%DE2BR2A19)8JL$D56B2*K
M1)%5HL@J4625*+(J%%D5BJP*15:%(JM"D56AR*I09%4HLBH4616*K,/_E/7=
MF-5?_Y-L[FFEB_J8S]H?O]-/4$L! A0#%     @ PHEO4P=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" #"B6]3@-<.2^T    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " #"B6]3F5R<(Q &  "<)P  $P
M    @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ,*);U,R
MR1)U+04  &X6   8              " @0P(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " #"B6]3?E6[FN$(   A+@  &
M    @(%O#0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @
MPHEO4Q<XJ[L*!   \Q,  !@              ("!AA8  'AL+W=O<FMS:&5E
M=',O<VAE970S+GAM;%!+ 0(4 Q0    ( ,*);U-S=J%A?@<  $\D   8
M          " @<8:  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M    " #"B6]3I?G^_%<$  !M%0  &               @(%Z(@  >&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ PHEO4_6 N^#K!@  "QP
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M965T,3 N>&UL4$L! A0#%     @ PHEO4Y\N0ON6 @  >P4  !D
M     ("!FU(  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,*);U->VU"F;@(  - %   9              "
M@?1C  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ PHEO
M4_S#\A3+!P  PA$  !D              ("!F68  'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6Q02P$"% ,4    " #"B6]3/!/$S&H*  "0&   &0
M        @(&;;@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0
M   ( ,*);U-M7I0WY@0  "H+   9              " @3QY  !X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ PHEO4U;@TQM3 @  (@4
M !D              ("!67X  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q0
M2P$"% ,4    " #"B6]3=D912:8*  "0&P  &0              @('C@
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( ,*);U/;FD',
M& ,  *\&   9              " @<"+  !X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L! A0#%     @ PHEO4_KO"9$[!   L H  !D
M ("!#X\  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " #"
MB6]3E&X%W,@"  #A!0  &0              @(&!DP  >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( ,*);U,JT-R=9 (  /T$   9
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M970R.2YX;6Q02P$"% ,4    " #"B6]3$(3Y.14#  #B!@  &0
M    @(&\I0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (
M ,*);U.1^SSM;@(  ,,%   9              " @0BI  !X;"]W;W)K<VAE
M971S+W-H965T,S$N>&UL4$L! A0#%     @ PHEO4S0+@K6)!   W!(  !D
M             ("!K:L  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"
M% ,4    " #"B6]3*A:L&WD"  !M!0  &0              @(%ML   >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( ,*);U.6))K?$ 0
M "41   9              " @1VS  !X;"]W;W)K<VAE971S+W-H965T,S0N
M>&UL4$L! A0#%     @ PHEO4SXJ/]U? @  O 4  !D              ("!
M9+<  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " #"B6]3
M<I48,B<#  "Z"0  &0              @('ZN0  >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;%!+ 0(4 Q0    ( ,*);U/P90!FSP(  ,(&   9
M      " @5B]  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%
M  @ PHEO4\MZ\$TA P  -@P  !D              ("!7L   'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " #"B6]3KM(9.#8"  "'!
M&0              @(&VPP  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+
M 0(4 Q0    ( ,*);U/2]P&O90(  ,$%   9              " @2/&  !X
M;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ PHEO4P(=*I/!
M @  FP<  !D              ("!O\@  'AL+W=O<FMS:&5E=',O<VAE970T
M,2YX;6Q02P$"% ,4    " #"B6]3D:EC]VD#   3#   &0
M@(&WRP  >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( ,*)
M;U-7U] MXP(  (X(   9              " @5?/  !X;"]W;W)K<VAE971S
M+W-H965T-#,N>&UL4$L! A0#%     @ PHEO4[AB%QUV P  C0H  !D
M         ("!<=(  'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4
M    " #"B6]3ZA=<- D$   [#P  &0              @($>U@  >&PO=V]R
M:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( ,*);U/)_ACM@0(  - %
M   9              " @5[:  !X;"]W;W)K<VAE971S+W-H965T-#8N>&UL
M4$L! A0#%     @ PHEO4SVR(\"^ P  X@@  !D              ("!%MT
M 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " #"B6]3EA*'
M2K8#  #2"0  &0              @($+X0  >&PO=V]R:W-H965T<R]S:&5E
M=#0X+GAM;%!+ 0(4 Q0    ( ,*);U/X**%H#0,  ",)   9
M  " @?CD  !X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @
MPHEO4V"0EA57 P  % H  !D              ("!/.@  'AL+W=O<FMS:&5E
M=',O<VAE970U,"YX;6Q02P$"% ,4    " #"B6]35+L\UB$#   T$@  #0
M            @ '*ZP  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( ,*);U.7
MBKL<P    !,"   +              "  1;O  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( ,*);U.H\O186@0  /0A   /              "  ?_O  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " #"B6]3.(-O)L0!   -'@  &@
M        @ &&]   >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " #"B6]3@(3XG< !    '@  $P              @ &"]@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     .@ Z ,T/  !S^      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>89</ContextCount>
  <ElementCount>324</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>25</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfIncome</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - NOTE 1 ??? DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentation</Role>
      <ShortName>NOTE 1 ??? DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - NOTE 3 ??? ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</Role>
      <ShortName>NOTE 3 ??? ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - NOTE 4 ??? OPERATING &amp; FINANCING LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note4OperatingFinancingLeases</Role>
      <ShortName>NOTE 4 ??? OPERATING &amp; FINANCING LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - NOTE 5 - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5-Inventories</Role>
      <ShortName>NOTE 5 - INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - NOTE 6 ??? CONTRACT ASSETS AND LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6ContractAssetsAndLiabilities</Role>
      <ShortName>NOTE 6 ??? CONTRACT ASSETS AND LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - NOTE 7 ??? OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7OtherIntangibleAssets</Role>
      <ShortName>NOTE 7 ??? OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - NOTE 8 ??? OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8OtherCurrentLiabilities</Role>
      <ShortName>NOTE 8 ??? OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note9-SegmentAndRelatedInformation</Role>
      <ShortName>NOTE 9 - SEGMENT AND RELATED INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - NOTE 10 ??? SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note10SupplementalCashFlowInformation</Role>
      <ShortName>NOTE 10 ??? SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - NOTE 11 ??? COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note11CommitmentsAndContingencies</Role>
      <ShortName>NOTE 11 ??? COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - NOTE 12 - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note12-IncomeTaxes</Role>
      <ShortName>NOTE 12 - INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - NOTE 13 ??? ACQUISITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note13Acquisition</Role>
      <ShortName>NOTE 13 ??? ACQUISITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - NOTE 14 ??? SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note14SubsequentEvents</Role>
      <ShortName>NOTE 14 ??? SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - NOTE 3 ??? ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</Role>
      <ShortName>NOTE 3 ??? ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - NOTE 4 ??? OPERATING &amp; FINANCING LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note4OperatingFinancingLeasesTables</Role>
      <ShortName>NOTE 4 ??? OPERATING &amp; FINANCING LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note4OperatingFinancingLeases</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - NOTE 5 - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5-InventoriesTables</Role>
      <ShortName>NOTE 5 - INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note5-Inventories</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - NOTE 6 ??? CONTRACT ASSETS AND LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6ContractAssetsAndLiabilitiesTables</Role>
      <ShortName>NOTE 6 ??? CONTRACT ASSETS AND LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note6ContractAssetsAndLiabilities</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - NOTE 7 ??? OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7OtherIntangibleAssetsTables</Role>
      <ShortName>NOTE 7 ??? OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note7OtherIntangibleAssets</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - NOTE 8 ??? OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8OtherCurrentLiabilitiesTables</Role>
      <ShortName>NOTE 8 ??? OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note8OtherCurrentLiabilities</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note9-SegmentAndRelatedInformationTables</Role>
      <ShortName>NOTE 9 - SEGMENT AND RELATED INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note9-SegmentAndRelatedInformation</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - NOTE 13 ??? ACQUISITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note13AcquisitionTables</Role>
      <ShortName>NOTE 13 ??? ACQUISITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note13Acquisition</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - NOTE 1 ??? DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative</Role>
      <ShortName>NOTE 1 ??? DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails</Role>
      <ShortName>NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - NOTE 3 ??? ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative</Role>
      <ShortName>NOTE 3 ??? ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - NOTE 4 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails</Role>
      <ShortName>NOTE 4 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - NOTE 4 ??? OPERATING &amp; FINANCING LEASES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note4OperatingFinancingLeasesDetailsNarrative</Role>
      <ShortName>NOTE 4 ??? OPERATING &amp; FINANCING LEASES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note4OperatingFinancingLeasesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5-Inventories-InventoriesDetails</Role>
      <ShortName>NOTE 5 - INVENTORIES - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details</Role>
      <ShortName>NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails</Role>
      <ShortName>NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - NOTE 7 ??? OTHER INTANGIBLE ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative</Role>
      <ShortName>NOTE 7 ??? OTHER INTANGIBLE ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note7OtherIntangibleAssetsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details</Role>
      <ShortName>NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details</Role>
      <ShortName>NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - NOTE 10 ??? SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note10SupplementalCashFlowInformationDetailsNarrative</Role>
      <ShortName>NOTE 10 ??? SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note10SupplementalCashFlowInformation</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - NOTE 11 ??? COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>NOTE 11 ??? COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note11CommitmentsAndContingencies</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - NOTE 12 - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative</Role>
      <ShortName>NOTE 12 - INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note12-IncomeTaxes</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails</Role>
      <ShortName>NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - NOTE 13 - ACQUISITION - Net assets acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails</Role>
      <ShortName>NOTE 13 - ACQUISITION - Net assets acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="fonar_10-q.htm">fonar_10-q.htm</File>
    <File>fonar_exhibit-31.htm</File>
    <File>fonar_exhibit-32.htm</File>
    <File>fonr-20210930.xsd</File>
    <File>fonr-20210930_cal.xml</File>
    <File>fonr-20210930_def.xml</File>
    <File>fonr-20210930_lab.xml</File>
    <File>fonr-20210930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fonar-logo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>66
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "fonar_10-q.htm": {
   "axisCustom": 0,
   "axisStandard": 8,
   "contextCount": 89,
   "dts": {
    "calculationLink": {
     "local": [
      "fonr-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fonr-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "fonar_10-q.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fonr-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fonr-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "fonr-20210930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 363,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 37,
    "http://fonar.com/20210930": 10,
    "http://xbrl.sec.gov/dei/2021": 7,
    "total": 54
   },
   "keyCustom": 54,
   "keyStandard": 270,
   "memberCustom": 10,
   "memberStandard": 14,
   "nsprefix": "FONR",
   "nsuri": "http://fonar.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://fonar.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - NOTE 4 \u2013 OPERATING & FINANCING LEASES",
     "role": "http://fonar.com/role/Note4OperatingFinancingLeases",
     "shortName": "NOTE 4 \u2013 OPERATING & FINANCING LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - NOTE 5 - INVENTORIES",
     "role": "http://fonar.com/role/Note5-Inventories",
     "shortName": "NOTE 5 - INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - NOTE 6 \u2013 CONTRACT ASSETS AND LIABILITIES",
     "role": "http://fonar.com/role/Note6ContractAssetsAndLiabilities",
     "shortName": "NOTE 6 \u2013 CONTRACT ASSETS AND LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - NOTE 7 \u2013 OTHER INTANGIBLE ASSETS",
     "role": "http://fonar.com/role/Note7OtherIntangibleAssets",
     "shortName": "NOTE 7 \u2013 OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - NOTE 8 \u2013 OTHER CURRENT LIABILITIES",
     "role": "http://fonar.com/role/Note8OtherCurrentLiabilities",
     "shortName": "NOTE 8 \u2013 OTHER CURRENT LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION",
     "role": "http://fonar.com/role/Note9-SegmentAndRelatedInformation",
     "shortName": "NOTE 9 - SEGMENT AND RELATED INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - NOTE 10 \u2013 SUPPLEMENTAL CASH FLOW INFORMATION",
     "role": "http://fonar.com/role/Note10SupplementalCashFlowInformation",
     "shortName": "NOTE 10 \u2013 SUPPLEMENTAL CASH FLOW INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - NOTE 11 \u2013 COMMITMENTS AND CONTINGENCIES",
     "role": "http://fonar.com/role/Note11CommitmentsAndContingencies",
     "shortName": "NOTE 11 \u2013 COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - NOTE 12 - INCOME TAXES",
     "role": "http://fonar.com/role/Note12-IncomeTaxes",
     "shortName": "NOTE 12 - INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - NOTE 13 \u2013 ACQUISITION",
     "role": "http://fonar.com/role/Note13Acquisition",
     "shortName": "NOTE 13 \u2013 ACQUISITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "role": "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - NOTE 14 \u2013 SUBSEQUENT EVENTS",
     "role": "http://fonar.com/role/Note14SubsequentEvents",
     "shortName": "NOTE 14 \u2013 SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "role": "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables",
     "shortName": "NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - NOTE 4 \u2013 OPERATING & FINANCING LEASES (Tables)",
     "role": "http://fonar.com/role/Note4OperatingFinancingLeasesTables",
     "shortName": "NOTE 4 \u2013 OPERATING & FINANCING LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - NOTE 5 - INVENTORIES (Tables)",
     "role": "http://fonar.com/role/Note5-InventoriesTables",
     "shortName": "NOTE 5 - INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - NOTE 6 \u2013 CONTRACT ASSETS AND LIABILITIES (Tables)",
     "role": "http://fonar.com/role/Note6ContractAssetsAndLiabilitiesTables",
     "shortName": "NOTE 6 \u2013 CONTRACT ASSETS AND LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - NOTE 7 \u2013 OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://fonar.com/role/Note7OtherIntangibleAssetsTables",
     "shortName": "NOTE 7 \u2013 OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - NOTE 8 \u2013 OTHER CURRENT LIABILITIES (Tables)",
     "role": "http://fonar.com/role/Note8OtherCurrentLiabilitiesTables",
     "shortName": "NOTE 8 \u2013 OTHER CURRENT LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION (Tables)",
     "role": "http://fonar.com/role/Note9-SegmentAndRelatedInformationTables",
     "shortName": "NOTE 9 - SEGMENT AND RELATED INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:TreasuryStockShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "role": "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:TreasuryStockShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - NOTE 13 \u2013 ACQUISITION (Tables)",
     "role": "http://fonar.com/role/Note13AcquisitionTables",
     "shortName": "NOTE 13 \u2013 ACQUISITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2015-07-01_custom_HDMMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - NOTE 1 \u2013 DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "role": "http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
     "shortName": "NOTE 1 \u2013 DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2015-07-01_custom_HDMMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)",
     "role": "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
     "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-012021-09-30_us-gaap_CommonStockMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "role": "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:AccountsReceivableServiceAndRepairFees",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "role": "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
     "shortName": "NOTE 3 -  ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "lang": null,
      "name": "FONR:AccountsReceivableNetRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractReceivableDueOneToTwoYears",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)",
     "role": "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails",
     "shortName": "NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractReceivableDueOneToTwoYears",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfPatientFeeRevenueTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "role": "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails",
     "shortName": "NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfPatientFeeRevenueTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "role": "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative",
     "shortName": "NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - NOTE 4 - OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "role": "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails",
     "shortName": "NOTE 4 - OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - NOTE 4 \u2013 OPERATING & FINANCING LEASES (Details Narrative)",
     "role": "http://fonar.com/role/Note4OperatingFinancingLeasesDetailsNarrative",
     "shortName": "NOTE 4 \u2013 OPERATING & FINANCING LEASES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherInventorySupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)",
     "role": "http://fonar.com/role/Note5-Inventories-InventoriesDetails",
     "shortName": "NOTE 5 - INVENTORIES - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherInventorySupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
       "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:CostsIncurredOnUncompletedContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)",
     "role": "http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details",
     "shortName": "NOTE 6 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
       "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:CostsIncurredOnUncompletedContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)",
     "role": "http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
     "shortName": "NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-012021-09-30_custom_PatentsAndCopyrightsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - NOTE 7 \u2013 OTHER INTANGIBLE ASSETS (Details Narrative)",
     "role": "http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative",
     "shortName": "NOTE 7 \u2013 OTHER INTANGIBLE ASSETS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-012021-09-30_custom_PatentsAndCopyrightsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "role": "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details",
     "shortName": "NOTE 8 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:NetRevenuesFromExternalCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "role": "http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details",
     "shortName": "NOTE 9 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:NetRevenuesFromExternalCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - NOTE 10 \u2013 SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "role": "http://fonar.com/role/Note10SupplementalCashFlowInformationDetailsNarrative",
     "shortName": "NOTE 10 \u2013 SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:LitigationSettelementDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - NOTE 11 \u2013 COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "role": "http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "NOTE 11 \u2013 COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:LitigationSettelementDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - NOTE 12 - INCOME TAXES (Details Narrative)",
     "role": "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative",
     "shortName": "NOTE 12 - INCOME TAXES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details)",
     "role": "http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails",
     "shortName": "NOTE 13 - ACQUISITION - Fair value assets and assumed liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-03-29_custom_RocklandManagementGroupMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2020-06-30_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)",
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2020-06-30_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - NOTE 13 - ACQUISITION - Net assets acquired (Details)",
     "role": "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails",
     "shortName": "NOTE 13 - ACQUISITION - Net assets acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-03-29_custom_RocklandManagementGroupMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:LeaseholdImprovementsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - NOTE 1 \u2013 DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "role": "http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentation",
     "shortName": "NOTE 1 \u2013 DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies",
     "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "role": "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable",
     "shortName": "NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 25,
   "tag": {
    "FONR_AccountReceivableRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable from service and repair fees of Related MRI scanner customers; net of allowances for doubtful accounts.",
        "label": "Accounts receivable - related party"
       }
      }
     },
     "localname": "AccountReceivableRelatedParties",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsReceivableNetLongTerm": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 long term"
       }
      }
     },
     "localname": "AccountsReceivableNetLongTerm",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsReceivableNetRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts",
        "label": "Accounts receivable - Related party"
       }
      }
     },
     "localname": "AccountsReceivableNetRelatedParty",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsReceivableServiceAndRepairFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable - net - Current from service and repair fees of Non Related MRI scanner customers; net of allowances for doubtful accounts.",
        "label": "Accounts receivable \u2013 net",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableServiceAndRepairFees",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_BillingsToDate": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": 2.0,
       "parentTag": "FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount within current period that has been billed to customer.",
        "label": "Less: Billings to date",
        "negatedLabel": "Less: Billings to date"
       }
      }
     },
     "localname": "BillingsToDate",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right to use assets.",
        "label": "Right to use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightToUseAssets",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ClassANonVotingPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class A Non Voting Preferred Stock Member",
        "label": "Class A Non Voting Preferred Stock [Member]"
       }
      }
     },
     "localname": "ClassANonVotingPreferredStockMember",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ClosingCostsExpensed": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing Costs Expensed.",
        "label": "Closing costs - expensed"
       }
      }
     },
     "localname": "ClosingCostsExpensed",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CommercialInsuranceManagedCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Insurance Managed Care Member",
        "label": "Commercial Insurance / Managed Care"
       }
      }
     },
     "localname": "CommercialInsuranceManagedCareMember",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ConvertibleClassCStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Class C Stock"
       }
      }
     },
     "localname": "ConvertibleClassCStock",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_CostsAndEstimatedEarningsOnUncompletedContracts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": 1.0,
       "parentTag": "FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs and estimated earnings on uncompleted contracts.",
        "label": "Management and other fees - related medical practices - net",
        "totalLabel": "Costs and estimated earnings on uncompleted contracts"
       }
      }
     },
     "localname": "CostsAndEstimatedEarningsOnUncompletedContracts",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsIncurredOnUncompletedContracts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": 1.0,
       "parentTag": "FONR_CostsAndEstimatedEarningsOnUncompletedContracts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs incurred on uncompleted contracts"
       }
      }
     },
     "localname": "CostsIncurredOnUncompletedContracts",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToManagementAndOtherFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees"
       }
      }
     },
     "localname": "CostsRelatedToManagementAndOtherFees",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs related To Management and other fees - Related medical practices",
        "label": "Costs related to management and other fees \u2013 related medical practices"
       }
      }
     },
     "localname": "CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToProductSales": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to product sales"
       }
      }
     },
     "localname": "CostsRelatedToProductSales",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToServiceAndRepairFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees"
       }
      }
     },
     "localname": "CostsRelatedToServiceAndRepairFees",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToServiceAndRepairFeesRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees - related parties"
       }
      }
     },
     "localname": "CostsRelatedToServiceAndRepairFeesRelatedParties",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CovenantNotToCompete": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covenant not to compete.",
        "label": "Covenant Not to Compete"
       }
      }
     },
     "localname": "CovenantNotToCompete",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CustomerDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits"
       }
      }
     },
     "localname": "CustomerDeposits",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_DiagnosticEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic Equipment.",
        "label": "Diagnostic Equipment"
       }
      }
     },
     "localname": "DiagnosticEquipment",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_DisclosureNote4OperatingFinancingLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 4 Operating Financing Leases",
        "verboseLabel": "Note 4 - Operating Financing Leases - Lease Payments"
       }
      }
     },
     "localname": "DisclosureNote4OperatingFinancingLeasesAbstract",
     "nsuri": "http://fonar.com/20210930",
     "xbrltype": "stringItemType"
    },
    "FONR_EstimatedEarnings": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": 2.0,
       "parentTag": "FONR_CostsAndEstimatedEarningsOnUncompletedContracts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated Earnings on uncompleted contracts.",
        "label": "Estimated earnings"
       }
      }
     },
     "localname": "EstimatedEarnings",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_GainOnForgivenessOfPppLoan": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "GainOnForgivenessOfPppLoan",
        "negatedLabel": "Gain on forgiveness of PPP loan"
       }
      }
     },
     "localname": "GainOnForgivenessOfPppLoan",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_HDMMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HDM Member",
        "label": "H D M [Member]"
       }
      }
     },
     "localname": "HDMMember",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name Health Management Company of America.",
        "label": "The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"
       }
      }
     },
     "localname": "HmcaOwnershipSizeOfImperialManagementServicesPercent",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_IncreaseDecreaseInCustomerAdvance": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer advances"
       }
      }
     },
     "localname": "IncreaseDecreaseInCustomerAdvance",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IncreaseDecreaseInFinancingLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInFinancingLiabilities",
        "negatedLabel": "Financing lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInFinancingLiabilities",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IntersegmentNetRevenues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inter-segment net revenues"
       }
      }
     },
     "localname": "IntersegmentNetRevenues",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconcilliation of operating and financing lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note4OperatingFinancingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_LitigationSettelementDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description related to litigation settelement.",
        "label": "Litigation settelement description"
       }
      }
     },
     "localname": "LitigationSettelementDescription",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "FONR_ManagementAndOtherFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable - net"
       }
      }
     },
     "localname": "ManagementAndOtherFees",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherFeesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees \u2013 net"
       }
      }
     },
     "localname": "ManagementAndOtherFeesNet",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees - related medical practices \u2013 net"
       }
      }
     },
     "localname": "ManagementAndOtherFeesRelatedMedicalPracticesNet",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherFees_NonRelatedParties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management and other fees receivable from MRI Centers owned by non-related parties - net of allowances for doubtful accounts.",
        "label": "Management and other fees receivable"
       }
      }
     },
     "localname": "ManagementAndOtherFees_NonRelatedParties",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementOfDiagnosticImagingCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management of Diagnostic Imaging Centers - Member - Custom element",
        "label": "Management Of Diagnostic Imaging Centers"
       }
      }
     },
     "localname": "ManagementOfDiagnosticImagingCentersMember",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management of, and other fees receivable from MRI Centers owned by related parties - net of allowances for doubtful accounts.",
        "label": "Management and other fees receivable \u2013 related medical practices \u2013 net",
        "verboseLabel": "Management and other fees receivable from related medical practices (\"PC's\")"
       }
      }
     },
     "localname": "ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.",
        "label": "Maximum limit for individual claims under stop-loss umbrella policy for health insurances"
       }
      }
     },
     "localname": "MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_MedicalEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical equipment - Member - Custom element",
        "label": "Medical Equipment"
       }
      }
     },
     "localname": "MedicalEquipmentMember",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_MedicalReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical receivable \u2013 net",
        "verboseLabel": "Medical Receivables"
       }
      }
     },
     "localname": "MedicalReceivable",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_MedicareMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Medicaid",
        "label": "Medicare/Medicaid"
       }
      }
     },
     "localname": "MedicareMedicaidMember",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_NetRevenuesFromExternalCustomers": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances.",
        "label": "Net revenues from external customers"
       }
      }
     },
     "localname": "NetRevenuesFromExternalCustomers",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_OtherRevenueSourceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Revenue Source",
        "label": "Other"
       }
      }
     },
     "localname": "OtherRevenueSourceMember",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name Health Management Company of America.",
        "label": "The ownership interest of the original investors of HDM after reorganization of newly expanded HDM"
       }
      }
     },
     "localname": "OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name Health Management Company of America.",
        "label": "The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"
       }
      }
     },
     "localname": "OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PatentsAndCopyrightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents and copyrights - Member - Custom elements",
        "label": "Patents and copyrights"
       }
      }
     },
     "localname": "PatentsAndCopyrightsMember",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Patient fee revenue, net of contractual allowances and discounts"
       }
      }
     },
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscount",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Patient fee revenue \u2013 net of contractual allowances and discounts"
       }
      }
     },
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PercentageOfConsolidatedNetRevenueFromManagementFees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of consolidated net revenue from management fees.",
        "label": "Percentage of consolidated net revenue from management fees charged to related party medical practices"
       }
      }
     },
     "localname": "PercentageOfConsolidatedNetRevenueFromManagementFees",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of PCs net revenue derived from nofault and personal injury protection claims.",
        "label": "Percentage of PC's net revenue derived from no-fault and personal injury protection claim"
       }
      }
     },
     "localname": "PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PresentValueDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value discount.",
        "label": "PresentValueDiscount",
        "negatedLabel": "Operating Lease Payments Present Value discount"
       }
      }
     },
     "localname": "PresentValueDiscount",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PresentValueDiscountFinancingLease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value discount financing lease.",
        "label": "PresentValueDiscountFinancingLease",
        "negatedLabel": "Financing Lease Payments Present Value discount"
       }
      }
     },
     "localname": "PresentValueDiscountFinancingLease",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ProductSalesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Product sales \u2013 net"
       }
      }
     },
     "localname": "ProductSalesNet",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ProvisionForBadDebts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision (Recovery) for bad debts"
       }
      }
     },
     "localname": "ProvisionForBadDebts",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of reimbursement of alternative minimum tax credits.",
        "label": "Reimbursement of alternative minimum tax credits description"
       }
      }
     },
     "localname": "ReimbursementOfAlternativeMinimumTaxCreditsDescription",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "FONR_RightToUseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to use liability.",
        "label": "Right to use liability"
       }
      }
     },
     "localname": "RightToUseLiability",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_RocklandManagementGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rockland Management Group [Member]"
       }
      }
     },
     "localname": "RocklandManagementGroupMember",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails",
      "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ScheduleOfPatientFeeRevenueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of patient fee revenue"
       }
      }
     },
     "localname": "ScheduleOfPatientFeeRevenueTableTextBlock",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_ServiceAndRepairFeesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees \u2013 net"
       }
      }
     },
     "localname": "ServiceAndRepairFeesNet",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ServiceAndRepairFeesRelatedPartiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees - related parties \u2013 net"
       }
      }
     },
     "localname": "ServiceAndRepairFeesRelatedPartiesNet",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_StateIncomeTaxesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "State income taxes payable"
       }
      }
     },
     "localname": "StateIncomeTaxesPayable",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings, net of current billings in excess of costs and estimated earnings on uncompleted contracts",
        "label": "TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet",
        "totalLabel": "Total costs and estimated earnings in excess of billings on uncompleted contracts"
       }
      }
     },
     "localname": "TotalCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContractsNet",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note6-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_TotalFacilitiesOwnedOrManagedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Facilities"
       }
      }
     },
     "localname": "TotalFacilitiesOwnedOrManagedTableTextBlock",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_TotalPurchaseConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total purchase consideration"
       }
      }
     },
     "localname": "TotalPurchaseConsideration",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_UnearnedRevenueOnServiceContractsRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue on service contracts \u2013 related party"
       }
      }
     },
     "localname": "UnearnedRevenueOnServiceContractsRelatedParties",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_WorkersCompensationPersonalInjuryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workers Compensation Personal Injury",
        "label": "Workers Compensation/Personal Injury"
       }
      }
     },
     "localname": "WorkersCompensationPersonalInjuryMember",
     "nsuri": "http://fonar.com/20210930",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r340",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "NOTE 8 \u2013 OTHER CURRENT LIABILITIES"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8OtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r36",
      "r285"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accounts payable to related parties, due after one year or beyond the normal operating cycle, if longer.",
        "label": "Due to related medical practices"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms": {
     "auth_ref": [
      "r289"
     ],
     "calculation": {
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.",
        "label": "Construction Contractor, Receivable, Excluding Contract Retainage",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccountsReceivableBilledForLongTermContractsOrPrograms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r38"
     ],
     "calculation": {
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Legal and other professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r302",
      "r317"
     ],
     "calculation": {
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Accounting fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r38"
     ],
     "calculation": {
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued salaries, commissions and payroll taxes"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r24",
      "r214",
      "r285"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Paid-in capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r211",
      "r212",
      "r213",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r77",
      "r170",
      "r176"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r90",
      "r136",
      "r141",
      "r148",
      "r161",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r253",
      "r259",
      "r267",
      "r283",
      "r285",
      "r297",
      "r312"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r49",
      "r90",
      "r161",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r253",
      "r259",
      "r267",
      "r283",
      "r285"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r209",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails",
      "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r209",
      "r210",
      "r241",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails",
      "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails",
      "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredOther1": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.",
        "label": "Cash Consideration Paid"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredOther1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "NOTE 13 \u2013 ACQUISITION"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13Acquisition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r243",
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r243",
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combination"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r94",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "NOTE 1 \u2013 DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r81",
      "r82",
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r35",
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and Cash Equivalents - End of Period",
        "periodStartLabel": "Cash and Cash Equivalents - Beginning of Period"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r73",
      "r268"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net (Decrease) Increase in Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "NOTE 10 \u2013 SUPPLEMENTAL CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10SupplementalCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r89",
      "r90",
      "r110",
      "r111",
      "r114",
      "r116",
      "r118",
      "r124",
      "r125",
      "r126",
      "r161",
      "r187",
      "r191",
      "r192",
      "r193",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r267",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "NOTE 11 \u2013 COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation.",
        "label": "Common Class C [Member]"
       }
      }
     },
     "localname": "CommonClassCMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r95",
      "r96",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r23",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23",
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r86",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractReceivableDueFourToFiveYears": {
     "auth_ref": [
      "r288"
     ],
     "calculation": {
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "ContractReceivableDueFourToFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractReceivableDueOneToTwoYears": {
     "auth_ref": [
      "r288"
     ],
     "calculation": {
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2022"
       }
      }
     },
     "localname": "ContractReceivableDueOneToTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractReceivableDueThreeToFourYears": {
     "auth_ref": [
      "r288"
     ],
     "calculation": {
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "ContractReceivableDueThreeToFourYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractReceivableDueTwoToThreeYears": {
     "auth_ref": [
      "r288"
     ],
     "calculation": {
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "ContractReceivableDueTwoToThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r206",
      "r207",
      "r208"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total Costs and Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COSTS AND EXPENSES"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-term contract or program.",
        "label": "Costs and Estimated Earnings on Uncompleted Contracts"
       }
      }
     },
     "localname": "CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note6ContractAssetsAndLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r91",
      "r225",
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Income tax component - current"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r91",
      "r226",
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Income tax component - deferred"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r77",
      "r91",
      "r226",
      "r232",
      "r233",
      "r234"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred income tax \u2013 net"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.",
        "label": "Deferred income tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Unearned revenue on service contracts"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "verboseLabel": "Unearned revenue on service contracts"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r223",
      "r224"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred income tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r220"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.",
        "label": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r77",
      "r134"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DoubtfulMember": {
     "auth_ref": [
      "r158",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A category of financing receivables that have all the weaknesses inherent in those classified as substandard, with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable.",
        "label": "Doubtful [Member]"
       }
      }
     },
     "localname": "DoubtfulMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r59",
      "r100",
      "r101",
      "r102",
      "r103",
      "r104",
      "r108",
      "r110",
      "r116",
      "r117",
      "r118",
      "r121",
      "r122",
      "r265",
      "r266",
      "r306",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic Net Income Per Common Share Available to Common Stockholders",
        "verboseLabel": "Basic income per common share"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Basic and Diluted Income Per Share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r59",
      "r100",
      "r101",
      "r102",
      "r103",
      "r104",
      "r110",
      "r116",
      "r117",
      "r118",
      "r121",
      "r122",
      "r265",
      "r266",
      "r306",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted Net Income Per Common Share Available to Common Stockholders",
        "verboseLabel": "Diluted income per common share"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r119",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r52",
      "r53",
      "r54",
      "r95",
      "r96",
      "r97",
      "r99",
      "r105",
      "r107",
      "r123",
      "r162",
      "r202",
      "r203",
      "r211",
      "r212",
      "r213",
      "r228",
      "r229",
      "r264",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r322",
      "r323",
      "r324",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r278"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Financing lease liability \u2013 current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r278"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Financing lease liability \u2013 net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Financing Lease Payments Total lease liability"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Financing Lease Payments Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Financing Lease Payments 2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Financing Lease Payments 2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Financing Lease Payments 2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Financing Lease Payments 2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Financing Lease Payments 2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r277"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Right-of-use Asset \u2013 financing lease"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedCustomerListsGross": {
     "auth_ref": [
      "r175"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of an asset comprised of customer information, acquired in a business combination or other transaction, having a finite beneficial life.",
        "label": "Customer Lists"
       }
      }
     },
     "localname": "FiniteLivedCustomerListsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r175"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Less: Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r171",
      "r172",
      "r175",
      "r177",
      "r292",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r175",
      "r293"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Gross other intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r171",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r166",
      "r167",
      "r285",
      "r295"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails",
      "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Axis]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations."
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r61",
      "r78",
      "r100",
      "r101",
      "r102",
      "r103",
      "r115",
      "r118",
      "r251"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "(Loss) Income from operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r57",
      "r136",
      "r140",
      "r144",
      "r147",
      "r150",
      "r294",
      "r304",
      "r308",
      "r320"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income Before Provision for Income Taxes and Noncontrolling Interests"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).",
        "label": "Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net",
        "totalLabel": "Income From Operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxCreditsAndAdjustments": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A credit or adjustment for government or taxing authority authorized decrease in taxes owed as a result of meeting certain tax policy conditions.",
        "label": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxCreditsAndAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r92",
      "r217",
      "r219",
      "r221",
      "r230",
      "r235",
      "r237",
      "r238",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "NOTE 12 - INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r93",
      "r106",
      "r107",
      "r135",
      "r216",
      "r231",
      "r236",
      "r321"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.",
        "label": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r74",
      "r80"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts, medical and management fee receivable(s)"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in intangible assets (for example patents and licenses).",
        "label": "Increase (Decrease) in Intangible Assets, Current",
        "negatedLabel": "Abandoned patents"
       }
      }
     },
     "localname": "IncreaseDecreaseInIntangibleAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Increase) decrease in operating assets, net:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilities": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in operating liabilities, net:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Notes receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "auth_ref": [
      "r112",
      "r113",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.",
        "label": "Shares included upon conversion of Class C Common to calculate a diluted EPS"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "NOTE 7 \u2013 OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7OtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r169",
      "r173"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Other intangible assets \u2013 net",
        "verboseLabel": "Other intangible assets-net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r55",
      "r133",
      "r275",
      "r276",
      "r307"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest paid"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "NOTE 5 - INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note5-Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsAndWorkInProcess": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://fonar.com/role/Note5-Inventories-InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.",
        "label": "Inventories",
        "totalLabel": "TOTAL INVENTORIES"
       }
      }
     },
     "localname": "InventoryFinishedGoodsAndWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/Note5-Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://fonar.com/role/Note5-Inventories-InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note5-Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r65",
      "r66"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r6",
      "r180"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Operating Lease Payments Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Operating Lease Payments 2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Operating Lease Payments 2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Operating Lease Payments 2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Operating Lease Payments 2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Operating Lease Payments 2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "NOTE 4 \u2013 OPERATING &amp; FINANCING LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4OperatingFinancingLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r37",
      "r90",
      "r142",
      "r161",
      "r187",
      "r188",
      "r189",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r254",
      "r259",
      "r260",
      "r267",
      "r283",
      "r284"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r28",
      "r90",
      "r161",
      "r267",
      "r285",
      "r299",
      "r315"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r39",
      "r90",
      "r161",
      "r187",
      "r188",
      "r189",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r254",
      "r259",
      "r260",
      "r267",
      "r283",
      "r284",
      "r285"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r19",
      "r20",
      "r90",
      "r161",
      "r187",
      "r188",
      "r189",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r254",
      "r259",
      "r260",
      "r267",
      "r283",
      "r284"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total Long-Term Liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term debt and capital leases, less current portion"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Current portion of long-term debt and capital leases"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r44",
      "r90",
      "r161",
      "r187",
      "r191",
      "r192",
      "r193",
      "r196",
      "r197",
      "r267",
      "r298",
      "r314"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r203"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions - Non controlling"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r73",
      "r75",
      "r78"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r50",
      "r51",
      "r54",
      "r58",
      "r78",
      "r90",
      "r98",
      "r100",
      "r101",
      "r102",
      "r103",
      "r106",
      "r107",
      "r115",
      "r136",
      "r140",
      "r144",
      "r147",
      "r150",
      "r161",
      "r187",
      "r188",
      "r189",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r266",
      "r267",
      "r305",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income - Attributable to FONAR",
        "terseLabel": "Basic Numerator: Net income available to common stockholders",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r50",
      "r51",
      "r54",
      "r106",
      "r107",
      "r257",
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Income - Non controlling interests",
        "negatedLabel": "Net Income - Noncontrolling Interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r203",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r278"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease Payments Total lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r278"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease liability \u2013 current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r278"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease liability \u2013 net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r279",
      "r280"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating lease payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4OperatingFinancingLeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r277"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Right-of-use Asset \u2013 operating lease"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Amortization on right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r222"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r38"
     ],
     "calculation": {
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Litigation accruals"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Accrued interest and penalty"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r17",
      "r296",
      "r311"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities.",
        "label": "Costs related to patient fee revenue"
       }
      }
     },
     "localname": "OtherCostOfOperatingRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r63",
      "r77",
      "r179"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInventorySupplies": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://fonar.com/role/Note5-Inventories-InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.",
        "label": "Purchased parts, components and supplies"
       }
      }
     },
     "localname": "OtherInventorySupplies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note5-Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r38",
      "r285"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other current liabilities",
        "totalLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Income (Expenses)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r38",
      "r186"
     ],
     "calculation": {
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Cost of patents"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Preferred Class A [Member]"
       }
      }
     },
     "localname": "PreferredClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r22",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r22",
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock Value"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r33",
      "r34"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r50",
      "r51",
      "r54",
      "r72",
      "r90",
      "r98",
      "r106",
      "r107",
      "r136",
      "r140",
      "r144",
      "r147",
      "r150",
      "r161",
      "r187",
      "r188",
      "r189",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r252",
      "r256",
      "r258",
      "r262",
      "r263",
      "r266",
      "r267",
      "r308"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net income",
        "totalLabel": "Net Income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r15",
      "r16",
      "r181",
      "r285",
      "r309",
      "r316"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment \u2013 net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RegulatedOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Regulated Operations [Abstract]"
       }
      }
     },
     "localname": "RegulatedOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Repayment of borrowings and capital lease obligations"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r215",
      "r290",
      "r330"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r25",
      "r203",
      "r214",
      "r285",
      "r313",
      "r325",
      "r326"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r95",
      "r96",
      "r97",
      "r99",
      "r105",
      "r107",
      "r162",
      "r211",
      "r212",
      "r213",
      "r228",
      "r229",
      "r264",
      "r322",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r87",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenues"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r56",
      "r90",
      "r131",
      "r132",
      "r139",
      "r145",
      "r146",
      "r152",
      "r153",
      "r155",
      "r161",
      "r187",
      "r188",
      "r189",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r267",
      "r308"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues [Default Label]",
        "totalLabel": "Total Revenues \u2013 Net"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "REVENUES"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "auth_ref": [
      "r9",
      "r36"
     ],
     "calculation": {
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales tax payable"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r302",
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.",
        "label": "Recorded tax obligations"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8OtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r241",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails",
      "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock": {
     "auth_ref": [
      "r157",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.",
        "label": "Receivables - Non Current - net"
       }
      }
     },
     "localname": "ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative assets at fair value.",
        "label": "Fair value assets and assumed liabilities"
       }
      }
     },
     "localname": "ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13AcquisitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r171",
      "r174",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note7OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Other Intagible Assets - Net"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7OtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r11",
      "r30",
      "r31",
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note5-InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Net assets acquired"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13AcquisitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for detailed information about regulatory assets and liabilities, including current and noncurrent assets created when regulatory agencies permit the deferral of costs to the balance sheet that would otherwise be required to appear on the company's income statement and would be charged against current expenses or revenues, as well as current and noncurrent liabilities created when regulatory agencies permit.",
        "label": "NOTE 6 \u2013 CONTRACT ASSETS AND LIABILITIES"
       }
      }
     },
     "localname": "ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note6ContractAssetsAndLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r136",
      "r137",
      "r143",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Suuummarrized Segment Financial Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-SegmentAndRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecurityDeposit": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
        "label": "Security Deposit"
       }
      }
     },
     "localname": "SecurityDeposit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-Acquisition-FairValueAssetsAndAssumedLiabilitiesDetails",
      "http://fonar.com/role/Note13-Acquisition-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations."
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r136",
      "r138",
      "r144",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r154",
      "r155",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "NOTE 9 - SEGMENT AND RELATED INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-SegmentAndRelatedInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self-funded health insurance reserve"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11CommitmentsAndContingenciesDetailsNarrative",
      "http://fonar.com/role/Note8-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 8.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r18",
      "r300",
      "r301",
      "r310"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r85",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r89",
      "r90",
      "r110",
      "r111",
      "r114",
      "r116",
      "r118",
      "r124",
      "r125",
      "r126",
      "r161",
      "r187",
      "r191",
      "r192",
      "r193",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r267",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r42",
      "r52",
      "r53",
      "r54",
      "r95",
      "r96",
      "r97",
      "r99",
      "r105",
      "r107",
      "r123",
      "r162",
      "r202",
      "r203",
      "r211",
      "r212",
      "r213",
      "r228",
      "r229",
      "r264",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r322",
      "r323",
      "r324",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails",
      "http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r123",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/Note1DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails",
      "http://fonar.com/role/Note9-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r26",
      "r27",
      "r90",
      "r159",
      "r161",
      "r267",
      "r285"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Fonar Corporation\u2019s Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r53",
      "r90",
      "r95",
      "r96",
      "r97",
      "r99",
      "r105",
      "r161",
      "r162",
      "r203",
      "r211",
      "r212",
      "r213",
      "r228",
      "r229",
      "r249",
      "r250",
      "r261",
      "r264",
      "r267",
      "r269",
      "r270",
      "r274",
      "r323",
      "r324",
      "r351"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Total Stockholders\u2019 Equity",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r286",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "NOTE 14 \u2013 SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note14SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r41",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r41",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r41",
      "r204",
      "r205"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost - 12 shares of common stock at September 30, 2021 and June 30, 2021"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r109",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Diluted Shares Outstanding - Common Stockholders",
        "verboseLabel": "Total Denominator for diluted earnings per share"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Basic and Diluted Shares Outstanding Class C Common"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r108",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Basic Denominator: Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2029-109256"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613673-111683"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r331": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r332": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r333": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r334": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r335": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r336": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r337": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r338": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r339": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r341": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r342": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r343": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r344": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r345": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r346": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r347": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r348": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r349": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1),(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>67
<FILENAME>0000355019-21-000044-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000355019-21-000044-xbrl.zip
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MN]CI6OZA[A G(PE%56/[&*E;9A'B*N(#-K7^"0]$4C2-UIV56+TX/7D-SCK
M5_'=_&;'A#!(Z?O5ZREX8\?Z!\^-3^MX7;,ZZG+VNA#^O'/> FC4[OQFU10;
M$I.F$4QUF;/ISM,*X<^?-F3-:FZ1WC!L<&C.R9.#,L9,-=RO"@O A?ATP]T
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M%8[TJG>*./<^,/D6B/Z]J'C.[!OW)3O^-O6;/3Q%&]&&O2ZI-'>&OY/#Q.K
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MHEUW"#U6817X(/VS6J;<R9>E*BC,'O1C$2RW,U_<!_JQ0HV4L :W?6>JD-%
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M=^7X/NMM(V/OVB85FH[T&=ZX]V4Q'/M)B^\V;H/F;K\OBW$O7B^LW&)_OD*
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M/GEC&^LZ#XB..@Q(1FF"P?-^1>0>9$731;X^Y!X0]\L0]RHX$8UU(+A<\X4
M[H@=^$1S14QS1=8$;@<2T5QQUES1 ]QB?2:=3!5MF+45_DGB9&'!UJ^J,AZ=
M!K)*8TV4(7+3>:2*-*-CW1*2=@X]W+48/$-^K\6DYPX3P4/T\+#N!J6/<8.6
M8?1V93)&(;&!H7NVLH&$H=$(#GX1-263HO/7Z!K[8?97JZ_ 3]OR?'; J5#;
M^@J+"<9%1[\#T=?:\AX!V1[!@;?XWL9XB&V4HFXB\  >K-/H]-2EEU:@K Q%
M>=]K]_-E_;U.#[:_7^&""X:VT&OV3-D(_>ARPCY?B9-K- ZSU !_9'PR@)Q@
M"-WG*T0?^A?_^3P"FCZ5D(X9<BKR JX!=?'E\]7(^/KS?Y))4!.A)%R#]EB"
MR1:2;9!,?OF,'F#?A[&>Y"3Q =TKP;[^"9A/2NK*Z!K0]&CQ24_1D9J\!NF1
M?K'RC)ZB(M+,.TH2QS^!U$@'FB*)PB=@?6G?;'Y/+[[O(WE+:N(,7@/C9:^B
MH _0SQ3U#WJ+-N)D^S7+5U+X4O,#_.4UD!5UR$G69Z\0K_/9'UY\^;__A\Y1
MGSY?X:=],?EG_;W$HJL5'FWGKB\DC=9>B.]!SRR,]"OS#L"H(B<EP V47B#R
M^K@$8#E92[)(A_7M*4($?@++,\H;3J%G1->:[3M$I?$P#/R),.D6J5P7"E!,
M)BL*/\;J'_=MZ?)8#5-YBNYVC9^*R+V?-36UT:[EA?*K@&A"H)85V5  (@\L
MO=N&_?74AJXL(ML+('/8I*(77B^_[^(+325_&(*R>.:7.7O-?X*<N4RT9HZM
MEN_;]4Z]RKY_QS0JH/J[?,,TOE9!N7EW5V?9>K.Q;T2T5R/:]H*47RRSV6 P
M;>>S+[[\XK0!BJ9T14Z\?U>Y+%^"%)7-%$^,.0OAS:X)[X\Q<K"@*DW;<*2H
MNK,<T_?3<C[3'/^HY"Z.9?21XM_'+]#_O1 G^G5/422(X@-U#)WTPMI0L.06
M\YG<IVU:XBVP,97"CWNFW:FV;_^\?]>NMIKM#KAO5*IM@*2O@R0,T&G0; ,Z
M^T'X")HUT+FI@H5@+F22*7<LFH!'XM^LO7]'%].9?3#V"V6E=1.AHF>)9F'E
M=IC]K-=S-T^SM'J3OW@[#[P#7)^3-$?$K0_+@EQF*^2\4R?&GS1]F<4\V9P2
MZS-1Q@'F-4A2EUE1]MB9J2GJ^W?Z ()G6_" &6$!%(!! :R#@ED#1<NXN&H&
M:\Z(X%^?M%]LGK]_R7HRH0).OZ'[!@(WG4(4/<A.T[I"&+:EK4[UKH3D.DTE
M '[T'K\C]%GVW6IY R/<7TO4<-[B_;N^*$$@CXUTQC9M4C72"C5T9<.XT!DS
MZ>_I7#.CM7XA8_5VIW/]G1=?J"1-I3*%P##@ZQ2X<VX/)-J,#*F-0-+?H7P6
MAP] 4WGC&9R:E)0'Y?)Q]' !. F)_]RB#*S[TM1H,@\_4Q3Z[0)<^<.02,QB
MRML092&>Z17Q;,,'4=.18=0;2(B<171,UW[^+3+U I,-S]"OR_@JX4:BE&FC
M>*F-'#NF8P1,?AOU V.$B*'P0W7"\?K[=YBQ0.D#=<Y0P&E &T$>9[H%("+P
MZ!K@!X;7\/$D9$W'#6S1JR0)?8Y;W/Y[@2"&?Q]Q@F#_OC&P/2-:RHW-$VN\
M(DG<2$-DVC_A5.1G7;6?_@)5_"3)'K^I?<V+A+44GJV9>^M9.B=?0Q)EF+2U
M)TUG_]E4!?D555"7>45%?K&Q0\Q8^BSCIL#JM*P(6S2#_I>Z956I4+UY##'2
M3&J0QTL/.ARIR@O&\ZJCZ&)X%U\$*'&X&<-6M:$+JW.RE;]OBE&WOLXG"- K
M$.APD[JUQL4;?-KEN?W,E7^\CJO5Z8],T)._/K=;Z+[X0M/)5":7H=/Y7?.*
M_E*/D$I+5R1Q8OX:9"\SV]Q^KZ'RP8#O^W>*"A3<X @\CE51$T0>#QWK\L\]
M%3E'2'4O01[@JY=Z)GV,"K+#8V/]LGW)7KY_5QV.)&6*0QF3;ZM8 @WE\F.<
MX;*'_^<RW9MT'3F1^U2QY0=DLL@->/MH%[JZLJ*K&4%0\8X!\Y];=#OMK*>?
M?OV2"_F_&>V'%+:>=J 9ZV@*W'$J/]9 115?MEG@C3Q#RHD=9?1C4^THK[(3
M,R(R_@61%U_NT M%2=KJ=[P%\8G-U<"2$],,<])46\A[0B;#T=<+SD]SINGB
M2P.^@C^*^K0OD[.N;^9>^3^!:]:P% 7E-,DM!;%>^BN.MKGS$1&.%3JQ=LAG
M3LIYLX:)O+<^&*D(V^((W0@GD!_K2/LA]PTY'E C[MD'A('W[S *'+VO*R.(
MCW$2(N)$+Q)L__?_%%)T_A."K XE.!HHLIW[3^ 00QIC?  4.W-(]@7TW&VK
MV-CN,>BR[0F%:>;Y1RGU]6E4S'B@5Y;?A_"42],?=UN/#<KM9.FM@O1)"X]\
M5T3\)_TMDTG5:I,,'X5$Z3K1%U]RQ4PR5<1;+T/*C<9)GA['&@H"IYY179=Q
M\0F.VWM3P \@\@70FY_ ZP :03Q>FUU*PGZ@/X(!IX'^YNO[W%"4IM=[]*<H
M00%PDH0>BE>[-?3O\UA4T8>Z GK07,03 "*&A6;F@$[C)(&Y 0)9)TP0^FJL
M&@4/H#KA!YS\  '#Z_AKO&,!".A;)/SXTI$*>6BH CH%C&5;#7Q ST,>(-#&
M_ !H P6GD.UE9WW Z?C&]^^61OW*K=)I+#0:=UNC^)@ G"R #RF3.SWD0Z+O
M>X]H"/AZXU)T$R;#>HY1HF]085#):3HH4D#@IMKEAKR75SRG\EA5T<WF;@'T
M1.R3CC5GV9])+R7^-\TW&]P:8K#;FQ0GR8$H"!#A"KTI)>)=I125RE]\^8,W
M?:T[L3LWQAUFW(U--:;$-)KOW\VW/(0E/&]P32)-ZX'BC<&+<#L4=1TA'=E5
M7E<5&;NMTA1 Y,).@7%@-<<;7F&%TSF U[77I'CI&:.QJHWQH]$7>+/L^W<9
M*HL%%5GRL5GW#=AD!XE..G5I?:4/1&-I9X27=EP+L[,<@RUBC-P&Q2)S+IY(
MG:R+7FUM,6(^=CQT2Q*WK$_V&C^+TM?^\Y_4 :)7,$3/#XG#F+7D[OV[1A,0
MD8N&R"&H<T!"!$' \3P2.97#<H/AJ&*KXO@I(D=..GRA(1K1#Y99PH*"V\)P
M\C1AY.71TY#AP6-_  ^J\JH/[.\OD4V%0(!]W,C!RM<[/'\KG5M?;-C%M9>^
M?V=_*<J&4D#BW$NF;.N^;-(OP8>RP4+D+WZ\OG5^O8UE=,.V;[;M/U]LS5'+
MZ+8'19WZFF@RJYH,VGCK?4[IIA6"+KXTG&;;5=#P-@/]_AV[=5[7.5I=X:AQ
MGUT_YA='MVWF=2!A[T9>+[A6M6#^_MVJ<&WPJK#"*_NVK\9-9?,>OWFVL1]U
M!RW[MZ3&02^?N@W1!A"%53;D/B!?QU#GYF:9W5KVXR5 7H>M+"U&K6&VN"K?
M^&4[H-J=_6S?*/?%F^GW- P M\OT('W97$?J1C#C@7:,!Y3B"7N,4&LG+\*K
M6:0)E+&.:[N-  !]"CGDMEMH%C5M#%4[)PAXW&T*W]'' H$B!421PC\E\"8R
MZPY>4C1H_X("$8@B\)'AW//&/BR\S?LR;MF<H"=[<^O:\E:U]:ULAVY=V[I;
M;:WBT^4ZBU$YNW4=;*/(=+W*U;LMZQB<*XL'F^L:-E7TR+OW.BVIV#Q!G,4?
M_WN1OCB&/QZG4IL+03=)1+%\0WDQ&Q6D[?J)PU?;$*30()!S-I8%#"M%O0;J
M0^]#BLHD4NE"(I7-?G1 BC4I=BU%BEJJ.<[C%5S_H&(H+Y,@UM1@(TX%+YPT
MAN"_EQ1%T5N M%A@#@0_:V_UDR<..V8V"2BL46 T<=Y<D\ZL9E8-;AM\-GL=
M+.&P*]9-/X>FJ737[NF83,Z[\1A2W>P;=^,N&4O7+#W7;(/1G66YTLWWO%28
MI#TL4ZL9Y@L9NW7O:-? +E:\L7G7&QKWPUBTKEP?P:IOABRUH.@"Y$5,#K!^
MT/Z]J#=J%P!W*3 >;C>0R"6R621P-&5[:3;A7_;,:L"P>H-6^340=>A6E?AK
M:4#)I,*<0Y=J)$"=$8ZB<*$<J(.4PTA.R^DWJ@CC@I*M(^[R^D_^6SIW?R_&
M1T<L#\&EDDABGP-)%32\CPUM06=R;O5$3)3#L2Z'SWJB3/3$47JB'(Z>*-MZ
M0M+YQWZ^_^./X.$&CT#T1-E+/9$NI!)9.GUBNB)*C@1C4M%281^J>+&7Z BW
M.J+FOXXP.Q(B%6%T6F\H\D\%+]C,9VLE_F"+Y9]YZH%_:G-1UAE6ET470_)(
MA]#I1"9=B+ .6=I@NM[.S;?L'LEZ.O-EJ1$<;@'W";#P>0QE'H_ [ =GJ*?-
MKG>K.;6EQG<K??12#GWT<D8^T)]TZVH7/02W+4BWMU:O7&_TP%OFB,V+3P#W
M6L/; KF>R'\"N##>Y%=#P4RB5_KIV7<9+0?GN+=1;[<Q7&?K"#TMV5,A]Y3L
M0:0'T LXZ96;:JL<S3DP%',YFARU4;V3"<N\<VY#>!SZPVF_8?4$PDT3WK];
MZIH </LY]K[$UBMUIEU?VB!%M@;[1G2]4:G^CAG-I]%88>';.]2OK/5K<NHN
M>LB2:XMI=]Z_JP.D1NH-IE&N,[>@WL!-.ZU^);L+<(ZFT;L08&7Y*K5M^6JC
MS&UY $$4#K68KU7O*L0,LBT$%FFG(L+ YV [@:F(TY=S6BP*G>2WXV.56N\A
M74>AZ/MW]"7R0&1.YM&E8!Z?:C'1'-O8=C@4 ITV#@Q4'+C^GQ(G(=9#=@"A
M4_AYR'26%?Q.#0H _61H26.SJ?4&8+Q"0X:"A2/=6HJW>AF"#_<R-Q9$=/E'
M8\/OM[$,ESH=6DSGS@@-WM"9#D4GS,&%NQ,-X5RF_<'70F7@W5CF*^>%41U$
M"01WBE'J435:@CK #T-NXV-J&94$@T?3F0L7@YT!G._K]!]^96-/K(:WS.+S
MN/0I06)TD)@/%XEE3AO4).4U$!RB=P'\,HT ,#H +(0+P(:B0ZVCS+WM!63>
M"$GCP;A"<PLVG?Q[ BE/Z"S&+NI;X/&NPIA!($A=@L4Q8/-=^!51X\=&;VY#
M+3$R)TTUT=!O"T1AR)DEA_B:-M3&DJD"K>,-$0Y-7)U9..D-G:EP(@AO\/5C
MC&A""@>76R,H20H^ DNS()>^!#]P8;EU@8&>I1O TAV Z2EC';=S>X(Z:(O:
M$T'4\2%IG!&%E(VN*I+&R$)+57@H+ $J<PGLKPTP+2X@:#D>+1G/T1+0B@A>
M$FEV;JKM&"Z'G $*@M,9M_"!DPQE8+0>L=4%?0F,;\#25T11G"=$L$M1XWA=
M4>?H8"X-1P-8'Q-DG"<R[C78[%L:0EL$2_>R6;T/C5VTG&26*EL9QZ7N9M@/
MN3?+E.V'$"0=CZ1P$HC>(*D"-5X51S@@;O87$%E$0Q78YXS8^7Z$RS>@+"KJ
M$I8(;LX3-V5NC#'#J5.<Y5O$.G?HC>B6/D0:9RE6)C Y3YC<*2JLR^8>>@07
M"R?92] T&LXL?440<IX(J4X&8D_4;8N3NP3V)P01YXD(%A'$Z68*;?$S08/G
M:/"VJWSDM[6[*[%)D1(;ER4V*5)B$ZD2&R>Z]I3=>"RSK@MM8EFY4FXV*M4&
M6ZW@L378YFV]PG2J%5!B;IE&N0K8FVJU$UP-44RX]H$9XJ,GM??O<-;):KDG
MRD ?*&,-?:0E )SP$$GD"*KF]X S;PGN_-6X\/*^P=Q7Z@ATIW$T;<2)7E3;
MKVV'-X?!L&R0\N[G1+@SHG;?@325[](T;?43F+W>EIYUX=L=W\%E4N,A&LC4
MN/!ZL:\+),%<?8(=VA,L03S4SH[1;9KAV#/B=)MAV*#+%%.;I[=M;9'A$S&A
ML. <YC9OSFWNO.;V@*S,CHGRUT*01K*;E,YWPIL$XNWPUFG*&RUD">M6*<4E
M?(Y< __;(AIS)8$/J)MW+&(T#>J:=50.T\,=ZWF]*Y:ZLQQ\K*H_OQ:5_N/%
MX3;>11,]_]IAF:,!YMBNS\8,G(_")[-X"K/HI)M22[H)5UDQLH#_P7MO7C@)
M5[;4.%']B=O9+9;%NR)%U[M#KCRK_.QT9WQ#R_0ZV=M9X^D(S750=&*%0]GU
M'@4^L,[\&S/#:KHN(YN$Z]#@@C>[&S073J[9^'_W=*1.[>HS_O:\AF-?/0N^
MUZ[1NZ7%GL,A*X?VS;MG*Q=?,NE$ALI&O)<WP6J\L9KS"*N91"87G[[S"[-%
M+9DM%A]UV8'JL"Z_0$TWRC'7+-33[/?]ST[I*3?PR;<.(Y5FC-ND!$4Z0R N
MAD^<MV#DV EZ/IN7="J*[5@)QB*!,8_,0C0QYF0'"EUH-WIF>-Y8?6U#'B*+
MVI,@"]47D8?(T+;A"-G6&H3KAB$C]MGJ[[O<K]HQAB%*"ROV\$UBU#D3@%%_
M3G\",M2)R/HKLK5FHWWM#H=^!R&);":2?;L)ZJ*(.J_"B40V%?'3:1:F@]XP
M'0O>M2$^ E-H<2JN%5JS&8-!L=+^=??T.S<XG6!BJ_E(HE\,9N!S+?0I$>;@
MA'D;'GVV'3052?>/@"U28//(9-"1Q)J3O2@N[,4=Q <S2PN6K5F(@O):[4@M
M\?$^%_.HPAHI"2I"%M(-Q/EM PJ)=#:2KAQ!6,@(\TKQYQ-%?#9:]!"V)UA8
M=/9#H951#NR05\J*PZ_C<F$VR)_0@L-BY(L5<<6HA^XC#JP&#<0P!"2VCFCT
M>PV"3N2*KI>XB74X-YAYM0Q!)8K1S&(ZF8C\FHE89]9&@&59W)8Q+AYJ#:@S
MDJ2\XHJ==7O"O#[HG3^9\M.?0FPC"O?FPXXN[,S3T.04&-FL(O%'&/+_-D3[
M;).0.UF,I*X@D(P=)#VR7_E$@<Y$$9).YBNSM*,*[S20=46=UD19U 90^*HH
M NX2_$M1G^JRT7M/V]ACU;IOC+^VL]^^I@,+>3QFDCUNHS\<$>$@=K>X@YK?
MV:Y$(4W"&0(\]\#S*@F6R.72402>DX4H+5F(EHKW% C5R0B?CV);X)7BMC7S
M0,/TTVLAR^JC8U;-HQ'!F(RRQF[2 DT.:$O1#&^5PW$&-R)656D]_)!*RN!T
MP2%4!:DK7*#==PN5H5TOQSA@*ZP9)3 _#YA[9@]3J7QL8+XOC-HPAQUD#W73
M'F*[.!9?NC-!^-;+_BZ4OSX(I[-29/[=471[Z\!JB3A1%O%7%H%:/ZJ82!?B
MHQ@(I$\7TEY9.JJ0R!9<QWZA0]IERQ\WL1O)ET0S7Q*9/A5D%D]A%IV\X\JN
M<KT&U&\5^0&7.BYR1X:/7,K>59\KO4<ZW3\='WEOP9Z$F&%4=A/A"*6 :@F/
M/ONWJ42.*D8Q#4S %B&P>>1YIA*%@NN6'V$;C/Q2.J4"^Q"YYD*'FYB>NOU!
M7>:5(5RS&7]OGA^+K6&'[\5]O<$>IDF,: P6Z-S$7& @\AI,<+@'?7YG0#*)
M?"Z2>TD(Y*(&.:\R%-E$,1M)K\3)4-16%J>5$=+TTY;$&;O#<(NM$=XIAHSL
MFI7(9'B]?S]3U.D)9=_M\2^VV4*; V3C;!C+:MOAZ'=@02>*^4@661&\10IO
M7L46=**0C65PT40LXW2DJ6\AI\$V?EZS?Z]!P_"N&8VLP%.UXN#OT]]CC$:4
M0@MCG$FEGQQK5G=S8[QS*Z'87$$O1VPA$AR,!.\$H]\FHYC(DLVP!'#[ >==
ME1^=CLTFV,*2S:B),BXC<6,Q7FKM3OXEK](GU#)JG_'H&^PAQB-@6=Z!2M\W
MJ5)YUYMTB.4X5[1YME>4=K]7-&RSL1QJX$*35U&2UFS$5R7=&^J9VS)W3/W<
M 5&%QV.WAT,D+AB)L_GM>P?95"Z2V5\"K="@Y5F;V(A":Y_FKLLZ)S^(/<DT
M<+B8O#KAI3'6L%NT>N&;_'3W[2O_1Y!.Q_,WZD+LY6B;)5:]&UEA"*.6=3\N
M_6X)E2AF(^F-$=A%$G:>F1(J'<FN+_O. 5TJK5NS&-\;@TF''94ZO.^GZ05G
M)D@M]*%"'=4BF27@^FQ2<NY/)@N]/(: ^53![)&ARN7B4[[HKJYYJ:#9L%N=
MT6-N\+7"<_T36N/84LY\4!ESZC(; 1U@4 $$98S<M1!.W3R0IN#+/GUOJ(YP
MG7*=]7#$4%1,&@%TG 'MU?)+H9C(4D?WI D!T)99N])QO0WZ"?_Y/%I^%7H+
M,K97YC, HXJ<E  W4'J!V(HE ,O)6I*%JMC_!(:<^B BJBF_2!Y]B1J!_RLK
MLH!;PPCOW_5590@X%.KC_KS62C\B2=,YW6CQJUU&>""1YS0+X?MW',\K0_2X
M*=Y"(2LZU("N8*$VYP#_9+C/W.E,P7^225 3H21<@Q;W@%0H"Y_'4.;1T](@
MF;0M@R"^[%;#B\C"I#RI*R-$8@J3:'UBWY$S3)FA$P /)<E25/]>("6)?T<$
M\O;O&]S;PS;[P&R*PJ>K(_6S)1G%H]F"ZMKUF %@F2,V+SZ!SG2$.,*H7$_D
M/X$&4OXFOQH*9E)Z^:8K^R[\S4(/VEKP\Q7BI0-;1^AIR9X*N:=D#R);@5[
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M,TE'8?CGL:A"I-B0K="G+8F3=486JNC3T7#]$# JE^O..L4'=2)4'TM2?/>
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M,Z9T@;N#_$&U7"<P"D)H]YV8)CK0! PN3^1[J4P3HX>98YE0459-HN(5>U-
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M(;!D2M[R-U.T6U$AQ<3))O/)7/.,L4;$V#D _/BSB!$=1?77YQ<,S(4HO-N
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M17CSH"+(BC4N3AX.<=I(ZH)RCYG(RBMVK;B@!=?BM^'+NH(H0L:&KS"]+7Z
MJ]R@,JK>/6-5%0V[HH!( 0)& ;,6$8SM-]-:,7[LP/'3X66RQ+#,$,@[$*<,
M#/%-9Q4PWO"ERZJ":@_&I"7#RW"_)&ND,B=(,'L@VUC J2:^3D46T4#VA=Y2
MDG<1#!'N8U4-D^\WTW8]'S]6D465X0AWF:7,7?944D5=9-CI"9FQ-E!DO3]@
M!,U^,AJSHLZ2JB5, 08,88[Y)\)<^ IT$319P7,CE_"Z8DH&Y.BJ+,&+IQ /
MR8I&X&,1K8$"^8;J[*Q,Y@)-9*DOX^>9;V)U"+(4P2#C4!F:]0-'9F61$(6%
MK\ 0XEM);0D( 0Q;):.8QY0U( G'IMK':9"JP%S(2X']C+V5V$_['_)@<=3N
M$BW8#5%D^DA"N!P+VC%&V& 12R$"K\ZPID;@5NF,P_9:%&GUS-0VU70*6(66
MJ9EEZ'XS95T#RV"_ &[KPBC .,E]"28!5G8,7@&;T9Z,%S>P >C)NL),$8L-
MN0:6>J21U4K&R9.Q(5#-.]2_CXT1*PO<SF+%S.I.&;A"5W<R9]&8)KL1W9'*
ML2-<451T],.]QM26-58LLYP@"KB_KSZ1$%]7Z*H;WR;K\_#\<U'F7C]=',WF
M7  \GW@170+L&)52?UB2WDLP4T@\]"'0?4J>_#=3%%1.E%4L,V<,COJ9!'SP
M/-P_8\BP&6?<S,\BTEA!5']]OM1K%CCQ(M??V&_)FX"HIZ+_L^]4J(#@6S?"
M5?=B9Y+-S/-TQTC5ZWQ7J4X:LM/2R@OJ2&2G6&XE9(GW5H8'DYJ.RZ'WBK7$
M_?8"['&U_T 8.LG<><<^:</(5]N/]WSVHLO%EBX)>;L"OK;]XC#-O#99HLD.
MLMN2"J9;<R*2HH[J$FK+[8G\A!U11ZB8QFO(YIOGY:HQ[38Z!GJ(LVRC_-"[
M=.CI"^QUPD_41I"/^,?(?P<%V8R11;2]*>M!L#(_8/D^NE-,C?C[8X7P^9R9
M6(0L@WP:GO+05J7XD54!^@$1!PI"Z^S*16S<KW5OVI7V8 N[LO<]RL#Z1 #,
M_%?VY[X[ZRT,PIPL!\DD'-H.Q#ZT YAL;;D,J>XZ0W#;ODT,VD]&/=_W)\#P
MTR8D \"<T";LV2;,R;7/1B$9V_B0R4.;A \3#DPSH)PP7AL://#/R5=!?TZD
M7HXD-$AM?HQ24/8"[.M$)_/AGSG%:7]$^<RH#FYWYI3'9[.3VQK*<^]"OLP4
MG;M,T>)6PW.R_%F6%;QH@Y=L+(*K=:6AR'V%'8)Q:MO627-9IVR^42AWU2(K
M;).X>!.O6.0@Q%M;N35+D\'=UA#N5EI;*@G@_A[+2&VG5CZ;K7@DE3PF3*-/
M[^HI= Q!C;&:EJBD4QXT[P5^Q=AKX&1W5Y8:X.$>YPJ\362G.8=VH^!6*?"#
M= ?D&>CYF;6H[JRXD[5Y;2 H)MXZ_'<J*VJ$475N@)?#![(Z$L"=P4]]O*HN
MD28J=21+JHS;8EQ[K4:FO8F<GHQ838#K[$XP$?6!7-AXJ4@D:_J\ ,/5Q"D=
M@7F]^IMIZ5U58R4-" M_A/^097QKI9]VC]%& ?,6W*=$VZ$$B2F#QQ=XEC0#
MG9[ J)0I_@MMY\*-7?AAPP4X;]SG Y/1.9A0%]XJX1?3/9%P!ZO!'WNXVT@%
MGEH;3.VY=9&J,?!_,)4:LMYA-Y#!W:<GI"\"-W%UD=6XA-O%W!U+/,+-$8*$
M>6?OQ\3&V6:6#D-F>2P]0S)O3$5=LOJ@\"SL-JTNJ])6,]S!)?0$CF%!$ON8
M,_8OA-'N-BI!575$1\P,V#'N&T-X01=>!C>8?7+VD\W;1595\>/,?BI\R4!0
M<0\7IC!Z'X$JD!U;\%#$@DBID"J&[5&>&UI;+.F> K+_E\$;@'UMB H\@??7
M^V2; [<5-JVKT_6*>8/;GZSO8#)["#1(EHAY5$:R8FK23P<CZ1=N.W4913 (
M*N@8-C6D\U#6-?Q7; -/3ZC!'[KVP?<51#Z!<6VP4ZL'%H_*=:/=9\NC$2*;
M7K"2NZP#F$5\BS,J^_4++F3H."1AV-45U6R\5?JL9'5>1G"'KL0)(S(C05)U
MA5A;CE!3,+L^J7-QSV;F(3MNZDVLW-2;Z1C)U]?W&L?G$NGDH3?UICM&[/[F
MYK6E3VZ+<<\W]:8Z!KKF&H/4<[<KONYC4V_"FTV]\8[Q-.P7LE>EP=VC>,!-
MO:6.P;7>QN\WI4:MNVS7RVX,RG:,_IC/#5-7UW</[.8,VL-V7V !E\O%DU>7
M3WIOUZUX*[?V[F&WD[_;?6,=HWY3*+?R@ZOW82[@V[]J>]ON>]XQM.3MBY N
M];)W7#"V)48[1O;J:=B\[=:44=!9Y?EV7W!\M\WV$WL3?4CE/-^_MS5'WKKI
M44M'C]-1+^ <V?O67K# +[%D_>7Z2>FG L(Q,'?J;:Y825;&?7Y9P!(HCNV^
MM;=]F],>^(?H)1]T\=S!AX&QKL>?BD*EVHAF^7!K[X9;>U>1,P]6C;NY$0=/
MT:>*Y]O??2^ ;#[1<L=X3G/I&_3<Z)63 :J>;U0S 3[+=-\E[_<6[F]>3#%K
M$Z<G5I762?I[""TOJ[BJ$4-VBJNKPA!O%:-E7'R%($$.*@K:U*IYN&[!FWMI
M@0-[:);1A"$2I_C%$E).3^!J0;&+Q>Y2!UI:,<??!$X7666VHL$JBH"W#W.X
M?$ZJT3JD-3(,"\'DSWJL+E*T0KPMF5XX'"%))36.TQ-.9(6A:NU[QMOH0$I'
M9B&'FW+6WFE%Z,L*!!GP:KJD1XM*"F370!"G9,PA16-AOA0;D1=44FX&BM$7
M_6;RHY$BOY-J-DQD=EM/#J_R6WNT&DC![@FX5.\U.)6<>TK*]$68YQCQ>(=9
M32;SRTL\7(UW\(H5Z457I@U%UFAEJ4!>V^%')JAC)AKKN#:7*)7'RY%P7KD;
M9M:B'WHYF!\;;Y3;:/&T4BO;JZ=G<=?R:4-7T(]_T^G?:\Z+H/]XHV+_HX9N
MGJ51?UD:M5D:I2RM9&MUZ77P7.13AV5IE+*4?O*2H7MCIVW45-.J,1+2K-4R
MNGQ$S94")I2@#N -[3QH^[(-L&;F&+&V_@.1Q6F$F2"\F$AI3DW@C-D:F80_
M/1$(Z7%1VZ2];5/F$ =4@<>&CBR4]4W(!8P4L QG $R5M39F8AZXEO.<93H\
M5=[$(08Q-Q\T^V:Z,QD7G#7VE2ZTT95)O-(X9@6Z'5G5T&C6.<P,")Y9,%$+
M9%7%3U%5F1-(.9_@)M!ZOWTY#,:%#$#&:<)4 B%XL//8].+55%'@R4-Z%  ;
M;+>JP0^.Y2:+<L[J&H:,P"MT^*7PQ"4KDWCYC=/,6OFQQ0/'&<6 D<+K'I;^
M8649KL0DYB#][U,L%/<B$6BSI0FFP+!K77)^N?TNN(3*L9W8]#F1+SFV997K
M';P7Q9'XKA;D_L9V>M.7[M?%QF*_UQQ.<#@7^UD6+;C2YBN??>,NU'(FN1\6
M^>0R8_$],LATFC-&UW.W&=K;_2S!@Q]D!QB2"9V>W+!]"0\%\G<<D>"PH#(D
M 4:$:>1A?'BQF[D;,3?-"HX>SF6.99JL)DOX[X21,Y?\/W8X^L,4!7BLK.+G
M%D@UCES\$P</*T'D?YV>S. &L4Q?9R$?A'317H^'C%%75!U^Q Y@,A X$CM
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M?K$KZYJEO.;!C524(N:O<ZJ)J8J1X/!9G*<GG*Q:D+DL3WE'9R.XY&; 8A7
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M.?$ I4HL+5*8VV7F'K?/,9=MHNYAS%N<9F"CUL?75Q;W@UK_A%CS)(>21%9
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MLZM$NVM*(I));+Q-[>!G9OE6M_%C)I69!@[)):)?,"5<H^IE1]4)24R*N+3
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MGO!H*(O4G((/T,$&"]3XBHA5T6^F[1I7%XD"&N/76'^'-TMH G2=# 2P].;
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MSG=_U=EUCT]>#TWYL[3&U5)S?:U_N+M;_]/Q@C#9N_W%>*.]WEK[,NU0\&=
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M/]@&/JWE?[( LR,Z53.Y[GC8%3Q,H^S&T.)2L/#O&1]'W/\,U,K] DDU+!!
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MY +&C6#4-WP!9GZGZ#A=N#G#KN>2^^/!<-CR9P,)[D\&O6(W8KB(P5*Y Q6
M7)2^]ST%]PA-Z FW<%S0SG<!K8B6EZBK'S^:$7UFD%EKQPV()G6(0CL^[31F
M9DVB>^.T(A@H8&*("Y8;'_V)O?P.AE8X]@>VC]?4?:)E//(H#"3&7LP^?@5L
MI+[K<]2%%PM=D5X*/A\:5^A.A#JN2-$@89B :6RFD:)2;<$_@7DST61<S#/
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MK;<"FFXX ;:R;2HS:\&=!T( )@3M+MACWHA%92-R#G;-'\I'.<*=O:3A#L/
MD90DI1<R2PWO9[&,!(>'\FPL&P77-?4_V;N/2)1$QFVPD?&>+U@R$"'WUV]L
MAJGO4"L"U$-J]!:96&0:XL[('RVT+N&\!"&](J(3@.-DV^Z)P6CI5:I.%!Q9
M</QQ/HIJ )3']*G7FPS:-#GR6L$+.G1BY^=$X3TZD-%35%#FGI\J<:6#Z@5<
M_XI_%W=HA;">L.&*)L3 *(9;(U=2.;;JS)#&)!NTV"2>[*9DNVFH3#+QZ<1I
M0Y95R2PG\?O,C7/6\N0DG.BKZ[W-XL\QFJ[17Z-]8#MI@$@G!SX<#55>,OXW
MFSEVD*)9@.H\@Q&)X=-%[0SS_'!TOO?1<A7S:T$4LQ?G<YJ49RY(,;%*D.8<
M-2.3*G&%>.++E$N%Z<@_^%@_%?]?FL7_GQO_7YK%_]]#_/_/N3[?OG;XG<WH
M?5HQ1_HN)#\2[[&ZBGZ#HWZ^-X%T_IU,[<\Q;10.6B#,N"MY,'06AR9LY=(:
M IZ?CUU4H,GG/R;E!Q;Q&;*/SA_/CTNE'!P%&*V4<Y_XV7J)TN*Z^3S%H9];
MEE*TML3CSR76J -<.' 1B^)U&VD4LZT6488-/X3+C>F2N, A<<=5D1LV)C%8
MP DE=-O4KP-TZ7@QX$%P"C$X ?YE0-$Q_*7\*A:4(M(B?4>$OMOL!*$?MLD,
M;=J]K#O=![?8+EI=!!M+%H3R+_0B>.O'XOS<)F/\<628$N%MX#R/@'@24WX*
M:M5PZ_A/#"_V8HI[1"[YLX$+5FO,502"A\-@";R/\E3@4SOQ'VRSOL>9B!;7
M]2AX2KLV0;TP7Y<06"Z97 [Q,\<2S\\S7S(_]_C9K&6Y03Z-><DU<E$2T;7P
M%'0Y?D;A,:^1FG%"I7HHV2DWFDY<4S=%3KUQR0NI)P+1R:$4_&H/? W,4%.W
M2EUNTHY<#E<5+.[\9\0SO0PZ#'_C1=; CB*;XD\%=/B\($XQ..A1'(KRWO21
MW'!\A#5*X BC#'1R?1I#?GR)?><&=*@Q(L7CFQW$J9H)79%X#+,X-O=SI8"C
MB!25-?^U4EFFZTU%)W]8KT"';[6R]-RGN"ZL:&VXD@5AA(2!W80GO$1.<"Y]
MT<J0$.K"TK)(IP=?9(0]8#1'L!>@%-R"=0PGZROB-C ;8#FVAPF4AAU[ F?E
MOK+-Q*SD(KQN%+GMU+<CE?-&+Q7&"/\3HTI)8VG)&6/:6S"M:';T73_L%29G
ML268GM7Z4 AO;$]FQVBJ9G*!@7@$J&#0K@>[=:^T_U]K927_*!XPHJP\Z/DF
M\$AAU<@G2N72R#>,B_79]46%+ ^ @F;G+JFQL<.SE7*Q_#?A.)R0##'.*G!F
M!.^'^3F5DF0KC'';6/5I1W0GV+* EJTR1PC_@)N3+U<&4/?A@/&ME96RT9E&
M$](P'M40Z6Z>G8^IFLDUF7K2G#KGA; EE8D57Q,"$,CJ_DC%PPGP790$!0\@
M):WBU5P\8!@J*GF8]<2..<.GONW%9K3=,4IZC8<P24T"BRE3.]*H.I%YT_F(
MW):/]P2::A05)I ;'-4VNF3PDF&&EH ;9IA=6GP]VKK,@TY5(_5\=N/4@%4]
MEVKLU7413JD0>PTW:';0XV,,G9<@7RA<5T;A MXJ'MK7OF]S1W65EN0O4&J<
MAD[7K1=X7=PPLICA5%J^W8;/) .\L<"M3Z,HZ]F Z0DS7J,_"(OI>CV= 27\
MV]BB2/0@-STC90UF)W4F=UP??+MH2#9YK#!E(XE=+$6+T4U,AGJT.;D8W5[1
M@LH14$4L04I^ -^_6># @(P6\N]EK$5.MD=ET/R>!FAJJ8HSDYU%5?T$'N/5
MX'HR>"\B-U&09IINJF9B1,/DXE4Y.YVMRPH1<X&Q?U+ KX-CCQ44YX)08]7_
M!I&(@')5H.CQ06=1,S1$ J-D$E]!] Q+Z\1I4'C^4,8MG(DO7EXI_53L<,9O
M\%(S>4Z"='F6('UN@G1YEB"=P@0I+]CBV'+-RJ:F7FV]0D/K^;GM+&!D@((E
M=CT#4_VV"Q%!2$:$(S.CGAF:+",VJE0IKOW-AE>IN))93YP*7'\N0PO2PA@&
MU05')@VO-4?F Q<A-@;.8I(&;\5CJ"PVNSA"V]?YL[&/& LR]I7GF* QP51]
MBK.NEXJEOY]OA JOS?IB<>7OS.Z=&6?O:R:*:80Y:106'WD;$K<]Q& )A:=3
MO"0XGT0EFK2KC^>H&\,<OY2$&B1NIT("9F2>"&0P<(+10SP&] ZV3\RZ/AW?
MMQ-=.* H7[CT5'^5CH NIQ2"" 3RYU)8.08-HJ<HS,]U8&)]C(N857_"HQ'
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M]H6H&U /%RWB%D3U2HH\M%P[XLL>EB_ RR5+A*I;0*\E18KE".#S';O/*:+
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M2MCY-JMC2=#"92_[[4<X%F';)5N+Y$IUZ8YAR N*?+(@#8@S'SI?;"XR!$>
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MV0+E6KTX.=JK69M;%]6]0W4*&J&3\<)<[5U@^=W)]H5UL5>O7V[5K0^$JBO
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MS6.=:O@[1K<9:F9A-A[D'AU-AAC Q9^%^/%9X^S.#NE4S80/:2K$!JRJ7_J
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M5"'A#!"RAW28<*7I0@HT='10%*.A<I%YU%G.I<&HFJ^L.H-\=&IZ@\_0&92
MJN':2U,[O*VD!4DGQ%L3KAIP5)#2#S.,8'Q1(KWA\O/<  7?&$8,.*!V/./M
M\]Q8T7!S/0W"*"\R"C..<B'G'H:MN&AS9,S44YZ84SB\H!L?N4'?B\) Q1KP
M7U6S+.GZ 0O5\Z62D&M.VX*&[-IWO "(;\11QH*L9IPAXA-=[,V<9$.=GQ/R
M%T&,>@E3A<!(?>\.4[545(8(:DVAEG57Q#M?-4P<WTEN,@BZ=6!'#B(Y$=V
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MLO9+LZS]<[/V2[.L_11F[6=%DK,\>*6(W#Y!B@0)'*FJJ0H@K.X[(K>C1;=
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M>]C!?"9SM#]XUDT]$P5K]+XHH,4FX132G\+1)8O98NIS/16."$Z(>I)R1^8
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MEFXZA#\ZIP!TA'342(+BI%A9@O AA[EQF?!<VOM(/R!$LF!=A=NQ_9;5&#)
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M,>"3#U#VW#9%P_2&:!C=><-"#(_-;VL+[VTSW9^!Z#PFC?\OW#]02P,$%
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M\,7;5M(6\C3DML_B1(_LA)A&]*1UAL,J3H5Y1.!_,,<R.[%\%H>:4#6A/BK
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MJ6=)=N*5EB@G^!=?,XG >-1G*O0;O!OU#L;;\P=&L%-XW#6REGP(\_JR;V)
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M+E\BY)(9P<Z)%B(ZQR&W5K9 -E9EE=H[\OT F@6TS>0-?[=8$+![>/&W#]Q
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M%G:@*P!5,9GPV. .6"9\:B3ESOFV2,9%'2B.>XK^KL*\WVS55B /##Q?:/G
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MJ^.!2BR:M-42"Q=9#]$2.,![M.]\< -<O'*\?H%D>6,']CT9&>C#'"TN< )
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M1OL][[NZ8<, ?8X6 %H/-@1Z1EB;6W%E)STSW03;8]MN2P'1VU$(]&D8W*\
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M2B% J@P[(U)OUP@_83_*?Z7DY>M%E$H&D*>2 R'N?8RHO\8P\),(F3;Q!?Q
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MU:MK+"J-QBOY!%S,:'2^2Y]QRJ6 KKPB0@*05CYW%Y4V?L(I92W)5E:I0FX
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MTI&#&5*QX63RQE*#6LOC$?) '!O.(E]:OFS;.5/AAKCY8+G[72]T31YU730
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MTZMLRD-PJ/U:4+*RMZNTB>KC,#ER.$1T<Y='+D<[]?X8],B$*GL8 YC9\T\
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MN&<L 3CH&'<D0'!$"4O5+>[>%> G=][^(8G#ZR0+U+,L/1G'&?-$>(-D>:T
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MOKX,BL?K)'LVI>O2J[B]:-D,OL]@M3R8&&4!4CC95ZO0N32JA)@6^G.M]W^
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MZZMJ&Y=!QR\])?#UO.PHP">D"%987LI*7'2H!I9G--532AXGWM!AJ>-['"+
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M*]J_>BE7SSAYPK>D1_2H&N =;L[E$.^M3G<'>8?:\AXDC^2 D&*KJ0)]OB-
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M Q R6]57-8GMU<%%7 5I;77!D'4DX#$1%PI);>LC2U-YI+ [L 4Q]DK=/20
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MZN)BG"+,GD)S+SS4M>94T?+HM^'0,4^);V@&E%E:$M_I=5J3HL!E87<!CMF
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M")[>SHC[EDF(_<!%Q<5$?_F=?ZCU$'&5)!_)<QZ(Q\?_G;;9:?+V8*KF3O3
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M+EP/ H@5J[ :4$(==CG;(TY$1N[B,1[,[^EQRMB5@Z7I!D4+U]4 X\4JN-(
M+6(&EK(3%"I<GP6$$ZN 8N;$L^N),C)E338MH!#@.C;VR+9*WETJ+W_A4F4F
M98;NM)V7J9>P6&T]%K#>4)QP?1A&+%F%8<%^4YP\Q4901*QP.0C8LT3P.IF;
MBML*]X!4TD<V02O"J.<Z#Z[GLOL/<,B!J@_X5A0]\D#/N27+*+>A;\A#S"_;
M5RZ;.TQ9V:0;T[M_#(>! EF;XP& 3W (@U9AG#M/ALXK\YSH?7F2]E#4:G,_
M&*.FYMP2>/@9N\^:1IT0=8 "5)O#P1@@#>^6()1[KD;DB?B)?@')VD/QJ<W%
M8(R/FO.:;H7O?>*$_OJC S\+9VD'/J<U H66&(\"1:<VKP(<G5+\6;6D<BI_
M<^/'=A+%P7*S#[QJ%QBL-Q10Q'?;1OQ8!>"V!Q(.G:X?%#3$-]Q 3JR"J^B%
MA(.E[@6%"C&/&HB/6@^S?#G?D!5[GRP[K?:;0:6+F"=-3+A5\]Y$KSY I<8L
M3:6@_OS\2/W GY9P)8FZ0:%%S,,&8\2J!;=C,6SH!9M+Q2Y0C([A<E"(7FDT
M[8N@]()\(N%#0(\P_"6Y'<PQ<5Y(E$>S"46F1Q\^$G12',/-83PI3 5FR;+>
M\:1MVY80F,$#0-$]AI,$C*ZA>"P!56+!0. $=(4">0Q_"AA(L$@L@5!HV4
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M_.P='\8'JWP@((C?HB^HDB(Z@]UX][3)6(8?K^L.0+"_0P=;P_*I)[B"WB/
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M (1@7;R R1AV8&DZ>TN@7&\".!;Y2L*IRY+G4*V!.3:S2I^,*F5N.%A7;$^
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M U!+ 0(4 Q0    ( ,*);U- EB*S$#X  (Y+   .              "  0
M  !F;VYA<BUL;V=O+FIP9U!+ 0(4 Q0    ( ,*);U/UE_HFM3(! /%*#0 .
M              "  3P^  !F;VYA<E\Q,"UQ+FAT;5!+ 0(4 Q0    ( ,*)
M;U/)3XPND@<  *A-   4              "  1UQ 0!F;VYA<E]E>&AI8FET
M+3,Q+FAT;5!+ 0(4 Q0    ( ,*);U/_UNN!#P0  .\E   4
M  "  >%X 0!F;VYA<E]E>&AI8FET+3,R+FAT;5!+ 0(4 Q0    ( ,*);U-
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M &9O;G(M,C R,3 Y,S!?;&%B+GAM;%!+ 0(4 Q0    ( ,*);U-A4',GPC4
M /U6 P 5              "  9L: @!F;VYR+3(P,C$P.3,P7W!R92YX;6Q0
52P4&      D "0!' @  D% "

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
